0001213900-24-028789.txt : 20240401
0001213900-24-028789.hdr.sgml : 20240401
20240401163418
ACCESSION NUMBER: 0001213900-24-028789
CONFORMED SUBMISSION TYPE: 10-K
PUBLIC DOCUMENT COUNT: 110
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240401
DATE AS OF CHANGE: 20240401
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: C-Bond Systems, Inc
CENTRAL INDEX KEY: 0001421636
STANDARD INDUSTRIAL CLASSIFICATION: INVESTORS, NEC [6799]
ORGANIZATION NAME: 05 Real Estate & Construction
IRS NUMBER: 261315585
STATE OF INCORPORATION: CO
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 10-K
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53029
FILM NUMBER: 24809992
BUSINESS ADDRESS:
STREET 1: 6035 SOUTH LOOP EAST
CITY: HOUSTON
STATE: TX
ZIP: 77033
BUSINESS PHONE: 832-649-5658
MAIL ADDRESS:
STREET 1: 6035 SOUTH LOOP EAST
CITY: HOUSTON
STATE: TX
ZIP: 77033
FORMER COMPANY:
FORMER CONFORMED NAME: WestMountain Alternative Energy Inc
DATE OF NAME CHANGE: 20071218
10-K
1
ea0202661-10k_cbond.htm
ANNUAL REPORT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
(Mark One)
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended: December 31, 2023
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________ to ___________
Commission file number: 000-53029
C-BOND SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
Colorado
26-1315585
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
2029 Pat Booker Rd., San Antonio, TX
78148
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including
area code: (210)490-3977
Securities registered pursuant to Section 12(b)
of the Exchange Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
N/A
N/A
N/A
Securities registered pursuant to Section 12(g)
of the Exchange Act: Common Stock, par value $0.001 per share
Indicate by check mark if the registrant is a
well-known seasoned issuer as defined in Rule 405 of the Securities Act. Yes ☐ No ☒
Indicate by check mark if the registrant is not
required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒
Indicate by check mark whether the registrant
(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant
has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes
☒ No ☐
Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.
See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and
“emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☐
Accelerated filer
☐
Non-accelerated filer
☒
Smaller reporting company
☒
Emerging growth company
☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant
has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial
reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or
issued its audit report. ☐
If securities are registered pursuant to Section
12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction
of an error to previously issued financial statements. ☐
Indicate by check mark whether any of those error
corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s
executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
Indicate by check mark whether the registrant
is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The aggregate market value of the voting and non-voting
common equity held by non-affiliates based upon the closing price of $0.01 per share of common stock as of June 30, 2023 (the last business
day of the registrant’s most recently completed second fiscal quarter), was $1,273,202.
Indicate the number of shares outstanding of each
of the registrant’s classes of common stock, as of the latest practicable date: 539,122,586 shares of common stock are issued and
outstanding as of March 29, 2024.
This Annual Report on Form
10-K (this “Report”) contains forward-looking statements that involve substantial risks and uncertainties. All statements,
other than statements of historical facts, contained in this Report, including statements regarding our strategy, future operations, future
financial position, future revenue, projected costs, prospects, plans and objectives of management and expected market growth, are forward-looking
statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “could,”
“will,” “would,” “should,” “expect,” “plan,”, “anticipate,” “believe,”
“estimate,” “intend,” “predict,” “seek,” “contemplate,” “project,”
“continue,” “potential,” “ongoing” or the negative of these terms or other comparable terminology.
These forward-looking statements include, but are not limited to, statements about:
●
our
ability to obtain additional funds for our operations;
●
our
ability to obtain and maintain intellectual property protection for our products and our ability to operate our business without infringing
the intellectual property rights of others;
●
our
reliance on third party distributors;
●
the
initiation, timing, progress and results of our research and development programs;
●
our
dependence on current and future collaborators for developing new products;
●
the
rate and degree of market acceptance of our commercial products;
●
the
implementation of our business model and strategic plans for our business;
●
our
estimates of our expenses, losses, future revenue and capital requirements, including our needs for additional financing;
●
our
reliance on third party suppliers to supply the materials and components for our products;
●
our
ability to attract and retain qualified key management and technical personnel;
●
our
financial performance;
●
the
impact of government regulation and developments relating to our competitors or our industry; and
●
other
risks and uncertainties, including those listed under the caption “Risk Factors.”
These statements relate to
future events or our future operational or financial performance, and involve known and unknown risks, uncertainties and other factors
that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements
expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations
include, among other things, those listed under the section titled “Risk Factors” and elsewhere in this Report.
Any forward-looking statement
in this Report reflects our current view with respect to future events and is subject to these and other risks, uncertainties and assumptions
relating to our business, results of operations, industry, and future growth. Given these uncertainties, you should not place undue reliance
on these forward-looking statements. No forward-looking statement is a guarantee of future performance. You should read this Report completely
and with the understanding that our actual future results may be materially different from any future results expressed or implied by
these forward-looking statements. Except as required by law, we assume no obligation to update or revise these forward-looking statements
for any reason, even if new information becomes available in the future.
This Report also contains
estimates, projections and other information concerning our industry, our business and the markets for certain glass strengthening solutions,
hydrophobic products, and window film mounting solutions, including data regarding the estimated size of those markets and their projected
growth rates. Information that is based on estimates, forecasts, projections, or similar methodologies is inherently subject to uncertainties
and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise
expressly stated, we obtained these industry, business, market and other data from reports, research surveys, studies and similar data
prepared by third parties, industry, and general publications, government data and similar sources. In some cases, we do not expressly
refer to the sources from which these data are derived.
You are cautioned not to
place undue reliance on any forward-looking statements, which speak only as of the date of this Report. Except as required by law, we
do not undertake any obligation to update or release any revisions to these forward-looking statements to reflect any events or circumstances,
whether as a result of new information, future events, changes in assumptions or otherwise, after the date hereof.
ii
PART I
ITEM 1. BUSINESS
The following discussion
should be read in conjunction with our consolidated financial statements and the related notes to the consolidated financial statements
that appear elsewhere in this Report.
As used in this Report and
unless otherwise indicated, the terms “C-Bond Systems, Inc.,” “Company,” “we,” “us,” or
“our” refer to C-Bond Systems, Inc. and its wholly owned subsidiary, C-Bond Systems, LLC, and its 80% owned subsidiary, Patriot
Glass Solutions LLC (formerly known as Mobile Tint, LLC), as the context may require.
Overview
We are a nanotechnology company
and sole owner and developer of the patented C-Bond technology. We are engaged in the implementation of proprietary nanotechnology applications
and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. Our present primary focus
is in the multi-billion-dollar glass and window film industry with target markets in the United States and internationally. We operate
in two divisions: C-Bond Transportation Solutions (through the date of sale on May 8, 2023) and Patriot Glass Solutions. C-Bond Transportation
Solutions sold a windshield strengthening, water repellent solution called C-Bond nanoShield™ and disinfection products. Our Patriot
Glass Solutions subsidiary sells multi-purpose glass strengthening primer and window film mounting solutions, including C-Bond BRS, a
ballistic-resistant film system, and C-Bond Secure, a forced entry system. We currently own four U.S. patents and one patent license spanning
core and strategic nano-technology applications and processes.
On June 30, 2021, we entered
into a Share Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Patriot Glass Solutions LLC
(formerly Mobile Tint LLC), a Texas limited liability company doing business as A1 Glass Coating (“Patriot Glass”), (ii) the
sole member of Patriot Glass (the “Patriot Glass Member”), and (iii) Michael Wanke as the Representative of the Patriot Glass
Member. Pursuant to the Exchange Agreement, we agreed to acquire 80% of Patriot Glass’s member units, representing 80% of Patriot
Glass’s issued and outstanding capital stock (the “Patriot Glass Member Units”). On July 22, 2021, we closed the Exchange
Agreement and acquired 80% of the Patriot Glass Shares. The Patriot Glass Member Units were exchanged for restricted shares of the Company’s
common stock, in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during
the 30-day period immediately prior to the closing as defined in the Exchange Agreement. In connection with the Exchange Agreement, we
issued 28,021,016 shares of its common stock. Initially, for two years after closing, we had the option to acquire the remaining 20% of
Patriot Glass’s issued and outstanding membership interests in exchange for a number of shares of the Company’s common stock
equal to 300% of Patriot Glass’s average EBIT value, divided by the price of the Company’s common stock as defined in the
Exchange Agreement. On September 20, 2023, the Company and the Patriot Glass Shareholder entered into amendment #2 to the Exchange Agreement
(the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, we shall have the option (the “Option”),
beginning on July 1, 2025 (the “Option Start Date”) and ending on 5:00 P.M. EST on the date that is thirty calendar days after
the Option Start Date (the “Option Period”), to acquire the remaining 20% of Patriot Glass Units (the “Additional Units”),
representing 20% of Patriot Glass’s issued and outstanding membership interests. Patriot Glass provides quality window tint solutions
for auto, home, and business owners across Texas, specializing in automotive window tinting, residential window film, and commercial window
film that stop harmful UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills.
Patriot Glass also carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types
of vandalism, and even bullets, including our C-Bond BRS and C-Bond Secure products. As part of the transaction, Patriot Glass’s
owner-operator, Michael Wanke, joined the Company as President of its Patriot Glass Solutions Group. Patriot Glass has been in business
for more than 30 years and produced annual revenue of approximately $2 million in both 2019 and 2020. On October 10, 2023, we filed a
Certificate of Amendment with the Secretary of State of the State of Texas to change Mobile’s name to Patriot Glass Solutions LLC
(“PGS” or “Patriot Glass”).
We expect that our acquisition
of PGS will be the springboard to provide glass security solutions across the United States. Patriot Glass Solutions protects personal,
school, government and commercial/business property across the United States using C-Bond’s proprietary glass strengthening technology
to protect property from looting, rioting, break-ins, and gunfire. Patriot Glass Solutions’ primary products include C-Bond BRS,
a ballistic-resistant film system; and C-Bond Secure, a multi-purpose glass strengthening primer and window film mounting solution that
deters forced entry.
On May 8, 2023, the Company
entered into an Asset Purchase Agreement (the “APA”) with Apex Protect GPS, LLC (the “Buyer”), a Texas limited
liability company, whereby the Company agreed to sell its C-Bond nanoShield™ product line, including intangible assets, intellectual
property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShield
division (the “Assets”) to the Buyer for a purchase price of $4,000,000 in cash (the “Transaction”). The Transaction
closed on May 8, 2023. From the proceeds of the sale, the Company repaid over $2 million of debt (both convertible debt and straight loans/debt).
1
The Assets were sold and transferred
to buyer by means of (i) with respect to the physical assets, a bill of sale; and (ii) with respect to intangible assets or intellectual
property, a Patent and Trademark Assignment Agreement, a Patent and Know-How License Agreement, and a Patent License-Back Agreement (collectively,
the “IP Agreements”).
On June 15, 2023, an Assignment
and Agreement to Re-Execute was entered into by and among the Company (“Seller”); Apex Protect GPS, LLC, (“Assignor”)
and CB Nanoshield, LLC, a Texas limited liability company (“Assignee”), whereby the Assignor assigned to the Assignee all
its right to the (i) APA; (ii) bill of sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing
to Assignee.
The APA contains customary
representations, warranties, and covenants by each party including, among other things, that no bankruptcy or similar insolvency proceeding
under state or federal law has been filed, or is currently being contemplated, with respect to the Company; that the Company has provided
the Seller a true and accurate list of each of the following items of Intellectual Property which comprises a part of the Assets, including,
among other things, patents and trademarks (the “Sold Intellectual Property”); and that the Company has good, valid, and legal
title to, and is the sole and exclusive owner of all rights, title and interest in and to, the Sold Intellectual Property, free and clear
of all liens.
Under the terms of the APA,
the Parties entered into a Patent and Trademark Assignment Agreement, whereby the Company conveyed, transferred, and assigned to Buyer,
among other assets, the C-Bond nanoShield trademark (the “Trademark”) and U.S. Patent No. 11,155,491 B2 (the “C-Bond
nanoShield Patent”), and the Company agreed to execute and deliver an assignment of the Trademark and C-Bond nanoShield Patent,
for recording with governmental authorities including, but not limited to, the U.S. Patent and Trademark Office.
The Parties also entered
into a Patent and Know-How License Agreement whereby the Company granted to the Buyer a non-transferable, non-sub-licensable, exclusive
right and license to four patents owned by the Company and licensed know-how to make, have made, use, offer to sell, sell and import glass
and other products and components used in or in relation to the manufacture and operation of civilian, agricultural or military vehicles
and equipment (the “Licensed Product”) in the United States and its legal territories.
Lastly, the Parties entered
into a Patent License-Back Agreement whereby the Buyer agreed to grant to the Company a perpetual, non-exclusive, worldwide, royalty-free,
non-transferable, non-sublicensable license to the C-Bond nanoShield Patent, for all uses and applications except for any that involve,
market to, sell to, do business with, provide related goods or services to, or are consumed by any uses and applications of the patented
technology within the civilian or military automotive, vehicle and/or transportation industry. The Patent License-Back Agreement also
stipulates that all improvements made by either Party to the technology covered by the C-Bond nanoShield Patent shall be owned by the
Buyer. In the event that the Company desires to utilize such improvements to the C-Bond nanoShield Patent made by either Party, the Parties
hereby agree that they will negotiate in good faith a separate license agreement having pricing and other terms and conditions that are
mutually acceptable to both Parties.
Following the Closing, the
Parties completed a transaction wherein the Company assigned to Buyer, and Buyer took assignment from the Company, the lease for the premises
located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to a lease assignment and assumption agreement
as to be reasonably agreed to by the Parties and the lessor pursuant to the Lease.
On May 8, 2023, in connection
with the APA, the Company received net proceeds of $1,989,755, after paying debt and accrued interest of approximately $2,053,000.
Our Business
Product and Service Offerings
On May 8, 2023, the Company
entered into an APA with Apex Protect GPS, LLC (the “Buyer”), a Texas limited liability company, whereby the Company agreed
to sell its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process, furniture, fixtures,
equipment, inventory and other physical assets of the Company’s C-Bond nanoShield division (the “Assets”) to the Buyer
for a purchase price of $4,000,000 in cash (the “Transaction”). The Transaction closed on May 8, 2023. Following the sale
of our C-Bond nanoShield division on May 8, 2023, through our subsidiary, Patriot Glass Solutions, we sell multi-purpose glass strengthening
primer and window film mounting solutions, including C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a forced entry
system. C-Bond BRS and C-Bond Secure are low-cost technologies that significantly increase the mechanical performance of glass.
2
Patriot Glass Solutions
Subsequent to May 8, 2023, we will only have one
reportable business segment, the distribution and installation of window film solutions.
PGS offers two main security
film products: C-Bond Secure, which includes a liquid glass strengthening primer/window film mounting solution used in conjunction with
security film to deter forced entry, and C-Bond BRS, a ballistic-resistant film system that includes patented glass strengthening technology
and security film to help stop bullets from penetrating glass. C-Bond’s patented technology and third-party certifications for its
C-Bond BRS (ballistic-resistant film system) meet National Institute of Justice Level I, Level IIA, Level II, and Underwriters Laboratories
(UL) 752 ballistic-resistant protection standards. PGS also offers other types of window film for various applications, including solar,
decorative, reflective, and more.
C-Bond Secure Strengthening Primer and Window Film Mounting Solution
C-Bond Secure is a patented,
non-toxic, water-based nanotechnology solution designed to significantly increase the strength of architectural glass and improve the
performance properties of window film-to-glass products. C-Bond Secure improves the performance of window film-to-glass products by reducing
glass breakage from impact and stress environments and filling the capillary voids on the glass surface to prevent the trapping of moisture
and impurities that impede cure time and adhesion between the glass and any succeeding window film product. This is important because
when glass does break, this nanotechnology improves the chances that no large shards/pieces will escape the immediate area of the glass
surface and result in serious laceration or personal injury. C-Bond Secure has been tested against untreated glass by third-party
laboratories and shown to outperform untreated glass in this capacity. C-Bond Secure faces market competition from basic soap and
water products (such as baby shampoo and dishwashing soap) as the recognized industry standard window film application solutions, which
we believe provide no structural benefits and are designed to wash hair and dishes, respectively. C-Bond Secure increases overall glass
strength, improves window film product performance, and can be used in conjunction with any manufacturer’s film product.
C-Bond BRS (Ballistic-Resistant Film System)
C-Bond BRS is a patented,
nanotechnology Ballistic-Resistant Film System that increases the structural integrity of glass and provides National Institute of Justice
(NIJ) Level I, Level IIA, Level II, and Underwriter Laboratories (UL) 752 ballistic-resistant protection. C-Bond BRS includes a specified
glass thickness and glass type, the C-Bond window film mounting solution to improve the glass mechanical strength, and the C-Bond window
film product. This product is targeted to police, fire, emergency services, media outlets, schools, airports, and government buildings
due to the utility of ballistic-resistant glass protection in their respective fields. The C-Bond BRS system seeks to combine simplicity
and affordability with a one-way capability (the ability to shoot-out but prevent shooting in) ballistic protection compared to other
costlier ballistic resistant material (polycarbonate and glass laminate) products.
Commercial Market Strategy
Patriot Glass Solutions sells
ballistic-resistant glass solutions and forced entry deterrent solutions to private enterprises, schools, government agencies, and general
contractors. We take advantage of existing resources and relationships between us and construction contractors to leverage our products
and services. On many projects, we rely on construction contractors to hire us as a subcontractor for our multi-purpose glass strengthening
primer and window film mounting solutions services, which helps us generate economic growth, support commercialization activities, provide
more developed business networks, knowledge of and access to supply and demand channels, and supplement limited financial resources. Additionally,
through our sales effort, we market our multi-purpose glass strengthening primer and window film mounting solutions to residential customers
and direct to commercial customers.
C-Bond Authorized Dealer Network
Our Authorized Dealer Network
focuses on entering into Dealer agreements with window film installation businesses to develop a national distribution network. This program
aims to partner with high quality distributors that can grow revenues and margins. For the year ended December 31, 2023, one customer
accounted for approximately 11% of total sales. For the year ended December 31, 2023, all sales were in the United States. Almost all
sales generated through PGS are performed in Texas. No other geographical area accounted for more than 10% of total sales during the years
ended December 31, 2023 and 2022. A reduction in sales from or loss of our customers could have a material adverse effect on the Company’s
consolidated results of operations and financial condition.
Suppliers
Currently, we rely on four
main suppliers, Madico, Inc., Eastman Performance Films, LLC., and Decorative Films, LLC, for our window film; and one supplier for our
C-Bond Secure and C-Bold BRS solution, CB Nanoshield, LLC. We believe that, if necessary, alternate window film suppliers could
be found without material disruption to our business. However, we rely on CB Nanoshield, LLC to supply our C-Bond Secure and C-Bold BRS
solutions.
3
Intellectual Property
We currently own four U.S.
patents and one patent license spanning core and strategic nano-technology applications and processes. Our focus remains on maintaining
a patent portfolio that protects our core intellectual property and delivers shareholder value.
Pursuant to an agreement
dated April 8, 2016, between us and Rice University, Rice University granted a non-exclusive license to us, in nanotube-based surface
treatment for strengthening glass and related materials under Rice’s intellectual property rights, to use, make, distribute, offer
and sell the licensed products specified in the agreement. In consideration, we had to pay a one-time non-refundable license fee of $10,000
and royalty payments of 5% of net sales of the licensed products during the term of the agreement and a sell-off period of 180 days from
termination. In addition, we were required to pay for the maintenance of the patents. This agreement expired per its terms on December
29, 2023. Due to the advancement of our proprietary technology and awards of our own patents, we did not need to rely upon any of the
patents included in the license agreement with Rice University as they were not core to our current product offerings.
The “C-Bond Systems™”
name and logo are registered trademarks issued by the U.S. Patent and Trademark Office.
Research and Development
We did not incur any research
and development expenses during 2023.
Competition
C-Bond Secure Glass Strengthening Primer and
Window Film Mounting Solution
C-Bond Secure faces competition
from alternative window film mounting products in the market; however, all these products have similar ingredients to a soap and water
mix, which we believe provides no structural benefit. These solutions are used to provide a window film installer the ability to
slip or move the film on the surface to which it is applied. The industry standard solution most commonly used to apply window film
to glass is a mixture containing commonly available baby shampoo or dishwashing soap and water that we believe has the following negative
attributes: provides no structural benefits, often bubbles or yellows and scatters light, can only be applied within a limited temperature
range, and may require 30 to 120 days of “dry” time to set completely depending on the film thickness. C-Bond Secure
provides the same slip properties while also strengthening the glass and improving film adhesion.
C-Bond BRS
C-Bond BRS faces competition
from alternative bulletproof or bullet-resistant glass products in the market. Alternative bulletproof solutions use polycarbonate or
glass laminate materials that are expensive, thick, heavy, often require reframing and retrofit of existing structure and revised building
codes, and yellow and discolor over time. These alternative solutions are often cost prohibitive to cost sensitive customers such
as educational and municipal facilities. C-Bond BRS allows for increased safety and security at an affordable cost. Most importantly,
it provides a deterrent to an intruder and valuable time to secure the facility.
Employees
As of December 31, 2023,
C-Bond had one full-time employee, and two individuals, including our chief executive officer, who operate as independent contractors
of the Company. Additionally, Patriot Glass had 19 full-time employees. We have established an extensive network of external partners,
contractors, and consultants to minimize administrative overhead and maximize efficiency.
We believe that a diverse
workforce is important to our success. We will continue to focus on the hiring, retention and advancement of women and underrepresented
populations, and to cultivate an inclusive and diverse corporate culture. In the future, we intend to continue to evaluate our use of
human capital measures or objectives in managing our business such as the factors we employ or seek to employ in the development, attraction
and retention of personnel and maintenance of diversity in our workforce.
The success of our business
is fundamentally connected to the well-being of our people. Accordingly, we are committed to the health, safety and wellness of our employees.
We provide our employees and their families with access to a variety of innovative, flexible and convenient health and wellness programs,
including benefits that provide protection and security so they can have peace of mind concerning events that may require time away from
work or that impact their financial well-being; that support their physical and mental health by providing tools and resources to help
them improve or maintain their health status and encourage engagement in healthy behaviors; and that offer choice where possible so they
can customize their benefits to meet their needs and the needs of their families.
We also provide robust compensation
and benefits programs to help meet the needs of our employees. We believe that we maintain a satisfactory working relationship with our
employees and have not experienced any labor disputes.
4
General Company Information
C-Bond Systems, Inc., formerly
WestMountain Alternative Energy, Inc. (“WestMountain”), was incorporated in the state of Colorado on November 13, 2007. C-Bond
Systems, LLC is a Texas-based limited liability company that was formed in 2013 and headquartered in Texas. On April 25, 2018, WestMountain
Energy, WestMountain’s wholly owned subsidiary, WETM Acquisition Corp., a corporation formed in the State of Colorado on April 18,
2018, (the “Acquisition Sub”), and C-Bond Systems, LLC, entered into an Agreement and Plan of Merger and Reorganization (“Merger
Agreement”). Pursuant to the terms of the Merger Agreement, on April 25, 2018, referred to as the Closing Date, the Acquisition
Sub merged with and into C-Bond Systems, LLC, which was the surviving corporation and became a wholly owned subsidiary of WestMountain
(the “Merger”). The Merger was effective as of April 26, 2018, upon the filing of a Certificate of Merger with the Secretary
of State of the State of Texas. On July 18, 2018, we changed our name to C-Bond Systems, Inc. Our common stock is currently quoted
on the OTC Pink marketplace on a limited basis under the trading symbol “CBNT”. Our principal executive offices are located
at 2029 Pat Booker Rd., San Antonio, Texas, 78148. Our website address is http://cbondsystems.com/ and our telephone number is (210)
490-3977. The content of any website of ours is not a part of, or incorporated by reference in, this Report. The Company’s Annual
Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to reports filed pursuant to Sections
13(a) and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are filed with the Securities and
Exchange Commission (the “SEC”). These reports and any other information filed by the Company with the SEC are available free
of charge on our website. The SEC maintains an internet site that contains reports, proxy and information statements, and other information
regarding issuers that file electronically with the SEC at www.sec.gov.
ITEM 1A. RISK FACTORS
Investing in our common
stock involves a high degree of risk. You should not invest in our stock unless you are able to bear the complete loss of your investment.
You should carefully consider the risks described below, as well as other information provided to you in this annual report on Form 10-K,
including information in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and
“Cautionary Note Regarding Forward-Looking Information” before making an investment decision. The risks and uncertainties
described below are not the only ones facing C-Bond Systems. Additional risks and uncertainties not presently known to us or that we currently
believe are immaterial may also impair our business operations. If any of the following risks actually occur, our business, financial
condition or results of operations could be materially adversely affected, the value of our common stock could decline, and you may lose
all or part of your investment.
We have incurred substantial losses to date,
may continue to incur losses in the future, and we may never achieve or sustain profitability.
As reflected in our accompanying
consolidated financial statements, we reflected net income of $1,886,807 for the year ended December 31, 2023. Additionally, as of
December 31, 2023, the Company had an accumulated deficit, shareholders’ deficit, and working capital deficit of $60,851,714, $4,324,535
and $1,351,954, respectively. On May 8, 2023, we sold our nanoShield product line for approximately $4,000,000 and for the year ended
December 31, 2023, we recorded a gain from this sale of the nanoShield product line of $4,051,709. Aside from the 2023 gain recognized
from the sale of the nanoShield product line, we have incurred substantial losses since our inception, including a net loss of $5,156,478
(which included stock-based compensation of $1,039,943), for the year ended December 31, 2022. Net cash used in operations was $1,602,218
and $1,584,918 for the years ended December 31, 2023 and 2022, respectively. These factors raise substantial doubt about the Company’s
ability to continue as a going concern for a period of twelve months from the issuance date of this report. Management cannot provide
assurance that the Company will ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or
equity capital.
Our ability to continue as a going concern
will require us to obtain additional financing to fund our current operations, which may be unavailable on attractive terms, if at all.
As of December 31, 2023,
our recurring operating losses (excluding the gain we recognized from the sale of our nanoShield product line), cash used in operations
and our current operating plans raise substantial doubt about our ability to continue as a going concern for a period of twelve months
from the issuance date of this report. Our ability to continue as a going concern will require us to obtain additional financing to fund
our current operating plans. We believe that our existing cash and cash equivalents will not be sufficient to fund our current operating
plans. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce or eliminate our commercialization
efforts.
Unfavorable global economic, business, or
political conditions could adversely affect our business, financial condition, or results of operations.
Our results of operations
could be adversely affected by general conditions in the global economy and in the global financial markets, including conditions that
are outside of our control, including the impact of health and safety concerns, such as those relating to global pandemics. The most recent
global financial crisis caused extreme volatility and disruptions in the capital and credit markets. A severe or prolonged economic downturn
could result in a variety of risks to our business, including weakened demand for our products and our ability to raise additional capital
when needed on acceptable terms, if at all. A weak or declining economy could strain our domestic and international customers, possibly
resulting in delays in customer payments. Any of the foregoing could harm our business and we cannot anticipate all the ways in which
the current economic climate and financial market conditions could adversely impact our business.
5
We hold our cash and cash equivalents that
we use to meet our working capital and operating expense needs in deposit accounts that could be adversely affected if the financial institution
holding such funds fails.
We hold our cash and cash
equivalents that we use to meet our working capital and operating expense needs in deposit accounts. At times, the balance held in these
accounts may exceed the Federal Deposit Insurance Corporation, or FDIC, standard deposit insurance limit of $250,000. If the financial
institution in which we hold such funds fails or is subject to significant adverse conditions in the financial or credit markets, we could
be subject to a risk of loss of all or a portion of such uninsured funds or be subject to a delay in accessing all or a portion of such
uninsured funds. Any such loss or lack of access to these funds could adversely impact our short-term liquidity and ability to meet our
operating expense obligations, including payroll obligations.
For example, on March 10,
2023, Silicon Valley Bank, or SVB, and Signature Bank, were closed by state regulators and the FDIC was appointed receiver for each bank.
The FDIC created successor bridge banks and all deposits of SVB and Signature Bank were transferred to the bridge banks under a systemic
risk exception approved by the United States Department of the Treasury, the Federal Reserve and the FDIC. If the financial institution
in which we hold funds for working capital and operating expenses were to fail, we cannot provide any assurances that such governmental
agencies would take action to protect our uninsured deposits or investments in a similar manner.
Our future revenues are very difficult to
predict with any accuracy.
Predicting the timing or
the amount of revenues that we will receive from the sale of our products is very difficult. Any delay in the development and acceptance
of one or more of our products, could result in significant delays in the realization of revenues, the need to raise additional capital
through the issuance of additional equity or debt securities sooner than we intend, and may allow competitors to reach certain of such
markets with products before we do. In view of the emerging nature of the technology involved in certain of these markets, and the attendant
uncertainty as to whether our products will achieve meaningful commercial acceptance, if at all, there can be no assurance that we will
realize revenues sufficient to achieve profitability.
Our intellectual property is subject to
patents that may expire.
We rely on U.S. patents to
protect our propriety products that form the core of our revenue potential. These patents are subject to standard patent expiration terms.
Upon expiration of our patents, we will no longer be able to prevent our competitors from developing similar products to ours.
If we are unable to adequately protect our
intellectual property, our competitive position and results of operations may be adversely impacted.
Protecting our intellectual
property is critical to our innovation efforts. We own patents, trade secrets, copyrights, trademarks and/or other intellectual property
rights related to many of our products, and also have a non-exclusive license right under intellectual property owned by others. Our
intellectual property rights may be challenged or infringed upon by third parties, particularly in countries where property rights are
not highly developed or protected, or we may be unable to maintain, renew or enter into new license agreements with third-party owners
of intellectual property on reasonable terms. Unauthorized use of our intellectual property rights or inability to preserve existing
intellectual property rights could adversely impact our competitive position and results of operations.
We are dependent on key personnel, and
our ability to grow and compete in our industry will be harmed if we do not retain the continued services of our key personnel, or we
fail to identify, hire, and retain additional qualified personnel.
Our success depends on the
efforts of our senior management team and other key personnel. The loss of services of members of our senior management team could have
an adverse effect on our business. In addition, if we expect to grow our operations, it will be necessary for us to attract and retain
additional qualified personnel. If we are unable to attract or retain qualified personnel as needed, the growth of our operations could
be slowed or hampered.
Potential adverse outcomes in legal proceedings
may adversely affect results.
Our business exposes us to
product liability claims that are inherent in the design, manufacture and sale of our products and the products of suppliers. We may not
be able to obtain insurance on acceptable terms or our insurance may not provide adequate protection against actual losses. In addition,
we are subject to the risk that one or more of our insurers may become insolvent and become unable to pay claims that may be made in the
future. Even if we maintain adequate insurance, claims could have a material adverse effect on our financial condition, liquidity and
results of operations and on our ability to obtain suitable, adequate or cost-effective insurance in the future.
If we are unable to successfully introduce
new products, our future growth may be adversely affected.
Our ability or failure to
develop new products based on innovation can affect our competitive position and requires the investment of significant time and resources.
Difficulties or delays in research, development, production or commercialization of new products and services may reduce future revenues
and adversely affect our competitive position. If we are unable to create sustainable product differentiation, our organic growth may
be adversely affected.
Research and development for continued growth
of our IP portfolio and product offerings is expensive, and we may not have sufficient funds to continue research and develop activities
and may not be able to acquire additional funding.
Our ability to continue our
research and development activities to improve and expand our products and service offerings requires extensive amounts of funding. We
may not be able to obtain the necessary funding on attractive terms and on a timely basis to continue our research and development activities,
which could cause our research and development activities to be delayed, reduced or terminated. Delaying, reducing or terminating our
research activities could impede our estimated growth and results of operations.
6
We rely heavily on collaborative partners such as distributors,
manufacturers and vendors and our relationships with such parties may restrict or limit our business operations.
We are currently working
with several third-party entities with respect to the validation, optimization, and distribution of our products. Our current and future
collaborations and joint ventures are important as they allow greater access to funds, to research, development and testing resources,
validation, and to manufacturing, sales and distribution resources that we would otherwise not have. We intend to continue to significantly
rely on such collaborative and joint venture arrangements. Some of the risks and uncertainties related to the reliance on such collaborations
and joint ventures include the fact that such relationships could actually serve to limit or restrict us, while our partners are free
to pursue other products either on their own or with others. Further, our partners may terminate a collaborative technology relationship
and such termination may require us to seek other partners or expend substantial resources to pursue these activities independently.
We rely somewhat on a third-party distribution
model for our products and the number and quality of distributors can vary and may impact our revenues.
We rely somewhat on numerous
third-party distributors for the distribution of our products. While we believe that alternative distributors could be located if required,
our product sales could be affected if any of these distributors do not continue to distribute our products in required quantities or
at all, or with the required levels of quality. In addition, difficulties encountered by these distributors, such as fire, accident, natural
disasters, or political unrest, could halt or disrupt distributions, resulting in delay or cancellation of orders. Any of these events
could result in delayed deliveries by us of our products, causing reduced sales and harm to our reputation and brand name.
We only have one manufacturing facility for our propriety products.
Our proprietary products
are manufactured for us by CB Nanoshield, the Buyer of the nanoShield product, in their Houston, Texas facility. In the event of a fire,
flood, tornado, hurricane or other form of a catastrophic event, we may be unable to fulfill any then-existing demand for our products,
possibly for a prolonged period, depending upon the severity of the event. As a result, should a catastrophic event occur, our financial
condition and results of operation would be materially adversely affected.
Our Contract Manufacturing
Agreement with CB Nanoshield expires on May 8, 2024 (the “Anniversary Date”). For each year thereafter automatic one-year
extensions to the agreement automatically trigger on the Anniversary Date unless terminated or revised. If a party elects to terminate
the agreement, they must provide written notification to the other party no less than sixty (60) days prior to the Anniversary Date. If
we are not able to renew or extend our manufacturing agreement, we may have to move our corporate headquarters and manufacturing facility.
Doing so could cause us to incur significant expenses and could delay or reduce our ability to manufacture our products for some time.
Our financial condition and results of operation could be materially adversely affected by any such move.
The requirements of being a public company
may strain our resources, divert management’s attention, and affect our ability to attract and retain qualified members of the board
of directors.
As a public company, we are
subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act of 2002, as amended (the “Sarbanes-Oxley Act”),
the Dodd-Frank Act, the listing requirements of the OTC and other applicable securities rules and regulations. Compliance with these rules
and regulations requires significant legal and financial compliance costs, makes some activities more difficult, time-consuming or costly
and increases demand on our systems and resources. The Exchange Act requires, among other things, that we file annual, quarterly and current
reports with respect to our business and operating results. The Sarbanes-Oxley Act requires, among other things, that we maintain effective
disclosure controls and procedures and internal control over financial reporting. In order to maintain and, if required, improve our disclosure
controls and procedures and internal control over financial reporting to meet this standard, significant resources and management oversight
may be required. As a result, management’s attention may be diverted from other business concerns, which could harm our business
and operating results. We may need to hire more employees in the future to comply with these regulatory requirements, which will increase
our costs and expenses.
In addition, changing laws,
regulations and standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing
legal and financial compliance costs and making some activities more time consuming. These laws, regulations and standards are subject
to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve
over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance
matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to invest resources to comply
with evolving laws, regulations and standards, and this investment may result in increased general and administrative expenses and a diversion
of management’s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new
laws, regulations and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to practice,
regulatory authorities may initiate legal proceedings against us and our business may be harmed.
7
We also expect that being a public company with these rules and regulations
will make it more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage
or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain qualified
members for our board of directors, particularly to serve any committees, and qualified executive officers.
As a result of disclosure
of information in filings required of a public company, our business and financial condition will become more visible, which we believe
may result in threatened or actual litigation, including by competitors and other third parties. If such claims are successful, our business
and operating results could be harmed, and even if the claims do not result in litigation or are resolved in our favor, these claims,
and the time and resources necessary to resolve them, could divert the resources of our management and harm our business and operating
results.
We may not reach sufficient size to justify our
public reporting status. If we are forced to become a private company, then our stockholders may lose their ability to sell their shares.
We may not be able to fulfill our obligation
to develop and maintain proper and effective internal controls over financial reporting.
We are required, pursuant
to Section 404 of the Sarbanes-Oxley Act, to furnish a report by management on, among other things, the effectiveness of our internal
control over financial reporting annually. This assessment needs to include disclosure of any material weaknesses identified by our management
in our internal control over financial reporting. Management concluded that our internal control over financial reporting as of December
31, 2023 was not effective, see “We have identified material weaknesses in our internal control over financial reporting which
could, if not remediated, result in a material misstatement in our financial statement.” In the future, we may not be able to
complete our evaluation, testing and any required remediation in a timely fashion. Failure to comply, or any adverse results from such
evaluation, could result in a loss of investor confidence in our financial reports and have an adverse effect on the trading price of
our equity securities. Achieving continued compliance with Section 404 may require us to incur significant costs and expend significant
time and management resources. We cannot assure you that we will be able to fully comply with Section 404 or that we will be able to conclude
that our internal control over financial reporting is effective.
Risks Related to the Glass Strengthening and Water Repellent
Industries
We face competition from companies that
have substantially greater capital resources, research and development, manufacturing, and marketing resources.
While we believe that we
have significant competitive benefits offered by our proprietary products, there are competitors with much longer operating histories,
greater name recognition, larger customer bases and significantly greater financial, technical, and marketing resources than we have.
As we grow and become successful with our products, we expect these competitors to increase the resources they dedicate to our market.
Such competition could materially adversely affect our business, operating results, or financial condition.
We may face increased pricing pressures
from current and future competitors and, accordingly, there can be no assurance that competitive pressures will not require us to reduce
our prices.
It is likely that we will
experience significant competitive pressure over time. Accordingly, the use and pricing of our products may decline as the market becomes
more competitive. Any material reduction in the price of our products will negatively affect our gross margin and results of operations.
We may have difficulty developing brand
awareness for our products.
We believe that a developed
market for glass strengthening products currently does not exist. Generation of the brand and market communications are essential to the
Company’s long-term success. Funding constraints will limit the Company’s ability to build product awareness through marketing
and advertising. Without clear market communication the risk of having the product confused with other applications such as a stand-alone
hydrophobic product is possible. If we are unable to develop such a market or create demand for our products, it would adversely impact
our business and operating results.
8
Risks Related to our Common Stock
Our common stock is quoted on the OTC Pink,
which may limit the liquidity and price of our common stock more than if our common stock were listed on the Nasdaq Stock Market or another
national exchange.
Our securities are currently
quoted on the OTC Markets, specifically the OTC Pink (the “OTC Pink”), an inter-dealer automated quotation system for equity
securities. Quotation of our securities on the OTC Pink may limit the liquidity and price of our securities more than if our securities
were listed on the Nasdaq Stock Market or another national exchange. As an OTC Pink company, we do not attract the extensive analyst coverage
that accompanies companies listed on national securities exchanges. Further, institutional and other investors may have investment guidelines
that restrict or prohibit investing in securities traded on the OTC Pink. These factors may have an adverse impact on the trading and
price of our common stock.
The trading price of our common stock may
decrease due to factors beyond our control.
The stock market from time
to time has experienced extreme price and volume fluctuations, which have particularly affected the market prices for smaller reporting
companies, and which often have been unrelated to the operating performance of the companies. These broad market fluctuations may adversely
affect the market price of our common stock. If our shareholders sell substantial amounts of their common stock in the public market,
the price of our common stock could fall. These sales also might make it more difficult for us to sell equity, or equity-related securities,
in the future at a price we deem appropriate.
The market price of our common
stock may also fluctuate significantly in response to the following factors, most of which are beyond our control:
●
variations
in our quarterly operating results,
●
changes
in general economic conditions and in our industry,
●
changes
in market valuations of similar companies,
●
announcements
by us or our competitors of significant new contracts, acquisitions, strategic partnerships or joint ventures, or capital commitments,
●
loss
of a major customer, partner or joint venture participant and
●
the
addition or loss of key managerial and collaborative personnel.
Any such fluctuations may
adversely affect the market price of our common stock, regardless of our actual operating performance. As a result, stockholders may be
unable to sell their shares, or may be forced to sell them at a loss.
The market price for our common shares is
particularly volatile given our status as a relatively unknown company with a small and thinly traded public float, limited operating
history and lack of profits which could lead to wide fluctuations in our share price. You may be unable to sell your common shares at
or above your purchase price, which may result in substantial losses to you.
The market for our common
shares is characterized by significant price volatility when compared to seasoned issuers, and we expect that our share price will continue
to be more volatile than a seasoned issuer for the indefinite future. The volatility in our share price is attributable to a number of
factors. First, as noted above, our common shares are sporadically and thinly traded. As a consequence of this lack of liquidity, the
trading of relatively small quantities of shares by our shareholders may disproportionately influence the price of those shares in either
direction. The price for our shares could, for example, decline precipitously in the event that a large number of our common shares are
sold on the market without commensurate demand, as compared to a seasoned issuer which could better absorb those sales without adverse
impact on its share price. Secondly, we are a speculative or “risky” investment due to our limited operating history and lack
of profits to date. As a consequence of this enhanced risk, more risk-adverse investors may, under the fear of losing all or most of their
investment in the event of negative news or lack of progress, be more inclined to sell their shares on the market more quickly and at
greater discounts than would be the case with the stock of a seasoned issuer. Many of these factors are beyond our control and may decrease
the market price of our common shares, regardless of our operating performance. We cannot make any predictions or projections as to what
the prevailing market price for our common shares will be at any time, including as to whether our common shares will sustain their current
market prices, or as to what effect that the sale of shares or the availability of common shares for sale at any time will have on the
prevailing market price.
9
Penny stock regulations may impose certain
restrictions on marketability of our securities.
Our common stock is subject
to penny stock rules, which may discourage broker-dealers from effecting transactions in our common stock or affect their ability to sell
our securities. As a result, purchasers and current holders of our securities could find it more difficult to sell their securities. Trading
volume of OTC Pink stocks have been historically lower and more volatile than stocks traded on an exchange or the Nasdaq Stock Market.
In addition, we may be subject to rules of the SEC that impose additional requirements on broker-dealers when selling penny stocks to
persons other than established customers and accredited investors. In general, an accredited investor is a person with net worth in excess
of $1,000,000 or annual income exceeding $200,000 individually, or $300,000 together with his or her spouse. The relevant SEC regulations
generally define penny stocks to include any equity security not traded on an exchange or the Nasdaq Stock Market with a market price
(as defined in the regulations) of less than $5 per share. Under the penny stock regulations, a broker-dealer must make a special suitability
determination as to the purchaser and must have the purchaser’s prior written consent to the transaction. Prior to any transaction
in a penny stock covered by these rules, a broker-dealer must deliver a disclosure schedule about the penny stock market prepared by the
SEC. Broker-dealers must also make disclosure concerning commissions payable to both the broker-dealer and any registered representative
and provide current quotations for the securities. Finally, broker-dealers are required to send monthly statements disclosing recent price
information for the penny stock held in an account and information on the limited market in penny stocks.
You may find it difficult to sell our common
stock.
As mentioned above, there
has been a limited trading market in our common stock. We cannot assure you that an active trading market for our common stock will develop
or be sustained. Regardless of whether an active and liquid public market exists, negative fluctuations in our actual or anticipated operating
results will likely cause the market price of our common stock to fall, making it more difficult for you to sell our common stock at a
favorable price, or at all.
We intend to issue additional equity and
stock options to employees and consultants as compensation in the future, which will result in dilution to existing and new investors.
We provide and intend to
continue to provide additional equity-based compensation to our employees, officers, directors, consultants, and independent contractors
through an equity incentive plan. Our equity incentive plan permits the award of options to purchase shares of common stock and the issuance
of restricted shares of our common stock. Because stock options granted under the plan will generally only be exercised when the exercise
price for such option is below the then market value of the common stock, the exercise of such options or the issuance of shares will
cause dilution to the book value per share of our common stock and to existing and new investors.
Holders of convertible debt issued by the
Company may convert their promissory notes and exercise warrants into shares of our common stock, which will result in significant dilution
to existing and new investors.
We closed various financing
transactions with investors whereby the respective investor purchased convertible promissory notes and warrants from the Company. If the
investors convert their notes and exercise their warrants, the Company will issue shares of the Company’s common stock to the investor,
which may cause substantial dilution to the book value per share of our common stock and to existing and new investors.
Holders of Series B Preferred Shares or
Series C Preferred Shares issued by the Company may, as of December 31, 2023, convert such shares into approximately 335,772,000
and 438,151,000 shares of our common stock, respectively, which could result in significant dilution to existing and new investors.
As of December 31, 2023, we
had 1,144 Series B and 15,150 Series C shares of Preferred Stock issued and outstanding. If a holder of Series B Preferred shares or Series
C Preferred shares issued by the Company elects to convert such shares into approximately 335,772,000 and 438,151,000 shares of our common
stock, respectively, it would result in significant dilution to existing and new investors.
10
Sales of a substantial number of shares
of our common stock in the public market by our existing stockholders could cause our stock price to fall.
We have not entered into
lock-up agreements with any of our existing stockholders. As a result, sales of a substantial number of shares of our common stock in
the public market could depress the market price of our common stock and could impair our ability to raise capital through the sale of
additional equity securities. We are unable to predict the effect that sales may have on the prevailing market price of our common stock.
Our stock price is likely to be volatile.
There is generally significant
volatility in the market prices and limited liquidity of securities of companies at our stage. Contributing to this volatility are various
events that can affect our stock price in a positive or negative manner. These events include, but are not limited to: governmental regulations
or actions; market acceptance and sales growth of our products; litigation involving our industry; developments or disputes concerning
our patents or other proprietary rights; departure of key personnel; future sales of our securities; fluctuations in our financial results
or those of companies that are perceived to be similar to us; investors’ general perception of us; announcements by us of significant
contracts, acquisitions, strategic partnerships, joint ventures or capital commitments, and general economic, industry and market conditions.
If any of these events occur, it could cause our stock price to fall.
The price of our common stock may be adversely
affected by the future issuance and sale of shares of our common stock or other equity securities.
We cannot predict the size
of future issuances or sales of our common stock or other equity securities future acquisitions or capital raising activities, or the
effect, if any, that such issuances or sales may have on the market price of our common stock. The issuance and sale of substantial amounts
of common stock or other equity securities or announcement that such issuances and sales may occur, could adversely affect the market
price of our common stock. Any decline in the price of our common stock may encourage short sales, which could place further downward
pressure on the price of our common stock and may impair our ability to raise additional capital through the sale of equity securities.
Our reduced stock price may adversely affect
our liquidity.
Our common stock has limited
trading history. Many market makers are reluctant to make a market in stock with a trading price of less than $5.00 per share, as well
as shares quoted on the OTC Pink. To the extent that we have fewer market makers for our common stock, our volume and liquidity will likely
decline, which could further depress our stock price.
We have never paid dividends on our common
stock and cannot guarantee that we will pay dividends to our stockholders in the future.
We have never paid dividends
on our common stock. For the foreseeable future, we intend to retain our future earnings, if any, to reinvest in the development and growth
of our business and, therefore, do not intend to pay dividends on our common stock. However, in the future, our board of directors may
declare dividends on our common stock. Any future determination to pay dividends will be at the discretion of our board of directors and
will depend on our financial condition, results of operations, capital requirements, and such other factors as our board of directors
deems relevant. Accordingly, investors may need to sell their shares of our common stock to realize a return on their investment, and
they may not be able to sell such shares at or above the price paid for them. We cannot guarantee that we will pay dividends to our stockholders
in the future.
Colorado law and our Articles of Incorporation
protect our directors from certain types of lawsuits, which could make it difficult for us to recover damages from them in the event of
a lawsuit.
Colorado law provides that
our directors will not be liable to our company or to our stockholders for monetary damages for all but certain types of conduct as directors.
Our Articles of Incorporation require us to indemnify our directors and officers against all damages incurred in connection with our business
to the fullest extent provided or allowed by law. The exculpation provisions may have the effect of preventing stockholders from recovering
damages against our directors caused by their negligence, poor judgment, or other circumstances. The indemnification provisions may require
our company to use our assets to defend our directors and officers against claims, including claims arising out of their negligence, poor
judgment, or other circumstances.
11
Additional risks may exist since we became
public through a “reverse merger.”
Because our business became
public by means of a “reverse merger,” we may not be able to attract the attention of major brokerage firms. Securities analysts
of major brokerage firms may not provide coverage of us since there is little incentive to brokerage firms to recommend the purchase of
our common stock. We cannot assure you that brokerage firms will want to conduct any secondary offerings on our behalf in the future.
We have identified material weaknesses in
our internal control over financial reporting which could, if not remediated, result in a material misstatement in our financial statements.
We are subject to the reporting
and other obligations under the Exchange Act, including the requirements of Section 404 of the Sarbanes-Oxley Act, which require annual
management assessments of the effectiveness of our internal control over financial reporting. Our management is responsible for establishing
and maintaining adequate internal control over financial reporting. As reported in Item 9A hereof, our management concluded that our internal
control over financial reporting was not effective as of December 31, 2023 because of a material weakness in our internal control over
financial reporting. The ineffectiveness of our disclosure controls and procedures was due to the following material weaknesses in our
internal control over financial reporting: (1) the lack of multiple levels of management review on complex business, accounting, and financial
reporting issues and (2) a lack of adequate segregation of duties as a result of our limited financial resources to support hiring of
personnel. Until such time as we expand our staff to include additional accounting and executive personnel, it is likely we will continue
to report material weaknesses in our internal control over financial reporting.
While management has undertaken
and will continue to undertake steps to improve our internal control over financial reporting to address and remediate the material weaknesses,
there can be no assurance that we will be able to successfully remediate the identified material weaknesses, or that we will not identify
additional control deficiencies or material weaknesses in the future. If we are unable to successfully remediate our existing or any future
material weaknesses in our internal control over financial reporting, the accuracy and timing of our financial reporting may be adversely
affected, we may be unable to maintain compliance with securities laws regarding the timely filing of periodic reports, investors may
lose confidence in our financial reporting and the price of our ordinary shares may decline.
ITEM 1B. UNRESOLVED STAFF COMMENTS
None.
ITEM 1C. CYBERSECURITY
Risk Management and
Strategy
We recognize the critical importance of developing,
implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect the confidentiality, integrity,
and availability of our data. The Company’s information security program is managed by its CEO and CFO, and Vice President of Operations,
who are responsible for leading Company-wide cybersecurity strategy, policy, standards, architecture, and processes.
At this time, we have not identified risks from
known cybersecurity threats, including as a result of any prior cybersecurity incidents, that have materially affected us, including our
operations, business strategy, results of operations, or financial condition. We face certain ongoing risks from cybersecurity threats
that, if realized, are reasonably likely to materially affect us, including our operations, business strategy, results of operations,
or financial condition. See “Risk Factors”.
Governance
The Company’s Board of Directors oversees
management’s cybersecurity strategy. Management provides a full briefing on various cybersecurity risk matters including risk
assessments, mitigation strategies, areas of emerging risk and other areas of importance at least annually. In the event of a cybersecurity
incident determined to be significant, management will notify the Board.
12
ITEM 2. PROPERTIES
Our corporate headquarters
and manufacturing facility was located in an 8,385 square foot facility in Houston, Texas at 6035 South Loop East. The lease on the Houston
facility was to expire on May 31, 2025. On June 15, 2023, in connection with the sale of the Company’s nanoShield product line,
the purchaser assumed the operating lease and we vacated the premises.
In connection with the
Exchange Agreement with PGS, the Company was named as guarantor of a Commercial Lease Agreement dated July 21, 2021, by and between
landlord MDW Management, LLC, a company owned by Michael Wanke and his wife and tenant PGS. The term of this lease is 60 months, at
a minimum monthly rent of $5,600 (not including tax), with two five-year options for the tenant to renew. The Company’s
obligation as guarantor of the Lease will terminate upon the occurrence of earlier of the following: (i) the date of the
Company’s acquisition of 100% of the ownership interests of PGS; (ii) the date that the Company beneficially owns less than an
80% ownership interest in PGS; or (iii) two (2) years from and after the effective date of the guaranty. This guarantee expired in
July 2023. Our PGS production and warehouse facility is located in an approximate 4,000 square foot facility in San Antonio, Texas
at 2029 Pat Booker Rd., which is now our corporate headquarters.
ITEM 3. LEGAL PROCEEDINGS
From time to time, we may
become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject
to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business.
Except as set forth below,
the Company is not involved in any pending or threatened legal proceedings that it believes could reasonably be expected to have a material
adverse effect on its financial condition, results of operations, or cash flows.
On January 20, 2022, we received
an order from the SEC (the “Formal Order”). The Formal Order authorizes that an examination be made to determine whether a
stop order should be issued under Section 8(d) of the Securities Act with respect to the Company’s Registration Statement on Form
S-1, and any supplements and amendments thereto. The Formal Order indicates that the Form S-1 may be deficient in that it may contain
untrue statements of material fact or omit to state material facts necessary in order to make the statements made, in light of the circumstances
under which they were made, not misleading concerning, among other things, the Company’s revenue and financial condition. On April
15, 2022, the Company filed an amendment to its Annual Report on Form 10-K for the fiscal year ended December 31, 2020. The restatement
had the cumulative effect of decreasing the Company’s reported revenue for fiscal year 2020 by $102,569 and decreasing the Company’s
bad debt expense for the same period by $102,569. There was no effect on the Company’s reported net loss for fiscal year 2020 or
on the financial condition of the Company on December 31, 2020. The Company received a subpoena from the SEC on April 25, 2022, requesting
all documents and communications concerning the review of C-Bond’s revenue recognition practices for fiscal year 2020. In response,
the Company has provided the requested information and its Chief Executive Officer provided his testimony regarding this Formal Order
in October 2022. The Company also filed a request to withdraw its Registration Statement on Form S-1 (“S-1”) (File No. 333-261472)
(the “Registration Statement”), filed by the Company with the Securities and Exchange Commission on December 3, 2021. The
S-1 related to shares of common stock underlying certain convertible promissory notes held by selling securityholders. The S-1 was not
declared effective and no securities were sold in reliance thereon. The Company and its Chief Executive Officer have submitted an offer
to settle and close the pending SEC investigation. The Company and its Chief Executive Officer are awaiting a formal response to such
offer of settlement.
On March 8, 2021, the former
President and Acting CFO of the Company resigned. The Company and the former officer alleged certain claims against each other, including
with respect to certain compensation claims. Neither party has initiated litigation. The Company intends to vigorously defend itself against
any possible claims and assert any relevant claims against the former executive and believes it will prevail. As a result of the evidence
disclosed and discovered during the aforementioned SEC investigation, the Company has concluded that the actions of the former President
and Acting CFO of the Company may be viewed as potentially dishonest and fraudulent. As a result, the Board of Directors of the Company
have resolved and taken action to cause the forfeiture of equity and deferred compensation owed/outstanding by said officer and forwarded
a formal demand letter to said officer and his wife, the former Controller of the Company.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
13
PART II
ITEM 5. MARKET FOR REGISTRANT’S COMMON
EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Our common stock is quoted
on the OTC Pink operated by the OTC Markets Group, under the symbol “CBNT.” Trading in OTC Pink stocks can be volatile, sporadic
and risky, as thinly traded stocks tend to move more rapidly in price than more liquid securities. Such trading may also depress the market
price of our common stock and make it difficult for our stockholders to resell their common stock. Our common stock does not have an established
public trading market.
The following table reflects
the high and low closing price for our common stock for the period indicated. The bid information was obtained from the OTC Markets Group,
Inc. and reflects inter-dealer prices, without retail mark-up, markdown or commission, and may not necessarily represent actual transactions.
Quarter Ended
High
Low
December 31, 2023
$
0.0075
$
0.0032
September 30, 2023
$
0.0102
$
0.0031
June 30, 2023
$
0.0150
$
0.0031
March 31, 2023
$
0.0089
$
0.0036
December 31, 2022
$
0.0160
$
0.0050
September 30, 2022
$
0.0170
$
0.0070
June 30, 2022
$
0.0289
$
0.0106
March 31, 2022
$
0.0300
$
0.0130
On March 29, 2024, the closing price of the Company’s
common stock on OTC Pink was $0.0048.
Holders of Common Stock
As of March 29, 2024, there
were approximately 213 record holders of our common stock. The number of record holders does not include beneficial owners of common
stock whose shares are held in the names of banks, brokers, nominees, or other fiduciaries.
Dividends
Historically, we have not
paid any cash dividends on our common stock. It is our present intention not to pay any cash dividends in the foreseeable future, but
rather to reinvest earnings, if any, in our business operations. However, in the future, our board of directors may declare dividends
on our common stock. Payment of future dividends on our common stock, if any, will be at the discretion of our board of directors and
will depend on, among other things, our results of operations, cash requirements and surplus, financial condition, contractual restrictions
and other factors that our board of directors may deem relevant. We cannot guarantee that we will pay dividends to our stockholders in
the future.
Securities Authorized for Issuance under Equity Compensation Plans
See “Part III. Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” for information concerning our
equity compensation plans as of December 31, 2023.
Recent Sales of Unregistered Securities
None.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
None.
14
ITEM 6. [RESERVED]
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion
and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements
and the related notes and other financial information included in this Report. Some of the information contained in this discussion and
analysis or set forth elsewhere in this Report, including information with respect to our plans and strategy for our business, includes
forward-looking statements that involve risks and uncertainties as described under the heading “Cautionary Note Regarding Our Forward-Looking
Statements” elsewhere in this Report. You should review the disclosure under the heading “Risk Factors” in this Report
for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by
the forward-looking statements contained in the following discussion and analysis.
Overview
We are a nanotechnology company
and marketer of the patented C-Bond technology. We are engaged in the implementation of proprietary nanotechnology applications and processes
to enhance properties of strength, functionality, and sustainability of brittle material systems. Our present primary focus is in the
multi-billion-dollar glass and window film industry with target markets in the United States. Our PGS subsidiary sells two main security
products: C-Bond BRS, a ballistic-resistant window film solution and C-Bond Secure, a forced entry deterrent solution, to private enterprises,
schools, government agencies, and general contractors. PGS also sells offers other types of window film for various applications, including
solar, decorative, reflective, and more.
On May 8, 2023, we entered
into an APA with Apex Protect GPS, LLC (the “Buyer”), a Texas limited liability company, whereby we agreed to sell its C-Bond
nanoShield™ product line, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory
and other physical assets of our C-Bond nanoShield product line (the “Assets”) to the Buyer for a purchase price of $4,000,000
in cash (the “Transaction”). The Transaction closed on May 8, 2023.
The Assets were sold and transferred
to buyer by means of (i) with respect to the physical assets, a bill of sale; and (ii) with respect to intangible assets or intellectual
property, a Patent and Trademark Assignment Agreement, a Patent and Know-How License Agreement, and a Patent License-Back Agreement.
On June 15, 2023, an Assignment
and Agreement to Re-Execute was entered into by and among the Company (“Seller”); Apex Protect GPS, LLC, (“Assignor”)
and CB Nanoshield, LLC, a Texas limited liability company (“Assignee”), whereby the Assignor assigned to the Assignee all
its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing
to Assignee.
The APA contains customary
representations, warranties, and covenants by each party including, among other things, that no bankruptcy or similar insolvency proceeding
under state or federal law has been filed, or is currently being contemplated, with respect to the Company; that the Company has provided
the Seller a true and accurate list of each of the following items of Intellectual Property which comprises a part of the Assets, including,
among other things, patents and trademarks (the “Sold Intellectual Property”); and that the Company has good, valid, and legal
title to, and is the sole and exclusive owner of all rights, title and interest in and to, the Sold Intellectual Property, free and clear
of all liens.
15
Under the terms of the APA,
the Parties entered into a Patent and Trademark Assignment Agreement, whereby the Company conveyed, transferred, and assigned to Buyer,
among other assets, the C-Bond nanoShield trademark (the “Trademark”) and U.S. Patent No. 11,155,491 B2 (the “C-Bond
nanoShield Patent”), and the Company agreed to execute and deliver an assignment of the Trademark and C-Bond nanoShield Patent,
for recording with governmental authorities including, but not limited to, the U.S. Patent and Trademark Office.
The Parties also entered into
a Patent and Know-How License Agreement whereby the Company granted to the Buyer a non-transferable, non-sub-licensable, exclusive right
and license to four patents owned by the Company and licensed know-how to make, have made, use, offer to sell, sell and import glass and
other products and components used in or in relation to the manufacture and operation of civilian, agricultural or military vehicles and
equipment (the “Licensed Product”) in the United States and its legal territories.
Lastly, the Parties entered
into a Patent License-Back Agreement whereby the Buyer agreed to grant to the Company a perpetual, non-exclusive, worldwide, royalty-free,
non-transferable, non-sublicensable license to the C-Bond nanoShield Patent, for all uses and applications except for any that involve,
market to, sell to, do business with, provide related goods or services to, or are consumed by any uses and applications of the patented
technology within the civilian or military automotive, vehicle and/or transportation industry. The Patent License-Back Agreement also
stipulates that all improvements made by either Party to the technology covered by the C-Bond nanoShield Patent shall be owned by the
Buyer. In the event that the Company desires to utilize such improvements to the C-Bond nanoShield Patent made by either Party, the Parties
hereby agree that they will negotiate in good faith a separate license agreement having pricing and other terms and conditions that are
mutually acceptable to both Parties.
Following the Closing, the
Parties completed a transaction wherein the Company assigned to Buyer, and Buyer took assignment from the Company, the lease for the premises
located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to a lease assignment and assumption agreement
as to be reasonably agreed to by the Parties and the lessor pursuant to the Lease.
On May 8, 2023, in connection
with the APA, the Company received net proceeds of $1,989,755, after paying debt and accrued interest of approximately $2,053,000.
On December 31, 2023, we had
cash of $736,461.
The following discussion highlights
our results of operations and the principal factors that have affected our financial condition as well as our liquidity and capital resources
for the periods described and provides information that management believes is relevant for an assessment and understanding of the statements
of financial condition and results of operations presented herein. The following discussion and analysis are based on our consolidated
financial statements contained in this Report, which have been prepared in accordance with United States generally accepted accounting
principles (“GAAP”). You should read the discussion and analysis together with such financial statements and the related notes
thereto.
16
Going Concern
The consolidated financial
statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities
and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, the Company had
net income of $1,886,807 for the year ended December 31, 2023. Net cash used in operations was $1,602,218 for the year ended December
31, 2023. Additionally, as of December 31, 2023, the Company had an accumulated deficit, shareholders’ deficit, and working capital
deficit of $60,851,714, $4,324,535 and $1,351,954, respectively. On May 8, 2023, the Company sold its nanoShield product line and received
proceeds of $4,042,631. The proceeds were used to repay convertible notes payable, notes payable and related accrued interest. On December
31, 2023, the Company had cash of $736,461. These factors raise substantial doubt about the Company’s ability to continue as a going
concern for a period of twelve months from the issuance date of this report. Management cannot provide assurance that the Company will
ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or equity capital. The Company is seeking
to raise capital through additional debt and/or equity financings to fund its operations in the future. Although the Company has historically
raised capital from sales of common shares and preferred shares, and from the issuance of promissory notes and convertible promissory
notes, there is no assurance that it will be able to continue to do so. If the Company is unable to raise additional capital or secure
additional lending in the near future, management expects that the Company will need to curtail its operations. These consolidated financial
statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification
of liabilities that might be necessary should the Company be unable to continue as a going concern.
Critical Accounting Estimates
The following discussion and
analysis of our consolidated financial condition and consolidated results of operations are based upon our consolidated financial statements,
which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these consolidated
financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues
and expenses, and related disclosure of contingent assets and liabilities. Management continually evaluates such estimates, including
those related to critical estimates for estimates used in the calculation of percentage of completion on uncompleted jobs, assumptions
used in assessing impairment of long-term assets, and the fair value of non-cash equity transactions. Management bases its estimates on
historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which
form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.
Any future changes to these estimates and assumptions could cause a material change to our reported amounts of revenues, expenses, assets
and liabilities. Actual results may differ from these estimates under different assumptions or conditions. Management believes the following
critical accounting policies affect our more significant judgments and estimates used in the preparation of the consolidated financial
statements.
17
Revenue recognition
We follow the Financial Accounting
Standards Board’s (the “FASB”) Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts
with Customers (“ASC 606”). This standard establishes a single comprehensive model for entities to use in accounting for
revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. ASC 606 requires an entity
to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to
which the entity expects to be entitled in exchange for those goods or services and requires certain additional disclosures.
We sell our products, which
include standard warranties primarily to distributors and authorized dealers. Product sales are recognized at a point in time when the
product is shipped to the customer and title is transferred and are recorded net of any discounts or allowances. The warranty does not
represent a separate performance obligation.
Revenues from contracts for
the distribution and installation of window film solutions are recognized over time on the basis of the Company’s estimates of the
progress towards completion of contracts using various output or input methods depending on the type of contract terms including (1) the
ratio of number of labor hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method,
or (3) using a units completed method. These methods are used because management considers these to be the best available measure of progress
on these contracts. We use the same method for similar types of contracts. The asset, “contract assets” represents revenues
recognized in excess of amounts billed. The liability, “contract liabilities,” represents billings in excess of revenues recognized.
Stock-based compensation
Stock-based compensation is
accounted for based on the requirements of ASC 718 – “Compensation –Stock Compensation”, which requires
recognition in the financial statements of the cost of employee, director, and non-employee services received in exchange for an award
of equity instruments over the period the employee, director, or non-employee is required to perform the services in exchange for the
award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee, director, and non-employee services
received in exchange for an award based on the grant-date fair value of the award. The Company has elected to recognize forfeitures as
they occur as permitted under Accounting Standards Update (“ASU”) 2016-09 Improvements to Employee Share-Based Payment.
See Note 2 to our consolidated
financial statements for a summary of significant accounting policies and recent accounting pronouncements.
Results of Operations
The following comparative
analysis on results of operations was based primarily on the comparative consolidated financial statements, footnotes and related information
for the periods identified below and should be read in conjunction with the consolidated financial statements and the notes to those statements
for the years ended December 31, 2023 and 2022, which are included elsewhere in this annual report on Form 10-K. The results discussed
below are for the years ended December 31, 2023 and 2022.
Comparison of Results of Operations for the Years ended December
31, 2023 and 2022
Sales
For the year ended December
31, 2023, sales amounted to $2,488,493 as compared to $2,232,646 for the year ended December 31, 2022, an increase of $255,847, or 11.5%.
This increase was attributable to an increase in sales of window tint installation and sales of C-Bond Secure multi-purpose and BRS ballistic
resistant glass protection systems of $510,211 to school districts in Texas. The Texas Education Agency (TEA) mandated that each school
district and open-enrollment charter school install either entry-resistant film or fencing on ground-floor windows that would allow access,
glass doors, and windows adjacent to glass doors. This increase was offset by a decrease in sales of our recently sold C-Bond nanoShield
solutions product line of approximately $254,364 due to its sale in May 2023.
Cost of Goods Sold
In connection with our C-Bond
Solutions segment, cost of goods sold is comprised primarily of the cost of raw materials and finished inventory sold, packaging costs,
and warranty costs. In connection with our Patriot Glass segment, cost of goods sold is comprised primarily of cost of raw materials such
as film, labor, subcontractor costs, equipment rental, and supplies.
For the year ended December
31, 2023, cost of sales amounted to $1,180,979 as compared to $954,402 for the year ended December 31, 2022, an increase of $226,577,
or 23.7%.
18
Gross Profit
For the year ended December
31, 2023, gross profit amounted to $1,307,514, or 52.5% of sales, as compared to $1,278,244, or 57.3% of sales, for the year ended December
31, 2022, an increase of $29,270, or 2.3%. Generally, we recognized a higher gross profit percentage on the sale of C-Bond nanoShield
and C-Bond ballistic resistant glass protections systems than we do on the sale of disinfection products and from Patriot Glass installations
and services.
Operating Expenses
For the year ended December
31, 2023, operating expenses amounted to $3,303,818 as compared to $4,470,738 for the year ended December 31, 2022, a decrease of $1,166,920,
or 26.1%. For the years ended December 31, 2023 and 2022, operating expenses consisted of the following:
Year Ended December 31,
2023
2022
Compensation and related benefits, including stock-based compensation charges of $42,183 and $1,039,943 for the years ended December 31, 2023, and 2022, respectively
$
2,036,514
$
2,844,783
Professional fees
601,214
815,542
General and administrative expenses
666,090
810,413
Total
$
3,303,818
$
4,470,738
Compensation and related benefits
For the year ended December
31, 2023, compensation and related benefits decreased by $808,269, or 28.4%, as compared to the year ended December 31, 2022. This decrease
was primarily due to a decrease in stock-based compensation of $997,760, offset by a net increase in compensation and related benefits
of $189,491 primarily attributable to an increase in executive bonuses of approximately $320,000 and an overall decrease in compensation
and related benefits of $130,509 due to a decrease in the number of employees.
On January 6, 2022, the Board
of Directors of the Company agreed to satisfy $278,654 of accrued compensation owed to its executive officers (collectively, the “Management”)
as of December 31, 2021. Management agreed to accept 278 shares of the Company’s Series B convertible preferred stock in settlement
of this accrued compensation. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial
on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur
any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $957,556 related to the beneficial
conversion feature arising from the issuance of Series B Preferred Stock.
Professional fees
For the year ended December
31, 2023, professional fees decreased by $214,328, or 26.3%, as compared to the year ended December 31, 2022. This decrease was primarily
related to a decrease in consulting fees of $160,127 and a decrease in accounting fees of $74,883, offset by a net increase in other professional
fees of $20,682.
General and administrative
For the year ended December
31, 2023, general and administrative expenses decreased by $144,323, or 17.8%, as compared to the year ended December 31, 2022. These
decreases are primarily attributable to a decrease in sales and marketing expenses, and other cost-cutting measures, including the reduction
of rent of $66,374 and other costs associated with our recently sold C-Bond Nanoshield product line.
Other Operating Income
During the year ended December
31, 2023, we reported a gain on sale of our nanoShield product line of $4,051,709. We did not record other operating income during the
2022 period.
Income (Loss) from Operations
For the year ended December
31, 2023, income (loss) from operations amounted to $2,055,405 and $(3,192,494), respectively, a positive change of $5,247,899, or 164.4%.
19
Other Income (Expenses), net
For the year ended December
31, 2023, other income (expenses), net amounted to $(168,598) as compared to $(1,963,984) for the year ended December 31, 2022, a positive
change of $1,795,386, or 91.4%. This change was primarily due to a decrease in interest expense of $1,144,659 related to a decrease in
the amortization of debt discount and a decrease in interest-bearing debt, an increase in gain on debt extinguishment of $825,727 related
to the payoff and settlement of debt using proceeds from the sale of nanoShield product line and related technologies the payoff and settlement
of accrued compensation, and an increase in settlement expense of $175,000.
Net Income (Loss)
Due to factors discussed above,
for the year ended December 31, 2023 and 2022, net income (loss) amounted to $1,886,807 and $(5,156,478), respectively. For the year ended
December 31, 2023, net income attributable to common shareholders, which included dividends accrued on Series B and C preferred stock
of $54,195 and the deduction of net loss attributable to noncontrolling interests of $8,858, amounted to $1,841,470, or $0.00 per common
share (basic) and $0.00 per common share (diluted). For the year ended December 31, 2022, net loss attributable to common shareholders,
which included dividends accrued on Series B and C preferred stock of $60,090 and the deduction of net loss attributable to noncontrolling
interests of $38,513, amounted to $(5,178,055), or $(0.02) per basic and diluted common share.
Liquidity and Capital Resources
Liquidity is the ability of
an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. We had cash of $736,461 and $97,091 as of
December 31, 2023 and 2022, respectively.
Our primary uses of cash have
been for compensation and related benefits, fees paid to third parties for professional services, and general and administrative expenses.
We have received funds from the sales of products, from various financing activities such as from the sale of our common shares, from
the sale of preferred shares and from debt financings. Additionally, we received net proceeds from the sale of our nanoShield product
line and related technologies of $1,989,755, after the repayment and settlement of notes payable and convertible notes payable. The following
trends are reasonably likely to result in changes in our liquidity over the near to long term:
●
An
increase in working capital requirements to finance our current business,
●
Research
and development fees;
●
Addition
of administrative and sales personnel needed for business growth;
●
The cost of being a public company;
●
Marketing
expense for building brand;
●
Capital requirements for production capacity.
●
Working capital requirements to support acquired companies.
Since inception, we have raised
proceeds from the sale of common shares and preferred shares, and from debt to fund our operations and research and development initiatives.
As discussed elsewhere, on
May 8, 2023, the Company entered into an Asset Purchase Agreement (the “APA”) with Apex Protect GPS, LLC (the “Buyer”),
a Texas limited liability company, whereby the Company agreed to sell its C-Bond nanoShield™ product line, including intangible
assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s
C-Bond nanoShield division (the “Assets”) to the Buyer for a purchase price of $4,000,000 in cash (the “Transaction”).
The Transaction closed on May 8, 2023.
In connection with the APA,
we received net proceeds of $1,989,755, after the repayment and settlement of notes payable and convertible notes payable as follows:
1)
The Company repaid and settled the BOCO Investments, LLC Note with a principal balance of $400,000 and accrued interest payable of $317,293 for a cash payment of $200,000 and the issuance of 22,000,000 shares of the Company’s common stock.
2)
The Company repaid GS Capital Partners, LLC $419,260 for notes dated June 23, 2022, July 26, 2022, and September 6, 2022 (collectively, the “GS Notes”), and GS Capital Partners, LLC deemed the GS Notes paid in full.
3)
The Company repaid Mercer Street Global Opportunity Fund, LLC (“Mercer”) $271,825 for notes dated March 14, 2022 and November 22, 2022 (collectively, the “Secured Mercer Notes”).
4)
The Company repaid Jeff Badders $875,000 plus $87,868 of interest for notes dated May 5, 2021, November 8, 2022, and April 4, 2023.
20
5)
The Company repaid 1800 Diagonal Lending, LLC $288,035 for notes dated November 4, 2022, December 27, 2022, and March 17, 2023 (collectively, the “1800 Diagonal Notes”), and 1800 Diagonal Lending, LLC deemed the 1800 Diagonal Notes paid in full.
6)
The Company repaid its CEO $250,000 for the note dated May 2, 2022, and the CEO deemed the note paid in full.
Additional cash liquidity
is generated from product sales. However, to date, we are not profitable, and we cannot provide any assurances that we will be profitable.
We believe that our existing cash and cash equivalents will not be sufficient to fund our current operating plans.
Cash Flows
For the year ended December 31, 2023 and 2022
The following table shows
a summary of our cash flows for the year ended December 31, 2023 and 2022.
Year Ended December 31,
2023
2022
Net cash used in operating activities
$
(1,602,218
)
$
(1,584,918
)
Net cash provided by investing activities
3,936,861
5,500
Net cash (used in) provided by financing activities
(1,695,273
)
1,156,611
Net increase (decrease) in cash
639,370
(422,807
)
Cash - beginning of the year
97,091
519,898
Cash - end of the year
$
736,461
$
97,091
Net Cash Used in Operating Activities:
Net cash flow used in operating
activities was $1,602,218 for the year ended December 31, 2023 as compared to net cash flow used in operating activities of $1,584,918
for the year ended December 31, 2022, an increase of $17,300.
Net cash flow used in operating
activities for the year ended December 31, 2023 primarily reflected net income of $1,886,807, which was then adjusted for the add-back
(deduction) of non-cash items primarily consisting of depreciation and amortization of $88,859, stock-based compensation expense of $42,183,
stock-based professional fees of $121,950, amortization of debt discount of $96,258, non-cash interest expense for put premiums of $29,212,
non-cash gain on debt extinguishment and inducement expense of $481,832, bad debt expense of $21,296, a gain from the sale of property
and equipment of $9,000, and a gain from sale of nanoShield product line of $4,051,709, and changes in operating assets and liabilities
consisting primarily of an increase in accounts receivable of $175,945, an increase in inventory of $113,712, a decrease in accounts payable
of $69,543, an increase in contract liabilities of $478,083, an increase in accrued compensation of $357,822, an increase in accrued expenses
of $183,647, and a decrease in accrued interest – related party of $10,027.
Net cash flow used in operating
activities for the year ended December 31, 2022 primarily reflected a net loss of $5,156,478, which was then adjusted for the add-back
(deduction) of non-cash items primarily consisting of depreciation and amortization of $89,219, stock-based compensation expense of $1,039,943,
stock-based professional fees of $298,571, amortization of debt discount of $1,059,752, non-cash interest expense for default penalty
and put premiums of $296,981, bad debt expense of $7,716, gain on sale of property and equipment of $(5,500), and a non-cash loss on debt
extinguishment of $343,895, and changes in operating assets and liabilities consisting primarily of an increase in accounts receivable
of $100,160, a decrease in inventory of $5,485, an increase in prepaid expenses of $746, a decrease in contract assets of $82,526, a decrease
in accounts payable of $49,709, an increase in accrued expenses of $299,660, an increase in contract liabilities of $12,211, an increase
in accrued compensation of $180,609, and an increase in accrued interest – related party of $10,027.
.
Net Cash Provided by Investing Activities:
Net cash provided by investing
activities was $3,936,861 for the year ended December 31, 2023 as compared to $5,500 for the year ended December 31, 2022. During the
year ended December 31, 2023, we received net proceeds of $4,042,631 from the sale of our nanoShield product line and related technologies
and $9,000 from the sale of property and equipment. Additionally, we purchased property and equipment for $114,770. During the year ended
December 31, 2022, we received proceeds of $5,500 from the sale of property and equipment.
Net Cash (Used in) Provided by Financing Activities:
Net cash used in financing
activities was $(1,695,273) for the year ended December 31, 2023 as compared to net cash provided by financing activities of $1,156,611
for the year ended December 31, 2022.
During the year ended December
31, 2023, we received net proceeds from the sale of our common stock to our chief executive officer of $275,000, we received net proceeds
from convertible notes payable of $50,000, and we received proceeds from notes payable of $291,621. These proceeds were offset by the
repayment of notes payable of $1,824,144, the repayment of note payable – related party of $250,000, and the repayment of convertible
notes payable of $237,750.
During the year ended December
31, 2022, we received net proceeds from notes payable of $903,760, received proceeds from a related party note payable of $250,000, and
received net proceeds from convertible notes payable of $160,000. These proceeds were offset by the repayment of notes payable of $157,149.
21
Funding Requirements
We expect the primary use
of capital to continue to be salaries, legal, accounting and regulatory expenses and general overhead costs including sales and marketing.
Additional uses of capital will include additional headcount, tools and equipment, capacity expansion and operational control software.
We believe current cash and cash equivalents will not be sufficient to meet anticipated cash requirements. Additional capital will be
required to further research new product verticals and enhancements to current product offerings based on customer requirements.
As of December 31, 2023, we
determined that there was substantial doubt about our ability to maintain operations as a going concern. Our consolidated financial statements
have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments
in the normal course of business. Management cannot provide assurance that we will ultimately achieve profitable operations or become
cash flow positive or raise additional debt and/or equity capital. We will seek to raise capital through additional debt and/or equity
financings to fund operations in the future. Although we have historically raised capital from sales of common and preferred shares, from
the issuance of notes payable, and from the issuance of convertible promissory notes, there is no assurance that it will be able to continue
to do so. If we are unable to raise additional capital or secure additional lending in the near future, management expects that the Company
will need to curtail its operations. Our consolidated financial statements do not include any adjustments related to the recoverability
and classification of assets or the amounts and classification of liabilities that might be necessary should the company be unable to
continue as a going concern.
On March 1, 2024, we executed
a Promissory Note (“Note”) in favor of 1800 Diagonal Lending LLC (the “Investor”) in the aggregate principal amount
of $157,000 (the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of
a default, as discussed below, is the Note convertible into shares of the Company’s common stock. The Note was funded on March 4,
2023, in the amount of $125,000, which is net of an original issue discount of $13,000 and a one-time interest charge of $19,000. A one-time
interest charge of twelve percent (12%) (the “Interest Rate”) was applied on the issuance date to the Principal. Under the
terms of the Note, the Company is required to make monthly payments as outlined in the Note, beginning on August 30, 2024 and the Note
matures on December 30, 2024. Any amount of principal or interest on this Note which is not paid when due shall bear interest at the rate
of 22% per annum from the due date thereof until the same is paid (“Default Interest”).
Monthly payment shall be as follows:
Payment Date
August 30, 2024
$
87,920
September 30, 2024
$
21,980
October 30, 2024
$
21,980
November 30, 2024
$
21,980
December 30, 2024
$
21,980
Total
$
175,840
Among other things, an event
of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether
at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the Note shall become immediately due and payable
and the Company shall pay to the Investor, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of
the then outstanding principal amount of this Note plus accrued and unpaid interest on the unpaid principal amount of this Note to the
date of payment plus Default Interest, if any. At any time following an Event of Default, the Holder shall have the right to convert all
or any part of the outstanding and unpaid amount of this Note into fully paid and non-assessable shares of the Company’s Common
Stock. The conversion price (the “Conversion Price”) shall be the greater of $0.0025 per share (the “Fixed Conversion
Price”) or 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing
a discount rate of 35%) (the “Variable Conversion Price”). At no time may the Note be converted into shares of our common
stock if such conversion would result in the Investor and its affiliates owning an aggregate of in excess of 4.99% of the then outstanding
shares of our common stock.
Our forecast of the period
of time through which our financial resources will be adequate to support our operations is a forward-looking statement that involves
risks and uncertainties, and actual results could vary materially because of a number of factors. We have based this estimate on assumptions
that may prove to be wrong and could utilize our available capital resources sooner than we currently expect. Our capital requirements
are difficult to forecast. Please see the section titled “Risk Factors” in this Annual Report on Form 10-K for additional
risks associated with our capital requirements.
Until such time as we generate
substantial product revenue to offset operational expenses, we expect to finance our cash needs through a combination of public and private
equity offerings and debt financings. We may be unable to raise capital or enter into such other arrangements when needed or on favorable
terms or at all. Our failure to raise capital or enter into such other arrangements as and when needed would have a negative impact on
our financial condition.
22
Contractual Obligations and Off-Balance Sheet Arrangements
Contractual Obligations
We have certain fixed contractual
obligations and commitments that include future estimated payments. Changes in our business needs, cancellation provisions, changing interest
rates, and other factors may result in actual payments differing from the estimates. We cannot provide certainty regarding the timing
and amounts of payments. We have presented below a summary of the most significant assumptions used in our determination of amounts presented
in the tables, to assist in the review of this information within the context of our consolidated financial position, results of operations,
and cash flows.
The following tables summarize
our contractual obligations as of December 31, 2023, and the effect these obligations are expected to have on our liquidity and cash flows
in future periods.
Payments Due by Period
Contractual obligations:
Total
Less than 1 year
1-2 years
3-5 years
5 + years
Notes payable
$
124,781
$
82,672
$
28,705
$
13,404
$
-
Convertible note payable
1,098,091
180,000
918,091
-
-
Interest on notes payable
176,800
176,800
-
-
-
Operating lease gross base rent
183,054
75,866
107,188
-
-
Total
$
1,582,726
$
515,338
$
1,053,984
$
13,404
$
-
As disclosed elsewhere, in
connection with net proceeds received from the sale of our C-Bond nanoShield product line, we repaid or settled substantially all our
notes payable and a portion of our convertible notes payable. We enter into agreements in the normal course of business with contracted
research and testing organization, product distribution and material vendors which are payable or cancelable at any time with 30-day prior
written approval.
Off-balance Sheet Arrangements
We do not have any off-balance
sheet arrangements during the period presented as defined in the rules and regulations of the SEC.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK
Not applicable.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY
DATA
Our consolidated financial
statements, together with the related notes and report of independent registered public accounting firm, are set forth on the pages indicated
in Item 15, Part IV of this Report.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
ITEM 9A. CONTROLS AND PROCEDURES
Disclosure controls and procedures
We maintain “disclosure
controls and procedures,” as that term is defined in Rule 13a-15(e) and 15d-15(e), promulgated by the SEC pursuant to the Securities
Exchange Act of 1934, as amended (the “Exchange Act”). Disclosure controls and procedures include controls and procedures
designed to ensure that information required to be disclosed in our company’s reports filed under the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is
accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely
decisions regarding required disclosure. Our management, with the participation of our principal executive officer and principal financial
officer, evaluated our company’s disclosure controls and procedures as of the end of the period covered by this annual report on
Form 10-K. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of December 31,
2023, our disclosure controls and procedures were not effective. The ineffectiveness of our disclosure controls and procedures was due
to material weaknesses, which we identified, in our report on internal control over financial reporting.
23
Internal control over financial reporting
Management’s annual report on internal
control over financial reporting
Our management, including
our principal executive officer and principal financial officer, are responsible for establishing and maintaining adequate internal control
over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our management, with the participation of our principal
executive officer and principal financial officer, evaluated the effectiveness of our internal control over financial reporting as of
December 31, 2023. Our management’s evaluation of our internal control over financial reporting was based on the 2013 framework
in Internal Control-Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this
evaluation, our management concluded that as of December 31, 2023, our internal control over financial reporting was not effective.
The ineffectiveness of our
disclosure controls and procedures was due to the following material weaknesses in our internal control over financial reporting: (1)
the lack of multiples levels of management review on complex business, accounting and financial reporting issues, and (2) a lack of adequate
segregation of duties as a result of our limited financial resources to support hiring of personnel.
Until such time as we expand our staff to include
additional accounting and executive personnel, it is likely we will continue to report material weaknesses in our internal control over
financial reporting.
A material weakness is a
deficiency or a combination of control deficiencies in internal control over financial reporting such that there is a reasonable possibility
that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.
Limitations on Effectiveness of Controls
Internal control over financial
reporting cannot provide absolute assurance of achieving financial reporting objectives because of its inherent limitations. Internal
control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns
resulting from human failures. Internal control over financial reporting can also be circumvented by collusion or improper management
override. Because of such limitations, there is a risk that material misstatements may not be prevented or detected on a timely basis
by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process.
Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.
Changes in internal control over financial
reporting
There were no changes in
our internal control over financial reporting during the fourth quarter of our fiscal year ended December 31, 2023 that have materially
affected, or are reasonably likely to materially affect, our internal control over financial reporting.
ITEM 9B. OTHER INFORMATION
None.
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS
THAT PREVENT INSPECTIONS
Not applicable.
24
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND
CORPORATE GOVERNANCE
The following table sets
forth certain information regarding our current directors and executive officers:
Name
Age
Position
Scott R. Silverman
60
Chief Executive Officer, Interim Chief Financial Officer, Treasurer, Chairman of the Board and Director
Allison Tomek
48
President, Vice President of Corporate Communications, Secretary and Director
Barry M. Edelstein
59
Director
Scott R. Silverman has
been the Chairman of the Board and a director of the Company since June 1, 2018. Mr. Silverman has served as Chief Executive Officer of
C-Bond Systems, LLC since December 2017 and Interim Chief Financial Officer since March 8, 2021. From 2003 to 2011, Mr. Silverman
served as Executive Chairman of VeriChip Corporation which completed an initial public offering on the NASDAQ in 2007 raising more than
$30 million. VeriChip Corporation subsequently sold to Stanley Works in 2008. From 2011 to 2016, Mr. Silverman founded and served
as Chairman and Chief Executive Officer of Veriteq Corporation, a leader in RFID technology for medical devices which went public in 2013
and was subsequently sold to a leading breast implant manufacturer. Mr. Silverman is a graduate from the University of Pennsylvania and
Villanova University School of Law. We believe that Mr. Silverman’s knowledge of our company, industry and business makes him
well-suited to serve on the board of directors.
Allison Tomek has
served as Vice President of Corporate Communications and Corporate Secretary since April 2018, and as President and Director since March
8, 2021. She was previously Senior Vice President Investor Relations at PositiveID Corporation from 2007 to 2018, as well as Vice President
of Investor Relations at Veriteq Corporation from 2011 to 2015. She served as the director of investor relations and corporate communications
at Andrx Corporation at the time of its acquisition by Watson Pharmaceuticals in 2006 for $1.9 billion. She is a former two-time President
of the National Investor Relations Institute, South Florida chapter. She holds a B.S. in News/Editorial from the School of Journalism
and Mass Communication at the University of Colorado, Boulder. We believe that Ms. Tomek’s knowledge of our company, regulations,
and business makes her well-suited to serve on the board of directors.
Barry M. Edelstein has
been a director on the Board of the Company since June 1, 2018. Since June 2008, Mr. Edelstein has served as a Managing Partner of Structured
Growth Capital, Inc., which provides monetization financing to non-investment grade entities. Since January 2002, Mr. Edelstein
has also served as President and CEO of ScentSational Technologies, LLC, a leader in developing, patenting and licensing Olfaction Packaging
technologies to food, beverage and other consumer products companies. Mr. Edelstein has a JD from the Widener University School of Law
and a Bachelor of Science in Business Administration, Marketing from Drexel University’s LeBow College of Business. Mr. Edelstein
brings a wealth of operational and financial experience to our board as well as a deep knowledge of the packaging industry.
Terms of Office
All directors will hold office
until the next annual meeting of stockholders or until their successors have been elected and qualified or appointed, unless sooner displaced.
Family Relationships
There are no family relationships
between or among any of our directors or executive officers.
Director Independence
The Company’s securities
are not listed on a national securities exchange, or an inter-dealer quotation system which has requirements that a majority of the board
of directors be independent. No member of the Board of Directors other than Mr. Edelstein is independent, as that term is defined in the
listing standards of The Nasdaq Stock Market.
Board Meetings; Annual Meeting Attendance
During the fiscal year ended
December 31, 2023, the Board held one board meeting in person and via teleconference, and acted via unanimous written consent on
8 occasions. The Company did not hold an annual meeting.
Holders of our securities
can send communications to the Board via mail or telephone to the Secretary at the Company’s principal executive offices. The Company
has not yet established a policy with respect to our directors’ attendance at the annual meetings. A stockholder who wishes to communicate
with the Board may do so by directing a written request addressed to our Corporate Secretary at the address appearing on the cover page
of this Annual Report.
Committees of the Board of Directors
As our Common Stock is not
presently listed for trading on a national securities exchange, we are not required to have board committees. However, the Company has
an audit committee which is comprised of Mr. Edelstein, an independent director.
25
Code of Business Conduct and Ethics
On March 12, 2019, we adopted
a Code of Business Conduct and Ethics that applies to our principal executive officer, principal financial officer, principal accounting
officer or controller, or persons performing similar functions in that our officers and directors serve in these capacities. A copy of
the Code of Business Conduct and Ethics is available, without charge, on our website at http://cbondsystems.com/. We intend to satisfy
the disclosure requirements of Form 8-K regarding any amendment to, or a waiver from, any provision of our Code of Business Conduct and
Ethics by posting such amendment or waiver on our website.
Board Leadership Structure and Role in Risk
Oversight
Currently, the Board is comprised
of three directors: Scott Silverman, Allison Tomek and Barry Edelstein, with Scott Silverman serving as our Chairman. Scott Silverman
is also our Chief Executive Officer.
The Board recognizes that
the leadership structure and combination or separation of the Chief Executive Officer and Chairman roles is driven by the needs of the
Company at any point in time. We have no policy requiring combination or separation of these leadership roles and our governing documents
do not mandate a particular structure. This has allowed the Board the flexibility to establish the most appropriate structure for the
Company at any given time.
ITEM 11. EXECUTIVE COMPENSATION
The following summarizes
the compensation earned by our executive officers named in the “Summary Compensation Table” below (referred to herein as our
“named executive officers”) in the fiscal years ended December 31, 2023 and 2022.
This section also discusses
the material elements of our executive compensation policies and decisions and important factors relevant to an analysis of these policies
and decisions. It provides qualitative information regarding the manner and context in which compensation is awarded to and earned by
our named executive officers and is intended to place in perspective the information presented in the following tables and the corresponding
narrative.
Overview
Our named executive officers
for the years ended December 31, 2023 and 2022, are as follows:
●
Scott R. Silverman – Chief Executive Officer and Chief Financial Officer;
●
Allison Tomek – President, Vice President of Corporate Communications and Secretary;
2023 Summary Compensation Table
The following table sets
forth information regarding compensation awarded to, earned by or paid to each of the named executive officers for the years ended December
31, 2023 and 2022.
Name and Principal Position
Year
Salary
($)
Bonus ($) (1)
Stock
Awards
($) (2)
Option Awards
($)
All Other Compensation
($)
Total
($)
Scott R. Silverman
2023
495,232
(3)
322,375
-
-
6,054
(6)
823,661
Chief Executive Officer, Interim Chief Financial Officer and Treasurer
2022
450,211
(3)
155,469
-
-
681,740
(4)(6)
1,287,420
Allison Tomek
2023
192,000
(3)
182,625
-
-
-
374,625
President, Vice President of Corporate Communications, Secretary
2022
180,000
(3)
70,219
-
-
279,000
(5)
529,219
(1)
Cash bonuses earned by Mr. Silverman
and Ms. Tomek in 2023 were based on a bonus approved by the Board of Directors in December 2023 and also included bonuses accrued or paid
based on a percentage of capital raises, in accordance with Mr. Silverman’s employment agreement. In connection with the December
2023 bonus, Mr. Silverman and the Company agreed to pay 50% of the 2023 year-end bonus in Series B preferred stock rather than cash, which
was issued in January 2024. In connection with the December 2023 bonus, Ms. Tomek and the Company agreed to pay 90% of the 2023 year-end
bonus in Series B preferred stock rather than cash, which was issued in January 2024. Cash bonuses earned by Mr. Silverman and Ms. Tomek
in 2022 were based on a bonus approved by the Board of Directors in December 2022 and also included bonuses accrued or paid based on a
percentage of capital raises, in accordance with Mr. Silverman’s employment agreement.. In connection with the December 2022 bonus,
the bonus recipients and the Company agreed to pay 90% of the 2022 year-end bonus in Series B preferred stock rather than cash.
(2)
As required by SEC rules, the amounts
in this column reflect the grant date or modification date fair value as required by FASB ASC Topic 718. A discussion of the assumptions
and methodologies used to calculate these amounts, are contained in the notes to our financial statements under “Note 10 –
Shareholders’ Deficit”.
(3)
Includes accrued and unpaid deferred compensation.
26
(4)
On January 6, 2022, Mr. Silverman’s
Series B preferred share issuance included non-cash compensation of $678,556 related to the conversion of accrued compensation to convertible
Series B preferred shares. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial
on the issue date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur any
time from the date of issuance, during the year ended December 31, 2022, the Company immediately recorded non-cash stock-based compensation
of $678,556 related to the beneficial conversion feature arising from the issuance of Series B Preferred Stock which is included in Stock
Awards.
(5)
In 2022, in lieu of cash compensation, Ms. Tomek received 81 shares of series B preferred shares for unpaid and deferred compensation. In 2022, Ms. Tomek’s series B preferred share issuance included non-cash compensation of $279,000 related to the conversion of accrued compensation to convertible Series B preferred shares. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial on the issue date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur any time from the date of issuance, during the year ended December 31, 2022, the Company immediately recorded non-cash stock-based compensation of $279,000 related to the beneficial conversion feature arising from the issuance of Series B Preferred Stock which is included in Stock Awards.
(6)
Includes reimbursement of medical expenses of $6,054 and $3,184 in 2023 and 2022, respectively.
Narrative Disclosure to Summary Compensation
Table
Except as otherwise described
below, there are no compensatory plans or arrangements, including payments to be received from the Company with respect to any named executive
officer, that would result in payments to such person because of his or her resignation, retirement or other termination of employment
with the Company, or our subsidiaries, any change in control, or a change in the person’s responsibilities following a change in
control of the Company.
Employment Agreement with Executive Officer
Employment Agreement with Scott R. Silverman
We entered into an employment
agreement with Mr. Silverman on October 18, 2017, pursuant to which he serves as our Chief Executive Officer for an initial term of three
years that extends for successive one-year renewal terms unless either party gives 30-days’ advance notice of non-renewal. As consideration
for these services, the employment agreement provides Mr. Silverman with the following compensation and benefits:
●
An
annual base salary of $300,000, with a 10% increase on each anniversary date contingent upon achieving certain performance objectives
as set by the Board.
●
When
the first $500,000 of equity investments was raised by the Company after entering into this employment agreement, Mr. Silverman receives
a capital raise success bonus of 5% of all equity capital raised from investors/lenders introduced by him to the Company.
●
Annual
cash performance bonus opportunity as determined by the Board.
●
An
option to acquire 3,000,000 common shares of the Company, with a strike price of $0.31 per share. These options vested pro rata on a
monthly basis for the term of the employment agreement. On each anniversary, Mr. Silverman will be eligible to be granted a minimum of
500,000 stock options of the Company at a strike price of $0.85 per common share contingent upon the achievement of certain performance
objectives.
●
Certain
other employee benefits and perquisites, including reimbursement of necessary and reasonable travel and participation in retirement and
welfare benefits.
Mr. Silverman’s employment
agreement provides that, in the event that his employment is terminated by the Company without “cause” (as defined in his
employment agreement), or if Mr. Silverman resigned for “good reasons” (as defined in his employment agreement), subject to
a complete release of claims, he will be entitled to (i) retain all stock options previously granted; and (ii) receive any benefits then
owed or accrued along with one year of base salary and any unreimbursed expenses incurred by him. All amounts shall be paid on the termination
date. In the event that Mr. Silverman’s employment is terminated by the Company for “cause” (as defined in his employment
agreement), or if Mr. Silverman resigned without “good reasons” (as defined in his employment agreement), subject to a complete
release of claims, he will be entitled to receive any unpaid base salary and benefits then owed or accrued and any unreimbursed expenses
incurred by him. Additionally, if a change of control (as defined in his employment agreement) occurs during the term of this agreement,
all unvested stock options will vest in full, and Mr. Silverman shall be paid a bonus equal to three times his current minimum base salary
and minimum target bonus.
Pursuant to the employment
agreement, Mr. Silverman is subject to a confidentiality covenant, a two-year post-termination non-competition covenant and a two-year
post-termination non-solicitation covenant. On June 30, 2020, the Company amended the employment agreement of Mr. Silverman to provide
for successive one-year extensions until either the executive or the Board of Directors of the Company gives notice to terminate the employment
agreement per its terms. This employment agreement amendment also included an allowance of up to $10,000 per year to cover uncovered medical/dental
expenses for Mr. Silverman and his family.
27
Elements of Executive Compensation
Base Salaries.
Base salaries for the named executive officers during 2023 and 2022 were determined, subject in each case to their employment agreements,
on the scope of each officer’s responsibilities along with his or her respective experience and contributions during the prior year.
When reviewing base salaries, our board of directors took factors into account such as each officer’s experience and individual
performance, company performance as a whole, and general industry conditions, but did not assign any specific weighting to any factor.
Equity Awards.
Equity awards granted by the board of directors to the named executive officers during 2023 and 2022 were determined based on their employment
agreements, on the scope of each officer’s responsibilities along with his or her respective experience and contributions during
the prior year. When reviewing equity awards, our board of directors took factors into account such as each officer’s experience
and individual performance, company performance as a whole, and general industry conditions, but did not assign any specific weighting
to any factor.
Capital Raise Success
Bonus. Pursuant to Mr. Silverman’s employment agreement, he receives a capital raise success bonus of 5% of all equity capital
raised from investors/lenders introduced by him to the Company. Mr. Silverman agreed to share this capital raise bonus with other executives.
Bonus. In December
2023, the board of directors approved a bonus to Mr. Silverman and Ms. Tomek of $300,000 and $180,000, respectively. In December 2022,
the board of directors approved a bonus to Mr. Silverman and Ms. Tomek of $100,000 and $60,000, respectively.
Other Benefits.
On June 30, 2020, we amended the employment agreement of Mr. Silverman to include an allowance of up to $10,000 per year to cover uncovered
medical/dental expenses for Mr. Silverman and his family. Currently, we do not offer any additional benefit packages to other employees.
Outstanding Equity Awards at Fiscal Year-End
The following are the outstanding
equity awards for the named executive officers as of December 31, 2023:
Option Awards
Name
Number of
Securities
Underlying
Unexercised
Options
(Exercisable)
Number of
Securities
Underlying
Unexercised
Options
(Unexercisable)
Equity Incentive
Plan Awards:
Number of
Securities
Underlying
Unexercised Unearned
Options
Option
Exercise
Price
($)(1)
Option
Expiration
Date
Scott R. Silverman
3,000,000
(2)
-
0
$
0.31
10/18/2027
(1)
This reflects the exercise price of such options.
(2)
These shares were fully vested prior to 2021.
Stock Awards
Name
Number of Shares or Units of Stock That Have Not Vested (#)
Market Value of Shares or Units of Stock That Have Not Vested
($)(*)
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested
(#)
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)
Scott R. Silverman (1)
6,970,120
$
38,336
6,970,120
$
38,336
Allison Tomek (2)
4,750,000
$
26,125
4,750,000
$
26,125
*
The market value of shares of stock is computed by multiplying the closing market price of our stock at the end of the last completed fiscal year of December 31, 2023 of $0.0055 by the number of shares of stock set forth to the left of such figure.
(1)
6,970,120 shares vest on May 1, 2024, as extended by agreement. As of December 31, 2023, Mr. Silverman also owns 745 shares of Series B Preferred stock, which may convert into approximately 244,916,835 common shares.
(2)
4,750,000 shares vest on May 1, 2024, as extended per agreement. As of December 31, 2023, Ms. Tomek also owns 200 shares of Series B Preferred stock, which may convert into approximately 65,049,675 common shares.
28
C-Bond Systems, Inc. 2018 Long-Term Incentive
Plan
On June 7, 2018, our Board
of Directors and our stockholders approved the C-Bond Systems, Inc. 2018 Long-Term Incentive Plan (the “2018 Plan”), which
became effective on August 2, 2018. The purposes of the 2018 Plan is to advance the interests of the Company, its affiliates and its stockholders
and promote the long-term growth of the Company by providing employees, non-employee Directors and third-party service providers with
incentives to maximize stockholder value and to otherwise contribute to the success of the Company and its affiliates, thereby aligning
the interests of such individuals with the interests of the Company’s stockholders and providing them additional incentives to continue
in their employment or affiliation with the Company.
Summary of the Plan
Administration
The 2018 Plan will be administered
by a committee designated by the Board of Directors (the “Committee”) or, in the absence of the Committee or in the case of
awards issued to non-employee Directors, the 2018 Plan will be administered by the Board of Directors (as applicable, the “Administrator”). The
Administrator also has full and exclusive power and authority to administer the 2018 Plan. In administering awards under our 2018
Plan, the Administrator, has the power, subject to the terms of the 2018 Plan, to determine the terms of the awards granted under our
2018 Plan, including any applicable exercise or grant price, the number of shares subject to each award and the exercisability of the
awards. The Administrator also has full power to determine the persons to whom and the time or times at which awards will be made
and to make all other determinations and take all other actions advisable for the administration of the 2018 Plan.
On a calendar year basis,
the Board of Directors may, by resolution, delegate to the Chief Executive Officer of the Company the limited authority to grant awards
under the 2018 Plan during such calendar year to designated classes of employees, who are not officers of the Company or any affiliate
and subject to the provisions of Section 16 of the Exchange Act, and to service providers.
Types of Awards
Under our 2018 Plan, the
Administrator may grant:
●
options
to acquire our Common Stock, both incentive stock options that are intended to satisfy the requirements of Section 422 of the Internal
Revenue Code and nonqualified stock options which are not intended to satisfy such requirements. The exercise price of options granted
under our 2018 Plan must at least be equal to the fair market value of our Common Stock on the date of grant and the term of an option
may not exceed ten years, except that with respect to an incentive stock option granted to any employee who owns more than 10% of the
voting power of all classes of our outstanding stock as of the grant date the term must not exceed five years and the exercise price
must equal at least 110% of the fair market value on the grant date.
●
stock appreciation rights, or SARs, which allow the recipient to receive the appreciation in the fair market value of our Common Stock between the date of grant and the exercise date. The amount payable under the stock appreciation right may be paid in cash or with shares of our Common Stock, or a combination thereof, as determined by the Administrator.
●
restricted stock awards, which are awards of our shares of Common Stock that vest in accordance with terms and conditions established by the Administrator.
●
restricted stock units, which are awards that are based on the value of our Common Stock and may be paid in cash or in shares of our Common Stock.
●
other types of stock-based or stock-related awards not otherwise described by the terms and provision of the 2018 Plan, including the grant or offer for sale of unrestricted shares of the Company’s Common Stock, and which may involve the transfer of actual shares of the Company’s Common Stock or payment in cash or otherwise of amounts based on the value of shares of our Common Stock and may be designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States.
●
other cash-based awards to eligible persons in such amounts and upon such terms as the Administrator shall determine.
An award granted under the
2018 Plan must include a minimum vesting period of at least one year, provided, however, that an award may provide that the award will
vest before the completion of such one-year period upon the death or qualifying disability of the grantee of the award or a change of
control of the Company and awards covering, in the aggregate, 25,000,000 shares of our Common Stock may be issued without any minimum
vesting period.
29
Shares Authorized for Issuance
The aggregate number of shares
of Common Stock that may be issued under the 2018 Plan and number of shares of our Common Stock that may be subject to incentive stock
options granted under the 2018 Plan is 50,000,000 shares.
Term
The Board may alter, amend,
or terminate our 2018 Plan and the Administrator may alter, amend, or terminate any award agreement in whole or in part; however, no termination,
amendment, or modification shall adversely affect in any material way any award previously granted, without the written consent of the
holder. Our 2018 Plan was adopted on June 7, 2018, became effective on August 2, 2018, and will continue indefinitely until it is terminated
by the Board as provided in the 2018 Plan. However, as required by the Internal Revenue Code, no incentive stock option awards may be
granted under our 2018 Plan on or after the tenth anniversary of the date the plan was adopted by the Board, unless our 2018 Plan is subsequently
amended, with the approval of stockholders, to extend the period for granting such awards.
Disclosure of Equity Awards Based on Material Nonpublic Information:
None
Pay Versus Performance (PVP)
In accordance with the SEC’s
disclosure requirements regarding pay versus performance, or PVP, this section presents the SEC-defined “Compensation Actually Paid,”
or CAP of our PEO and NEOs for each of the fiscal years ended December 31, 2023, 2022 and 2021, and our financial performance. Also as
required by the SEC, this section compares CAP to various measures used to gauge performance at the Company for each such fiscal year.
Also as required by the SEC, this section compares CAP to various measures used to gauge performance at the Company.
Pay versus Performance Table - Compensation
Definitions
Salary, Bonus, Stock Awards,
and All Other Compensation are each calculated in the same manner for purposes of both CAP and Summary Compensation Table, or SCT values.
The primary difference between the calculation of CAP and SCT total compensation is the calculation of the value of “Stock Awards,”
with the table below describing the differences in how these awards are valued for purposes of SCT total and CAP:
SCT Total
CAP
Stock Awards
Grant date fair value of stock awards granted during the year
Fair value of stock awards that are unvested as of the end of the year, or vested during the year
Pay Versus Performance Table
In accordance with the SEC’s
PVP rules, the following table sets forth information concerning the compensation of our NEOs for each of the fiscal years ended December
31, 2023, 2022 and 2021, and our financial performance for each such fiscal year:
Year (1)
Summary Compensation Table Total for PEO
Compensation Actually Paid to PEO (2)(3)
Average Summary Compensation Table Total for Non-PEO NEOs
Average Compensation Actually Paid to Non-PEO NEOs
Value of Initial Fixed $100 Investment Based On Total Shareholder Return
Net Income (Loss)
2023
$
823,661
$
804,842
$
374,625
$
381,800
$
5.00
$
1,886,807
2022
$
1,287,420
$
1,146,624
$
529,219
$
473,669
$
7.45
$
(5,156,478
)
2021
$
3,202,434
$
2,633,672
$
1,027,876
$
211,683
$
25.82
$
(7,128,858
)
(1)
The
PEO (CEO) in the 2023, 2022 and 2021 reporting year is Scott Silverman. The non-PEO NEO in the 2023 and 2022 reporting year is Allison
Tomek. The non-PEO NEO’s in the 2021 reporting year was Vince Pugliese and Allison Tomek.
(2)
The
CAP was calculated beginning with the PEO’s and NEO’s SCT total. In 2023, 2022 and 2021, the following amounts were deducted
from and added to the applicable SCT total compensation:
30
SCT Total
Stock awards deducted from SCT
Increase for fair value of awards granted during the year that remain unvested as of year end
Decrease for change in fair value from prior year-end to current year- end for awards granted in prior years and unvested as of year end
Other adjustments
Total CAP
(A)
(B)
(C)
(D)
(E)
A - B + C + E
PEO
2023
823,661
-
-
(18,819
)
-
804,842
2022
1,287,420
-
-
(140,796
)
-
1,146,624
2021
3,202,434
-
-
(568,762
)
-
2,633,672
Average Non-PEO NEO
2023
374,625
-
-
(12,825
)
-
361,800
2022
529,219
-
-
(55,550
)
-
473,669
2021
1,027,876
(132,000
)
16,400
(700,593
)
-
211,683
(3)
The fair value of stock awards reported for CAP purposes in columns
(C) and (D) are based on the quoted closing price of the Company’s common stock on the vesting date or the year end date for unvested
stock awards in accordance with the SEC rules. See Note 9, “Shareholder’s Deficit” in the Notes to the Company’s
Consolidated Financial Statements for the fiscal years ended 2023 and 2022 included in the Company’s Annual Report on Form 10-K
for the year ended 2023 for more information regarding the Company’s accounting for share-based compensation.
Director Compensation
Our non-executive board member
receives $5,000 in cash compensation each quarter plus $2,500 per quarter for serving as committee chair.
The following table sets
forth compensation paid, earned or awarded during 2023 to each of our directors, other than Scott Silverman and Allison Tomek, whose compensation
is described in “Summary Compensation Table”.
2023 Director Compensation
Name
Fees Earned or Paid in Cash ($)
Stock Awards ($)
All Other Compensation ($)
Total ($)
Barry M. Edelstein
30,000
-
-
30,000
Directors are also entitled
to the protection provided by the indemnification provisions in our articles of incorporation, as amended, and our amended and restated
bylaws.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The following table sets
forth certain information relating to the beneficial ownership of our common stock as of March 29, 2024, by:
●
each person, or group of affiliated persons, known by us to beneficially own more than five percent of the outstanding shares of our common stock;
●
each of our directors;
●
each of our named executive officers; and
●
all directors and executive officers as a group.
The number of shares beneficially
owned by each entity, person, director or executive officer is determined in accordance with the rules of the SEC, and the information
is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares
over which the individual has sole or shared voting power or dispositive power as well as any shares that the individual has the right
to acquire within 60 days of March 29, 2024 through the exercise of any stock option, warrants or other rights. Except as otherwise indicated,
and subject to applicable community property laws, the persons named in the table have sole voting and dispositive power with respect
to all shares of common stock held by that person.
31
The percentage of shares
beneficially owned is computed on the basis of 539,122,586 shares of our common stock outstanding as of March 29, 2024, the implied conversion
of 1,386 shares of our Series B Preferred Stock and related accrued dividends as of March 29, 2024 into 463,697,291 shares of common stock,
and the implied conversion of 15,150 shares of our Series C Preferred Stock and related accrued dividends as of March 29, 2024 into 438,151,351
shares of common stock for total shares outstanding of 1,396,643,140. Shares of common stock that a person has the right to acquire within
60 days of March 29, 2024, are deemed outstanding for purposes of computing the percentage ownership of the person holding such rights,
but are not deemed outstanding for purposes of computing the percentage ownership of any other person, except with respect to the percentage
ownership of all directors and executive officers as a group. As a result of the Company’s issuance of 1,386 shares of Series B
Preferred Stock, which carries majority voting rights of 50 votes of Common Stock to every 1 share of Series B Preferred Stock, to named
executive officers and directors, they have the rights to 21,050,712,091 votes through their Series B holdings, of a total of 21,589,834,677
votes. The percentage of voting rights in the table below assumes that all Series B shares held by directors and named officers are voted
in any instance requiring shareholder vote. Unless otherwise noted below, the address of the persons listed on the table is c/o C-Bond
Systems, Inc., 2029 Pat Booker Rd., San Antonio, TX 78148.
Name of Beneficial Owner
Common
Stock
Beneficially Owned
Percent of
Outstanding Shares
Percent of
Voting Rights
Named Executive Officers and Directors:
Scott Silverman (2)
334,278,536
41.3
%
62.1
%
Barry M. Edelstein (3)
40,030,434
7.1
%
6.3
%
Allison Tomek (4)
120,059,055
18.3
%
26.7
%
All directors and executive officers as a group (3 persons) (5)
494,368,025
66.7
%
95.1
%
Other Greater Than 5% Stockholders:
Jeff Badders (1)
30,844,916
6.9
%
*
Mike Wanke
28,021,016
6.3
%
*
Mercer Street Global
Opportunity Fund, LLC (6)
26,902,217
4.9
%
*
*
Indicates beneficial ownership of less than 1% of the total outstanding common stock.
(1)
Jeff
Badders has sole voting and dispositive power with respect to these shares. Mr. Badders also holds 12,500 shares of Series C Preferred
Stock, which may convert into a total of 361,511,016 shares of the Company’s Common Stock. The Series C holds no voting rights
and cannot be converted into an amount of more than 4.99% of the Company’s common stock outstanding. Mr. Badders’ address
is 4002 North Street, Nacogdoches, TX 75965.
(2)
Includes (i) 64,315,575 shares outstanding pursuant to restricted stock awards and subscription agreement; (ii) 895 shares of Series B Preferred Stock, which may convert into 266,962,961 shares of Common Stock; and (iii) 3,000,000 shares issuable upon the exercise of vested stock options.
(3)
Includes (i) 12,886,364 shares outstanding pursuant to restricted stock awards; and (ii) 91 shares of Series B Preferred Stock, which may convert into 27,144,070 shares of Common Stock.
(4)
Includes (i) 5,050,000 shares outstanding pursuant to restricted stock awards; and (ii) 362 shares of Series B Preferred Stock, which may convert into 115,009,055 shares of Common Stock.
(5)
Includes (i) 82,251,939 shares held pursuant to restricted stock awards; (iii) 1,348 shares of Series B Preferred Stock, which may convert into 409,116,086 shares of Common Stock; and (iv) 3,000,000 shares issuable upon exercise of vested stock options.
(6)
Mercer Street Global Opportunity Fund, LLC holds 2,250 shares of Series C Preferred Stock, which may convert into a total of 76,640,335 shares of the Company’s Common Stock. The Series C holds no voting rights and cannot be converted into an amount of more than 4.99% of the Company’s common stock outstanding. Mercer Street Global Opportunity Fund, LLC’s address is 1111 Brickell Avenue, Suite 2920, Miami, FL 33131.
32
Equity Compensation Plan Information
The following table sets
forth as of December 31, 2023 information regarding our common stock that may be issued under the Company’s equity compensation
plans:
Plan Category
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights (a)
Weighted Average Exercise Price of Outstanding Options, Warrants and Rights (b)
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding Securities Reflected in Columns (a)) (c) (1)
Equity compensation plans approved by security holders
8,445,698
$
0.40
9,403,232
Equity compensation plans not approved by security holders
-
-
-
Total
8,445,698
$
0.40
9,403,232
*
The
table above includes 8,445,698 options that were issued pursuant to the Merger Agreement (adjusted for forfeitures and exercises since
the issuance), by converting each option to purchase Common Units issued and outstanding immediately prior to the closing of the Merger
into an option to purchase an equivalent number of shares of our common stock.
(1)
Represents
shares available under the C-Bond Systems, Inc. 2018 Long-Term Incentive Plan, under which the Company can issue options, stock appreciation
rights, restricted stock awards, restricted stock units and other types of stock-based awards.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE
In December 2021, the Company
advanced $3,750 to a company partially owned by officers of the Company. The advance was non-interest bearing, payable on demand, and
as of December 31, 2021 was reflected as due from related party on the accompanying consolidated balance sheets. In June 2022, this advance
was deemed uncollectible and the balance was written off to bad debt expense.
For information regarding
the number of restricted shares of stock, preferred stock, or options held by the Company’s executive officers, and directors, or
an affiliate or immediate family member thereof, see “Security Ownership of Certain Beneficial Owners and Management” and
“Executive Compensation.”
33
Our board of directors intends
to adopt a written related person transaction policy, to set forth the policies and procedures for the review and approval or ratification
of related person transactions. This policy will cover, with certain exceptions set forth in Item 404 of Regulation S-K promulgated under
the Exchange Act, any transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships,
in which we were or are to be a participant, where the amount involved exceeds or will exceed the lesser of $120,000 or 1% of the average
of our total assets as of the end of the last two completed fiscal years and a related person had, has or will have a direct or indirect
material interest, including purchases of goods or services by or from the related person or entities in which the related person has
a material interest, indebtedness, guarantees of indebtedness and employment by us of a related person.
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The following table sets
forth the fees billed by our principal independent accountants, Salberg & Company, P.A., for each of our last two fiscal years for
the categories of services indicated.
Years Ended December 31,
Category
2023
2022
Audit Fees
$
92,500
$
100,100
Audit Related Fees
$
-
$
7,500
Tax Fees
$
-
$
-
All Other Fees
$
-
$
-
Audit fees.
Consists of fees billed for the audit of our annual consolidated financial statements included in our Form 10-K, review of our interim
financial statements included in our Form 10-Q and services that are normally provided by the accountant in connection with year-end statutory
and regulatory filings or engagements.
Audit-related fees.
Consists of fees billed for assurance and related services that are reasonably related to the performance of the audit or review
of our consolidated financial statements and are not reported under “Audit Fees”, review of our Forms 8-K filings and services
that are normally provided by the accountant in connection with non-year-end statutory and regulatory filings or engagements.
Tax fees. Consists
of professional services rendered for tax compliance, tax advice and tax planning.
Other fees. The services
provided by our accountants within this category consisted of advice and other services not related to the above categories.
In June 2018, we established
an audit committee, which consists of Barry Edelstein (audit committee chairman). The audit committee’s charter requires that the
audit committee pre-approve all audit and non-audit services that our independent auditors provide to the Company, provided that pre-approval
of non-audit services is not required if (i) the fees for all such services do not aggregate to more than 5% of total fees paid to the
independent auditors in that fiscal year; (ii) such services were not recognized as non-audit services at that time of engagement; and
(iii) such services are promptly brought to the attention of the audit committee and approved by the audit committee prior to the completion
of the audit. Prior to the formation of the audit committee, our board of directors would evaluate the scope and cost of the engagement
of an auditor before the auditor renders audit and audit-related services. All of the audit and audit related fees described above for
fiscal years ended December 31, 2023 and 2022 were pre-approved by the audit committee.
34
PART IV
ITEM 15. EXHIBIT AND FINANCIAL STATEMENT SCHEDULES
A.
The following documents are filed as part of this Report:
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
+
Indicates a management contract or any compensatory plan, contract or arrangement.
*
Filed herewith
**
Furnished herewith
ITEM 16. 10-K SUMMARY
As permitted, the registrant
has elected not to supply a summary of information required by Form 10-K.
37
SIGNATURES
Pursuant to the requirements
of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
C-BOND SYSTEMS, INC.
Date: April 1, 2024
By:
/s/ Scott R. Silverman
Scott R. Silverman
Chief Executive Officer and
Chairman of the Board
POWER OF ATTORNEY
Each person whose signature
appears below hereby appoints Scott R. Silverman as attorney-in-fact with full power of substitution, severally, to execute in the name
and on behalf of the registrant and each such person, individually and in each capacity stated below, one or more amendments to the annual
report on Form 10-K, which amendments may make such changes in the report as the attorney-in-fact acting deems appropriate and to file
any such amendment to the annual report on Form 10-K with the Securities and Exchange Commission. Pursuant to the requirements of the
Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities
and on the dates indicated.
Signature
Title
Date
/s/ Scott R. Silverman
Chief Executive Officer, Interim Chief Financial Officer and Treasurer, Chairman of the Board and Director
April 1, 2024
Scott R. Silverman
(principal executive officer and principal financial and accounting officer)
Report of Independent Registered Public Accounting
Firm
To the Board of Directors and Shareholders of:
C-Bond Systems, Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated
balance sheets of C-Bond Systems, Inc. and Subsidiaries (the “Company”) as of December 31, 2023 and 2022, the related consolidated
statements of operations, changes in shareholders’ deficit, and cash flows, for each of the two years in the period ended December
31, 2023, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the
consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company as of December
31, 2023 and 2022, and the consolidated results of its operations and its cash flows for each of the two years in the period ended December
31, 2023, in conformity with accounting principles generally accepted in the United States of America.
Going Concern
The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements,
the Company has cash used in operations of $1,602,218, in 2023 and a working capital deficit, shareholders’ deficit and accumulated
deficit of $1,351,954, $4,324,535 and $60,851,714 respectively, at December 31, 2023. These matters raise substantial doubt
about the Company’s ability to continue as a going concern. Management’s Plan in regard to these matters is also described
in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These consolidated financial statements are the
responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial
statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated
financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we
engaged to perform, an audit of internal control over financial reporting. As part of our audits we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s
internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess
the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures
that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the
consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by
management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide
a reasonable basis for our opinion.
Critical Audit Matters
The critical audit matters are matters arising
from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit
committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved
our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.
/s/ Salberg & Company, P.A.
SALBERG & COMPANY, P.A.
We have served as the Company’s auditor
since 2017.
Member National Association of Certified
Valuation Analysts ● Registered with the PCAOB
Member CPAConnect with Affiliated
Offices Worldwide ● Member Center for Public Company Audit Firms
F-2
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
December 31,
December 31,
2023
2022
ASSETS
CURRENT ASSETS:
Cash
$
736,461
$
97,091
Accounts receivable, net
424,091
269,442
Inventory
181,663
77,446
Prepaid expenses and other current assets
28,503
71,171
Contract assets
2,400
279
Total Current Assets
1,373,118
515,429
OTHER ASSETS:
Property and equipment, net
171,606
96,306
Right of use asset, net
158,484
375,412
Intangible asset, net
229,414
279,918
Goodwill
350,491
350,491
Security deposit
-
6,482
Total Other Assets
909,995
1,108,609
TOTAL ASSETS
$
2,283,113
$
1,624,038
LIABILITIES AND SHAREHOLDERS' DEFICIT
CURRENT LIABILITIES:
Convertible note payable, net of discount - current portion
$
180,000
$
1,031,250
Notes payable, net of discount - current portion
81,908
1,576,438
Accounts payable
710,222
779,765
Accrued expenses
474,515
736,393
Accrued interest payable - related party
-
10,027
Accrued compensation
717,204
590,632
Contract liabilities
500,720
22,637
Lease liabilities, current portion
60,503
117,671
Total Current Liabilities
2,725,072
4,864,813
LONG-TERM LIABILITIES:
Convertible notes payable, net of current portion
918,091
251,263
Notes payable, net of current portion and discount
42,109
208,804
Note payable - related party
-
250,000
Lease liabilities, net of current portion
97,249
258,895
Total Long-term Liabilities
1,057,449
968,962
Total Liabilities
3,782,521
5,833,775
Commitments and Contingencies (See Note 10)
Series B convertible preferred stock: $0.10 par value, 100,000 shares designated; 1,144 and 1,000 shares issued and outstanding at December 31, 2023 and 2022, respectively ($1,203,967 redemption and liquidation value at December 31, 2023)
1,203,967
1,037,201
Series C convertible preferred stock: $0.10 par value, 100,000 shares designated; 15,150 and 17,290 shares issued and outstanding at December 31, 2023 and 2022, respectively ($2,431,740 redemption and liquidation value at December 31, 2023)
1,621,160
1,803,731
SHAREHOLDERS' DEFICIT:
Preferred stock: $0.10 par value, 2,000,000 shares authorized; 100,000 Series B and 100,000 Series C designated, none issued and outstanding
-
-
Common stock: $0.001 par value, 4,998,000,000 shares authorized; 532,818,051 and 350,270,172 issued and outstanding at December 31, 2023 and 2022, respectively
532,818
350,270
Additional paid-in capital
55,852,477
55,141,503
Accumulated deficit
(60,851,714
)
(62,693,184
)
Total C-Bond Systems, Inc. shareholders' deficit
(4,466,419
)
(7,201,411
)
Noncontrolling interest
141,884
150,742
Total Shareholders' Deficit
(4,324,535
)
(7,050,669
)
Total Liabilities and Shareholders' Deficit
$
2,283,113
$
1,624,038
See accompanying notes to
the consolidated financial statements.
F-3
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
For the Year Ended
December 31,
2023
2022
SALES:
$
2,488,493
$
2,232,646
COST OF SALES (excluding depreciation expense)
1,180,979
954,402
GROSS PROFIT
1,307,514
1,278,244
OPERATING EXPENSES:
Compensation and related benefits (including stock-based compensation of $42,183 and $1,039,943 for the years ended December 31, 2023, and 2022, respectively)
(2,036,514
)
(2,844,783
)
Professional fees
(601,214
)
(815,542
)
General and administrative expenses
(666,090
)
(810,413
)
Total Operating Expenses
(3,303,818
)
(4,470,738
)
OTHER OPERATING INCOME:
Gain on sale of product line
4,051,709
-
INCOME (LOSS) FROM OPERATIONS
2,055,405
(3,192,494
)
OTHER INCOME (EXPENSES):
Gain (loss) on debt extinguishment, net
481,832
(343,895
)
Interest expense
(469,767
)
(1,610,062
)
Interest expense - related party
(5,663
)
(10,027
)
Settlement expense
(175,000
)
-
Total Other Expenses, net
(168,598
)
(1,963,984
)
NET INCOME (LOSS)
1,886,807
(5,156,478
)
Net loss of subsidiary attributable to noncontrolling interest
8,858
38,513
Preferred stock dividend
(54,195
)
(60,090
)
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS
$
1,841,470
$
(5,178,055
)
NET INCOME (LOSS) PER COMMON SHARE:
Basic
$
0.00
$
(0.02
)
Diluted
$
0.00
$
(0.02
)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic
490,113,378
308,121,062
Diluted
2,524,605,528
308,121,062
See accompanying notes to the consolidated financial statements.
F-4
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT
FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022
Additional
Total
Common Stock
Paid-in
Accumulated
Noncontrolling
Shareholders'
# of Shares
Amount
Capital
Deficit
Interest
Deficit
Balance, December 31, 2021
282,216,632
$
282,217
$
53,064,616
$
(57,515,129
)
$
189,255
$
(3,979,041
)
Common stock issued for accounts payable
90,859
90
2,084
-
-
2,174
Common stock issued for compensation
3,500,000
3,500
10,750
-
-
14,250
Common stock issued for professional fees
17,954,545
17,954
199,296
-
-
217,250
Common stock issued for conversion of Series C preferred stock
21,262,973
21,263
117,737
-
-
139,000
Common stock issued in connection with debt
10,245,163
10,246
100,385
-
-
110,631
Common stock issued as inducement to extend note payable
15,000,000
15,000
97,500
-
-
112,500
Preferred stock dividends and deemed dividend
-
-
4,435
(60,090
)
-
(55,655
)
Accretion of stock-based compensation
-
-
68,137
-
-
68,137
Relative fair value of warrants issued in connection with debt
-
-
325,785
-
-
325,785
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation
-
-
957,556
-
-
957,556
Beneficial conversion feature on convertible debt
-
-
354,215
-
-
354,215
Beneficial conversion feature buyback related to debt extinguishment
-
-
(160,993
)
-
-
(160,993
)
Net loss
-
-
-
(5,117,965
)
(38,513
)
(5,156,478
)
Balance, December 31, 2022
350,270,172
350,270
55,141,503
(62,693,184
)
150,742
(7,050,669
)
Common stock issued for cash and accrued compensation
54,545,455
54,545
245,455
-
-
300,000
Common stock issued for professional fees
14,166,667
14,167
69,783
-
-
83,950
Common stock issued for accrued compensation
9,636,364
9,636
43,364
-
-
53,000
Common stock issued for compensation
2,500,000
2,500
23,500
-
-
26,000
Common stock issued for conversion of Series C preferred stock
58,327,912
58,328
155,672
-
-
214,000
Common stock issued for conversion of debt, accrued interest and fees
43,371,481
43,372
157,017
-
-
200,389
Preferred stock dividends
-
-
-
(54,195
)
-
(54,195
)
Accretion of stock-based compensation
-
-
16,183
-
-
16,183
Net income
-
-
-
1,895,665
(8,858
)
1,886,807
Balance, December 31, 2023
532,818,051
$
532,818
$
55,852,477
$
(60,851,714
)
$
141,884
$
(4,324,535
)
See accompanying notes to the consolidated financial statements.
F-5
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Year Ended
December 31,
2023
2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)
$
1,886,807
$
(5,156,478
)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization expense
88,859
89,219
Amortization of debt discount to interest expense
96,258
1,059,752
Interest expense for put premium on convertible notes
29,212
90,731
Default penalty included in interest expense
-
206,250
Non-cash interest expense from fees on debt conversion
2,250
-
Stock-based compensation
42,183
1,039,943
Stock-based professional fees
121,950
298,571
Bad debt expense
21,296
7,716
Gain on sale of property and equipment
(9,000
)
(5,500
)
Non-cash (gain) loss on debt extinguishment and inducement expense
(481,832
)
343,895
Gain from sale of Nanoshield product line
(4,051,709
)
-
Lease costs
(72
)
1,080
Change in operating assets and liabilities:
Accounts receivable
(175,945
)
(100,160
)
Inventory
(113,712
)
5,485
Prepaid expenses and other assets
3,376
(746
)
Contract assets
(2,121
)
82,526
Accounts payable
(69,543
)
(49,709
)
Accrued expenses
183,647
299,660
Accrued interest - related party
(10,027
)
10,027
Accrued compensation
357,822
180,609
Contract liabilities
478,083
12,211
NET CASH USED IN OPERATING ACTIVITIES
(1,602,218
)
(1,584,918
)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment
(114,770
)
-
Proceeds from the sale of property and equipment
9,000
5,500
Proceeds from the sale of Nanoshield product line
4,042,631
-
NET CASH PROVIDED BY INVESTING ACTIVITIES
3,936,861
5,500
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock
275,000
-
Proceeds from note payable - related party
-
250,000
Repayment of note payable - related party
(250,000
)
-
Proceeds from notes payable
291,621
903,760
Repayment of notes payable
(1,824,144
)
(157,149
)
Proceeds from convertible notes payable
50,000
160,000
Repayment of convertible notes payable
(237,750
)
-
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES
(1,695,273
)
1,156,611
NET INCREASE (DECREASE) IN CASH
639,370
(422,807
)
CASH, beginning of year
97,091
519,898
CASH, end of year
$
736,461
$
97,091
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for:
Interest
$
319,085
$
479,509
Income taxes
$
-
$
-
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued as prepaid for services
$
83,950
$
217,250
Common stock issued for accrued compensation
$
78,000
$
-
Series B preferred stock issued for accrued compensation
$
144,000
$
278,654
Preferred stock dividend accrued
$
54,195
$
55,655
Reclassfication of accrued interest payable to convertible note payable
$
81,841
$
-
Increase in debt discount and paid-in capital for shares issued with convertible debt
$
-
$
110,631
Increase in debt discount and paid-in capital for warrants and beneficial conversion features
$
-
$
680,000
Common stock issued for accounts payable
$
-
$
2,174
Conversion of series C preferred stock to common stock
$
214,000
$
139,000
Conversion of notes payable and accrued interest to common stock
$
198,139
$
-
Increase in right of use and lease liability
$
-
$
184,375
See accompanying notes to
the consolidated financial statements.
F-6
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
NOTE 1 – NATURE OF ORGANIZATION
Nature of Organization
C-Bond Systems, Inc., together with its subsidiaries
(the “Company”), is a materials development company and sole owner and developer of the patented C-Bond technology. The Company
is engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality,
and sustainability of brittle material systems. The Company’s primary focus is in the multi-billion-dollar glass and window film
industry with target markets in the United States and internationally. During the years ended December 31, 2023 and 2022, the Company
operated in two segments: C-Bond Transportation Solutions and Patriot Glass Solutions. C-Bond Transportation Solutions sold a windshield
strengthening, water repellent solution called C-Bond nanoShield™ through May 8, 2023, the date that the nanoShield product line
and related technologies were sold (see Note 16). Patriot Glass Solutions sells multi-purpose glass strengthening primer and window film
mounting solutions, including C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a forced entry system.
On June 30, 2021, the Company entered into a Share
Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Patriot Glass Solutions, LLC (formerly Mobile
Tint LLC), a Texas limited liability company doing business as A1 Glass Coating (“Patriot Glass”), (ii) the sole member of
Patriot Glass (the “Patriot Glass Shareholder”), and (iii) Michael Wanke as the Representative of the Patriot Glass Shareholder.
Pursuant to the Exchange Agreement, the Company agreed to acquire 80% of Patriot Glass’s units, representing 80% of Mobile’s
issued and outstanding capital stock (the “Patriot Glass Shares”). On July 22, 2021, the Company closed the Exchange Agreement
and acquired 80% of the Patriot Glass Shares. The Patriot Glass Shares were exchanged for 28,021,016 restricted shares of the Company’s
common stock in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the
30-day period immediately prior to the closing. Initially, for two years after closing, the Company had the option to acquire the remaining
20% of Patriot Glass’s issued and outstanding membership interests in exchange for a number of shares of the Company’s common
stock equal to 300% of Patriot Glass’s average EBIT value, divided by the price of the Company’s common stock as defined in
the Exchange Agreement. On September 20, 2023, the Company and the Patriot Glass Shareholder entered into amendment #2 to the Exchange
Agreement (the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, the Company shall have the option
(the “Option”), beginning on July 1, 2025 (the “Option Start Date”) and ending on 5:00 P.M. EST on the date that
is thirty calendar days after the Option Start Date (the “Option Period”), to acquire the remaining 20% of Patriot Glass Units
(the “Additional Units”), representing 20% of Patriot Glass’s issued and outstanding membership interests, collectively
(the “Additional Closing”) (See Note 10). Patriot Glass provides quality window tint solutions for auto, home, and business
owners across Texas, specializing in automotive window tinting, residential window film, and commercial window film that stop harmful
UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills. Patriot Glass also
carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types of vandalism, and
even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Patriot Glass’s owner-operator, Mr. Wanke,
joined the Company as President of Patriot Glass. On November 29, 2023, the name of Mobile Tint LLC was changed to Patriot Glass Solutions,
LLC..
On May 8, 2023, the Company entered into an Asset
Purchase Agreement (“APA”) with Apex Protect GPS, LLC (the “Buyer”), whereby the Company sold its C-Bond nanoShield™
product line, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other
physical assets of the Company’s C-Bond nanoShield division (the “Assets”) to the Buyer. Accordingly, the Company assigned,
transferred and delivered to the Buyer, free and clear of all liens, all of the Assets. Following the Closing, the Parties entered into
an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among the Company (“Seller”);
Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned all its
right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing
to Assignee. The Seller and Assignee also entered into a Lease and Assignment and Assumption Agreement on June 15, 2023 (the “Assignment
Agreement”), wherein the Seller assigned to Assignee, and Assignee took assignment from the Seller, of the lease for the premises
located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to the Assignment Agreement (See Note 16).
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Basis of Presentation and Principles of Consolidation
The Company’s consolidated financial statements
include the financial statements of its wholly owned subsidiary, C-Bond Systems, LLC, and its 80% owned subsidiary, Patriot Glass. All
significant intercompany accounts and transactions have been eliminated in consolidation.
Going Concern
These consolidated financial statements have been
prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the
normal course of business. As reflected in the accompanying consolidated financial statements, the Company had net income of $1,886,807
for the year ended December 31, 2023, which included a gain from the sale of the Company’s nanoShield product line of $4,051,709. Net
cash used in operations was $1,602,218 for the year ended December 31, 2023. Additionally, as of December 31, 2023, the Company had
an accumulated deficit, shareholders’ deficit, and working capital deficit of $60,851,714, $4,324,535 and $1,351,954, respectively.
On May 8, 2023, the Company sold its nanoShield product line and received proceeds of $4,042,631. The proceeds were used to repay
convertible notes payable, notes payable and related accrued interest. On December 31, 2023, the Company had cash of $736,461. These factors
raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance
date of this report. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash
flow positive or raise additional debt and/or equity capital. The Company is seeking to raise capital through additional debt and/or equity
financings to fund its operations in the future. Although the Company has historically raised capital from sales of common shares and
preferred shares, and from the issuance of promissory notes and convertible promissory notes, there is no assurance that it will be able
to continue to do so. If the Company is unable to raise additional capital or secure additional lending in the near future, management
expects that the Company will need to curtail its operations. These consolidated financial statements do not include any adjustments related
to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the
Company be unable to continue as a going concern.
F-7
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
Use of Estimates
The preparation of consolidated financial statements
in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those
estimates. Estimates during the years ended December 31, 2023 and 2022 include estimates for allowance for doubtful accounts on accounts
receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted
jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair
value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value
of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash
equity transactions.
Fair Value of Financial Instruments and Fair Value Measurements
The carrying amounts reported in the consolidated
balance sheets for cash, accounts receivable, contract assets and liabilities, notes payable, convertible note payable, accounts payable,
accrued expenses, accrued compensation, and lease liabilities approximate their fair market value based on the short-term maturity of
these instruments.
The Company analyzes all financial instruments
with features of both liabilities and equity under the Financial Accounting Standard Board’s (the “FASB”) accounting
standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest
level of input that is significant to the fair value measurement. The Company did not identify any assets or liabilities that are required
to be presented on the balance sheet at fair value in accordance with Accounting Standards Codification (“ASC”) Topic 820.
ASC 825-10 “Financial Instruments”,
allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair
value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value
option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent
reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.
Cash and Cash Equivalents
For purposes of the consolidated statements of
cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money
market accounts to be cash equivalents. The Company had no cash equivalents as of December 31, 2023 and 2022.
Accounts Receivable
The Company recognizes an allowance for losses
on accounts receivable and notes receivable in an amount equal to the estimated probable losses net of recoveries under the current expected
credit loss method. The allowance is based on an analysis of historical bad debt experience, current receivables aging and expected future
write-offs, as well as an assessment of specific identifiable customer accounts and notes receivable considered at risk or uncollectible.
On January 1, 2023, the Company adopted ASC 326, “Financial Instruments - Credit Losses”. In accordance with ASC 326, an allowance
is maintained for estimated forward-looking losses resulting from the possible inability of customers to make required payments (current
expected losses). The amount of the allowance is determined principally on the basis of past collection experience and known financial
factors regarding specific customers. The expense associated with the allowance for doubtful accounts on accounts receivable is recognized
in general and administrative expenses.
Inventory
Inventory, consisting of raw materials and finished
goods, are stated at the lower of cost and net realizable value utilizing the first-in, first-out (FIFO) method. A reserve is established
when management determines that certain inventories may not be saleable. If inventory costs exceed expected net realizable value due to
obsolescence or quantities in excess of expected demand, the Company will record reserves for the difference between the cost and the
net realizable value. These reserves are recorded based on estimates and included in cost of sales.
Property and Equipment
Property and equipment are stated at cost and
are depreciated using the straight-line method over their estimated useful lives, which range from one to seven years. Leasehold improvements
are depreciated over the shorter of the useful life or lease term including scheduled renewal terms. Maintenance and repairs are charged
to expense as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and
any resulting gains or losses are included in income in the year of disposition. The Company examines the possibility of decreases in
the value of these assets when events or changes in circumstances reflect the fact that their recorded value may not be recoverable.
Goodwill and Intangible Assets
Goodwill represents the future economic benefit
arising from other assets acquired that could not be individually identified and separately recognized. Any goodwill arising from the
Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets
may have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line
basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets are being amortized over
a useful life of 5 years.
F-8
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
Goodwill is not subject to amortization but is
subject to impairment tests at least annually. The Company reviews the carrying amounts of goodwill by reporting unit at least annually,
or when indicators of impairment are present, to determine if goodwill may be impaired. To test goodwill impairment, the Company first
assesses qualitative factors to determine whether it is more likely than not that the fair value of goodwill is less than its carrying
value. The Company would not be required to quantitatively determine the fair value of goodwill unless it determines, based on the qualitative
assessment there are indicators of impairment. Under the quantitative test of goodwill, the Company compares the fair value of the reporting
unit to its carrying value, including goodwill. If the carrying value exceeds the fair value, then the goodwill is impaired by the excess
amount. The Company performs its annual testing for goodwill during the fourth quarter of each fiscal year or more frequently if an event
occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit.
Intangible assets determined to have finite lives
are amortized over their estimated useful lives of 5 years. The useful life of an intangible asset is the period over which the asset
is expected to contribute directly or indirectly to future cash flows. The Company periodically evaluates both finite and indefinite lived
intangible assets for impairment upon occurrence of events or changes in circumstances that indicate the carrying amount of intangible
assets may not be recoverable.
As of December 31, 2023 and 2022, the Company
performed its annual goodwill impairment test for its one reporting unit. The results of the Company’s annual impairment test indicated
that the fair value of the reporting unit exceeded its carrying value. Therefore, no impairment of goodwill or intangibles assets was
recorded as of December 31, 2023 or 2022.
Impairment of Long-Lived Assets
In accordance with ASC Topic 360, the Company
reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may
not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future
cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s
estimated fair value and its book value.
Warranty Liability
The Company provides limited warranties on its
products for product defects for periods ranging from 12 months to the life of the product. Warranty costs may include the cost of product
replacement, refunds, labor costs and other costs. Allowances for estimated warranty costs are recorded during the period of sale. The
determination of such allowances requires the Company to make estimates of product warranty claim rates and expected costs to repair or
to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each
product line combined with liability estimates based on the prior 12 months’ sales activities. If actual return rates and/or repair
and replacement costs differ significantly from the Company’s estimates, adjustments to recognize additional cost of sales may be
required in future periods. Historically the warranty accrual and the expense amounts have been immaterial. The warranty liability is
included in accrued expenses on the accompanying consolidated balance sheets and amounted to $1,000 and $26,648 on December 31, 2023 and
2022, respectively. During the years ended December 31, 2023 and 2022, warranty costs were de minimis.
Revenue Recognition
The Company follows ASC Topic 606, Revenue
from Contracts with Customers (“ASC 606”). This standard establishes a single comprehensive model for entities to use
in accounting for revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. ASC
606 requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the entity expects to be entitled in exchange for those goods or services and requires certain additional disclosures.
The Company sells its products which include standard
warranties primarily to distributors and authorized dealers. Product sales are recognized at a point in time when the product is shipped
to the customer and title is transferred and are recorded net of any discounts or allowances. The warranty does not represent a separate
performance obligation.
Revenues from contracts for the distribution and
installation of window film solutions are recognized over time on the basis of the Company’s estimates of the progress towards completion
of contracts using various output or input methods depending on the type of contract terms including (1) the ratio of number of labor
hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed
method. These methods are used because management considers these to be the best available measure of progress on these contracts. We
use the same method for similar types of contracts. The asset, “contract assets” represents revenues recognized in excess
of amounts billed. The liability, “contract liabilities,” represents billings in excess of revenues recognized.
Cost of Sales
Cost of sales includes inventory costs, packaging
costs and warranty expenses.
Cost of revenues from fixed-price contracts for
the distribution and installation of window film solutions include all direct material, sub-contractor, labor and certain other direct
costs, as well as those indirect costs related to contract performance, such as indirect labor and fringe benefits. Provisions for estimated
losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions
and estimated profitability may result in revisions to cost and income, which are recognized in the period in which the revisions are
determined. Changes in estimated job profitability resulting from job performance, job conditions, claims, change orders, and settlements,
are accounted for as changes in estimates in the current period.
F-9
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
Shipping and Handling Costs
Shipping and handling costs incurred for product
shipped to customers are included in general and administrative expenses and amounted to $16,288 and $45,455 for the years ended December
31, 2023 and 2022, respectively. Shipping and handling costs charged to customers are included in sales.
Research and Development
Research and development costs incurred in the
development of the Company’s products are expensed as incurred and includes costs such as labor, materials, and other allocated
costs incurred. For the years ended December 31, 2023 and 2022, research and development costs incurred in the development of the Company’s
products were $0.
Advertising Costs
The Company may participate in various advertising
programs. All costs related to advertising of the Company’s products are expensed in the period incurred. For the years ended December
31, 2023 and 2022, advertising costs charged to operations were $31,743 and $69,737, respectively and are included in general and administrative
expenses on the accompanying consolidated statements of operations. These advertising expenses do not include cooperative advertising
and sales incentives which shall been deducted from sales.
Federal and State Income Taxes
The Company accounts for income tax using the
liability method prescribed by ASC 740, “Income Taxes”. Under this method, deferred tax assets and liabilities are determined
based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in
effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax
assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets
will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes
the enactment date.
The Company follows the accounting guidance for
uncertainty in income taxes using the provisions of ASC 740 “Income Taxes”. Using that guidance, tax positions initially
need to be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the
tax authorities. As of December 31, 2023 and 2022, the Company had no uncertain tax positions that qualify for either recognition or disclosure
in the financial statements. Tax years that remain subject to examination are the years ending on and after December 31, 2018. The Company
recognizes interest and penalties related to uncertain income tax positions in other expense. However, no such interest and penalties
were recorded as of December 31, 2023 and 2022.
Stock-Based Compensation
Stock-based compensation is accounted for based
on the requirements of ASC 718 – “Compensation –Stock Compensation”, which requires recognition in the
financial statements of the cost of employee, director, and non-employee services received in exchange for an award of equity instruments
over the period the employee, director, or non-employee is required to perform the services in exchange for the award (presumptively,
the vesting period). The ASC also requires measurement of the cost of employee, director, and non-employee services received in exchange
for an award based on the grant-date fair value of the award. The Company has elected to recognize forfeitures as they occur as permitted
under the FASB’s Accounting Standards Update (“ASU”) 2016-09 Improvements to Employee Share-Based Payment.
Leases
The Company accounts for leases in accordance
with ASC 842. The lease standard requires certain leases to be reported on the consolidated balance sheets as right-of-use assets and
lease liabilities. The Company elected the practical expedients permitted under the transition guidance of this standard that retained
the lease classification and initial direct costs for any leases that existed prior to adoption of the standard. The Company does not
reassess whether any contracts entered into prior to adoption are leases or contain leases.
The Company categorizes leases with contractual
terms longer than twelve months as either operating or finance. Finance leases are generally those leases that would allow the Company
to substantially utilize or pay for the entire asset over its estimated life. Assets acquired under finance leases are recorded in property
and equipment, net. All other leases are categorized as operating leases. The Company does not have any finance leases as of December
31, 2023 and 2022. The Company’s leases generally have terms that range from three to four years for property and equipment and
five years for property. The Company elected the accounting policy to include both the lease and non-lease components of our agreements
as a single component and account for them as a lease.
Lease liabilities are recognized at the present
value of the fixed lease payments using a discount rate based on the Company’s current borrowing rate. Lease assets are recognized
based on the initial present value of the fixed lease payments, reduced by landlord incentives, plus any direct costs from executing the
leases. Leasehold improvements are capitalized at cost and amortized over the lesser of their expected useful life or the lease term.
When the Company has the option to extend the
lease term, terminate the lease before the contractual expiration date, or purchase the leased asset, and it is reasonably certain that
the Company will exercise the option, the Company considers these options in determining the classification and measurement of the lease.
Costs associated with operating lease assets are recognized on a straight-line basis within operating expenses over the term of the lease.
F-10
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
Loss Per Common Share
ASC 260 “Earnings Per Share”, requires
dual presentation of basic and diluted earnings per common share (“EPS”) with a reconciliation of the numerator and denominator
of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilutive securities and
non-vested forfeitable shares. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue
common shares were exercised or converted into common shares or resulted in the issuance of common shares that then shared in the earnings
of the entity. Basic net loss per common share is computed by dividing net loss available to members by the weighted average number of
common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average
number of common shares, common share equivalents and potentially dilutive securities outstanding during each period. Potentially dilutive
common shares consist of stock options and non-vested forfeitable shares (using the treasury stock method) and shares issuable upon conversion
of preferred shares and convertible notes payable (using the as-if converted method). These common share equivalents may be dilutive in
the future.
The following table presents a reconciliation
of basic and diluted net income (loss) per common share:
Year Ended December 31,
2023
2022
Net income (loss) per common share - basic:
Net income (loss) attributable to common shareholders
$
1,841,470
$
(5,178,055
)
Weighted average common shares outstanding – basic
490,113,378
308,121,062
Net income (loss) per common share – basic
$
0.00
$
(0.02
)
Net income (loss) per common share - diluted:
Net income (loss) attributable to common shareholders - basic
$
1,841,470
$
(5,178,055
)
Add: preferred stock dividends
54,195
-
Add: interest of convertible debt
186,536
-
Numerator for income (loss) per common share – diluted
$
2,082,201
$
(5,178,055
)
Weighted average common shares outstanding – basic
490,113,378
308,121,062
Add: dilutive shares related to:
Convertible debt
1,220,101,111
-
Series B preferred
376,239,688
-
Series C preferred
438,151,351
-
Weighted average common shares outstanding – diluted
2,524,605,528
308,121,062
Net income (loss) per common share – diluted
$
0.00
$
(0.02
)
For the year ended December 31, 2022, all potentially
dilutive common shares were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact
on the Company’s net losses. For the year ended December 31, 2023, stock options and warrants were excluded from the computation
of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net income. As of December 31,
2023 and 2022, common share equivalents and potentially dilutive securities consisted of the following:
December 31,
2023
2022
Stock options
8,445,698
8,445,698
Warrants
34,000,000
34,000,000
Series B preferred stock
335,772,090
164,635,079
Series C preferred stock
438,151,351
432,250,000
Convertible debt
1,220,101,111
962,679,774
Non-vested, forfeitable common shares
-
16,970,120
2,036,470,250
1,618,980,671
F-11
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
Segment Reporting
From January 1, 2022 to May 8, 2023, the Company
operated in two reportable business segments which consisted of (1) the manufacture and sale of a windshield strengthening water repellent
solution as well as disinfection products, and the sale of multi-purpose glass strengthening primer and window film mounting solutions,
including ballistic-resistant film systems and a forced entry system, and (2) the distribution and installation of window film solutions.
The Company’s reportable segments were strategic business units that offered different products and were managed separately based
on the fundamental differences in their operations and locations. On May 8, 2023, the Company sold its C-Bond nanoShield™ product
line and the remaining segment (1) as described above was combined into segment (2) and is now being managed together (see Note 16).
Noncontrolling Interest
The Company accounts for noncontrolling interest
in accordance with ASC Topic 810-10-45, which requires the Company to present noncontrolling interests as a separate component of total
shareholders’ deficit on the consolidated balance sheets and the consolidated net loss attributable to its noncontrolling interest
be clearly identified and presented on the face of the consolidated statements of operations.
Risk and Uncertainties
The Company operates in an industry that is subject to intense competition
and changes in consumer and commercial demand. The Company’s operations are subject to significant risk and uncertainties including
financial and operational risks including the potential risk of business failure.
The Company has experienced, and in the future expects to continue
to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the
cyclical nature of the business, (ii) general economic conditions in the various local markets in which the Company competes, including
a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s products and services.
These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.
Recent Accounting Pronouncements
In August 2020, the FASB issued ASU 2020-06, Debt—Debt
with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for
convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments
will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain
settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity
contracts to qualify for the exception. The ASU also simplifies the diluted net income per share calculation in certain areas. The new
guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and early
adoption is permitted. The Company is currently evaluating the impact of the adoption of the standard on the consolidated financial statements.
In June 2016, the FASB issued ASU No. 2016-13, Financial
Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which significantly changes
how entities will measure credit losses for most financial assets, including accounts receivable. ASU No. 2016-13 will replace today’s
“incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based
on expected rather than incurred losses. On November 15, 2019, the FASB delayed the effective date of Topic 326 for certain small public
companies and other private companies until fiscal years beginning after December 15, 2022 for SEC filers that are eligible to be smaller
reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities. In March 2022, the FASB
issued ASU No. 2022-02, Financial Instruments-Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.
The guidance was issued as improvements to ASU No. 2016-13 described above. The vintage disclosure changes require an entity to disclose
current-period gross write-offs by year of origination for financing receivables. The guidance is effective for financial statements issued
for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The adoption of ASU No. 2022-02 on
January 1, 2023 did not have a material impact on the Company’s consolidated financial statements.
Other accounting standards that have been issued
or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial
statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated
to its financial condition, results of operations, cash flows or disclosures.
NOTE 3 – ACCOUNTS RECEIVABLE
On December 31, 2023 and 2022, accounts receivable
consisted of the following:
December 31, 2023
December 31, 2022
Accounts receivable
$
459,414
$
304,964
Less: allowance for doubtful accounts
(35,323
)
(35,522
)
Accounts receivable, net
$
424,091
$
269,442
For the years ended December 31, 2023 and 2022, bad debt expense amounted
to $21,296 and $7,716, respectively.
F-12
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
NOTE 4 – INVENTORY
On December 31, 2023 and 2022, inventory consisted
of the following:
December 31, 2023
December 31, 2022
Raw materials
$
-
$
1,501
Finished goods
181,663
75,945
Total Inventory
$
181,663
$
77,446
For the years ended December 31, 2023 and 2022,
the Company did not record any allowance for slow moving inventory.
NOTE 5 – PROPERTY AND EQUIPMENT
On December 31, 2023 and 2022, property and equipment
consisted of the following:
Useful Life
December 31, 2023
December 31, 2022
Machinery and equipment
5 – 7 years
$
73,411
$
124,133
Furniture and office equipment
3 – 7 years
2,061
32,306
Vehicles
1 – 5 years
68,050
62,195
Leasehold improvements
3 – 5 years
110,645
45,296
254,167
263,930
Less: accumulated depreciation
(82,561
)
(167,624
)
Property and equipment, net
$
171,606
$
96,306
During the years ended December 31, 2023 and 2022,
the Company sold vehicles and other equipment for proceeds of $9,000 and $5,500 and record a gain on sale of property and equipment of
$9,000 and $5,500, respectively, which is included in general and administrative expenses on the accompanying consolidated statement of
operations. Additionally, in connection with the Company’s sale of its C-Bond nanoShield product line (see Note 16), the Company
sold property and equipment with a net book value of $1,115, which is included in gain from sale of product line on the accompanying statement
of operations. For the years ended December 31, 2023 and 2022, depreciation expense is included in general and administrative expenses
and amounted to $38,355 and $38,716, respectively.
NOTE 6 – INTANGIBLE ASSETS AND GOODWILL
On December 31, 2023 and 2022, intangible assets
and goodwill, which were acquired from Patriot Glass in 2021, consisted of the following:
Useful life
December 31, 2023
December 31, 2022
Customer relations
5 years
$
212,516
$
212,516
Non-compete
5 years
40,000
40,000
Trade name
-
100,000
100,000
352,516
352,516
Less: accumulated amortization
(123,102
)
(72,598
)
Intangible assets, net
$
229,414
$
279,918
Useful life
December 31, 2023
December 31, 2022
Goodwill
-
$
350,491
$
350,491
For the years ended December 31, 2023 and 2022,
amortization expense of amortizable intangible assets amounted to $50,504 and $50,503, respectively. On December 31, 2023, accumulated
amortization amounted to $103,601 and $19,500 for the customer relations and non-compete, respectively. On December 31, 2022, accumulated
amortization amounted to $61,098 and $11,500 for the customer relations and non-compete, respectively.
F-13
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
Amortization of intangible assets with identifiable
useful lives that is attributable to future periods is as follows:
Twelve months ending December 31:
Amount
2024
$
50,503
2025
50,503
2026
28,408
Total
$
129,414
NOTE 7 – CONVERTIBLE NOTES PAYABLE
Mercer Convertible Debt
On October 15, 2021, the Company entered into
a Securities Purchase Agreement (the “SPA”) with Mercer Street Global Opportunity Fund, LLC (the “Investor”),
pursuant to which the Company issued and sold to Investor a 10% Original Issue Discount Senior Convertible Promissory Note in the principal
amount of $825,000 (the “Initial Note”) and five-year warrants to purchase up to 16,500,000 shares of the Company’s
common stock at an initial exercise price of $0.05 per share, an amount equal to 50% of the conversion shares that were issued (the “Initial
Warrants”). The Company received net proceeds of $680,000, which is net of original issue discounts of $75,000, placement fees of
$60,000, and legal fees of $10,000. The transactions contemplated under the SPA closed on October 18, 2021.
Pursuant to the SPA, the Investor agreed to purchase
an additional $825,00010% Original Issue Discount Senior Convertible Promissory Note (the “Second Note,” and together with
the Initial Note, the “Notes”), and a five-year warrant (the “Second Warrant,” and together with the Initial Warrant,
the “Warrants”) to purchase, in the aggregate, shares of the Company’s common stock at an initial exercise price of
$0.05 per share from the Company in an amount equal to 50% of the conversion shares to be issued upon the same terms as the Initial Note
and Initial Warrant (subject to there being no event of default under the Initial Note or other customary closing conditions), within
three trading days of a registration statement registering the shares of the Company’s common stock issuable under the Notes (the
“Conversion Shares”) and upon exercise of the Warrants (the “Warrant Shares”) being declared effective by the
SEC. To date, the Investor did not purchase the Second Note.
The Initial Note matured 12 months after issuance,
bore interest at a rate of 4% per annum through the date of default, and was initially convertible beginning on the six-month anniversary
of the original issue date into the Company’s common stock at a fixed conversion price of $0.025 per share, subject to adjustment
for stock splits, stock combinations, dilutive issuances, and similar events, as described in the Initial Note.
The Initial Note may be prepaid at any time for
the first 90 days at face value plus accrued interest. From day 91 through day 180, the Note may be prepaid in an amount equal to 110%
of the principal amount plus accrued interest. From day 181 through the day immediately preceding the maturity date, the Initial Note
may be prepaid in an amount equal to 120% of the principal amount plus accrued interest.
The Note and Warrants contain conversion limitations
providing that a holder thereof may not convert the Notes or exercise the Warrants to the extent (but only to the extent) that, if after
giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares
of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease
its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase
shall not be effective until the 61st day after such notice.
In connection with the SPA, the Company entered
into a Registration Rights Agreement dated October 15, 2021 (the “Registration Rights Agreement”), with the Investor pursuant
to which it is obligated to file a registration statement with the SEC within 45 days after the date of the agreement to register the
resale by the Investor of the conversion shares and warrant shares, and use all commercially reasonable efforts to have the registration
statement declared effective by the SEC within 60 days after the registration statement is filed.
Upon the occurrence of an event of default under
the Notes, the Investor has the right to be prepaid at 125% of the outstanding principal balance and accrued interest, and interest accrues
at 18% per annum. Events of default included, among other things,
(i)
any default in the payment of (A) principal and interest payment under this Note or any other Indebtedness, or (B) Late Fees, liquidated damages and other amounts owing to the Holder of this Note, as and when the same shall become due and payable (whether on a Conversion Date, or the Maturity Date, or by acceleration or otherwise), which default, solely in the case of a default under clause (B) above, is not cured within five Trading Days;
(ii)
the Company or any Subsidiary shall be subject to a Bankruptcy Event;
(iii)
the SEC suspends the Common Stock from trading or the Company’s Common Stock is not listed or quoted for trading on a Trading Market which failure is not cured, if possible to cure, within the earlier to occur of 10 Trading Days after notice of such failure is sent by the Holder or by any other Holder to the Company or the transfer of shares of Common Stock through the Depository Trust Company System is no longer available or is subject to a “chill” by the Depository Trust Company or any successor;
F-14
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
(iv)
the Company shall be a party to any Change of Control Transaction or shall agree to sell or dispose of all or in excess of 50% of its assets in one transaction or a series of related transactions (whether or not such sale would constitute a Change of Control Transaction);
(v)
the Company incurs any Indebtedness other than Permitted Indebtedness;
(vi)
the Company restates any financial statements included in its reports or registration statements filed pursuant to the Securities Act or the Exchange Act for any date or period from two years prior to the Original Issue Date of this Note and until this Note is or the Warrants issued to the Holder are no longer outstanding, if following first public announcement or disclosure that a restatement will occur the VWAP on the next Trading Day is 20% less than the VWAP on the prior Trading Day. For the purposes of this clause the next Trading Day if an announcement is made before 4:00 pm New York, NY time is either the day of the announcement or the following Trading Day. The Company filed a Report on Form 8-K announcing the restatement of its financial statements for the year ended December 31, 2020. Following the first public announcement or disclosure that a restatement occurred, the VWAP on the next Trading Day was not 20% less than the VWAP on the prior Trading Day and accordingly, the default provisions were not triggered.
The Company has also granted the investor a 12-month
(or until the Notes are no longer outstanding) right to participate in specified future financings, up to a level of 30%.
On April 20, 2022, the Company and the Investor
entered into an Exchange Agreement (the “Exchange Agreement”). The original SPA remains in effect. Per the terms of the Exchange
Agreement, the Parties agreed to exchange (i) the Initial Note for a new Convertible Promissory Note (the “New Note”) and
(ii) the Initial Warrant for a new five-year warrant to purchase, in the aggregate, 33,000,000 shares of the Company’s common stock
at an exercise price of $0.025 per share (the “New Warrant” and together with the New Note, the “New Securities”),
according to the terms and conditions of the Exchange Agreement. On April 20, 2022, pursuant to the terms of the Exchange Agreement, the
Investor surrendered the Prior Securities in exchange for the New Securities. Other than the surrender of the Prior Securities, no consideration
of any kind whatsoever was given by the Investor to the Company in connection with the Exchange Agreement. The terms of the New Securities
are the same as the Prior Securities except for the pricing of the shares issuable under the New Note and the shares issuable upon exercise
of the New Warrant. The New Securities are composed of the New Note, which is a 10% Original Issue Discount Senior Convertible Promissory
Note in the principal amount of $825,000, and the New Warrant. The New Note matured on October 15, 2022, bore interest at a rate of 4%
per annum through the date of default, and was initially convertible into the Company’s common stock at a fixed conversion price
of $0.0125 per share, subject to adjustment for stock splits, stock combinations, dilutive issuances, and similar events, as described
in the New Note. If the average Closing Price during any 10 consecutive Trading Day period beginning and ending during the 60 Day Effectiveness
Period (the “Average Closing Price”) is below the Conversion Price than the conversion price will be reduced to such Average
Closing Price but in no event less than $0.00875.
On October 15, 2022, the due date of the New Note,
the New Note defaulted due to non-payment. Accordingly, the Company added a default penalty of $206,250, or 25%, to the principal balance
and recorded interest expense of $206,250, and interest shall accrue at 18% per annum.
On December 4, 2023, the Company entered into
a letter agreement (the “Agreement”) with the Investor to eliminate the convertible features and implement a standstill on
the interest due under the Convertible Promissory Note Dated October 15, 2021 (the “Note”). This Note is the only remaining
convertible note on the Company’s balance sheet. Per the terms of the Agreement, provided that the Company continues making the
Payments as outlined in the Agreement and meets its obligations under the Agreement, the Investor shall not have the right to convert
the Note into the Company’s common stock. The Company shall make the Payments on the 15th of every month. “Payments”
shall mean $15,000 per month for 35 months with a balloon payment of $588,091 on the 36th month, for aggregate payments of $1,113,091.
Additionally, the Company shall pay Mercer 20%
of the gross proceeds from capital raised by the Company through the issuance of securities or incurrence of any Debt (regardless of whether
the incurrence of debt includes of the sale of any securities) (“Capital Raise Payments”). Capital Raise Payments shall only
be required for capital raises resulting in the Company receiving gross proceeds of at least $500,000. By way example, if the Company
receives $600,000 from the issuance of Debt, the Company shall make a Capital Raise Payment of $120,000 to Mercer. Any Capital Raise Payments
shall be first be applied to the then outstanding Balloon Payment and thereafter to the last Payments (35th, 34th and so on). “Debt”
means borrowed money including the sale of any existing and future receivables. The Capital Raise Payments shall be made within two business
days of the receipt of the funds under such raise. Any failure to make the Payments within the cure period or from the Capital Raise Payments
by the required date shall make this Agreement null and void.
Additionally, provided that the Company is in
compliance with this Agreement, Mercer agrees to a standstill on the interest due under the Note beginning with the date that the first
$15,000 Payment is made which the Company paid on December 15, 2023 as required by the Note. Further, if the Company pays off the entire
principal and accrued interest by the dates detailed below, the Investor agrees to reduce the total amount due on the Note (principal
and interest) by the percentages as follows: 20% if fully paid by March 31, 2024, 15% if fully paid by June 30, 2024, 10% if fully paid
by September 30, 2024, and 5% if fully paid by December 31, 2024. All rights and obligations under the original Note shall remain the
same. Mercer is not waiving any of its rights under the original Note, including but not limited to, rights available prior to this Agreement.
As of December 31, 2023 and 2022, the principal
balance of the Initial note was $1,098,091 and $1,031,250, respectively. Additionally, as of December 31, 2023 and 2022, accrued interest
payable amounted to $176,184 and $81,045, respectively, which is reflected in accrued expenses on the accompanying consolidated statements
of operations. Under the terms of the Agreement, $176,184 of accrued interest is subject to forgiveness if the Company complies with the
terms of the Agreement. As of the date of this report, the Company has made all required payments.
F-15
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
In accordance with ASC 470-50, Debt Modifications
and Extinguishments, on April 20, 2022, in connection in the Exchange Agreement discussed above, the Company performed an assessment of
whether the Exchange Agreement transaction was deemed to be new debt, a modification of existing debt, or an extinguishment of existing
debt. The Company evaluated the April 20, 2022 Exchange Agreement for debt modification and concluded that the debt qualified for debt
extinguishment. On April 20, 2022, the Company agreed to reduce the conversion price from $0.025 per share to $0.0125 per share, and to
cancel the Initial Warrant to purchase 16,500,000 shares of common exercisable at $0.05 per shares, and to issue a New Warrant to purchase
33,000,000 shares exercisable at $0.025 per share. All other terms of the convertible note and warrants remain unchanged, and therefore
did not change the cash flows of the note. The New Warrants did not contain any features requiring liability treatment and therefore were
classified as equity. The Company determined the transaction was considered a debt extinguishment because the change in conversion price
was substantial. Upon extinguishment, the Company had $395,313 of unamortized initial debt discount recorded which it wrote off, and the
Company recorded a buyback of $160,993 which represents the reversal of calculated beneficial conversion feature on the initial debt upon
settlement, for an aggregate net loss on debt extinguishment of $234,320. The Company recorded a new debt discount in connection with
the New Note which was calculated based on the relative fair value of the New Warrants of $325,785. Additionally, the New Note is convertible
into common shares at an initial conversion price of $0.0125 which was lower than the fair value of common shares based on the quoted
closing price of the Company’s common stock on the measurement date. The value allocated to the New Warrants was $325,785, and $354,215
was allocated to the beneficial conversion feature. Since the intrinsic value of the beneficial conversion feature and warrants was greater
than the proceeds allocated to the convertible instrument, the amount of the discount assigned to the beneficial conversion feature and
warrants issued was limited to the amount of the proceeds allocated to the convertible instrument. Accordingly, the Company recorded an
aggregate non-cash debt discount of $680,000 with the credit to additional paid in capital. This debt discount was amortized to interest
expense over the remaining term of the Convertible Note.
The Company uses the Binomial Valuation Model
to determine the fair value of its stock warrants which requires the Company to make several key judgments including:
●
the value of the Company’s common stock;
●
the expected life of issued stock warrants;
●
the expected volatility of the Company’s stock price;
●
the expected dividend yield to be realized over the life of the stock warrants; and
●
the risk-free interest rate over the expected life of the stock warrants.
The Company’s computation of the expected
life of issued stock warrants was based on the simplified method as the Company does not have adequate exercise experience to determine
the expected term. The interest rate was based on the U.S. Treasury yield curve in effect at the time of grant. The computation of volatility
was based on the historical volatility of the Company’s common stock.
On April 20, 2022 (the Exchange Agreement date)
along with various re-pricings as outlined below, the fair value of the stock warrants were estimated at issuance using the Binomial Valuation
Model with the following assumptions:
2022
Dividend rate
—%
Term (in years)
4 years
Volatility
246.6% to 329.6%
Risk—free interest rate
2.79% to 3.12%
At any time this Note or any amounts accrued and
payable thereunder remain outstanding, the Company or any Subsidiary, as applicable, sells or grants any option to purchase or sells or
grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or other disposition),
any common stock or common stock equivalents entitling any Person to acquire shares of the Company’s common stock at an effective
price per share that is lower than the conversion price then in effect (such lower price, the “Base Conversion Price” and
each such issuance or announcement a “Dilutive Issuance”), then the conversion price shall be immediately reduced to equal
the Base Conversion Price. Such adjustment shall be made whenever such common stock or common stock equivalents are issued. On June 23,
2022, the Company issued common stock equivalents with an initial conversion price of $0.011 per share and accordingly, the conversion
price and warrant down-round provisions were triggered. As a result, the conversion price of the New April 2022 Note was reduced to $0.011
per share and the exercise price of the New April 2022 Warrant was lowered to $0.011. As a result of the June 23, 2022 down-round provisions,
the Company calculated the difference between the warrants fair value on June 23, 2022, the date the down-round feature was triggered
using the then current exercise price of $0.025 and the new exercise price of $0.011. On June 23, 2022, the Company recorded a deemed
dividend of $3,702 which represents the fair value transferred to the warrant holders from the down round feature being triggered. No
additional beneficial conversion feature amount was recorded based on the June 23, 2022 valuation as the ratcheted beneficial conversion
feature value was lower than the original amount. Additionally, on September 6, 2022, the Company issued common stock equivalents with
an initial conversion price of $0.009 per share and accordingly, the conversion price and warrant down-round provisions were triggered.
As a result, the conversion price of the New April 2022 Note was reduced to $0.009 per share and the exercise price of the New April 2022
Warrant was lowered to $0.009. As a result of the September 6, 2022 down-round provisions, the Company calculated the difference between
the warrants fair value on September 6, 2022, the date the down-round feature was triggered using the then current exercise price of $0.011
and the new exercise price of $0.009. On September 6, 2022, the Company recorded a deemed dividend of $733 which represents the fair value
transferred to the warrant holders from the down round feature being triggered. No additional beneficial conversion feature amount was
recorded based on the September 6, 2022 valuation as the ratcheted beneficial conversion feature value was lower than the original amount.
F-16
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
Pursuant to the provisions of ASC 815-40 –
Derivatives and Hedging – Contracts in an Entity’s Own Stock, the convertible note and related warrants issued in connection
with the Mercer convertible note was analyzed and it was determined that the terms of the convertible note and warrants contained terms
that were not considered derivatives.
1800 Diagonal Lending Convertible Debt
On November 9, 2022, the Company closed a Securities
Purchase Agreement dated November 4, 2022, with 1800 DIAGONAL LENDING LLC, a Virginia limited liability company, (“Diagonal”),
pursuant to which a Promissory Note (the “November 2022 Diagonal Note”) dated November 4, 2022, was made to Diagonal in the
aggregate principal amount of $104,250 and the Company received net proceeds of $100,000 which was net of fees of $4,250. The November
2022 Diagonal Note bears interest at a rate of 12% per annum (22% upon the occurrence of an event of a default) and all outstanding principal
and accrued and unpaid interest are due on May 4, 2024. In May 2023, the November 2022 Diagonal Note and any interest due was repaid in
full (See Note 16).
On December 27, 2022, the Company closed a Securities
Purchase Agreement dated December 27, 2022, with 1800 Diagonal pursuant to which a Promissory Note (“December 2022 Diagonal Note”)
dated December 27, 2022, was made to Diagonal in the aggregate principal amount of $64,250 and the Company received net proceeds of $60,000
which was net of fees of $4,250. The December 2022 Diagonal Note bears interest at a rate of 12% per annum (22% upon the occurrence of
an event of a default) and all outstanding principal and accrued and unpaid interest are due on June 27, 2024. In May 2023, the December
2022 Diagonal Note and any interest due was repaid in full (See Note 16).
On March 17, 2023, the Company closed a Securities
Purchase Agreement dated November 4, 2022, with Diagonal pursuant to which a Promissory Note (the “March 2023 Diagonal Note”)
dated March 17, 2023, was made to Diagonal in the aggregate principal amount of $54,250 and the Company received net proceeds of $50,000
which was net of fees of $4,250. The March 2023 Diagonal Note bears interest at a rate of 12% per annum (22% upon the occurrence of an
event of a default) and all outstanding principal and accrued and unpaid interest are due on March 17, 2024. In May 2023, the March 2023
Diagonal Note and any interest due was repaid in full (See Note 16).
The Company had the right to prepay the November
2022, December 2022 and March 2023 Diagonal Notes (principal and accrued interest) at any time during the first six months the note is
outstanding at the rate of 115% during the first 30 days after issuance, 120% during the 31st to 60th day after
issuance, and 125% during the 61st to the 180th day after issuance. The November 2022, December 2022 and March 2023
Diagonal Notes may not be prepaid after the 180th day following the issuance date, unless Diagonal agrees to such repayment and such terms,
which was agreed to in connection with the May 8, 2023 repayment. Diagonal had in its option, at any time beginning 180 days after the
date of the Diagonal Note, to convert the outstanding principal and interest on the November 2022, December 2022 and March 2023 Diagonal
Notes into shares of our common stock at a conversion price per share equal to 65% of the average of the three lowest closing bid prices
of our common stock during the 10 trading days prior to the date of conversion.
The Company accounted for the November 2022 and
December 2022 Diagonal Notes as stock settled debt under ASC 480 and recorded an aggregate debt premium of $90,731 with a charge to interest
expense. The Company has accounted for the March 2023 Diagonal Note as stock settled debt under ASC 480 and recorded an aggregate debt
premium of $29,212 with a charge to interest expense. On May 11, 2023, upon repayment of the November 2022, December 2022 and March 2023
Diagonal Notes, the Company reversed the debt premium of $119,943 and recorded a gain on debt extinguishment of $119,943 on the accompanying
consolidated statement of operations.
For the years ended December 31, 2023 and 2022,
amortization of debt discounts related to the convertible notes payable amounted to $2,627 and $938,344, respectively, which has been
included in interest expense on the accompanying consolidated statements of operations.
On December 31, 2023 and 2022, accrued interest
payable under all outstanding convertible notes discussed above amounted to $176,184 and $83,138, respectively, and is included in accrued
expenses on the accompanying consolidated balance sheets.
On December 31, 2023 and 2022, convertible notes
payable consisted of the following:
December 31, 2023
December 31, 2022
Convertible notes payable
$
1,098,091
$
1,199,750
Add: put premium
-
90,731
Less: unamortized debt discount
-
(7,968
)
Convertible note payable, net
1,098,091
1,282,513
Less: current portion of convertible note payable
(180,000
)
(1,031,250
)
Convertible notes payable – long-term
$
918,091
$
251,263
F-17
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
On December 31, 2023, future annual maturities
of convertible note payable are as follows:
December 31,
Amount
2024
$
180,000
2025
180,000
2026
738,091
Total convertible note payable on December 31, 2023
$
1,098,091
NOTE 8 – NOTES PAYABLE
On December 31, 2023 and 2022, notes payable consisted
of the following:
December 31, 2023
December 31, 2022
Notes payable
$
105,958
$
1,899,380
Note payable – PPP note
18,823
18,823
Total notes payable
124,781
1,918,203
Less: unamortized debt discount
(764
)
(132,961
)
Note payable, net
124,017
1,785,242
Less: current portion of notes payable, net of discount
(81,908
)
(1,576,438
)
Notes payable – long-term
$
42,109
$
208,804
Notes Payable
BOCO Investment Note
On November 14, 2018, the Company entered into
a Revolving Credit Facility Loan and Security Agreement (“Loan Agreement”) and a Secured Promissory Note (the “Note”)
with BOCO Investments, LLC (the “Lender”). Subject to and in accordance with the terms and conditions of the Loan Agreement
and the Note, the Lender agreed to lend to the Company up to $400,000 (the “Maximum Loan Amount”) against the issuance and
delivery by the Company of the Note for use as working capital and to assist in inventory acquisition. In 2018, the Lender loaned $400,000
to the Company, the Maximum Loan Amount. The Company should have repaid all principal, interest and other amounts outstanding on or before
November 14, 2020. The Company’s obligations under the Loan Agreement and the Note are secured by a first-priority security interest
in substantially all the Company’s assets (the “Collateral”). The outstanding principal advanced to Company pursuant
to the Loan Agreement initially bore interest at the rate of 12% per annum, compounded annually. Upon the occurrence of an Event of Default
under the Loan Agreement and Note, all amounts then outstanding (including principal and interest) shall bear interest at the rate of
18% per annum, compounded annually until the Event of Default is cured.
In May 2023, the Company and the Lender entered
into a Debt Exchange and Release Agreement in regard to the $400,000 Note discussed above, whereby the Company paid the Lender cash of
$200,000 and issued the Lender 22,000,000 shares of Common Stock of the Company (see Note 9) in exchange for settlement of the remaining
$200,000 of the loan and all accrued interest amounting to $317,293, which were deemed paid in full (see Note 16). The 22,000,000 shares
issued were valued at $132,000, or $0.006 per share, based on the quoted closing price of the Company’s common stock on the measurement
date. In connection with the repayment and settlement of this debt, the Company recorded a gain from debt extinguishment of $385,293 consisting
of a) $68,000 calculated as the difference in the principal amount settled for shares of $200,000 and the fair value of the shares on
the measurement date of $132,000, and b) the forgiveness of interest due of $317,293.
On December 31, 2023 and 2022, principal amount
due under this Note amounted to $0 and $400,000, respectively. On December 31, 2023 and 2022, accrued interest payable under this Note
amounted to $0 and $292,241, respectively, and is included in accrued expenses on the accompanying consolidated balance sheets.
Mercer Street Global Opportunity Fund Notes
On March 14, 2022, the Company entered into an
Original Issue Discount Promissory Note and Security Agreement (the “March 2022 Note”) in the principal amount of $197,500
with Mercer Street Global Opportunity Fund, LLC (the “Investor”). The March 2022 Note was funded on March 14, 2022 and the
Company received net proceeds of $175,000 which is net of an original issue discount and investor legal fees of $22,500. The original
issue discount was recorded as a debt discount to be amortized over the life of the March 2022 note. The March 2022 Note matures 12 months
after issuance and bears interest at a rate of 3% per annum. At any time, the Company may prepay all or any portion of the principal amount
of the March 2022 Note and any accrued and unpaid interest without penalty. The March 2022 Note also creates a lien on and grants a priority
security interest in all the Company’s assets. In connection with the March 2022 Note, the Company issued 823,529 shares of its
common stock to the placement agent as a fee for the capital raise. The 823,529 shares of common stock issued were recorded as a debt
discount of $12,963 based on the relative fair value method to be amortized over the life of the March 2022 Note. On December 31, 2023,
the principal balance due on the March 2022 Note amounted to $0 and accrued interest payable amounted to $0. On December 31, 2022, the
principal balance due on the March 2022 Note amounted to $197,500 and accrued interest payable amounted to $4,756. In May 2023, the March
2022 Note and all accrued interest due was paid in full (See Note 16).
F-18
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
On November 22, 2022, the Company entered into
a Promissory Note and Security Agreement (the “November 2022 Note”) in the principal amount of $65,000 with Mercer Street
Global Opportunity Fund, LLC (the “Investor”). The November 2022 Note was funded on November 22, 2022 and the Company received
net proceeds of $62,500 which is net of investor legal fees of $2,500. The legal fees were recorded as a debt discount to be amortized
over the life of the November 2022 note. The November 2022 Note matures on August 22, 2023 and bears interest at a rate of 8% per annum.
At any time, the Company may prepay all or any portion of the principal amount of the November 2022 Note and any accrued and unpaid interest
without penalty. The November 2022 Note also creates a lien on and grants a priority security interest in all the Company’s assets.
On December 31, 2023, the principal balance due on the November 2022 Note amounted to $0 and accrued interest payable amounted to $0.
On December 31, 2022, the principal balance due on the November 2022 Note amounted to $65,000 and accrued interest payable amounted to
$214. In May 2023, the November 2022 Note and all accrued interest due was paid in full and the Company recorded a gain on debt extinguishment
of approximately $18,900 (See Note 16).
GS Capital Debt
On June 23, 2022, the Company entered into entered
into a Securities Purchase Agreement (“Agreement”) with GS Capital Partners, LLC (“GS Capital”), pursuant to which
a Promissory Note (the “GS Capital June 2022 Note”) was made to GS Capital in the aggregate principal amount of $195,000.
The GS Capital June 2022 Note was purchased for $176,000, reflecting an original issuance discount of $19,000, and was funded on June
24, 2022 (less legal and other administrative fees). The Company received net proceeds of $148,420. The Company further issued GS Capital
a total of 1,750,000 commitment shares (“Commitment Shares”) as additional consideration for the purchase of the Note (See
Note 9). Additionally, the GS Capital Note was convertible upon an event of default into common shares at an initial effective conversion
price which was lower than the fair value of common shares based on the quoted closing price of the Company’s common stock on the
measurement date. Principal and interest payments shall be made in 10 installments of $21,060 each beginning on the 90th-day anniversary
following the issue date and continuing thereafter each 30 days for nine months. The GS Capital Note matured 12 months after issuance
and bore interest at a rate of 8% per annum. GS Capital had the right at any time following an Event of Default to convert all or any
part of the outstanding and unpaid principal, interest, penalties, and all other amounts under this Note at a conversion price of $0.011,
subject to adjustment as defined in the GS Capital Note. The Company did not calculate a beneficial conversion feature since the GS Capital
Note was contingently convertible upon default on the GS Capital Note. As of December 31, 2022, the Company was not in default on this
note. In the event that following the Issue Date the closing trading price of the Company’s common stock was then being traded is
below $0.011 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.004 per
share. Events of default included, amongst other items, failure to pay principal or interest, bankruptcy, delisting of the Company’s
stock, financial statement restatements, or if the Company effectuates a reverse split. Upon the occurrence of any event of default, the
GS Capital Note shall become immediately and automatically due and payable and the Company shall pay to GS Capital, in full satisfaction
of its obligations hereunder, an amount equal to: (a) the then outstanding principal amount of this note plus (b) accrued and unpaid
interest on the unpaid principal amount of this note to the date of payment (the “mandatory prepayment date”) plus
(y) default interest, if any, multiplied by 120%. On December 15, 2022, the Company and GS Capital entered into a letter agreement to
extend the due date of the GS Capital June 2022 note by 60 days. Specifically, the maturity date of the GS Capital June 2022 note was
extended to August 23, 2023 and the next payment due date was extended to February 28, 2023. Through December 31, 2022, the Company paid
$53,512 of principal balance and during the year ended December 31, 2023, paid principal balance of $79,488. During April and May 2023,
the Company issued 21,371,481 shares of its common stock upon the conversion of principal of $62,000, accrued interest of $4,139, and
fees of $2,250 (See Note 9). On December 31, 2023, the principal balance due on the GS Capital Note and accrued interest payable amounted
to $0 (See Note 16). On December 31, 2022, the principal balance due on the GS Capital Note amounted to $141,488 and accrued interest
payable amounted to $7,471.
On July 26, 2022, the Company closed a Securities
Purchase Agreement (“July 2022 Agreement”) with GS Capital, pursuant to which a Promissory Note (“GS Capital July 2022
Note”) was made to GS Capital in the aggregate principal amount of $195,000. The GS Capital July 2022 Note was purchased for $176,000,
reflecting an original issuance discount of $19,000, and was funded on July 28, 2022 (less legal and other administrative fees). The Company
received net proceeds of $158,920. The Company further issued GS Capital a total of 2,600,000 commitment shares (“July 2022 Commitment
Shares”) as additional consideration for the purchase of the July 2022 Note. In addition, the Company issued 998,008 of its common
stock to the placement agent as a fee for the capital raise, respectively. The July Commitment Shares and the placement agent shares were
recorded as a debt discount of $34,606 based on the relative fair value method to be amortized over the life of the Note. Additionally,
the GS Capital July 2022 Note was convertible upon an event of default into common shares at an initial effective conversion price which
was lower than the fair value of common shares based on the quoted closing price of the Company’s common stock on the measurement
date. Principal and interest payments shall be made in 10 installments of $21,060 each beginning on the 90th-day anniversary following
the issue date and continuing thereafter each 30 days for nine months. The GS Capital July 2022 Note was to mature 12 months after issuance
and bore interest at a rate of 8% per annum. GS Capital had the right at any time following an Event of Default to convert all or any
part of the outstanding and unpaid principal, interest, penalties, and all other amounts under the GS Capital July 2022 Note at a conversion
price of $0.011, subject to adjustment as defined in the Note. The Company did not calculate a beneficial conversion feature since the
GS Capital July 2022 Note is contingently convertible upon a default on the July 2022 Note. As of December 31, 2022, the Company was not
in default on this note. In the event that following the Issue Date the closing trading price of the Company’s common stock was
then being traded is below $0.011 per share for more than ten consecutive trading days, then the conversion price shall
be equal to $0.004 per share. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date
of the GS Capital July 2022 note by 60 days. Specifically, the maturity date of the GS Capital July 2022 note was extended to September
26, 2023 and the next payment due date was extended to February 28, 2023. Through December 31, 2022, the Company paid $34,120 of principal
balance and in May 2023, the Company paid the remaining principal balance of $160,880 and all accrued interest due in full (See Note 16).
On December 31, 2023, the principal balance due on the GS Capital July 2022 Note and accrued interest payable amounted to $0. On December
31, 2022, the principal balance due on the GS Capital July 2022 Note amounted to $160,880 and accrued interest payable amounted to $6,441.
F-19
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
On September 6, 2022, the Company closed a Securities
Purchase Agreement (“September 2022 Agreement”) with GS Capital, pursuant to which a Promissory Note (“September 2022
Note”) was made to GS Capital in the aggregate principal amount of $195,000. The September 2022 Note was purchased for $176,000,
reflecting an original issuance discount of $19,000, and was funded on September 6, 2022 (less legal and other administrative fees). The
Company received net proceeds of $158,920. The Company further issued GS Capital a total of 3,300,000 commitment shares (“September
2022 Commitment Shares”) as additional consideration for the purchase of the September 2022 Note. In addition, the Company issued
773,626 of its common stock to the placement agent as fee for the capital raise, respectively. The September Commitment Shares and the
placement agent shares were recorded as a debt discount of $30,326 based on the relative fair value method to be amortized over the life
of the Note. Additionally, the September 2022 Note was convertible into common shares upon an event of default at an initial effective
conversion price which was lower than the fair value of common shares based on the quoted closing price of the Company’s common
stock on the measurement date. Principal and interest payments shall be made in 9 installments of $23,400 each beginning on the 120th-day
anniversary following the issue date and continuing thereafter each 30 days for eight months. The September 2022 Note was to mature 12
months after issuance and bears interest at a rate of 8% per annum. GS Capital shall have the right at any time following an Event of
Default to convert all or any part of the outstanding and unpaid principal, interest, penalties, and all other amounts under the September
2022 Note at a conversion price of $0.009, subject to adjustment as defined in the Note. The Company did not calculate a beneficial conversion
feature since the GS Capital July 2022 Note was contingently convertible upon a default on the September 2022 Note. As of December 31,
2022, the Company was not in default on this note. In the event that following the Issue Date the closing trading price of the Company’s
common stock was then being traded below $0.009 per share for more than ten consecutive trading days, then the conversion
price shall be equal to $0.0032 per share. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend
the due date of the GS Capital September 2022 note by 60 days. Specifically, the maturity date of the GS Capital September 2022 note was
extended to November 6, 2023 and the next payment due date was extended to March 6, 2023. In May 2023, the GS Capital September 2022 Note
and all accrued interest due was paid in full (See Note 16). On December 31, 2023, the principal balance due on the GS Capital September
2022 Note and accrued interest payable amounted to $0. On December 31, 2022, the principal balance due on the GS Capital September 2022
Note amounted to $195,000 and accrued interest payable amounted to $5,001.
In connection with the Letter Agreement dated
December 15, 2022, in order to induce GS Capital to extend the due dates of the GS Capital Notes, the Company issued 15,000,000 shares
of the Company’s common stock. These shares were valued at $112,500, or $0.0075 per common share, based on the quoted closing price
of the Company’s common stock on the measurement date. In connection with the issuance of these shares, during the year ended December
31, 2022, the Company recorded an inducement expense of $112,500 which was included in loss on debt extinguishment on the accompanying
consolidated statement of operations.
In May 2023, the GS Capital June 2022 Note, the
GS Capital July 2022 Note, and the September 2022 Note were paid in full without any default penalty and the Company recorded a gain on
debt extinguishment of approximately $25,400 (see Note 16).
Other Notes Payable
On May 10, 2021, the Company entered into a Loan
and Security Agreement (the “Loan Agreement”) and a Secured Promissory Note (the “Promissory Note”) in the amount
of $500,000 with a lender. The Promissory Note accrued interest at 8% per annum, compounded annually, and all outstanding principal and
accrued interest was due and payable of May 10, 2023. The Company’s obligations under the Loan Agreement and the Promissory Note
were secured by a second priority security interest in substantially all of the Company’s assets (the “Collateral”).
The Loan Agreement and Promissory Note contained customary representations, warranties, and covenants, including certain restrictions
on the Company’s ability to incur additional debt or create liens on its property. The Loan Agreement and the Promissory Note also
provided for certain events of default, including, among other things, payment defaults, breaches of representations and warranties and
bankruptcy or insolvency proceedings, the occurrence of which, after any applicable cure period, would permit Lender, among other things,
to accelerate payment of all amounts outstanding under the Loan Agreement and the Promissory Note, as applicable, and to exercise its
remedies with respect to the Collateral. On December 31, 2022, accrued interest payable under this Promissory Note amounted to $65,863
and is included in accrued expenses on the accompanying consolidated balance sheet. On December 31, 2022, the principal amount due under
this Promissory Note amounted to $500,000. In May 2023, this Promissory Note and all accrued interest was paid in full (See Note 16).
On July 22, 2021, in connection with the acquisition
of Patriot Glass, the Company assumed vehicle and equipment loans in the amount of $95,013. These loans bear interest at rates ranging
from 6.79% to 8.24% and are payable monthly through April 2025. On December 31, 2023 and 2022, notes payable related to these vehicle
and equipment loans amounted to $8,250 and $39,513, respectively.
On November 8, 2022, the Company entered into
a Promissory Note (the “November 2022 Note”) with a lender investor (the “Private Investor”) in the principal
amount of $200,000 and received net proceeds of $200,000. The November 2022 Note bore interest at a rate of 8% per annum and all outstanding
principal and accrued and unpaid interest was due on November 8, 2024. At any time, the Company may prepay all or any portion of the principal
amount of the November 2022 Note and any accrued and unpaid interest without penalty. As security for payment of the principal and interest
on the November 2022 Note, the Company and the lender Investor previously entered into that certain Loan and Security Agreement dated
May 10, 2021, which is incorporated into the November 2022 Note. On December 31, 2022, accrued interest payable under this Promissory
Note amounted to $2,367 and is included in accrued expenses on the accompanying consolidated balance sheets. On December 31, 2022, the
principal amount due under this Promissory Note amounted to $200,000. In May 2023, the November 2022 Note and all unpaid interest was
paid in full (See Note 16).
During the year ended December 31, 2023, in connection
with the acquisition of a vehicle and an air conditioner unit, the Company entered into three vehicle and equipment loans in the amount
of $117,721. These loans bear interest at rates ranging from 10.0% to 35.1% and are payable monthly through September 2028. On December
31, 2023, notes payable related to the vehicle and equipment loans amounted to $97,708. The net book value on December 31, 2023 relating
to the collateralized assets was $85,489.
For the years ended December 31, 2023 and 2022,
amortization of debt discounts related to all of the above notes payable amounted to $93,631 and $121,408, respectively, which has been
included in interest expense on the accompanying consolidated statements of operations. The Company recognized a loss on debt extinguishment
associated with the write off of the remaining debt discount and related note repayments in fiscal 2023 of approximately $49,300.
F-20
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
PPP Loan
On April 28, 2020, the Company entered into a
Paycheck Protection Program Promissory Note (the “PPP Note”) with respect to a loan of $156,200 (the “PPP Loan”)
from Comerica Bank. The PPP Loan was obtained pursuant to the Paycheck Protection Program (the “PPP”) of the Coronavirus Aid,
Relief, and Economic Security Act (the “CARES act”) administered by the U.S. Small Business Administration (“SBA”).
The PPP Loan matures on April 28, 2022 and bears interest at a rate of 1.00% per annum. The PPP Loan is payable in 18 equal monthly payments
of approximately $8,900 commencing November 1, 2020. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties.
The Company may apply to have the loan forgiven pursuant to the terms of the PPP if certain criteria are met. The Company applied for
forgiveness of its PPP Loan, and on November 4, 2021, the Company was notified that the Small Business Administration forgave $95,000
of the principal loan amount and $1,442 of interest. As of November 4, 2021, the remaining principal balance of the loan was $61,200 and
the remaining accrued interest balance was $935. During the year ended December 31, 2022, the Company repaid the PPP Loan principal of
$30,107. On December 31, 2023 and 2022, the principal amount due under the PPP Loan amounted to $18,823. As of December 31, 2023 and 2022,
accrued interest payable amounted to $358 and $170, respectively.
On December 31, 2023, future annual maturities
of notes payable are as follows:
December 31,
Amount
2024
$
82,672
2025
22,034
2026
6,671
2027
7,373
2028
6,031
Total notes payable on December 31, 2023
$
124,781
NOTE 9 – SHAREHOLDERS’ DEFICIT
Preferred Stock
Series B Preferred Stock
On December 12, 2019, the Company filed an Amendment
to its Articles of Incorporation to designate a series of preferred stock, the Series B Convertible Preferred Stock (the “Series
B”), with the Secretary of State of the State of Colorado. The Certificate of Designations established 100,000 shares of the Series
B, par value $0.10, having such designations, preferences, and rights as determined by the Company’s Board of Directors in its sole
discretion, in accordance with the Company’s Articles of Incorporation and Amended and Restated Bylaws. The Certificate of Designations
became effective with the State of Colorado upon filing.
The Series B ranks senior with respect to dividends
and right of liquidation with the Company’s common stock and junior to all existing and future indebtedness of the Company. The
Series B has a stated value per share of $1,000, subject to adjustment as provided in the Certificate of Designations (the “Stated
Value”), and a dividend rate of 2% per annum of the Stated Value.
The Series B is subject to redemption (at Stated
Value, plus any accrued, but unpaid dividends (the “Liquidation Value”) by the Company no later than three years after a Deemed
Liquidation Event and at the Company’s option after one year from the issuance date of the Series B, subject to a ten-day notice
(to allow holder conversion). A “Deemed Liquidation Event” will mean: (a) a merger or consolidation in which the Company is
a constituent party or a subsidiary of the Company is a constituent party and the Company issues shares of its capital stock pursuant
to such merger or consolidation, except any such merger or consolidation involving the Company or a subsidiary in which the shares of
capital stock of the Company outstanding immediately prior to such merger or consolidation continue to represent, or are converted into
or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting
power, of the capital stock of the surviving or resulting corporation or, if the surviving or resulting corporation is a wholly-owned
subsidiary of another corporation immediately following such merger or consolidation, the parent corporation of such surviving or resulting
corporation; or (b) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions,
by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a
whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially all of
the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease,
transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company.
The Series B is convertible into common stock
at the option of a holder or if the closing price of the common stock exceeds 400% of the Conversion Price for a period of twenty consecutive
trading days, at the option of the Company. Conversion Price means a price per share of the common stock equal to 100% of the lowest daily
volume weighted average price of the common stock during the two years preceding or subsequent two years following the Issuance Date,
subject to adjustment as otherwise provided in the Certificate of Designations (the “Conversion Price”).
In the event of a conversion of any Series B,
the Company shall issue to the holder a number of shares of common stock equal to the sum of the Stated Value plus accrued but unpaid
dividends multiplied by the number of shares of Series B Preferred Stock being converted divided by the Conversion Price.
F-21
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
Upon liquidation of the Company after payment
or provision for payment of liabilities of the Company and after payment or provision for any liquidation preference payable to the holders
of any preferred stock ranking senior to the Series B but prior to any distribution to the holders of Common Stock or preferred stock
ranking junior upon liquidation to the Series B, the holders of Series B will be entitled to be paid out of the assets of the Company
available for distribution to its stockholders an amount with respect to each share of Series B equal to the Liquidation Value.
The Series B has voting rights per Series B Share
equal to the Liquidation Value per share, divided by the Conversion Price, multiplied by fifty (50). Subject to applicable Colorado law,
the holders of Series B will have functional voting control in situations requiring shareholder vote.
These Series B preferred share issuances with
redemption provisions that permit the issuer to settle in either cash or common stock, at the option of the issuer, were evaluated to
determine whether temporary or permanent equity classification on the consolidated balance sheet was appropriate. As per the terms of
the Series B preferred stock agreements, Series B preferred stock is redeemable for cash and other assets on the occurrence of a deemed
liquidation event. A deemed liquidation event includes a change of control which is not in the Company’s control. As such, since
Series B preferred stock is redeemable upon the occurrence of an event that is not within the Company’s control, the Series B preferred
stock is classified as temporary equity.
The Company concluded that the Series B Preferred
Stock represented an equity host and, therefore, the redemption feature of the Series B Preferred Stock was not considered to be clearly
and closely related to the associated equity host instrument. However, the redemption features did not meet the net settlement criteria
of a derivative and, therefore, were not considered embedded derivatives that required bifurcation. The Company also concluded that the
conversion rights under the Series B Preferred Stock were clearly and closely related to the equity host instrument. Accordingly, the
conversion rights feature on the Series B Preferred Stock were not considered an embedded derivative that required bifurcation. The conversion
feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial on the commitment date.
On January 6, 2022, the Board of Directors of
the Company agreed to satisfy $278,654 of accrued compensation owed to its executive officers (collectively, the “Management”)
as of December 31, 2021. Management agreed to accept 278 shares of the Company’s Series B convertible preferred stock in settlement
of this accrued compensation. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial
on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur
any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $957,556 related to the beneficial
conversion feature arising from the issuance of Series B Preferred Stock.
On January 17, 2023, the Board of Directors of
the Company agreed to satisfy $144,000 of accrued compensation owed to its executive officers (collectively, the “Management”)
which, as of December 31, 2022 was included in accrued compensation on the accompanying consolidated balance sheet. Management agreed
to accept 144 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation. The beneficial
conversion feature of the Series B Preferred Stock at the time of issuance was determined to be deminimis on the commitment date.
By mutual agreement between the parties, the vesting
date of 842 previously granted shares of Series B Preferred stock was extended through May 2024.
During the years ended December 31, 2023 and 2022,
the Company accrued dividends of $22,766 and $19,936, respectively, which was included in Series B convertible preferred stock on the
accompanying consolidated balance sheets.
As of December 31, 2023, the net Series B Preferred
Stock balance was $1,203,967, which includes stated value of $1,144,624 and accrued dividends payable of $59,343. As of December 31, 2022,
the net Series B Preferred Stock balance was $1,037,201, which includes stated value of $1,000,624 and accrued dividends payable of $36,577.
The net Series B Preferred Stock balance is included on the accompanying consolidated balance sheets.
Series C Preferred Stock
On August 20, 2020, the Company filed an Amendment
to its Articles of Incorporation to designate a series of preferred stock, the Series C Convertible Preferred Stock (the “Series
C”), with the Secretary of State of the State of Colorado. The Certificate of Designations established 100,000 shares of the Series
C, par value $0.10, having such designations, preferences, and rights as determined by the Company’s Board of Directors in its sole
discretion, in accordance with the Company’s Articles of Incorporation and Amended and Restated Bylaws. The Certificate of Designations
became effective with the State of Colorado upon filing.
The Series C ranks senior with respect to dividends
and right of liquidation with the Company’s common stock and junior to all existing and future indebtedness of the Company. The
Series C has a stated value per share of $100, subject to adjustment as provided in the Certificate of Designations (the “Stated
Value”), and a dividend rate of 2% per annum of the Stated Value.
The Company has no option to redeem the Series
C Preferred Stock. If the Company determines to liquidate, dissolve or wind-up its business and affairs, or effect any Deemed Liquidation
Event as defined below, each of which has been approved by the holders of a majority of the shares of Series C Preferred Stock then outstanding,
the Company will redeem all of the shares of Series C Preferred Stock outstanding immediately prior to such mandatory redemption event
at a price per share of Series C Preferred Stock equal to the aggregate Series C Liquidation Value, which is 150% of the sum of the Stated
Value plus accrued and unpaid dividends, for the shares of Series C Preferred Stock being redeemed.
F-22
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
The Company will deliver ten-day advance written
notice prior to the consummation of any mandatory redemption event via email or overnight courier (“Notice of Mandatory Redemption”)
to each Holder whose shares are to be redeemed. The Series C is subject to redemption at liquidation Value noted above by the Company.
Upon receipt by any Holder of a Notice of Mandatory Redemption, if Holder does not choose to convert, such Holder will promptly submit
to the Company such Holder’s Series C Preferred Stock certificates on the Redemption Payment Date. Upon receipt of such Holder’s
Series C Preferred Stock certificates, the Company will pay the applicable redemption price to such Holder in cash. A “Deemed Liquidation
Event” will mean: (a) a merger or consolidation in which the Company is a constituent party or a subsidiary of the Company is a
constituent party and the Company issues shares of its capital stock pursuant to such merger or consolidation, except any such merger
or consolidation involving the Company or a subsidiary in which the shares of capital stock of the Company outstanding immediately prior
to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that represent,
immediately following such merger or consolidation, at least a majority, by voting power, of the capital stock of the surviving or resulting
corporation or, if the surviving or resulting corporation is a wholly-owned subsidiary of another corporation immediately following such
merger or consolidation, the parent corporation of such surviving or resulting corporation; or (b) the sale, lease, transfer, exclusive
license or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company
of all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger
or otherwise) of one or more subsidiaries of the Company if substantially all of the assets of the Company and its subsidiaries taken
as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition
is to a wholly owned subsidiary of the Company. Since the Company has determined that a deemed liquidation event is not probable, the
Series C is stated at the Stated Value plus accrued and unpaid dividends rather than redemption value, which is liquidation value.
The Series C is convertible at the option of a
holder at any time following the issuance date. In the event of a conversion of any Series C Preferred Stock, the Company shall issue
to such Holder a number of Conversion Shares equal to (x) the sum of (1) the Stated Value per share of Series C Preferred Stock plus (2)
any accrued but unpaid dividends thereon multiplied by (y) the number of shares of Series C Preferred Stock held by such Holder and subject
to the Holder Conversion Notice, divided by (z) the Conversion Price with respect to such Series C Preferred Stock. Conversion Price means
a price per share of the common stock equal to the lowest daily volume weighted average price of the common stock for any trading day
during the two years preceding the date of delivery of the conversion notice, subject to adjustment as otherwise provided in the Series
C Certificate of Designation.
Upon liquidation of the Company after payment
or provision for payment of liabilities of the Company and after payment or provision for any liquidation preference payable to the holders
of any preferred stock ranking senior to the Series C but prior to any distribution to the holders of Common Stock or preferred stock
ranking junior upon liquidation to the Series C, the holders of Series C will be entitled to be paid out of the assets of the Company
available for distribution to its stockholders an amount with respect to each share of Series C equal to the Liquidation Value.
Through April 28, 2021, each share of Series C
Preferred Stock was entitled to vote on all matters requiring shareholder vote. Each share of Series C Preferred Stock was entitled to
the number of votes per share based on the calculation of the number of conversion shares of Series C Preferred Stock is then convertible.
On April 28, 2021, the Company filed an Amended and Restated Certificate of Designations of Preferences, Rights, and Limitations of Series
C Convertible Preferred Stock (the “Amended Certificate”). The Amended Certificate changed the voting rights of the Series
C Preferred Stock on any matters requiring shareholder approval or any matters on which the common shareholders are permitted to vote.
Series C Preferred Stock shall have no right to vote on any matters requiring shareholder approval or any matters on which the common
shareholders (or other preferred stock of the Company which may vote with the common shareholders) are permitted to vote. With respect
to any voting rights of the Series C Preferred Stock set forth herein, the Series C Preferred Stock shall vote as a class, each share
of Series C Preferred Stock shall have one vote on any such matter, and any such approval may be given via a written consent in lieu of
a meeting of the Holders of the Series C Preferred Stock. Any reference herein to a determination, decision or election being made by
the “Majority Holders” shall mean the determination, decision or election as made by Holders holding a majority of the issued
and outstanding shares of Series C Preferred Stock at such time. It also adjusts the conversion feature of the Series C Preferred Stock
so that any Holder of Series C Preferred Stock cannot convert any portion of the Series C in excess of that number of Series C Preferred
Stock that upon conversion would result in beneficial ownership by the Holder of more than 4.99% of the outstanding shares of common stock
of the Company.
These Series C preferred stock issuances with
redemption provisions that permit the issuer to settle in either cash or common stock, at the option of the holder, were evaluated to
determine whether temporary or permanent equity classification on the consolidated balance sheet was appropriate. As per the terms of
the Series C preferred stock agreements, Series C preferred stock is redeemable for cash and other assets on the occurrence of a deemed
liquidation event. A deemed liquidation event includes a change of control which is not in the Company’s control. As such, since
Series C preferred stock is redeemable upon the occurrence of an event that is not within the Company’s control, the Series C preferred
stock is classified as temporary equity.
The Company concluded that the Series C Preferred
Stock represented an equity host and, therefore, the redemption feature of the Series C Preferred Stock was not considered to be clearly
and closely related to the associated equity host instrument. However, the redemption features did not meet the net settlement criteria
of a derivative and, therefore, were not considered embedded derivatives that required bifurcation. The Company also concluded that the
conversion rights under the Series C Preferred Stock were clearly and closely related to the equity host instrument. Accordingly, the
conversion rights feature on the Series C Preferred Stock were not considered an embedded derivative that required bifurcation. The conversion
feature of the Series C Preferred Stock at the time of issuance was determined to be beneficial on the commitment date.
On January 12, 2022, the Company issued 1,543,151
shares of its common stock upon the conversion of 120 shares of Series C preferred with a stated redemption value of $12,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
On April 20, 2022, the Company issued 13,184,548
shares of its common stock upon the conversion of 1,020 shares of Series C preferred with a stated redemption value of $102,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
F-23
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
On December 1, 2022, the Company issued 6,535,274
shares of its common stock upon the conversion of 250 shares of Series C preferred with a stated redemption value of $25,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
During the three months ended March 31, 2023,
the Company issued 26,585,614 shares of its common stock upon the conversion of 1,014 shares of Series C preferred with a stated redemption
value of $101,400. The conversion price was based on contractual terms of the related Series C preferred shares.
During the three months ended June 30, 2023, the
Company issued 23,157,922 shares of its common stock upon the conversion of 826 shares of Series C preferred with a stated redemption
value of $82,600. The conversion price was based on contractual terms of the related Series C preferred shares.
During the three months ended September 30, 2023,
the Company issued 8,584,376 shares of its common stock upon the conversion of 300 shares of Series C preferred with a stated redemption
value of $30,000. The conversion price was based on contractual terms of the related Series C preferred shares.
During the years ended December 31, 2023 and 2022,
the Company accrued dividends of $31,429 and $35,719, respectively, which was included in Series C convertible preferred stock on the
accompanying consolidated balance sheets.
As of December 31, 2023, the net Series C Preferred
Stock balance was $1,621,160, which includes stated liquidation value of $1,515,000 and accrued dividends payable of $106,160. As of December
31, 2022, the net Series C Preferred Stock balance was $1,803,731, which includes stated value of $1,729,000 and accrued dividends payable
of $74,731. The net Series C Preferred Stock balance is included on the accompanying consolidated balance sheets.
Common Stock
Common Stock Issued for Cash and Accrued
Compensation
On January 17, 2023, the Company entered into
a Subscription Agreement with its Chairman and Chief Executive Officer, Scott R. Silverman (the “Subscription Agreement”),
whereby Mr. Silverman purchased 54,545,455 shares (the “Subscription Shares”) of the Company’s common stock for $300,000,
or $0.0055 per share, based on the quoted closing price of the Company’s common stock on the measurement date (the “Consideration”).
The Consideration consisted of a cash payment of $275,000 the conversion of $25,000 of accrued compensation owed to Mr. Silverman.
On January 17, 2023, Barry Edelstein, a member
of the Company’s Board of Directors, elected to convert $53,000 of accrued compensation into 9,636,364 shares of unregistered common
stock of the Company. The shares were valued at $53,000, or $0.0055, based on the quoted closing price of the Company’s common stock
on the measurement date.
Issuance of Common Stock for Services
Issuance of Common Stock for Professional Fees
2022
On June 7, 2022, the Company issued an aggregate
of 4,000,000 shares of its common stock for business development and consulting services rendered and to be rendered. These shares were
valued at $48,000, or $0.012 per common share, based on the quoted closing price of the Company’s common stock on the measurement
date, and will be amortized into stock-based consulting fees over the term of the agreement. In connection with the issuance of these
shares, during the years ended December 31, 2023 and 2022, the Company recorded stock-based professional fees of $21,000 and $27,000,
respectively.
On June 24, 2022, the Company issued an aggregate
of 3,000,000 shares of its common stock for business development and consulting services rendered and to be rendered. These shares were
valued at $54,000, or $0.018 per common share, based on the quoted closing price of the Company’s common stock on the measurement
date, and will be amortized into stock-based consulting fees over the term of the agreement. In connection with the issuance of these
shares, during the year ended December 31, 2022, the Company recorded stock-based professional fees of $54,000.
On July 1, 2022, the Company granted a restricted
stock award of 2,500,000 common shares of the Company to a consultant of the Company for business development and consulting services
rendered, which shares were valued at $31,250, or $0.0125 per common share, based on the quoted closing price of the Company’s common
stock on the measurement date, and will be amortized into stock-based consulting fees over the term of the agreement. In connection with
the issuance of these shares, during the year ended December 31, 2022, the Company recorded stock-based professional fees of $31,250.
On July 15, 2022, the Company granted a restricted
stock award of 5,454,545 common shares of the Company to a consultant of the Company for government relations services to be rendered,
which shares were valued at $60,000, or $0.011 per common share, based on the quoted closing price of the Company’s common stock
on the measurement date, and will be amortized into stock-based consulting fees over the term of the agreement. In connection with the
issuance of these shares, during the years ended December 31, 2023 and 2022, the Company recorded stock-based professional fees of $5,000
and $55,000, respectively.
F-24
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
On October 3, 2022, the Company issued 3,000,000
shares of its common stock for investor relations services to be rendered. These shares were valued at $24,000, or $0.008 per common share,
based on the quoted closing price of the Company’s common stock on the measurement date. In connection with the issuance of these
shares, during the years ended December 31, 2023 and 2022, the Company recorded stock-based professional fees of $12,000 and $12,000,
respectively.
During the year ended December 31, 2022, the Company
recorded stock-based professional fees of $119,321 in connection with the amortization of prepaid expenses of $119,321 related to common
shares previously issued.
2023
On February 6, 2023, the Company issued 6,666,667
shares of its common stock for public relations services to be rendered. These shares were valued at $40,000, or $0.006 per common share,
based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares, the Company
recorded stock-based professional fees of $40,000, which was amortized into professional fees over the term of the agreement.
On April 3, 2023, the Company issued 5,000,000
shares of its common stock for investor relations services to be rendered. These shares were valued at $22,500, or $0.0045 per common
share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares,
the Company recorded stock-based professional fees of $22,500, which was amortized into professional fees over the term of the agreement.
On June 3, 2023, the Company issued 1,500,000
shares of its common stock for investor relations services to be rendered. These shares were valued at $16,950, or $0.0011 per common
share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares,
the Company recorded stock-based professional fees of $16,950, which was amortized into professional fees over the remaining term of the
agreement.
On September 3, 2023, the Company issued 1,000,000
shares of its common stock for investor relations services to be rendered. These shares were valued at $4,500, or $0.0045 per common share,
based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares, the Company
recorded stock-based professional fees of $2,250 and prepaid expenses of $2,250, which will be amortized into professional fees over the
remaining term of the agreement.
Issuance of Common Stock for Stock-Based Compensation
2022
On March 24, 2022, the Company granted restricted
stock awards of 500,000 vested common shares of the Company to an employee of the Company for services rendered. The awards were valued
at $14,250, or $0.0285 per common share, based on the quoted closing price of the Company’s common stock on the measurement date.
In connection with these shares, the Company recognized stock-based compensation of $14,250 on the date of issuance.
On July 12, 2022, the Company granted a restricted
stock award of 1,000,000 common shares of the Company to an employee of the Company. The shares will vest on May 1, 2023. These shares
were valued on the date of grant at $11,000, or $0.011 per common share based on the quoted closing price of the Company’s common
stock on the measurement date. In connection with these shares, the Company shall record stock-based compensation over the vesting period.
On August 12, 2022, the Company granted a restricted
stock award of 2,000,000 common shares of the Company to a board member of the Company. The shares will vest on May 1, 2023. These shares
were valued on the date of grant at $24,000 or $0.012 per common share based on the quoted closing price of the Company’s common
stock on the measurement date. In connection with these shares, the Company shall record stock-based compensation over the vesting period.
2023
On June 7, 2023, the Company issued 2,500,000
shares of its common stock to employees for services for services rendered. These shares were valued at $26,000, or $0.0104 per common
share, based on the quoted closing price of the Company’s common stock on the measurement date.
During the years ended December 31, 2023 and 2022,
aggregate accretion of stock-based compensation expense on granted common shares amounted to $42,183 and $82,387, respectively. Total
unrecognized compensation expense related to these unvested common shares on December 31, 2023 amounted to $0. By mutual agreement between
the parties, the vesting date of previously granted shares was extended through May 2024.
F-25
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
The following table summarizes activity related
to non-vested shares:
Number of Non-Vested Shares
Weighted Average Grant Date Fair Value
Non-vested, December 31, 2021
14,270,120
$
0.140
Granted
3,500,000
0.014
Shares vested
(800,000
)
(0.037
)
Non-vested, December 31, 2022
16,970,120
0.119
Shares vested
(2,000,000
)
(0.021
)
Non-vested, December 31, 2023
14,970,120
$
0.132
Shares Issued for Accounts Payable
On January 6, 2022, the Company issued 90,859
common shares upon conversion of accounts payable of $2,174, or $0.024 per common share, based on the quoted closing price of the Company’s
common stock on the measurement date.
Common Stock Issued in Connection with Notes
Payable
2022
In connection with the March 2022 Note, the Company
issued 823,529 shares of its common stock to the placement agent as a fee for the capital raise. The 823,529 shares of common stock issued
were recorded as a debt discount of $12,963 based on the relative fair value method to be amortized over the life of the Note.
In connection with the June 2022 GS Capital Note,
the Company issued 1,750,000 shares of its common stock as a commitment fee. The 1,750,000 shares of common stock issued were recorded
as a debt discount of $32,736 based on the relative fair value method to be amortized over the life of the Note (See Note 8).
In connection with the July 2022 GS Capital Note,
on July 28, 2022, the Company issued 2,600,000 shares of its common stock as a commitment fee and the Company issued 998,008 shares of
its common stock to the placement agent as a fee for the capital raises. The aggregate of 3,598,008 shares of common stock issued were
recorded as a debt discount of $34,606 based on the relative fair value method to be amortized over the life of the July 2022 Note (See
Note 8).
In connection with the September 2022 GS Capital
Note, on September 6, 2022, the Company issued 3,300,000 shares of its common stock as a commitment fee and the Company issued 773,626
shares of its common stock to the placement agent as fee for the capital raises. The aggregate of 4,073,626 shares of common stock issued
were recorded as a debt discount of $30,326 based on the relative fair value method to be amortized over the life of the September 2022
Note (See Note 8).
In connection with the Letter Agreement dated
December 15, 2022, to induce GS Capital to extend the due dates of the GS Capital Notes, the Company issued 15,000,000 shares of the Company’s
common stock. These shares were valued at $112,500, or $0.0075 per common share, based on the quoted closing price of the Company’s
common stock on the measurement date. In connection with the issuance of these shares, during the year ended December 31, 2022, the Company
recorded an expense of $112,500 which was included in loss on debt extinguishment on the accompanying consolidated statement of operations.
2023
During April and May 2023, the Company issued
21,371,481 shares of its common stock upon the conversion of principal of $62,000, accrued interest of $4,139, and fees of $2,250.
In May 2023, the Company issued the Lender 22,000,000
shares of common stock of the Company in exchange for settlement of the remaining $200,000 of the loan and all accrued interest amounting
to $317,293, which were deemed paid in full (see Note 8 - BOCO Investment Note). The 22,000,000 shares issued were valued at $132,000,
or $0.006 per share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with
the issuance of these shares, the Company recorded a gain from debt extinguishment of $68,000 calculated as the different in the principal
amount settled for shares of $200,000 and the fair value of the shares on the measurement date of $132,000.
F-26
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
Common Stock Issued for Conversion of Series
C Preferred Stock
2022
On January 12, 2022, the Company issued 1,543,151
shares of its common stock upon the conversion of 120 shares of Series C preferred with a stated redemption value of $12,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
On April 20, 2022, the Company issued 13,184,548
shares of its common stock upon the conversion of 1,020 shares of Series C preferred with a stated redemption value of $102,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
On December 1, 2022, the Company issued 6,535,274
shares of its common stock upon the conversion of 250 shares of Series C preferred with a stated redemption value of $25,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
2023
During the three months ended March 31, 2023,
the Company issued 26,585,614 shares of its common stock upon the conversion of 1,014 shares of Series C preferred with a stated redemption
value of $101,400. The conversion price was based on contractual terms of the related Series C preferred shares.
During the three months ended June 30, 2023, the
Company issued 23,157,922 shares of its common stock upon the conversion of 826 shares of Series C preferred with a stated redemption
value of $82,600. The conversion price was based on contractual terms of the related Series C preferred shares.
During the three months ended September 30, 2023,
the Company issued 8,584,376 shares of its common stock upon the conversion of 300 shares of Series C preferred with a stated redemption
value of $30,000. The conversion price was based on contractual terms of the related Series C preferred shares.
Stock Options
For the years ended December 31, 2023 and 2022,
the Company recorded no compensation expense related to stock options. Total unrecognized compensation expense related to unvested stock
options on December 31, 2023 and 2022 amounted to $0.
Stock option activities for the years ended December
31, 2023 and 2022 are summarized as follows:
Number of Options
Weighted Average Exercise Price
Weighted Average Remaining Contractual Term (Years)
Aggregate Intrinsic Value
Balance Outstanding, December 31, 2021
8,445,698
$
0.40
4.43
-
Exercised
-
-
-
-
Balance Outstanding, December 31, 2022
8,445,698
0.40
3.43
-
Exercised
-
-
-
-
Balance Outstanding, December 31, 2023
8,445,698
$
0.40
2.43
$
-
Exercisable, December 31, 2023
8,445,698
$
0.40
2.43
$
-
Warrants
On April 20, 2022, in connection with an Exchange
Agreement (See Note 8), the Company issued warrants to purchase an aggregate amount up to 33,000,000 shares of the Company’s common
stock (the “New Warrants”). The New Warrants are exercisable at any time on or after the date of the issuance and entitled
this investor to purchase shares of the Company’s common stock for a period of five years from the initial date the warrants become
exercisable. Under the terms of the New Warrants, the holder is entitled to exercise the Warrants to purchase up to 33,000,000 shares
of the Company’s common stock at an initial exercise price of $0.025, subject to adjustment as detailed in the New Warrants. In
connection with the issuance of the New Warrants, on the initial measurement date, the relative fair value of the warrants of $325,785
was recorded as a debt discount and an increase in paid-in capital (See Note 8). On June 23, 2022, the Company issued common stock equivalents
with an initial conversion price of $0.011 per share and accordingly, the conversion price and warrant down-round provisions were triggered.
As a result, the conversion price of the New April 2022 Note was reduced to $0.011 per share and the exercise price of the New April 2022
Warrant was lowered to $0.011. As a result of the June 23, 2022 down-round provisions, the Company calculated the difference between the
warrants fair value on June 23, 2022, the date the down-round feature was triggered using the then current exercise price of $0.025 and
the new exercise price of $0.011. On June 23, 2022, the Company recorded a deemed dividend of $3,702 which represents the fair value transferred
to the warrant holders from the down round feature being triggered. Additionally, on September 6, 2022, the Company issued common stock
equivalents with an initial conversion price of $0.009 per share and accordingly, the conversion price and warrant down-round provisions
were triggered. As a result, the conversion price of the New April 2022 Note was reduced to $0.009 per share and the exercise price of
the New April 2022 Warrant was lowered to $0.009. As a result of the September 6, 2022 down-round provisions, the Company calculated the
difference between the warrants fair value on September 6, 2022, the date the down-round feature was triggered using the then current
exercise price of $0.011 and the new exercise price of $0.009. On September 6, 2022, the Company recorded a deemed dividend of $733 which
represents the fair value transferred to the warrant holders from the down round feature being triggered. No additional beneficial conversion
feature amount was recorded based on the September 6, 2022 valuation as the ratcheted beneficial conversion feature value was lower than
the original amount.
F-27
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
Warrant activities for the years ended December
31, 2023 and 2022 are summarized as follows:
Number of Warrants
Weighted Average Exercise Price
Weighted Average Remaining Contractual Term (Years)
Aggregate Intrinsic Value
Balance Outstanding December 31, 2021
17,500,000
$
0.05
4.67
$
-
Granted
33,000,000
0.025
-
-
Cancelled
(16,500,000
)
(0.05
)
-
-
Balance Outstanding December 31, 2022
34,000,000
0.011
3.73
-
Granted
-
-
-
-
Balance Outstanding December 31, 2023
34,000,000
$
0.011
2.73
$
-
Exercisable, December 31, 2023
34,000,000
$
0.011
2.73
$
-
2018 Long-Term Incentive Plan
On June 7, 2018, a majority of the Company’s
shareholders and its board approved the adoption of a 2018 Long-Term Incentive Plan (the “2018 Plan”). The purpose of the
2018 Plan is to advance the interests of the Company, its affiliates and its stockholders and promote the long-term growth of the Company
by providing employees, non-employee directors and third-party service providers with incentives to maximize stockholder value and to
otherwise contribute to the success of the Company and its affiliates, thereby aligning the interests of such individuals with the interests
of the Company’s stockholders and providing them additional incentives to continue in their employment or affiliation with the Company.
The Plan was adopted on June 7, 2018 and effective on August 2, 2018. Under the 2018 Plan, the Plan Administrator may grant:
●
options to acquire the Company’s common stock, both incentive stock options that are intended to satisfy the requirements of Section 422 of the Internal Revenue Code and nonqualified stock options which are not intended to satisfy such requirements. The exercise price of options granted under our 2018 Plan must at least be equal to the fair market value of the Company’s common stock on the date of grant and the term of an option may not exceed ten years, except that with respect to an incentive stock option granted to any employee who owns more than 10% of the voting power of all classes of the Company’s outstanding stock as of the grant date the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date.
●
stock appreciation rights, or SARs, which allow the recipient to receive the appreciation in the fair market value of the Company’s common stock between the date of grant and the exercise date. The amount payable under the stock appreciation right may be paid in cash or with shares of the Company’s common stock, or a combination thereof, as determined by the Administrator.
●
restricted stock awards, which are awards of the Company’s shares of common stock that vest in accordance with terms and conditions established by the Administrator.
●
restricted stock units, which are awards that are based on the value of the Company’s common stock and may be paid in cash or in shares of the Company’s common stock.
●
other types of stock-based or stock-related awards not otherwise described by the terms and provision of the 2018 Plan, including the grant or offer for sale of unrestricted shares of the Company’s common stock, and which may involve the transfer of actual shares of the Company’s common stock or payment in cash or otherwise of amounts based on the value of shares of the Company’s common stock and may be designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States.
●
other cash-based awards to eligible persons in such amounts and upon such terms as the Administrator shall determine.
An award granted under the 2018 Plan must include
a minimum vesting period of at least one year, provided, however, that an award may provide that the award will vest before the completion
of such one-year period upon the death or qualifying disability of the grantee of the award or a change of control of the Company and
awards covering, in the aggregate, 25,000,000 shares of our Common Stock may be issued without any minimum vesting period.
The aggregate number of shares of common stock
and number of shares of the Company’s common stock that may be subject to incentive stock options granted under the 2018 Plan is
50,000,000 shares, of which 11,445,698 shares have been issued or granted under incentive stock options and 29,451,070 shares of restricted
stock have been issued as of December 31, 2023. All shares underlying grants are expected to be issued from the Company’s unissued
authorized shares available.
F-28
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
NOTE 10 – COMMITMENTS AND CONTINGENCIES
Legal Matters
From time to time, the Company may be involved
in litigation related to claims arising out of its operations in the normal course of business. As of December 31, 2023, other than discussed
below, the Company is not involved in any other pending or threatened legal proceedings that it believes could reasonably be expected
to have a material adverse effect on its financial condition, results of operations, or cash flows.
On January 20, 2022, we received
an Order Directing Examination and Designating Officers to Take Testimony (a “Formal Order”) from the SEC. The Formal Order
authorizes that an examination be made to determine whether a stop order should be issued under Section 8(d) of the Securities Act of
1933 with respect to the Company’s Registration Statement on Form S-1, and any supplements and amendments thereto. The Formal Order
indicates that the Form S-1 may be deficient in that it may contain untrue statements of material fact or omit to state material facts
necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading concerning, among
other things, the Company’s revenue and financial condition. On April 15, 2022, the Company filed an amendment to its Annual Report
on Form 10-K for the fiscal year ended December 31, 2020. The restatement had the cumulative effect of decreasing the Company’s
reported revenue for fiscal year 2020 by $102,569 and decreasing the Company’s bad debt expense for the same period by $102,569.
There was no effect on the Company’s reported net loss for fiscal year 2020 or on the financial condition of the Company on December
31, 2020. The Company received a subpoena from the SEC on April 25, 2022, requesting all documents and communications concerning the review
of C-Bond’s revenue recognition practices for fiscal year 2020. In response, the Company has provided the requested information
and its Chief Executive Officer provided his testimony regarding this Formal Order in October 2022. The Company also filed a request
to withdraw its Registration Statement on Form S-1 (“S-1”) (File No. 333-261472) (the “Registration Statement”),
filed by the Company with the Securities and Exchange Commission on December 3, 2021. The S-1 related to shares of common stock underlying
certain convertible promissory notes held by selling securityholders. The S-1 was not declared effective and no securities were sold in
reliance thereon. The Company and its Chief Executive Officer have submitted an offer to settle and close the pending SEC investigation.
The Company and its Chief Executive Officer are awaiting a formal response to such offer of settlement. As of December 31, 2023 and based
on a proposed settlement, the Company has accrued $175,000 of settlement expense association with this matter, which is reflected in other
income (expenses) on the accompanying statement of operations during the year ended December 31, 2023.
On March 8, 2021, a former officer of the Company
resigned. Both parties alleged certain claims against the other, including with respect to certain compensation claims. Neither party
has filed litigation. The Company intends to vigorously defend itself against any possible claims and assert any relevant claims against
the former executive and believes it will prevail. As a result of the evidence disclosed and discovered during the aforementioned SEC
investigation, the Company has concluded that the actions of the former President and Acting CFO of the Company may be viewed as potentially
dishonest and fraudulent. As a result, the Board of Directors of the Company have resolved and taken action in February 2024 to cause
the forfeiture of equity and deferred compensation owed/outstanding by said officer and forwarded a formal demand letter to said officer
and his wife, the former Controller of the Company.
In July 2021, a former consultant of the Company
filed a small claims case for approximately $16,000 in Harris County, TX, and the Company filed its response in August 2021. The
Company received a civil notice of trial setting for September 7, 2023. On September 7, 2023, the Company and the former consultant entered
into a settlement agreement, whereby the Company paid $9,000 as full settlement of this claim. Accordingly, the Company recorded a gain
on debt extinguishment of $9,250. As of December 31, 2023 and 2022, the Company had accrued compensation of $0 and $18,250 to this
former employee, which was included in accrued compensation on the accompanying consolidated balance sheets.
Employment Agreements
On October 18, 2017, the Company entered into
an employment agreement with Mr. Scott Silverman, pursuant to which he serves as the Chief Executive Officer of the Company for an initial
term of three years that extends for successive one-year renewal terms unless either party gives 30-days’ advance notice of non-renewal.
As consideration for these services, the employment agreement provides Mr. Silverman with the following compensation and benefits:
●
An annual base salary of $300,000, with a 10% increase on each anniversary date contingent upon achieving certain performance objectives as set by the Board. Until the Company raises $1,000,000 in debt or equity financing after entering into this agreement, Mr. Silverman will receive ½ of the base salary on a monthly basis with the other ½ being deferred. Upon the financing being raised, Mr. Silverman will receive the deferred portion of his compensation and his base salary will be paid in full moving forward.
●
After the first $500,000 of equity investments is raised by the Company, after entering into this employment agreement, Mr. Silverman will receive a capital raise success bonus of 5% of all equity capital raised from investors/lenders introduced by him to the Company.
●
Annual cash performance bonus opportunity as determined by the Board.
●
An option to acquire 3,000,000 common shares of the Company, with a strike price of $0.31 per unit. These options vested pro rata on a monthly basis for the term of the employment agreement. On each anniversary, Mr. Silverman will be eligible to be granted a minimum of 500,000 stock options of the Company at a strike price of $0.85 per common unit contingent upon the achievement of certain performance objectives.
●
Certain other employee benefits and perquisites, including reimbursement of necessary and reasonable travel and participation in retirement and welfare benefits.
The receipt of $1,240,000 in connection with
the April 25, 2018 financing triggered the right of the employee to receive the deferred salary and the 5% bonus provision disclosed above.
F-29
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
Mr. Silverman’s employment agreement provides
that, in the event that his employment is terminated by the Company without “cause” (as defined in his employment agreement),
or if Mr. Silverman resigned for “good reasons” (as defined in his new employment agreement), subject to a complete release
of claims, he will be entitled to (i) retain all stock options previously granted; and (ii) receive any benefits then owed or accrued
along with one year of base salary and any unreimbursed expenses incurred by him. All amounts shall be paid on the termination date. In
the event that Mr. Silverman’s employment is terminated by the Company for “cause” (as defined in his employment agreement),
or if Mr. Silverman resigned without “good reasons” (as defined in his employment agreement), subject to a complete release
of claims, he will be entitled to receive any unpaid base salary and benefits then owed or accrued and any unreimbursed expenses incurred
by him. Additionally, if a change of control (as defined in his employment agreement) occurs during the term of this agreement, all unvested
stock options will vest in full and if the valuation of the Company in the change of control transaction is greater than $0.85 per common
share, then Mr. Silverman shall be paid a bonus equal to two times his minimum base salary and minimum target bonus. Pursuant to the employment
agreement, Mr. Silverman will be subject to a confidentiality covenant, a two-year post-termination non-competition covenant and a two-year
post-termination non-solicitation covenant. On June 30, 2020, the Company amended the employment agreement of Mr. Silverman to provide
for successive one-year extensions until either the executive or the Board of Directors of the Company gives notice to terminate the employment
agreement per its terms. This employment agreement amendment also includes an allowance of up to $10,000 per year to cover uncovered medical/dental
expenses for Mr. Silverman and his family.
On July 21, 2021, the Company entered into the
Employment Agreement with Mr. Wanke, the President of Patriot Glass, to serve as the President of C-Bond’s Safety Solutions Group.
Under the three-year Employment Agreement, Mr. Wanke will receive a base salary of $240,000 per year, which may be increased from time
to time with the approval of the board of directors. In addition, Mr. Wanke may receive an annual bonus as determined by the board of
directors. It is understood that although Mr. Wanke’s base salary will be paid by Patriot Glass, 50% of the base salary will be
allocated to the expenses of Patriot Glass, and the other 50% of the base salary will be allocated to the expenses of the Company. The
term of this Agreement (the “Initial Term”) shall begin as of July 21, 2021 (the “Effective Date”) and shall end
on the earlier of (i) the third anniversary of the Effective Date and (ii) the time of the termination of the Executive’s employment
in accordance with the Employment Agreement. This Initial Term and any Renewal Term (as defined below) shall automatically be extended
for one or more additional terms of one (1) year each (each a “Renewal Term” and together with the Initial Term, the “Term”),
unless either the Company or Executive provide notice to the other Party of their desire to not so renew the Initial Term or Renewal Term
(as applicable) at least thirty (30) days prior to the expiration of the then-current Initial Term or Renewal Term, as applicable. All
unvested shares of stock and stock options shall expire upon such termination, if any. The Executive shall be eligible for an annual bonus
payment in an amount to be determined by the Board of Directors of the Company (the “Bonus”). The Bonus shall be determined
and payable based on the achievement of certain performance objectives of the Company as established by the Board and communicated to
and agreed to by the Executive in writing as soon as practicable after commencement of the year in respect of which the Bonus is paid.
The Bonus, if earned, is payable in cash and/or restricted stock at the discretion of the Board. It is understood between the Parties
that the target bonus for each year shall be up to 50% of the Base Salary.
On December 7, 2022, the Company’s board
of directors approved a bonus to certain officers in the aggregate amount of $160,000. This bonus was paid 10% in cash of $16,000, which
was paid in December 2022, and 90% in equity amounting to $144,000 which as of December 31, 2022 had been accrued and as of December 31,
2022, was included in accrued compensation on the accompanying consolidated balance sheet. On January 17, 2023, the Board of Directors
of the Company agreed to satisfy $144,000 of the bonus owed to its executive officers (collectively, the “Management”). Management
agreed to accept 144 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation (See
Note 9).
On December 7, 2023, the Company’s board
of directors approved a bonus to two officers in the aggregate amount of $480,000. For the bonus approved for Mr. Silverman, which amounted
to $300,000, this bonus was paid 50%, or $150,000, in cash, which was paid in December 2023, and 50% in equity amounting to $150,000 which
as of December 31, 2023 has been accrued and as of December 31, 2023, is included in accrued compensation on the accompanying consolidated
balance sheet. For the bonus approved for Ms. Tomek, which amounted to $180,000, this bonus is to be paid 10% in cash of $18,000 and 90%
in equity amounting to $162,000, which as of December 31, 2023 has been accrued and as of December 31, 2023, is included in accrued compensation
on the accompanying consolidated balance sheet. On January 2, 2024, the Board of Directors of the Company agreed to satisfy the aggregate
of $312,000 of the bonus owed to these executive officers (collectively, the “Management”). Management agreed to accept an
aggregate of 312 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation (See Note
18).
Anti-dilution rights related to C-Bond Systems,
LLC
Prior to the Merger, C-Bond Systems, LLC entered
into certain contracts, described below, which provided certain anti-dilution protection to the counterparties to those contracts.
The Company believes that these contracts do not apply to any future issuances of equity by C-Bond Systems, Inc.
In 2013, pursuant to a subscription agreement,
the Company’s subsidiary. C-Bond Systems, LLC issued 2,425,300 common shares. To the extent that during the term of the agreement
C-Bond Systems, LLC issues any “down-round” or subsequent investments based upon an enterprise value of less than $2,000,000
(“Dilutive Transaction”) (other than an issuance pursuant to an option agreement with an employee or otherwise to compensate
an employee, or incident to an acquisition of assets by C-Bond Systems, LLC in which common units were issued to the seller of such assets)
contemporaneously with the Dilutive Transaction, the contract obligated C-Bond Systems, LLC to issue the investor additional common units
in C-Bond Systems, LLC in an amount which would provide them with the ownership percentage interest which they would have held in C-Bond
Systems, LLC represented by the common units purchased by them on this date.
F-30
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
In 2015, pursuant to a subscription agreement,
C-Bond Systems, LLC issued 3,880,480 common shares to an entity at $0.77 per common share. This agreement entitled the subscriber to anti-dilution
protection to the extent that C-Bond Systems, LLC issued any equity in a “down-round” based upon a value of less than $0.77
per common unit of C-Bond Systems, LLC (other than an issuance pursuant to an option agreement with an employee or consultant or otherwise
to compensate an employee or consultant, or incident to an acquisition of assets by C-Bond Systems, LLC in which common units are issued
to the seller of such assets (“Dilutive Transaction”)). Contemporaneously with the Dilutive Transaction, the contract obligated
C-Bond Systems, LLC to issue the Subscriber additional common units in C-Bond Systems, LLC in an amount which would provide the investor
with the ownership percentage interest in C-Bond Systems, LLC on a fully diluted basis which Subscriber held immediately prior to the
Dilutive Transaction.
In 2016, pursuant to a subscription agreement,
C-Bond Systems, LLC issued 1,175,902 common shares to an entity at $0.85 per common share. This agreement entitled this investor to customary
broad-based weighted average anti-dilution protection to the extent that after the date of this subscription agreement C-Bond Systems,
LLC issued any equity in a “down round” based upon a value of less than $0.85 per common share, including the issuance of
options with an exercise price per share of less than $0.85 to compensate employees or consultants (“Dilutive Transaction”),
subject to exclusions for issuances of common shares or options in connection with strategic partnerships, equity kickers to lenders
or vendors, mergers or acquisitions. The agreement obligated C-Bond Systems, LLC to give to this investor written notice (an “Issuance
Notice”) of any proposed issuance by C-Bond Systems, LLC of any C-Bond Systems, LLC common units, or other form of equity interest
(excluding issuances of C-Bond Systems, LLC options or other equity to compensate employees or consultants and the issuance of shares
in connection with strategic partnerships, equity kickers to lenders or vendors, mergers or acquisitions) at least ten business days
prior to the proposed issuance date. This contract entitled the investor to purchase their pro rata portion of such shares or other equity
interest of C-Bond Systems, LLC at the price and on the other terms and conditions specified in the issuance notice.
Option to purchase 20% of Patriot Glass
In connection with the Exchange Agreement with
Patriot Glass and the Patriot Glass Shareholder (See Note 1), the Company had the option to acquire the remaining 20% of Patriot Glass’s
issued and outstanding membership interests in exchange for a number of shares of the Company’s common stock equal to 300% of Patriot
Glass’s average EBIT value, divided by the price of the Company’s common stock as defined in the Exchange Agreement. On September
20, 2023, the Company and the Patriot Glass Shareholder entered into an amendment to the Exchange Agreement (the “Amended Exchange
Agreement”). Pursuant to the Amended Exchange Agreement, the Company shall have the option (the “Option”), beginning
on July 1, 2025 (the “Option Start Date”) and ending on 5:00 P.M. EST on the date that is thirty calendar days after the Option
Start Date (the “Option Period”), to acquire the remaining 20% of Patriot Glass Units (the “Additional Units”),
representing 20% of Patriot Glass’s issued and outstanding membership interests, collectively (the “Additional Closing”).
If the Company exercises the Option, the Company
shall acquire the Additional Units in exchange for (i) a number of shares of Company Common Stock equal to (a) the Share Value (as defined
below) divided by (b) the Additional Closing Share Price (as defined below) (the “Additional Closing Exchange Shares”), and
(ii) a cash payment equal to the Net Income (as below). “Total EBIT Value” shall mean the sum of (i) Patriot Glass’s
net income, before income tax expense and interest expense have been deducted, for the period beginning on July 1, 2023 and ending on
June 30, 2025 plus (ii) $240,000. “EBIT Value” shall mean the Total EBIT Value divided by two (2). “Share Value”
shall mean (i) 300% of the EBIT Value (the “Triple EBIT Value”), minus (ii) the Net Income. “Net Income” shall
mean Patriot Glass’s net income, after income tax expense and interest expense have been deducted, for the period beginning on July
1, 2023 and ending on June 30, 2025. Any salary paid by Patriot Glass, including but not limited to any salary paid to the Patriot Glass
Shareholder, shall not be included in Net Income. If the Company Common Stock is quoted or listed for trading on a Trading Market on July
1, 2025, then “Additional Closing Share Price” shall mean the average of all of the closing prices of Company Common Stock
on such Trading Market during the calendar month of June 2024.
M&A advisory agreement
On October 18, 2023, the Company and Maxim Group
LLC (“Maxim”) entered into an engagement letter, whereby Maxim was engaged as the Company’s exclusive financial advisor
to perform merger and acquisition advisory services. Either Maxim or the Company may terminate this Agreement at any time upon thirty
(30) days’ prior written notice to the other party after the six (6) month anniversary of this Agreement. The Company paid Maxim
a one-time non-refundable cash fee of $25,000 due promptly upon execution of the Agreement (the “Retainer”). The Retainer
shall be creditable against the Success Fee. If during the term of this Agreement a Transaction is consummated or the Company enters into
an agreement regarding a Transaction (which is consummated subsequent to the completion of the Term), a fee (the “Success Fee”)
will be payable in U.S. dollars upon the closing of the Transaction to Maxim equal to six and a half percent (6.5%) of the Consideration
(as defined hereinafter), provided however, that if a Transaction is consummated or the company enters into an agreement regarding
a Transaction with Curtis Stout Inc., such Success Fee shall be reduced to four percent (4.0%) of Consideration from Curtis Stout Inc.
In the event that the Company enters into an agreement with respect to a Transaction during the term of this Agreement that is subsequently
terminated, and the Company becomes entitled to a break-up, termination, topping, expense reimbursement or similar fee or payment (including
any judgment for damages or amount in settlement of any dispute as a result of such termination, or any profit on any stock acquired from,
or stock option granted by, any party to such transaction), a fee (the “Break-up Fee”) equal to 10.0% of all such amounts,
payable promptly upon receipt of such amounts by the Company. Upon the closing of a Transaction, for a period of twelve (12) months from
such closing, the Company grants Maxim the right of first refusal to act as sole managing underwriter and sole book runner, sole placement
agent, or sole sales agent, for any and all future public or private equity, equity-linked or debt (excluding commercial bank debt) offerings
for which the Company retains the service of an underwriter, agent, advisor, finder or other person or entity in connection with such
offering period of the Company, or any successor to or any subsidiary of the Company. The Company shall not offer to retain any entity
or person in connection with any such offering on terms more favorable than terms on which it offers to retain Maxim. Such offer shall
be made in writing in order to be effective. Maxim shall notify the Company within ten (10) business days of its receipt of the written
offer contemplated above as to whether or not it agrees to accept such retention. If Maxim should decline such retention, the Company
shall have no further obligations to Maxim with respect to the offering for which it has offered to retain Maxim, except as otherwise
provided for herein. As of the date of this report, no funds have been raised.
F-31
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
NOTE 11 – CONCENTRATIONS
Concentrations Of Credit Risk
Financial instruments that potentially subject
the Company to concentrations of credit risk consist primarily of trade accounts receivable and cash deposits. The Company places its
cash in banks at levels that, at times, may exceed federally insured limits. On December 31, 2023, the Company had cash in bank in excess
of FDIC insured levels of $322,007. To reduce its risk associated with the failure of such financial institution, the Company evaluates
at least annually the rating of the financial institution in which it holds deposits. Any material loss that the Company may experience
in the future could have an adverse effect on its ability to pay its operational expenses or make other payments and may require the Company
to move its cash to other high quality financial institutions. The Company reviews its bank relationships in order to mitigate
its risk to ensure that its exposure is limited or reduced to the FDIC protection limits. The Company has not experienced any losses in
such accounts through December 31, 2023.
Geographic Concentrations of Sales
During the years ended December 31, 2023 and 2022,
all sales were in the United States.
Customer Concentrations
For the year ended December 31, 2023, one customer
accounted for approximately 10.8% of total sales. For the year ended December 31, 2022, no customer accounted for over 10% of total sales.
On December 31, 2023, two customers accounted for 41.8% (29.5% and 12.3%, respectively) of the total accounts receivable balance. On
December 31, 2022, three customers accounted for 41.1% (10.3%, 19.3% and 11.5%, respectively) of the total accounts receivable balance.
Vendor concentrations
Generally, the Company purchases substantially
all of its inventory from four suppliers. The loss of these suppliers may have a material adverse effect on the Company’s consolidated
results of operations and financial condition. However, the Company believes that, if necessary, alternate vendors could supply similar
products in adequate quantities to avoid material disruptions to operations.
NOTE 12 – SEGMENT REPORTING
Through May 8, 2023, the date that the Company
entered into an Asset Purchase Agreement with Apex Protect GPS, LLC agreed to sell its C-Bond nanoShield™ product line (See Note
16), the Company operated in two reportable business segments - (1) the manufacture and sale of a windshield strengthening water repellent
solution as well as a disinfection product, and the sale of multi-purpose glass strengthening primer and window film mounting solutions,
including ballistic-resistant film systems and a forced entry system (the “C-Bond Segment”), and (2) the distribution and
installation of window film solutions (the “Patriot Glass Segment”). The Company’s reportable segments were strategic
business units that offered different products. They were managed separately based on the fundamental differences in their operations
and locations. Upon the sale of the C-Bond nanoShield™ business, the legacy C-Bond business is being conducted through Patriot Glass
in order to combine administrative functions and they are now being managed together.
Information with respect to these reportable business
segments for the years ended December 31, 2023 and 2022 was as follows:
For the Year Ended December 31,
2023
2022
Revenues:
C-Bond
$
124,372
$
378,736
Patriot Glass
2,364,121
1,853,910
2,488,493
2,232,646
Depreciation and amortization:
C-Bond
570
7,109
Patriot Glass
88,289
82,110
88,859
89,219
Interest expense:
C-Bond
357
23
Patriot Glass
34,566
20,212
Other (a)
440,507
1,599,854
475,430
1,620,089
Net income (loss):
C-Bond
(912,436
)
(1,097,069
)
Patriot Glass
(44,289
)
(192,566
)
Other (a)
2,843,532
(3,866,843
)
$
1,886,807
$
(5,156,478
)
F-32
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
December 31, 2023
December 31, 2022
Identifiable long-lived tangible assets on December 31, 2023 and 2022 by segment:
C-Bond
$
-
$
1,684
Patriot Glass
171,606
94,622
$
171,606
$
96,306
(a)
The Company does not allocate any general and administrative or financing expenses of its holding company activities to its reportable segments, because these activities are managed at the corporate level.
NOTE 13 – REVENUE RECOGNITION
Prior to the sale of the Company’s C-Bond
segment in May 2023, the revenue that the Company recognized arose from purchase requests the Company received from its customers. The
Company’s performance obligations under purchase orders or by a verbal order correspond to each shipment of product that the Company
makes to its customer under the purchase order or verbal order. As a result, each purchase order or verbal order generally contains more
than one performance obligation based on the number of products ordered, the quantity of product to be shipped and the mode of shipment
requested by the customer. Control of the Company’s products transfers to its customers when the customer is able to direct the
use of, and obtain substantially all of the benefits from, the Company’s products, which generally occurs at the later of when the
customer obtains title to the product or when the customer assumes risk of loss of the product. The transfer of control generally occurs
at the time of shipment from the Company’s warehouse. Once this occurs, the Company has satisfied its performance obligation and
the Company recognizes revenue. In connection with the Company’s C-Bond segment, when the Company receives a purchase order
or verbal order from a customer, the Company is obligated to provide the product during a mutually agreed upon time period. Depending
on the terms of the purchase order or verbal order, either the Company or the customer arranges delivery of the product to the customer’s
intended destination. In situations where the Company has agreed to arrange delivery of the product to the customer’s intended destination
and control of the product transfers upon loading of the Company’s product onto transportation equipment, the Company has elected
to account for any freight income associated with the delivery of these products as freight revenue, since this activity fulfills the
Company’s obligation to transfer the product to the customer.
In connection with the Company’s Patriot
Glass segment, the revenue that the Company recognizes arises from purchase requests the Company receives from its customers. The Company’s
performance obligations under purchase order or a signed proposal correspond to each job for the distribution and installation of window
film solutions. As a result, each purchase order or signed proposal generally may contain more than one performance obligation based on
the specific job. Control of the Company’s products transfers to its customers when the customer is able to direct the use of, and
obtain substantially all of the benefits from, the Company’s products, which generally occurs when the job or a specific portion
of the job is completed. Once this occurs, the Company has satisfied its performance obligation and the Company recognizes revenue.
Revenues from contracts for the distribution and installation of window film solutions are recognized over time on the basis of the Company’s
estimates of the progress towards completion of contracts using various output of input methods including (1) the ratio of number of labor
hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed
method. These methods are used because management considers these methods to be the best available measure of progress on these contracts.
Transaction Price
The Company agrees with its customers on the selling
price of each transaction. This transaction price is generally based on the product, market conditions, including supply and demand balances,
labor costs, and freight. In the Company’s C-Bond contracts with customers, the Company allocates the entire transaction price to
the sale of product to the customer, which is the basis for the determination of the relative standalone selling price allocated to each
performance obligation. Returns of the Company’s product by its customers are permitted only when the product is not to specification
and were not material for the years ended December 31, 2023 and 2022. Any sales tax, value added tax, and other tax the Company collects
concurrently with its revenue-producing activities are excluded from revenue.
Revenue Disaggregation
The Company tracks its revenue by product. The
following table summarizes our revenue by product for the years ended December 31, 2023 and 2022:
For the Years Ended December 31,
2023
2022
C-Bond Secure multi-purpose and BRS ballistic resistant glass protection systems
$
9,709
$
17,311
C-Bond Nanoshield solution sales
112,413
345,470
Disinfection products
-
10,880
Window tint installation and sales recognized over time
2,364,121
1,853,910
Freight and delivery
2,250
5,075
Total
$
2,488,493
$
2,232,646
F-33
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In October 2019, the Company entered into an 18-month
lease agreement for the lease of office and warehouse space under a non-cancelable operating lease through May 31, 2021. From the lease
commencement date of December 1, 2019 until November 30, 2020, monthly rent shall be $4,444 and from December 1, 2020 to May 31, 2021,
monthly rent shall be $4,577 per month. On May 12, 2021 and effective June 1, 2021, the Company entered into an amendment to the lease
which extended the lease for one year until May 31, 2022 at a monthly base rent of $5,283. On May 4, 2022 and effective June 1, 2022,
the Company entered into an amendment to the lease which extended the lease for three years until May 31, 2025. On June 15, 2023, in connection
with the sale of the Company’s nanoShield product line, the purchaser assumed the operating lease and the Company vacated the premises.
In connection with the 2021 Exchange Agreement
between in the Company and Patriot Glass, the Company was named as guarantor (“Guarantor”) of a Commercial Lease Agreement
dated July 21, 2021, by and between landlord MDW Management, LLC, a company owned by Mr. Wanke and his wife and tenant Patriot Glass d/b/a
A-1 Glass (the “Lease”). The term of the Lease is 60 months, at a minimum monthly rent of $5,600 (not including tax), with
two five-year options for the tenant to renew. The Company’s obligation as Guarantor of the Lease will terminate upon the occurrence
of earlier of the following: (i) the date of Guarantor’s acquisition of 100% of the ownership interests of Patriot Glass; (ii) the
date that Guarantor beneficially owns less than an eighty percent (80%) ownership interest in Patriot Glass; or (iii) two (2) years from
and after the effective date of the guaranty. During the year ended December 31, 2023, the Company’s obligation as Guarantor expired.
In September 2021, the Company entered into a
48-month lease agreement for the lease of office equipment under a non-cancelable operating lease through September 2025. The monthly
base rent is $365 per month. This lease has been assumed by CB NANOSHIELD LLC as part of its purchase of the nanoShield Assets (see Note
16).
In February 2022, the Company entered into a 36-month
lease agreement for the lease of a vehicle under a non-cancelable operating lease through January 2025. The monthly base rent is $788
per month.
In adopting ASC Topic 842, Leases (Topic 842)
on January 1, 2019, the Company had elected the ‘package of practical expedients’, which permitted it not to reassess under
the new standard its prior conclusions about lease identification, lease classification and initial direct costs (see Note 2). In addition,
the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less. Upon signing of new leases for property
and equipment, the Company analyzed the new leases and determined it is required to record a lease liability and a right of use asset
on its consolidated balance sheets, at fair value.
During the years ended December 31, 2023 and 2022,
in connection with its property operating leases, the Company recorded rent expense of $101,501 and $167,875 respectively, which is expensed
during the year and included in general and administrative expenses on the accompanying consolidated statements of operations.
The significant assumption used to determine the
present value of the lease liabilities in February 2022 was a discount rate of 6.79% which was based on the Company’s estimated
incremental borrowing rate.
On December 31, 2023 and 2022, right-of-use asset
(“ROU”) is summarized as follows:
December 31, 2023
December 31, 2022
Office leases and office equipment right of use assets
$
279,162
$
480,293
Less: accumulated amortization
(120,678
)
(104,881
)
Balance of ROU assets
$
158,484
$
375,412
On December 31, 2023 and 2022, operating lease
liabilities related to the ROU assets are summarized as follows:
December 31,
2023
December 31, 2022
Lease liabilities related to office leases right of use assets
$
157,752
$
376,566
Less: current portion of lease liabilities
(60,503
)
(117,671
)
Lease liabilities – long-term
$
97,249
$
258,895
On December 31, 2023, future minimum base lease
payments due under non-cancelable operating leases are as follows:
Twelve months ended December 31,
Amount
2024
$
75,866
2025
67,988
2026
39,200
Total minimum non-cancelable operating lease payments
183,054
Less: discount to fair value
(25,302
)
Total lease liability on December 31, 2023
$
157,752
F-34
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
NOTE 15 – RELATED PARTY TRANSACTIONS
Note Payable - Related Party
On May 2, 2022, the Company entered into a Promissory
Note (the “May 2022 Note”) in the principal amount of $250,000 with the Company’s chief executive officer. The May 2022
Note was funded in May 2022 and the Company received net proceeds of $250,000. The May 2022 Note bears interest at a rate of 6% per annum
and all outstanding principal and accrued and unpaid interest is due on May 2, 2024. At any time, the Company may prepay all or any portion
of the principal amount of the May 2022 Note and any accrued and unpaid interest without penalty. For the year ended December 31, 2023,
interest expense – related party amounted to $5,663. In May 2023, the Company repaid $200,000 of the May 2022 Note. In August 2023,
the Company repaid the remaining $50,000 of the May 2022 Note and repaid accrued interest of $15,690. On December 31, 2023, the principal
amount due and accrued interest payable - related party amounted to $0. On December 31, 2022, the principal amount due and accrued interest
payable - related party amounted to $250,000 and $10,027, respectively.
NOTE 16 – SALE OF NANOSHIELD PRODUCT LINE
On May 8, 2023, the Company entered into an Asset
Purchase Agreement (the “APA”) with Apex Protect GPS, LLC (the “Buyer”), a Texas limited liability company, whereby
the Company agreed to sell its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process,
furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShield division (the “Assets”)
to the Buyer for a purchase price of $4,000,000 in cash (the “Transaction”). The Transaction closed on May 8, 2023. Following
the Closing, the parties entered into an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among
the Company; Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned
all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the
foregoing to Assignee.
The Assets were sold and transferred to buyer
by means of (i) with respect to the physical assets, a Bill of Sale; and (ii) with respect to intangible assets or intellectual property,
a Patent and Trademark Assignment Agreement, a Patent and Know-How License Agreement, and a Patent License-Back Agreement.
The APA contains customary representations, warranties,
and covenants by each party including, among other things, that no bankruptcy or similar insolvency proceeding under state or federal
law has been filed, or is currently being contemplated, with respect to the Company; that the Company has provided the Seller a true and
accurate list of each of the following items of Intellectual Property which comprises a part of the Assets, including, among other things,
patents and trademarks (the “Sold Intellectual Property”); and that the Company has good, valid, and legal title to, and is
the sole and exclusive owner of all rights, title and interest in and to, the Sold Intellectual Property, free and clear of all liens.
Under the terms of the APA, the Parties entered
into a Patent and Trademark Assignment Agreement, whereby the Company conveyed, transferred, and assigned to Buyer, among other assets,
the C-Bond nanoShield trademark (the “Trademark”) and U.S. Patent No. 11,155,491 B2 (the “C-Bond nanoShield Patent”),
and the Company agreed to execute and deliver an assignment of the Trademark and C-Bond nanoShield Patent, for recording with governmental
authorities including, but not limited to, the U.S. Patent and Trademark Office.
The Parties also entered into a Patent and Know-How
License Agreement whereby the Company granted to the Buyer a non-transferable, non-sub-licensable, exclusive right and license to four
patents owned by the Company and licensed know-how to make, have made, use, offer to sell, sell and import glass and other products and
components used in or in relation to the manufacture and operation of civilian, agricultural or military vehicles and equipment (the “Licensed
Product”) in the United States and its legal territories.
Lastly, the Parties entered into a Patent License-Back
Agreement whereby the Buyer agreed to grant to the Company a perpetual, non-exclusive, worldwide, royalty-free, non-transferable, non-sublicensable
license to the C-Bond nanoShield Patent, for all uses and applications except for any that involve, market to, sell to, do business with,
provide related goods or services to, or are consumed by any uses and applications of the patented technology within the civilian or military
automotive, vehicle and/or transportation industry. The Patent License-Back Agreement also stipulates that all improvements made by either
Party to the technology covered by the C-Bond nanoShield Patent shall be owned by the Buyer. In the event that the Company desires to
utilize such improvements to the C-Bond nanoShield Patent made by either Party, the Parties hereby agree that they will negotiate in good
faith a separate license agreement having pricing and other terms and conditions that are mutually acceptable to both Parties.
Following the Closing, the Parties completed a
transaction wherein the Company assigned to Buyer, and Buyer took assignment from the Company, the lease for the premises located at 6035
South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to a lease assignment and assumption agreement as agreed to by
the Parties and the lessor pursuant to the Lease.
F-35
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
In connection with the APA, the Company received
net proceeds of $1,989,755, after the repayment and settlement of notes payable and convertible notes payable as follows:
1)
The Company repaid and settled the BOCO Investments, LLC Note (See Note 8) with a principal balance of $400,000 and accrued interest payable of $317,293 for a cash payment of $200,000 and the issuance of 22,000,000 shares of the Company’s common stock (See Note 8 and 9).
2)
The Company repaid GS Capital Partners, LLC $419,260 for notes dated June 23, 2022, July 26, 2022, and September 6, 2022 (collectively, the “GS Notes”), and GS Capital Partners, LLC deemed the GS Notes paid in full (See Note 8).
3)
The Company repaid Mercer Street Global Opportunity Fund, LLC (“Mercer”) $271,825 for notes dated March 14, 2022 and November 22, 2022 (collectively, the “Secured Mercer Notes”) (See Note 7).
4)
The Company repaid Jeff Badders $875,000 for notes dated May 5, 2021, November 8, 2022, and April 4, 2023 (See Note 8).
5)
The Company repaid 1800 Diagonal Lending, LLC $288,035 for notes dated November 4, 2022, December 27, 2022, and March 17, 2023 (collectively, the “1800 Diagonal Notes”), and 1800 Diagonal Lending, LLC deemed the 1800 Diagonal Notes paid in full (See Note 7).
6)
The Company repaid its CEO $250,000 for the note dated May 2, 2022, and the CEO deemed the note paid in full.
In accordance with ASC 205-20, the sale of the
C-Bond nanoShield product line was not reported in discontinued operations since the disposal did not represent a strategic shift that
has (or will have) a major effect on the Company’s operations and financial results. The C-Bond nanoShield product line was only
a component of the C-Bond segment which comprised of operations and cash flows that were not clearly distinguished, operationally and
for financial reporting purposes, from the rest of the C-Bond segment.
In connection with the sale of the C-Bond nanoShield
product line, the Company recorded a gain from the sale of the product line of $4,051,709.
NOTE 17 - INCOME TAXES
The Company accounts for income tax using the
liability method prescribed by ASC 740, “Income Taxes”. Under this method, deferred tax assets and liabilities are determined
based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in
effect in the year in which the differences are expected to reverse. The deferred tax assets on December 31, 2023 and 2022 consist only
of net operating loss carryforwards. The net deferred tax asset has been fully offset by a valuation allowance because of the uncertainty
of the attainment of future taxable income.
The items accounting for the difference between income taxes at the
effective statutory rate and the provision for income taxes for the years ended December 31, 2023 and 2022 were as follows:
2023
2022
Income tax expense (benefit) at U.S. statutory rate
$
396,229
$
(1,081,240
)
Non-deductible expenses
(64,617
)
506,677
Change in valuation allowance
(331,612
)
574,563
Total provision for income tax
$
-
$
-
The Company’s approximate net deferred tax asset as of December
31, 2023 and 2022 was as follows:
Deferred Tax Asset:
December 31, 2023
December 31, 2022
Net operating loss carryforward
$
2,176,983
$
2,512,665
Allowance for bad debt
4,070
-
Total deferred tax asset before valuation allowance
2,181,053
2,512,665
Valuation allowance
(2,181,053
)
(2,512,665
)
Net deferred tax asset
$
-
$
-
The net operating loss carryforward was approximately
$10,386,000 on December 31, 2023. The Company provided a valuation allowance equal to the net deferred income tax asset as of December
31, 2023 and 2022 because it was not known whether future taxable income will be sufficient to utilize the loss carryforward. During the
year ended December 31, 2023, the valuation allowance decreased by $331,612. Additionally, the future utilization of the net operating
loss carryforward to offset future taxable income is subject to an annual limitation as a result of ownership changes that may occur in
the future. The potential tax benefit arising from the loss carryforward may be carried forward indefinitely subject to usage limitations.
The Company does not have any uncertain tax positions or events
leading to uncertainty in a tax position. The Company’s 2023, 2022 and 2021 Corporate Income Tax Returns are subject to
Internal Revenue Service examination.
F-36
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2023 and 2022
NOTE 18 – SUBSEQUENT EVENTS
Issuance of Series B preferred stock for accrued
compensation and compensation
On January 2, 2024, the Board of Directors of
the Company agreed to satisfy $312,000 of accrued compensation owed to its executive officers (collectively, the “Management”)
as of December 31, 2023, which was included in accrued compensation on the accompanying consolidated balance sheet. Management agreed
to accept 312 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation.
On January 2, 2024, the Board of Directors of
the Company agreed to issue 50 shares of the Company’s Series B convertible preferred stock to a director for services rendered.
Common Stock Issued for Conversion of Series
C Preferred Stock
On February 1, 2024, the Company issued 5,772,973
shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
On March 1, 2024, the Company issued 5,781,562
shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
Promissory Note
On March 1, 2024, the Company executed a Promissory
Note (“Note”) in favor of 1800 Diagonal Lending LLC (the “Investor”) in the aggregate principal amount of $157,000
(the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default,
as discussed below, is the Note convertible into shares of the Company’s common stock. The Note was funded on March 4, 2024, in
the amount of $125,000, which is net of an original issue discount of $13,000 and a one-time interest charge of approximately $19,000.
A one-time interest charge of twelve percent (12%) (the “Interest Rate”) was applied on the issuance date to the Principal.
Under the terms of the Note, the Company is required to make monthly payments as outlined in the Note, beginning on August 30, 2024 and
the Note matures on December 30, 2024. Any amount of principal or interest on this Note which is not paid when due shall bear interest
at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”).
Monthly payment shall be as follows:
Payment Date
August 30, 2024
$
87,920
September 30, 2024
$
21,980
October 30, 2024
$
21,980
November 30, 2024
$
21,980
December 30, 2024
$
21,980
Total
$
175,840
Among other things, an event of default (“Event
of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether at maturity, upon acceleration
or otherwise. Upon the occurrence of any Event of Default, the Note shall become immediately due and payable and the Company shall pay
to the Investor, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of the then outstanding principal
amount of this Note plus accrued and unpaid interest on the unpaid principal amount of this Note to the date of payment plus Default Interest,
if any. At any time following an Event of Default, the Holder shall have the right to convert all or any part of the outstanding and unpaid
amount of this Note into fully paid and non-assessable shares of the Company’s Common Stock. The conversion price (the “Conversion
Price”) shall be the greater of $0.0025 per share (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing
bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion
Price”). At no time may the Note be converted into shares of our common stock if such conversion would result in the Investor and
its affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of our common stock.
EX-21.1
2
ea020266101ex21-1_cbond.htm
LIST OF SUBSIDIARIES
Exhibit 21.1
C-Bond Systems, Inc.
List of Subsidiaries
Company Name
State of Incorporation
C-Bond Systems, LLC
Texas
Patriot Glass Solutions LLC (80% owned)
Texas
EX-23.1
3
ea020266101ex23-1_cbond.htm
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Exhibit 23.1
Consent of Independent Registered Public Accounting
Firm
We hereby consent to the incorporation by
reference in the Registration Statements on Form S-8 filed on January 9, 2020 (File No. 333-235868) and September 25, 2018 (File No.
333-227522), of our report dated April 1, 2024 on the consolidated financial statements of C-Bond Systems, Inc. as of and for the
years ended December 31, 2023 and 2022, which report is included in the Annual Report on Form 10-K of C-Bond Systems, Inc. for the
year ended December 31, 2023.
I have reviewed this annual report on Form 10-K for the year
ended December 31, 2023 of C-Bond Systems, Inc.;
2.
Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under
which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer(s) and I are
responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which
this report is being prepared;
(b)
Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure
controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s
internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the
registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer(s) and I have
disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the
audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s
ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrant’s internal control over financial reporting.
I have reviewed this annual report on Form 10-K for the year
ended December 31, 2023 of C-Bond Systems, Inc.;
2.
Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under
which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer(s) and I
are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which
this report is being prepared;
(b)
Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure
controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s
internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s
fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the
registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer(s) and I
have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors
and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s
ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management
or other employees who have a significant role in the registrant’s internal control over financial reporting.
In connection with the annual
report of C-Bond Systems, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2023, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), and pursuant to 18 U.S.C. Section 1350, as added by Section 906
of the Sarbanes-Oxley Act of 2002, as amended, I, Scott R. Silverman, Chief Executive Officer and Chairman of the Board of the Company,
certify to the best of my knowledge:
1. The Report fully complies
with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
2. The information contained
in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
In connection with the annual
report of C-Bond Systems, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2023, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), and pursuant to 18 U.S.C. Section 1350, as added by Section 906
of the Sarbanes-Oxley Act of 2002, as amended, I, Scott R. Silverman, Chief Financial Officer of the Company, certify to the best of my
knowledge:
1. The Report fully complies
with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
2. The information contained
in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current.
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.
Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Current portion of the total carrying amount as of the balance sheet date due within one year or the operating cycle, if longer, on all notes payable to banks paid on an installment with long term maturities. This can include the amount of any loans from the applicant firm. This does not, however, include any mortgage balances.
The total amount due within more than 12 month, or the operating cycle if longer, on all notes payable to banks paid on an installment. This can include the amount of any loans from the applicant firm. This does not, however, include any mortgage balances.
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.
Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.
The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.
Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.
Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
The gains (losses) included in earnings that represent the difference between the sale price and the carrying value of loans and leases that were sold during the reporting period. This element refers to the gain (loss) and not to the cash proceeds of the sales. This element is a noncash adjustment to net income when calculating net cash generated by operating activities using the indirect method.
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.
The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.
The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
The amount of employee benefit liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.
The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.
C-Bond Systems, Inc., together with its subsidiaries
(the “Company”), is a materials development company and sole owner and developer of the patented C-Bond technology. The Company
is engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality,
and sustainability of brittle material systems. The Company’s primary focus is in the multi-billion-dollar glass and window film
industry with target markets in the United States and internationally. During the years ended December 31, 2023 and 2022, the Company
operated in two segments: C-Bond Transportation Solutions and Patriot Glass Solutions. C-Bond Transportation Solutions sold a windshield
strengthening, water repellent solution called C-Bond nanoShield™ through May 8, 2023, the date that the nanoShield product line
and related technologies were sold (see Note 16). Patriot Glass Solutions sells multi-purpose glass strengthening primer and window film
mounting solutions, including C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a forced entry system.
On June 30, 2021, the Company entered into a Share
Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Patriot Glass Solutions, LLC (formerly Mobile
Tint LLC), a Texas limited liability company doing business as A1 Glass Coating (“Patriot Glass”), (ii) the sole member of
Patriot Glass (the “Patriot Glass Shareholder”), and (iii) Michael Wanke as the Representative of the Patriot Glass Shareholder.
Pursuant to the Exchange Agreement, the Company agreed to acquire 80% of Patriot Glass’s units, representing 80% of Mobile’s
issued and outstanding capital stock (the “Patriot Glass Shares”). On July 22, 2021, the Company closed the Exchange Agreement
and acquired 80% of the Patriot Glass Shares. The Patriot Glass Shares were exchanged for 28,021,016 restricted shares of the Company’s
common stock in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the
30-day period immediately prior to the closing. Initially, for two years after closing, the Company had the option to acquire the remaining
20% of Patriot Glass’s issued and outstanding membership interests in exchange for a number of shares of the Company’s common
stock equal to 300% of Patriot Glass’s average EBIT value, divided by the price of the Company’s common stock as defined in
the Exchange Agreement. On September 20, 2023, the Company and the Patriot Glass Shareholder entered into amendment #2 to the Exchange
Agreement (the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, the Company shall have the option
(the “Option”), beginning on July 1, 2025 (the “Option Start Date”) and ending on 5:00 P.M. EST on the date that
is thirty calendar days after the Option Start Date (the “Option Period”), to acquire the remaining 20% of Patriot Glass Units
(the “Additional Units”), representing 20% of Patriot Glass’s issued and outstanding membership interests, collectively
(the “Additional Closing”) (See Note 10). Patriot Glass provides quality window tint solutions for auto, home, and business
owners across Texas, specializing in automotive window tinting, residential window film, and commercial window film that stop harmful
UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills. Patriot Glass also
carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types of vandalism, and
even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Patriot Glass’s owner-operator, Mr. Wanke,
joined the Company as President of Patriot Glass. On November 29, 2023, the name of Mobile Tint LLC was changed to Patriot Glass Solutions,
LLC..
On May 8, 2023, the Company entered into an Asset
Purchase Agreement (“APA”) with Apex Protect GPS, LLC (the “Buyer”), whereby the Company sold its C-Bond nanoShield™
product line, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other
physical assets of the Company’s C-Bond nanoShield division (the “Assets”) to the Buyer. Accordingly, the Company assigned,
transferred and delivered to the Buyer, free and clear of all liens, all of the Assets. Following the Closing, the Parties entered into
an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among the Company (“Seller”);
Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned all its
right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing
to Assignee. The Seller and Assignee also entered into a Lease and Assignment and Assumption Agreement on June 15, 2023 (the “Assignment
Agreement”), wherein the Seller assigned to Assignee, and Assignee took assignment from the Seller, of the lease for the premises
located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to the Assignment Agreement (See Note 16).
The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES
Basis of Presentation and Principles of Consolidation
The Company’s consolidated financial statements
include the financial statements of its wholly owned subsidiary, C-Bond Systems, LLC, and its 80% owned subsidiary, Patriot Glass. All
significant intercompany accounts and transactions have been eliminated in consolidation.
Going Concern
These consolidated financial statements have been
prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the
normal course of business. As reflected in the accompanying consolidated financial statements, the Company had net income of $1,886,807
for the year ended December 31, 2023, which included a gain from the sale of the Company’s nanoShield product line of $4,051,709. Net
cash used in operations was $1,602,218 for the year ended December 31, 2023. Additionally, as of December 31, 2023, the Company had
an accumulated deficit, shareholders’ deficit, and working capital deficit of $60,851,714, $4,324,535 and $1,351,954, respectively.
On May 8, 2023, the Company sold its nanoShield product line and received proceeds of $4,042,631. The proceeds were used to repay
convertible notes payable, notes payable and related accrued interest. On December 31, 2023, the Company had cash of $736,461. These factors
raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance
date of this report. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash
flow positive or raise additional debt and/or equity capital. The Company is seeking to raise capital through additional debt and/or equity
financings to fund its operations in the future. Although the Company has historically raised capital from sales of common shares and
preferred shares, and from the issuance of promissory notes and convertible promissory notes, there is no assurance that it will be able
to continue to do so. If the Company is unable to raise additional capital or secure additional lending in the near future, management
expects that the Company will need to curtail its operations. These consolidated financial statements do not include any adjustments related
to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the
Company be unable to continue as a going concern.
Use of Estimates
The preparation of consolidated financial statements
in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those
estimates. Estimates during the years ended December 31, 2023 and 2022 include estimates for allowance for doubtful accounts on accounts
receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted
jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair
value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value
of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash
equity transactions.
Fair Value of Financial Instruments and Fair Value Measurements
The carrying amounts reported in the consolidated
balance sheets for cash, accounts receivable, contract assets and liabilities, notes payable, convertible note payable, accounts payable,
accrued expenses, accrued compensation, and lease liabilities approximate their fair market value based on the short-term maturity of
these instruments.
The Company analyzes all financial instruments
with features of both liabilities and equity under the Financial Accounting Standard Board’s (the “FASB”) accounting
standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest
level of input that is significant to the fair value measurement. The Company did not identify any assets or liabilities that are required
to be presented on the balance sheet at fair value in accordance with Accounting Standards Codification (“ASC”) Topic 820.
ASC 825-10 “Financial Instruments”,
allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair
value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value
option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent
reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.
Cash and Cash Equivalents
For purposes of the consolidated statements of
cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money
market accounts to be cash equivalents. The Company had no cash equivalents as of December 31, 2023 and 2022.
Accounts Receivable
The Company recognizes an allowance for losses
on accounts receivable and notes receivable in an amount equal to the estimated probable losses net of recoveries under the current expected
credit loss method. The allowance is based on an analysis of historical bad debt experience, current receivables aging and expected future
write-offs, as well as an assessment of specific identifiable customer accounts and notes receivable considered at risk or uncollectible.
On January 1, 2023, the Company adopted ASC 326, “Financial Instruments - Credit Losses”. In accordance with ASC 326, an allowance
is maintained for estimated forward-looking losses resulting from the possible inability of customers to make required payments (current
expected losses). The amount of the allowance is determined principally on the basis of past collection experience and known financial
factors regarding specific customers. The expense associated with the allowance for doubtful accounts on accounts receivable is recognized
in general and administrative expenses.
Inventory
Inventory, consisting of raw materials and finished
goods, are stated at the lower of cost and net realizable value utilizing the first-in, first-out (FIFO) method. A reserve is established
when management determines that certain inventories may not be saleable. If inventory costs exceed expected net realizable value due to
obsolescence or quantities in excess of expected demand, the Company will record reserves for the difference between the cost and the
net realizable value. These reserves are recorded based on estimates and included in cost of sales.
Property and Equipment
Property and equipment are stated at cost and
are depreciated using the straight-line method over their estimated useful lives, which range from one to seven years. Leasehold improvements
are depreciated over the shorter of the useful life or lease term including scheduled renewal terms. Maintenance and repairs are charged
to expense as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and
any resulting gains or losses are included in income in the year of disposition. The Company examines the possibility of decreases in
the value of these assets when events or changes in circumstances reflect the fact that their recorded value may not be recoverable.
Goodwill and Intangible Assets
Goodwill represents the future economic benefit
arising from other assets acquired that could not be individually identified and separately recognized. Any goodwill arising from the
Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets
may have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line
basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets are being amortized over
a useful life of 5 years.
Goodwill is not subject to amortization but is
subject to impairment tests at least annually. The Company reviews the carrying amounts of goodwill by reporting unit at least annually,
or when indicators of impairment are present, to determine if goodwill may be impaired. To test goodwill impairment, the Company first
assesses qualitative factors to determine whether it is more likely than not that the fair value of goodwill is less than its carrying
value. The Company would not be required to quantitatively determine the fair value of goodwill unless it determines, based on the qualitative
assessment there are indicators of impairment. Under the quantitative test of goodwill, the Company compares the fair value of the reporting
unit to its carrying value, including goodwill. If the carrying value exceeds the fair value, then the goodwill is impaired by the excess
amount. The Company performs its annual testing for goodwill during the fourth quarter of each fiscal year or more frequently if an event
occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit.
Intangible assets determined to have finite lives
are amortized over their estimated useful lives of 5 years. The useful life of an intangible asset is the period over which the asset
is expected to contribute directly or indirectly to future cash flows. The Company periodically evaluates both finite and indefinite lived
intangible assets for impairment upon occurrence of events or changes in circumstances that indicate the carrying amount of intangible
assets may not be recoverable.
As of December 31, 2023 and 2022, the Company
performed its annual goodwill impairment test for its one reporting unit. The results of the Company’s annual impairment test indicated
that the fair value of the reporting unit exceeded its carrying value. Therefore, no impairment of goodwill or intangibles assets was
recorded as of December 31, 2023 or 2022.
Impairment of Long-Lived Assets
In accordance with ASC Topic 360, the Company
reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may
not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future
cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s
estimated fair value and its book value.
Warranty Liability
The Company provides limited warranties on its
products for product defects for periods ranging from 12 months to the life of the product. Warranty costs may include the cost of product
replacement, refunds, labor costs and other costs. Allowances for estimated warranty costs are recorded during the period of sale. The
determination of such allowances requires the Company to make estimates of product warranty claim rates and expected costs to repair or
to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each
product line combined with liability estimates based on the prior 12 months’ sales activities. If actual return rates and/or repair
and replacement costs differ significantly from the Company’s estimates, adjustments to recognize additional cost of sales may be
required in future periods. Historically the warranty accrual and the expense amounts have been immaterial. The warranty liability is
included in accrued expenses on the accompanying consolidated balance sheets and amounted to $1,000 and $26,648 on December 31, 2023 and
2022, respectively. During the years ended December 31, 2023 and 2022, warranty costs were de minimis.
Revenue Recognition
The Company follows ASC Topic 606, Revenue
from Contracts with Customers (“ASC 606”). This standard establishes a single comprehensive model for entities to use
in accounting for revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. ASC
606 requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the entity expects to be entitled in exchange for those goods or services and requires certain additional disclosures.
The Company sells its products which include standard
warranties primarily to distributors and authorized dealers. Product sales are recognized at a point in time when the product is shipped
to the customer and title is transferred and are recorded net of any discounts or allowances. The warranty does not represent a separate
performance obligation.
Revenues from contracts for the distribution and
installation of window film solutions are recognized over time on the basis of the Company’s estimates of the progress towards completion
of contracts using various output or input methods depending on the type of contract terms including (1) the ratio of number of labor
hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed
method. These methods are used because management considers these to be the best available measure of progress on these contracts. We
use the same method for similar types of contracts. The asset, “contract assets” represents revenues recognized in excess
of amounts billed. The liability, “contract liabilities,” represents billings in excess of revenues recognized.
Cost of Sales
Cost of sales includes inventory costs, packaging
costs and warranty expenses.
Cost of revenues from fixed-price contracts for
the distribution and installation of window film solutions include all direct material, sub-contractor, labor and certain other direct
costs, as well as those indirect costs related to contract performance, such as indirect labor and fringe benefits. Provisions for estimated
losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions
and estimated profitability may result in revisions to cost and income, which are recognized in the period in which the revisions are
determined. Changes in estimated job profitability resulting from job performance, job conditions, claims, change orders, and settlements,
are accounted for as changes in estimates in the current period.
Shipping and Handling Costs
Shipping and handling costs incurred for product
shipped to customers are included in general and administrative expenses and amounted to $16,288 and $45,455 for the years ended December
31, 2023 and 2022, respectively. Shipping and handling costs charged to customers are included in sales.
Research and Development
Research and development costs incurred in the
development of the Company’s products are expensed as incurred and includes costs such as labor, materials, and other allocated
costs incurred. For the years ended December 31, 2023 and 2022, research and development costs incurred in the development of the Company’s
products were $0.
Advertising Costs
The Company may participate in various advertising
programs. All costs related to advertising of the Company’s products are expensed in the period incurred. For the years ended December
31, 2023 and 2022, advertising costs charged to operations were $31,743 and $69,737, respectively and are included in general and administrative
expenses on the accompanying consolidated statements of operations. These advertising expenses do not include cooperative advertising
and sales incentives which shall been deducted from sales.
Federal and State Income Taxes
The Company accounts for income tax using the
liability method prescribed by ASC 740, “Income Taxes”. Under this method, deferred tax assets and liabilities are determined
based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in
effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax
assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets
will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes
the enactment date.
The Company follows the accounting guidance for
uncertainty in income taxes using the provisions of ASC 740 “Income Taxes”. Using that guidance, tax positions initially
need to be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the
tax authorities. As of December 31, 2023 and 2022, the Company had no uncertain tax positions that qualify for either recognition or disclosure
in the financial statements. Tax years that remain subject to examination are the years ending on and after December 31, 2018. The Company
recognizes interest and penalties related to uncertain income tax positions in other expense. However, no such interest and penalties
were recorded as of December 31, 2023 and 2022.
Stock-Based Compensation
Stock-based compensation is accounted for based
on the requirements of ASC 718 – “Compensation –Stock Compensation”, which requires recognition in the
financial statements of the cost of employee, director, and non-employee services received in exchange for an award of equity instruments
over the period the employee, director, or non-employee is required to perform the services in exchange for the award (presumptively,
the vesting period). The ASC also requires measurement of the cost of employee, director, and non-employee services received in exchange
for an award based on the grant-date fair value of the award. The Company has elected to recognize forfeitures as they occur as permitted
under the FASB’s Accounting Standards Update (“ASU”) 2016-09 Improvements to Employee Share-Based Payment.
Leases
The Company accounts for leases in accordance
with ASC 842. The lease standard requires certain leases to be reported on the consolidated balance sheets as right-of-use assets and
lease liabilities. The Company elected the practical expedients permitted under the transition guidance of this standard that retained
the lease classification and initial direct costs for any leases that existed prior to adoption of the standard. The Company does not
reassess whether any contracts entered into prior to adoption are leases or contain leases.
The Company categorizes leases with contractual
terms longer than twelve months as either operating or finance. Finance leases are generally those leases that would allow the Company
to substantially utilize or pay for the entire asset over its estimated life. Assets acquired under finance leases are recorded in property
and equipment, net. All other leases are categorized as operating leases. The Company does not have any finance leases as of December
31, 2023 and 2022. The Company’s leases generally have terms that range from three to four years for property and equipment and
five years for property. The Company elected the accounting policy to include both the lease and non-lease components of our agreements
as a single component and account for them as a lease.
Lease liabilities are recognized at the present
value of the fixed lease payments using a discount rate based on the Company’s current borrowing rate. Lease assets are recognized
based on the initial present value of the fixed lease payments, reduced by landlord incentives, plus any direct costs from executing the
leases. Leasehold improvements are capitalized at cost and amortized over the lesser of their expected useful life or the lease term.
When the Company has the option to extend the
lease term, terminate the lease before the contractual expiration date, or purchase the leased asset, and it is reasonably certain that
the Company will exercise the option, the Company considers these options in determining the classification and measurement of the lease.
Costs associated with operating lease assets are recognized on a straight-line basis within operating expenses over the term of the lease.
Loss Per Common Share
ASC 260 “Earnings Per Share”, requires
dual presentation of basic and diluted earnings per common share (“EPS”) with a reconciliation of the numerator and denominator
of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilutive securities and
non-vested forfeitable shares. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue
common shares were exercised or converted into common shares or resulted in the issuance of common shares that then shared in the earnings
of the entity. Basic net loss per common share is computed by dividing net loss available to members by the weighted average number of
common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average
number of common shares, common share equivalents and potentially dilutive securities outstanding during each period. Potentially dilutive
common shares consist of stock options and non-vested forfeitable shares (using the treasury stock method) and shares issuable upon conversion
of preferred shares and convertible notes payable (using the as-if converted method). These common share equivalents may be dilutive in
the future.
The following table presents a reconciliation
of basic and diluted net income (loss) per common share:
Year Ended December 31,
2023
2022
Net income (loss) per common share - basic:
Net income (loss) attributable to common shareholders
$
1,841,470
$
(5,178,055
)
Weighted average common shares outstanding – basic
490,113,378
308,121,062
Net income (loss) per common share – basic
$
0.00
$
(0.02
)
Net income (loss) per common share - diluted:
Net income (loss) attributable to common shareholders - basic
$
1,841,470
$
(5,178,055
)
Add: preferred stock dividends
54,195
-
Add: interest of convertible debt
186,536
-
Numerator for income (loss) per common share – diluted
$
2,082,201
$
(5,178,055
)
Weighted average common shares outstanding – basic
490,113,378
308,121,062
Add: dilutive shares related to:
Convertible debt
1,220,101,111
-
Series B preferred
376,239,688
-
Series C preferred
438,151,351
-
Weighted average common shares outstanding – diluted
2,524,605,528
308,121,062
Net income (loss) per common share – diluted
$
0.00
$
(0.02
)
For the year ended December 31, 2022, all potentially
dilutive common shares were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact
on the Company’s net losses. For the year ended December 31, 2023, stock options and warrants were excluded from the computation
of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net income. As of December 31,
2023 and 2022, common share equivalents and potentially dilutive securities consisted of the following:
December 31,
2023
2022
Stock options
8,445,698
8,445,698
Warrants
34,000,000
34,000,000
Series B preferred stock
335,772,090
164,635,079
Series C preferred stock
438,151,351
432,250,000
Convertible debt
1,220,101,111
962,679,774
Non-vested, forfeitable common shares
-
16,970,120
2,036,470,250
1,618,980,671
Segment Reporting
From January 1, 2022 to May 8, 2023, the Company
operated in two reportable business segments which consisted of (1) the manufacture and sale of a windshield strengthening water repellent
solution as well as disinfection products, and the sale of multi-purpose glass strengthening primer and window film mounting solutions,
including ballistic-resistant film systems and a forced entry system, and (2) the distribution and installation of window film solutions.
The Company’s reportable segments were strategic business units that offered different products and were managed separately based
on the fundamental differences in their operations and locations. On May 8, 2023, the Company sold its C-Bond nanoShield™ product
line and the remaining segment (1) as described above was combined into segment (2) and is now being managed together (see Note 16).
Noncontrolling Interest
The Company accounts for noncontrolling interest
in accordance with ASC Topic 810-10-45, which requires the Company to present noncontrolling interests as a separate component of total
shareholders’ deficit on the consolidated balance sheets and the consolidated net loss attributable to its noncontrolling interest
be clearly identified and presented on the face of the consolidated statements of operations.
Risk and Uncertainties
The Company operates in an industry that is subject to intense competition
and changes in consumer and commercial demand. The Company’s operations are subject to significant risk and uncertainties including
financial and operational risks including the potential risk of business failure.
The Company has experienced, and in the future expects to continue
to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the
cyclical nature of the business, (ii) general economic conditions in the various local markets in which the Company competes, including
a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s products and services.
These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.
Recent Accounting Pronouncements
In August 2020, the FASB issued ASU 2020-06, Debt—Debt
with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for
convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments
will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain
settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity
contracts to qualify for the exception. The ASU also simplifies the diluted net income per share calculation in certain areas. The new
guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and early
adoption is permitted. The Company is currently evaluating the impact of the adoption of the standard on the consolidated financial statements.
In June 2016, the FASB issued ASU No. 2016-13, Financial
Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which significantly changes
how entities will measure credit losses for most financial assets, including accounts receivable. ASU No. 2016-13 will replace today’s
“incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based
on expected rather than incurred losses. On November 15, 2019, the FASB delayed the effective date of Topic 326 for certain small public
companies and other private companies until fiscal years beginning after December 15, 2022 for SEC filers that are eligible to be smaller
reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities. In March 2022, the FASB
issued ASU No. 2022-02, Financial Instruments-Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.
The guidance was issued as improvements to ASU No. 2016-13 described above. The vintage disclosure changes require an entity to disclose
current-period gross write-offs by year of origination for financing receivables. The guidance is effective for financial statements issued
for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The adoption of ASU No. 2022-02 on
January 1, 2023 did not have a material impact on the Company’s consolidated financial statements.
Other accounting standards that have been issued
or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial
statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated
to its financial condition, results of operations, cash flows or disclosures.
The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.
On December 31, 2023 and 2022, property and equipment
consisted of the following:
Useful Life
December 31, 2023
December 31, 2022
Machinery and equipment
5 – 7 years
$
73,411
$
124,133
Furniture and office equipment
3 – 7 years
2,061
32,306
Vehicles
1 – 5 years
68,050
62,195
Leasehold improvements
3 – 5 years
110,645
45,296
254,167
263,930
Less: accumulated depreciation
(82,561
)
(167,624
)
Property and equipment, net
$
171,606
$
96,306
During the years ended December 31, 2023 and 2022,
the Company sold vehicles and other equipment for proceeds of $9,000 and $5,500 and record a gain on sale of property and equipment of
$9,000 and $5,500, respectively, which is included in general and administrative expenses on the accompanying consolidated statement of
operations. Additionally, in connection with the Company’s sale of its C-Bond nanoShield product line (see Note 16), the Company
sold property and equipment with a net book value of $1,115, which is included in gain from sale of product line on the accompanying statement
of operations. For the years ended December 31, 2023 and 2022, depreciation expense is included in general and administrative expenses
and amounted to $38,355 and $38,716, respectively.
The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.
On December 31, 2023 and 2022, intangible assets
and goodwill, which were acquired from Patriot Glass in 2021, consisted of the following:
Useful life
December 31, 2023
December 31, 2022
Customer relations
5 years
$
212,516
$
212,516
Non-compete
5 years
40,000
40,000
Trade name
-
100,000
100,000
352,516
352,516
Less: accumulated amortization
(123,102
)
(72,598
)
Intangible assets, net
$
229,414
$
279,918
Useful life
December 31, 2023
December 31, 2022
Goodwill
-
$
350,491
$
350,491
For the years ended December 31, 2023 and 2022,
amortization expense of amortizable intangible assets amounted to $50,504 and $50,503, respectively. On December 31, 2023, accumulated
amortization amounted to $103,601 and $19,500 for the customer relations and non-compete, respectively. On December 31, 2022, accumulated
amortization amounted to $61,098 and $11,500 for the customer relations and non-compete, respectively.
Amortization of intangible assets with identifiable
useful lives that is attributable to future periods is as follows:
On October 15, 2021, the Company entered into
a Securities Purchase Agreement (the “SPA”) with Mercer Street Global Opportunity Fund, LLC (the “Investor”),
pursuant to which the Company issued and sold to Investor a 10% Original Issue Discount Senior Convertible Promissory Note in the principal
amount of $825,000 (the “Initial Note”) and five-year warrants to purchase up to 16,500,000 shares of the Company’s
common stock at an initial exercise price of $0.05 per share, an amount equal to 50% of the conversion shares that were issued (the “Initial
Warrants”). The Company received net proceeds of $680,000, which is net of original issue discounts of $75,000, placement fees of
$60,000, and legal fees of $10,000. The transactions contemplated under the SPA closed on October 18, 2021.
Pursuant to the SPA, the Investor agreed to purchase
an additional $825,000 10% Original Issue Discount Senior Convertible Promissory Note (the “Second Note,” and together with
the Initial Note, the “Notes”), and a five-year warrant (the “Second Warrant,” and together with the Initial Warrant,
the “Warrants”) to purchase, in the aggregate, shares of the Company’s common stock at an initial exercise price of
$0.05 per share from the Company in an amount equal to 50% of the conversion shares to be issued upon the same terms as the Initial Note
and Initial Warrant (subject to there being no event of default under the Initial Note or other customary closing conditions), within
three trading days of a registration statement registering the shares of the Company’s common stock issuable under the Notes (the
“Conversion Shares”) and upon exercise of the Warrants (the “Warrant Shares”) being declared effective by the
SEC. To date, the Investor did not purchase the Second Note.
The Initial Note matured 12 months after issuance,
bore interest at a rate of 4% per annum through the date of default, and was initially convertible beginning on the six-month anniversary
of the original issue date into the Company’s common stock at a fixed conversion price of $0.025 per share, subject to adjustment
for stock splits, stock combinations, dilutive issuances, and similar events, as described in the Initial Note.
The Initial Note may be prepaid at any time for
the first 90 days at face value plus accrued interest. From day 91 through day 180, the Note may be prepaid in an amount equal to 110%
of the principal amount plus accrued interest. From day 181 through the day immediately preceding the maturity date, the Initial Note
may be prepaid in an amount equal to 120% of the principal amount plus accrued interest.
The Note and Warrants contain conversion limitations
providing that a holder thereof may not convert the Notes or exercise the Warrants to the extent (but only to the extent) that, if after
giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares
of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease
its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase
shall not be effective until the 61st day after such notice.
In connection with the SPA, the Company entered
into a Registration Rights Agreement dated October 15, 2021 (the “Registration Rights Agreement”), with the Investor pursuant
to which it is obligated to file a registration statement with the SEC within 45 days after the date of the agreement to register the
resale by the Investor of the conversion shares and warrant shares, and use all commercially reasonable efforts to have the registration
statement declared effective by the SEC within 60 days after the registration statement is filed.
Upon the occurrence of an event of default under
the Notes, the Investor has the right to be prepaid at 125% of the outstanding principal balance and accrued interest, and interest accrues
at 18% per annum. Events of default included, among other things,
(i)
any default in the payment of (A) principal and interest payment under this Note or any other Indebtedness, or (B) Late Fees, liquidated damages and other amounts owing to the Holder of this Note, as and when the same shall become due and payable (whether on a Conversion Date, or the Maturity Date, or by acceleration or otherwise), which default, solely in the case of a default under clause (B) above, is not cured within five Trading Days;
(ii)
the Company or any Subsidiary shall be subject to a Bankruptcy Event;
(iii)
the SEC suspends the Common Stock from trading or the Company’s Common Stock is not listed or quoted for trading on a Trading Market which failure is not cured, if possible to cure, within the earlier to occur of 10 Trading Days after notice of such failure is sent by the Holder or by any other Holder to the Company or the transfer of shares of Common Stock through the Depository Trust Company System is no longer available or is subject to a “chill” by the Depository Trust Company or any successor;
(iv)
the Company shall be a party to any Change of Control Transaction or shall agree to sell or dispose of all or in excess of 50% of its assets in one transaction or a series of related transactions (whether or not such sale would constitute a Change of Control Transaction);
(v)
the Company incurs any Indebtedness other than Permitted Indebtedness;
(vi)
the Company restates any financial statements included in its reports or registration statements filed pursuant to the Securities Act or the Exchange Act for any date or period from two years prior to the Original Issue Date of this Note and until this Note is or the Warrants issued to the Holder are no longer outstanding, if following first public announcement or disclosure that a restatement will occur the VWAP on the next Trading Day is 20% less than the VWAP on the prior Trading Day. For the purposes of this clause the next Trading Day if an announcement is made before 4:00 pm New York, NY time is either the day of the announcement or the following Trading Day. The Company filed a Report on Form 8-K announcing the restatement of its financial statements for the year ended December 31, 2020. Following the first public announcement or disclosure that a restatement occurred, the VWAP on the next Trading Day was not 20% less than the VWAP on the prior Trading Day and accordingly, the default provisions were not triggered.
The Company has also granted the investor a 12-month
(or until the Notes are no longer outstanding) right to participate in specified future financings, up to a level of 30%.
On April 20, 2022, the Company and the Investor
entered into an Exchange Agreement (the “Exchange Agreement”). The original SPA remains in effect. Per the terms of the Exchange
Agreement, the Parties agreed to exchange (i) the Initial Note for a new Convertible Promissory Note (the “New Note”) and
(ii) the Initial Warrant for a new five-year warrant to purchase, in the aggregate, 33,000,000 shares of the Company’s common stock
at an exercise price of $0.025 per share (the “New Warrant” and together with the New Note, the “New Securities”),
according to the terms and conditions of the Exchange Agreement. On April 20, 2022, pursuant to the terms of the Exchange Agreement, the
Investor surrendered the Prior Securities in exchange for the New Securities. Other than the surrender of the Prior Securities, no consideration
of any kind whatsoever was given by the Investor to the Company in connection with the Exchange Agreement. The terms of the New Securities
are the same as the Prior Securities except for the pricing of the shares issuable under the New Note and the shares issuable upon exercise
of the New Warrant. The New Securities are composed of the New Note, which is a 10% Original Issue Discount Senior Convertible Promissory
Note in the principal amount of $825,000, and the New Warrant. The New Note matured on October 15, 2022, bore interest at a rate of 4%
per annum through the date of default, and was initially convertible into the Company’s common stock at a fixed conversion price
of $0.0125 per share, subject to adjustment for stock splits, stock combinations, dilutive issuances, and similar events, as described
in the New Note. If the average Closing Price during any 10 consecutive Trading Day period beginning and ending during the 60 Day Effectiveness
Period (the “Average Closing Price”) is below the Conversion Price than the conversion price will be reduced to such Average
Closing Price but in no event less than $0.00875.
On October 15, 2022, the due date of the New Note,
the New Note defaulted due to non-payment. Accordingly, the Company added a default penalty of $206,250, or 25%, to the principal balance
and recorded interest expense of $206,250, and interest shall accrue at 18% per annum.
On December 4, 2023, the Company entered into
a letter agreement (the “Agreement”) with the Investor to eliminate the convertible features and implement a standstill on
the interest due under the Convertible Promissory Note Dated October 15, 2021 (the “Note”). This Note is the only remaining
convertible note on the Company’s balance sheet. Per the terms of the Agreement, provided that the Company continues making the
Payments as outlined in the Agreement and meets its obligations under the Agreement, the Investor shall not have the right to convert
the Note into the Company’s common stock. The Company shall make the Payments on the 15th of every month. “Payments”
shall mean $15,000 per month for 35 months with a balloon payment of $588,091 on the 36th month, for aggregate payments of $1,113,091.
Additionally, the Company shall pay Mercer 20%
of the gross proceeds from capital raised by the Company through the issuance of securities or incurrence of any Debt (regardless of whether
the incurrence of debt includes of the sale of any securities) (“Capital Raise Payments”). Capital Raise Payments shall only
be required for capital raises resulting in the Company receiving gross proceeds of at least $500,000. By way example, if the Company
receives $600,000 from the issuance of Debt, the Company shall make a Capital Raise Payment of $120,000 to Mercer. Any Capital Raise Payments
shall be first be applied to the then outstanding Balloon Payment and thereafter to the last Payments (35th, 34th and so on). “Debt”
means borrowed money including the sale of any existing and future receivables. The Capital Raise Payments shall be made within two business
days of the receipt of the funds under such raise. Any failure to make the Payments within the cure period or from the Capital Raise Payments
by the required date shall make this Agreement null and void.
Additionally, provided that the Company is in
compliance with this Agreement, Mercer agrees to a standstill on the interest due under the Note beginning with the date that the first
$15,000 Payment is made which the Company paid on December 15, 2023 as required by the Note. Further, if the Company pays off the entire
principal and accrued interest by the dates detailed below, the Investor agrees to reduce the total amount due on the Note (principal
and interest) by the percentages as follows: 20% if fully paid by March 31, 2024, 15% if fully paid by June 30, 2024, 10% if fully paid
by September 30, 2024, and 5% if fully paid by December 31, 2024. All rights and obligations under the original Note shall remain the
same. Mercer is not waiving any of its rights under the original Note, including but not limited to, rights available prior to this Agreement.
As of December 31, 2023 and 2022, the principal
balance of the Initial note was $1,098,091 and $1,031,250, respectively. Additionally, as of December 31, 2023 and 2022, accrued interest
payable amounted to $176,184 and $81,045, respectively, which is reflected in accrued expenses on the accompanying consolidated statements
of operations. Under the terms of the Agreement, $176,184 of accrued interest is subject to forgiveness if the Company complies with the
terms of the Agreement. As of the date of this report, the Company has made all required payments.
In accordance with ASC 470-50, Debt Modifications
and Extinguishments, on April 20, 2022, in connection in the Exchange Agreement discussed above, the Company performed an assessment of
whether the Exchange Agreement transaction was deemed to be new debt, a modification of existing debt, or an extinguishment of existing
debt. The Company evaluated the April 20, 2022 Exchange Agreement for debt modification and concluded that the debt qualified for debt
extinguishment. On April 20, 2022, the Company agreed to reduce the conversion price from $0.025 per share to $0.0125 per share, and to
cancel the Initial Warrant to purchase 16,500,000 shares of common exercisable at $0.05 per shares, and to issue a New Warrant to purchase
33,000,000 shares exercisable at $0.025 per share. All other terms of the convertible note and warrants remain unchanged, and therefore
did not change the cash flows of the note. The New Warrants did not contain any features requiring liability treatment and therefore were
classified as equity. The Company determined the transaction was considered a debt extinguishment because the change in conversion price
was substantial. Upon extinguishment, the Company had $395,313 of unamortized initial debt discount recorded which it wrote off, and the
Company recorded a buyback of $160,993 which represents the reversal of calculated beneficial conversion feature on the initial debt upon
settlement, for an aggregate net loss on debt extinguishment of $234,320. The Company recorded a new debt discount in connection with
the New Note which was calculated based on the relative fair value of the New Warrants of $325,785. Additionally, the New Note is convertible
into common shares at an initial conversion price of $0.0125 which was lower than the fair value of common shares based on the quoted
closing price of the Company’s common stock on the measurement date. The value allocated to the New Warrants was $325,785, and $354,215
was allocated to the beneficial conversion feature. Since the intrinsic value of the beneficial conversion feature and warrants was greater
than the proceeds allocated to the convertible instrument, the amount of the discount assigned to the beneficial conversion feature and
warrants issued was limited to the amount of the proceeds allocated to the convertible instrument. Accordingly, the Company recorded an
aggregate non-cash debt discount of $680,000 with the credit to additional paid in capital. This debt discount was amortized to interest
expense over the remaining term of the Convertible Note.
The Company uses the Binomial Valuation Model
to determine the fair value of its stock warrants which requires the Company to make several key judgments including:
●
the value of the Company’s common stock;
●
the expected life of issued stock warrants;
●
the expected volatility of the Company’s stock price;
●
the expected dividend yield to be realized over the life of the stock warrants; and
●
the risk-free interest rate over the expected life of the stock warrants.
The Company’s computation of the expected
life of issued stock warrants was based on the simplified method as the Company does not have adequate exercise experience to determine
the expected term. The interest rate was based on the U.S. Treasury yield curve in effect at the time of grant. The computation of volatility
was based on the historical volatility of the Company’s common stock.
On April 20, 2022 (the Exchange Agreement date)
along with various re-pricings as outlined below, the fair value of the stock warrants were estimated at issuance using the Binomial Valuation
Model with the following assumptions:
2022
Dividend rate
—%
Term (in years)
4 years
Volatility
246.6% to 329.6%
Risk—free interest rate
2.79% to 3.12%
At any time this Note or any amounts accrued and
payable thereunder remain outstanding, the Company or any Subsidiary, as applicable, sells or grants any option to purchase or sells or
grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or other disposition),
any common stock or common stock equivalents entitling any Person to acquire shares of the Company’s common stock at an effective
price per share that is lower than the conversion price then in effect (such lower price, the “Base Conversion Price” and
each such issuance or announcement a “Dilutive Issuance”), then the conversion price shall be immediately reduced to equal
the Base Conversion Price. Such adjustment shall be made whenever such common stock or common stock equivalents are issued. On June 23,
2022, the Company issued common stock equivalents with an initial conversion price of $0.011 per share and accordingly, the conversion
price and warrant down-round provisions were triggered. As a result, the conversion price of the New April 2022 Note was reduced to $0.011
per share and the exercise price of the New April 2022 Warrant was lowered to $0.011. As a result of the June 23, 2022 down-round provisions,
the Company calculated the difference between the warrants fair value on June 23, 2022, the date the down-round feature was triggered
using the then current exercise price of $0.025 and the new exercise price of $0.011. On June 23, 2022, the Company recorded a deemed
dividend of $3,702 which represents the fair value transferred to the warrant holders from the down round feature being triggered. No
additional beneficial conversion feature amount was recorded based on the June 23, 2022 valuation as the ratcheted beneficial conversion
feature value was lower than the original amount. Additionally, on September 6, 2022, the Company issued common stock equivalents with
an initial conversion price of $0.009 per share and accordingly, the conversion price and warrant down-round provisions were triggered.
As a result, the conversion price of the New April 2022 Note was reduced to $0.009 per share and the exercise price of the New April 2022
Warrant was lowered to $0.009. As a result of the September 6, 2022 down-round provisions, the Company calculated the difference between
the warrants fair value on September 6, 2022, the date the down-round feature was triggered using the then current exercise price of $0.011
and the new exercise price of $0.009. On September 6, 2022, the Company recorded a deemed dividend of $733 which represents the fair value
transferred to the warrant holders from the down round feature being triggered. No additional beneficial conversion feature amount was
recorded based on the September 6, 2022 valuation as the ratcheted beneficial conversion feature value was lower than the original amount.
Pursuant to the provisions of ASC 815-40 –
Derivatives and Hedging – Contracts in an Entity’s Own Stock, the convertible note and related warrants issued in connection
with the Mercer convertible note was analyzed and it was determined that the terms of the convertible note and warrants contained terms
that were not considered derivatives.
1800 Diagonal Lending Convertible Debt
On November 9, 2022, the Company closed a Securities
Purchase Agreement dated November 4, 2022, with 1800 DIAGONAL LENDING LLC, a Virginia limited liability company, (“Diagonal”),
pursuant to which a Promissory Note (the “November 2022 Diagonal Note”) dated November 4, 2022, was made to Diagonal in the
aggregate principal amount of $104,250 and the Company received net proceeds of $100,000 which was net of fees of $4,250. The November
2022 Diagonal Note bears interest at a rate of 12% per annum (22% upon the occurrence of an event of a default) and all outstanding principal
and accrued and unpaid interest are due on May 4, 2024. In May 2023, the November 2022 Diagonal Note and any interest due was repaid in
full (See Note 16).
On December 27, 2022, the Company closed a Securities
Purchase Agreement dated December 27, 2022, with 1800 Diagonal pursuant to which a Promissory Note (“December 2022 Diagonal Note”)
dated December 27, 2022, was made to Diagonal in the aggregate principal amount of $64,250 and the Company received net proceeds of $60,000
which was net of fees of $4,250. The December 2022 Diagonal Note bears interest at a rate of 12% per annum (22% upon the occurrence of
an event of a default) and all outstanding principal and accrued and unpaid interest are due on June 27, 2024. In May 2023, the December
2022 Diagonal Note and any interest due was repaid in full (See Note 16).
On March 17, 2023, the Company closed a Securities
Purchase Agreement dated November 4, 2022, with Diagonal pursuant to which a Promissory Note (the “March 2023 Diagonal Note”)
dated March 17, 2023, was made to Diagonal in the aggregate principal amount of $54,250 and the Company received net proceeds of $50,000
which was net of fees of $4,250. The March 2023 Diagonal Note bears interest at a rate of 12% per annum (22% upon the occurrence of an
event of a default) and all outstanding principal and accrued and unpaid interest are due on March 17, 2024. In May 2023, the March 2023
Diagonal Note and any interest due was repaid in full (See Note 16).
The Company had the right to prepay the November
2022, December 2022 and March 2023 Diagonal Notes (principal and accrued interest) at any time during the first six months the note is
outstanding at the rate of 115% during the first 30 days after issuance, 120% during the 31st to 60th day after
issuance, and 125% during the 61st to the 180th day after issuance. The November 2022, December 2022 and March 2023
Diagonal Notes may not be prepaid after the 180th day following the issuance date, unless Diagonal agrees to such repayment and such terms,
which was agreed to in connection with the May 8, 2023 repayment. Diagonal had in its option, at any time beginning 180 days after the
date of the Diagonal Note, to convert the outstanding principal and interest on the November 2022, December 2022 and March 2023 Diagonal
Notes into shares of our common stock at a conversion price per share equal to 65% of the average of the three lowest closing bid prices
of our common stock during the 10 trading days prior to the date of conversion.
The Company accounted for the November 2022 and
December 2022 Diagonal Notes as stock settled debt under ASC 480 and recorded an aggregate debt premium of $90,731 with a charge to interest
expense. The Company has accounted for the March 2023 Diagonal Note as stock settled debt under ASC 480 and recorded an aggregate debt
premium of $29,212 with a charge to interest expense. On May 11, 2023, upon repayment of the November 2022, December 2022 and March 2023
Diagonal Notes, the Company reversed the debt premium of $119,943 and recorded a gain on debt extinguishment of $119,943 on the accompanying
consolidated statement of operations.
For the years ended December 31, 2023 and 2022,
amortization of debt discounts related to the convertible notes payable amounted to $2,627 and $938,344, respectively, which has been
included in interest expense on the accompanying consolidated statements of operations.
On December 31, 2023 and 2022, accrued interest
payable under all outstanding convertible notes discussed above amounted to $176,184 and $83,138, respectively, and is included in accrued
expenses on the accompanying consolidated balance sheets.
On December 31, 2023 and 2022, convertible notes
payable consisted of the following:
December 31, 2023
December 31, 2022
Convertible notes payable
$
1,098,091
$
1,199,750
Add: put premium
-
90,731
Less: unamortized debt discount
-
(7,968
)
Convertible note payable, net
1,098,091
1,282,513
Less: current portion of convertible note payable
(180,000
)
(1,031,250
)
Convertible notes payable – long-term
$
918,091
$
251,263
On December 31, 2023, future annual maturities
of convertible note payable are as follows:
December 31,
Amount
2024
$
180,000
2025
180,000
2026
738,091
Total convertible note payable on December 31, 2023
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
On December 31, 2023 and 2022, notes payable consisted
of the following:
December 31, 2023
December 31, 2022
Notes payable
$
105,958
$
1,899,380
Note payable – PPP note
18,823
18,823
Total notes payable
124,781
1,918,203
Less: unamortized debt discount
(764
)
(132,961
)
Note payable, net
124,017
1,785,242
Less: current portion of notes payable, net of discount
(81,908
)
(1,576,438
)
Notes payable – long-term
$
42,109
$
208,804
Notes Payable
BOCO Investment Note
On November 14, 2018, the Company entered into
a Revolving Credit Facility Loan and Security Agreement (“Loan Agreement”) and a Secured Promissory Note (the “Note”)
with BOCO Investments, LLC (the “Lender”). Subject to and in accordance with the terms and conditions of the Loan Agreement
and the Note, the Lender agreed to lend to the Company up to $400,000 (the “Maximum Loan Amount”) against the issuance and
delivery by the Company of the Note for use as working capital and to assist in inventory acquisition. In 2018, the Lender loaned $400,000
to the Company, the Maximum Loan Amount. The Company should have repaid all principal, interest and other amounts outstanding on or before
November 14, 2020. The Company’s obligations under the Loan Agreement and the Note are secured by a first-priority security interest
in substantially all the Company’s assets (the “Collateral”). The outstanding principal advanced to Company pursuant
to the Loan Agreement initially bore interest at the rate of 12% per annum, compounded annually. Upon the occurrence of an Event of Default
under the Loan Agreement and Note, all amounts then outstanding (including principal and interest) shall bear interest at the rate of
18% per annum, compounded annually until the Event of Default is cured.
In May 2023, the Company and the Lender entered
into a Debt Exchange and Release Agreement in regard to the $400,000 Note discussed above, whereby the Company paid the Lender cash of
$200,000 and issued the Lender 22,000,000 shares of Common Stock of the Company (see Note 9) in exchange for settlement of the remaining
$200,000 of the loan and all accrued interest amounting to $317,293, which were deemed paid in full (see Note 16). The 22,000,000 shares
issued were valued at $132,000, or $0.006 per share, based on the quoted closing price of the Company’s common stock on the measurement
date. In connection with the repayment and settlement of this debt, the Company recorded a gain from debt extinguishment of $385,293 consisting
of a) $68,000 calculated as the difference in the principal amount settled for shares of $200,000 and the fair value of the shares on
the measurement date of $132,000, and b) the forgiveness of interest due of $317,293.
On December 31, 2023 and 2022, principal amount
due under this Note amounted to $0 and $400,000, respectively. On December 31, 2023 and 2022, accrued interest payable under this Note
amounted to $0 and $292,241, respectively, and is included in accrued expenses on the accompanying consolidated balance sheets.
Mercer Street Global Opportunity Fund Notes
On March 14, 2022, the Company entered into an
Original Issue Discount Promissory Note and Security Agreement (the “March 2022 Note”) in the principal amount of $197,500
with Mercer Street Global Opportunity Fund, LLC (the “Investor”). The March 2022 Note was funded on March 14, 2022 and the
Company received net proceeds of $175,000 which is net of an original issue discount and investor legal fees of $22,500. The original
issue discount was recorded as a debt discount to be amortized over the life of the March 2022 note. The March 2022 Note matures 12 months
after issuance and bears interest at a rate of 3% per annum. At any time, the Company may prepay all or any portion of the principal amount
of the March 2022 Note and any accrued and unpaid interest without penalty. The March 2022 Note also creates a lien on and grants a priority
security interest in all the Company’s assets. In connection with the March 2022 Note, the Company issued 823,529 shares of its
common stock to the placement agent as a fee for the capital raise. The 823,529 shares of common stock issued were recorded as a debt
discount of $12,963 based on the relative fair value method to be amortized over the life of the March 2022 Note. On December 31, 2023,
the principal balance due on the March 2022 Note amounted to $0 and accrued interest payable amounted to $0. On December 31, 2022, the
principal balance due on the March 2022 Note amounted to $197,500 and accrued interest payable amounted to $4,756. In May 2023, the March
2022 Note and all accrued interest due was paid in full (See Note 16).
On November 22, 2022, the Company entered into
a Promissory Note and Security Agreement (the “November 2022 Note”) in the principal amount of $65,000 with Mercer Street
Global Opportunity Fund, LLC (the “Investor”). The November 2022 Note was funded on November 22, 2022 and the Company received
net proceeds of $62,500 which is net of investor legal fees of $2,500. The legal fees were recorded as a debt discount to be amortized
over the life of the November 2022 note. The November 2022 Note matures on August 22, 2023 and bears interest at a rate of 8% per annum.
At any time, the Company may prepay all or any portion of the principal amount of the November 2022 Note and any accrued and unpaid interest
without penalty. The November 2022 Note also creates a lien on and grants a priority security interest in all the Company’s assets.
On December 31, 2023, the principal balance due on the November 2022 Note amounted to $0 and accrued interest payable amounted to $0.
On December 31, 2022, the principal balance due on the November 2022 Note amounted to $65,000 and accrued interest payable amounted to
$214. In May 2023, the November 2022 Note and all accrued interest due was paid in full and the Company recorded a gain on debt extinguishment
of approximately $18,900 (See Note 16).
GS Capital Debt
On June 23, 2022, the Company entered into entered
into a Securities Purchase Agreement (“Agreement”) with GS Capital Partners, LLC (“GS Capital”), pursuant to which
a Promissory Note (the “GS Capital June 2022 Note”) was made to GS Capital in the aggregate principal amount of $195,000.
The GS Capital June 2022 Note was purchased for $176,000, reflecting an original issuance discount of $19,000, and was funded on June
24, 2022 (less legal and other administrative fees). The Company received net proceeds of $148,420. The Company further issued GS Capital
a total of 1,750,000 commitment shares (“Commitment Shares”) as additional consideration for the purchase of the Note (See
Note 9). Additionally, the GS Capital Note was convertible upon an event of default into common shares at an initial effective conversion
price which was lower than the fair value of common shares based on the quoted closing price of the Company’s common stock on the
measurement date. Principal and interest payments shall be made in 10 installments of $21,060 each beginning on the 90th-day anniversary
following the issue date and continuing thereafter each 30 days for nine months. The GS Capital Note matured 12 months after issuance
and bore interest at a rate of 8% per annum. GS Capital had the right at any time following an Event of Default to convert all or any
part of the outstanding and unpaid principal, interest, penalties, and all other amounts under this Note at a conversion price of $0.011,
subject to adjustment as defined in the GS Capital Note. The Company did not calculate a beneficial conversion feature since the GS Capital
Note was contingently convertible upon default on the GS Capital Note. As of December 31, 2022, the Company was not in default on this
note. In the event that following the Issue Date the closing trading price of the Company’s common stock was then being traded is
below $0.011 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.004 per
share. Events of default included, amongst other items, failure to pay principal or interest, bankruptcy, delisting of the Company’s
stock, financial statement restatements, or if the Company effectuates a reverse split. Upon the occurrence of any event of default, the
GS Capital Note shall become immediately and automatically due and payable and the Company shall pay to GS Capital, in full satisfaction
of its obligations hereunder, an amount equal to: (a) the then outstanding principal amount of this note plus (b) accrued and unpaid
interest on the unpaid principal amount of this note to the date of payment (the “mandatory prepayment date”) plus
(y) default interest, if any, multiplied by 120%. On December 15, 2022, the Company and GS Capital entered into a letter agreement to
extend the due date of the GS Capital June 2022 note by 60 days. Specifically, the maturity date of the GS Capital June 2022 note was
extended to August 23, 2023 and the next payment due date was extended to February 28, 2023. Through December 31, 2022, the Company paid
$53,512 of principal balance and during the year ended December 31, 2023, paid principal balance of $79,488. During April and May 2023,
the Company issued 21,371,481 shares of its common stock upon the conversion of principal of $62,000, accrued interest of $4,139, and
fees of $2,250 (See Note 9). On December 31, 2023, the principal balance due on the GS Capital Note and accrued interest payable amounted
to $0 (See Note 16). On December 31, 2022, the principal balance due on the GS Capital Note amounted to $141,488 and accrued interest
payable amounted to $7,471.
On July 26, 2022, the Company closed a Securities
Purchase Agreement (“July 2022 Agreement”) with GS Capital, pursuant to which a Promissory Note (“GS Capital July 2022
Note”) was made to GS Capital in the aggregate principal amount of $195,000. The GS Capital July 2022 Note was purchased for $176,000,
reflecting an original issuance discount of $19,000, and was funded on July 28, 2022 (less legal and other administrative fees). The Company
received net proceeds of $158,920. The Company further issued GS Capital a total of 2,600,000 commitment shares (“July 2022 Commitment
Shares”) as additional consideration for the purchase of the July 2022 Note. In addition, the Company issued 998,008 of its common
stock to the placement agent as a fee for the capital raise, respectively. The July Commitment Shares and the placement agent shares were
recorded as a debt discount of $34,606 based on the relative fair value method to be amortized over the life of the Note. Additionally,
the GS Capital July 2022 Note was convertible upon an event of default into common shares at an initial effective conversion price which
was lower than the fair value of common shares based on the quoted closing price of the Company’s common stock on the measurement
date. Principal and interest payments shall be made in 10 installments of $21,060 each beginning on the 90th-day anniversary following
the issue date and continuing thereafter each 30 days for nine months. The GS Capital July 2022 Note was to mature 12 months after issuance
and bore interest at a rate of 8% per annum. GS Capital had the right at any time following an Event of Default to convert all or any
part of the outstanding and unpaid principal, interest, penalties, and all other amounts under the GS Capital July 2022 Note at a conversion
price of $0.011, subject to adjustment as defined in the Note. The Company did not calculate a beneficial conversion feature since the
GS Capital July 2022 Note is contingently convertible upon a default on the July 2022 Note. As of December 31, 2022, the Company was not
in default on this note. In the event that following the Issue Date the closing trading price of the Company’s common stock was
then being traded is below $0.011 per share for more than ten consecutive trading days, then the conversion price shall
be equal to $0.004 per share. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date
of the GS Capital July 2022 note by 60 days. Specifically, the maturity date of the GS Capital July 2022 note was extended to September
26, 2023 and the next payment due date was extended to February 28, 2023. Through December 31, 2022, the Company paid $34,120 of principal
balance and in May 2023, the Company paid the remaining principal balance of $160,880 and all accrued interest due in full (See Note 16).
On December 31, 2023, the principal balance due on the GS Capital July 2022 Note and accrued interest payable amounted to $0. On December
31, 2022, the principal balance due on the GS Capital July 2022 Note amounted to $160,880 and accrued interest payable amounted to $6,441.
On September 6, 2022, the Company closed a Securities
Purchase Agreement (“September 2022 Agreement”) with GS Capital, pursuant to which a Promissory Note (“September 2022
Note”) was made to GS Capital in the aggregate principal amount of $195,000. The September 2022 Note was purchased for $176,000,
reflecting an original issuance discount of $19,000, and was funded on September 6, 2022 (less legal and other administrative fees). The
Company received net proceeds of $158,920. The Company further issued GS Capital a total of 3,300,000 commitment shares (“September
2022 Commitment Shares”) as additional consideration for the purchase of the September 2022 Note. In addition, the Company issued
773,626 of its common stock to the placement agent as fee for the capital raise, respectively. The September Commitment Shares and the
placement agent shares were recorded as a debt discount of $30,326 based on the relative fair value method to be amortized over the life
of the Note. Additionally, the September 2022 Note was convertible into common shares upon an event of default at an initial effective
conversion price which was lower than the fair value of common shares based on the quoted closing price of the Company’s common
stock on the measurement date. Principal and interest payments shall be made in 9 installments of $23,400 each beginning on the 120th-day
anniversary following the issue date and continuing thereafter each 30 days for eight months. The September 2022 Note was to mature 12
months after issuance and bears interest at a rate of 8% per annum. GS Capital shall have the right at any time following an Event of
Default to convert all or any part of the outstanding and unpaid principal, interest, penalties, and all other amounts under the September
2022 Note at a conversion price of $0.009, subject to adjustment as defined in the Note. The Company did not calculate a beneficial conversion
feature since the GS Capital July 2022 Note was contingently convertible upon a default on the September 2022 Note. As of December 31,
2022, the Company was not in default on this note. In the event that following the Issue Date the closing trading price of the Company’s
common stock was then being traded below $0.009 per share for more than ten consecutive trading days, then the conversion
price shall be equal to $0.0032 per share. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend
the due date of the GS Capital September 2022 note by 60 days. Specifically, the maturity date of the GS Capital September 2022 note was
extended to November 6, 2023 and the next payment due date was extended to March 6, 2023. In May 2023, the GS Capital September 2022 Note
and all accrued interest due was paid in full (See Note 16). On December 31, 2023, the principal balance due on the GS Capital September
2022 Note and accrued interest payable amounted to $0. On December 31, 2022, the principal balance due on the GS Capital September 2022
Note amounted to $195,000 and accrued interest payable amounted to $5,001.
In connection with the Letter Agreement dated
December 15, 2022, in order to induce GS Capital to extend the due dates of the GS Capital Notes, the Company issued 15,000,000 shares
of the Company’s common stock. These shares were valued at $112,500, or $0.0075 per common share, based on the quoted closing price
of the Company’s common stock on the measurement date. In connection with the issuance of these shares, during the year ended December
31, 2022, the Company recorded an inducement expense of $112,500 which was included in loss on debt extinguishment on the accompanying
consolidated statement of operations.
In May 2023, the GS Capital June 2022 Note, the
GS Capital July 2022 Note, and the September 2022 Note were paid in full without any default penalty and the Company recorded a gain on
debt extinguishment of approximately $25,400 (see Note 16).
Other Notes Payable
On May 10, 2021, the Company entered into a Loan
and Security Agreement (the “Loan Agreement”) and a Secured Promissory Note (the “Promissory Note”) in the amount
of $500,000 with a lender. The Promissory Note accrued interest at 8% per annum, compounded annually, and all outstanding principal and
accrued interest was due and payable of May 10, 2023. The Company’s obligations under the Loan Agreement and the Promissory Note
were secured by a second priority security interest in substantially all of the Company’s assets (the “Collateral”).
The Loan Agreement and Promissory Note contained customary representations, warranties, and covenants, including certain restrictions
on the Company’s ability to incur additional debt or create liens on its property. The Loan Agreement and the Promissory Note also
provided for certain events of default, including, among other things, payment defaults, breaches of representations and warranties and
bankruptcy or insolvency proceedings, the occurrence of which, after any applicable cure period, would permit Lender, among other things,
to accelerate payment of all amounts outstanding under the Loan Agreement and the Promissory Note, as applicable, and to exercise its
remedies with respect to the Collateral. On December 31, 2022, accrued interest payable under this Promissory Note amounted to $65,863
and is included in accrued expenses on the accompanying consolidated balance sheet. On December 31, 2022, the principal amount due under
this Promissory Note amounted to $500,000. In May 2023, this Promissory Note and all accrued interest was paid in full (See Note 16).
On July 22, 2021, in connection with the acquisition
of Patriot Glass, the Company assumed vehicle and equipment loans in the amount of $95,013. These loans bear interest at rates ranging
from 6.79% to 8.24% and are payable monthly through April 2025. On December 31, 2023 and 2022, notes payable related to these vehicle
and equipment loans amounted to $8,250 and $39,513, respectively.
On November 8, 2022, the Company entered into
a Promissory Note (the “November 2022 Note”) with a lender investor (the “Private Investor”) in the principal
amount of $200,000 and received net proceeds of $200,000. The November 2022 Note bore interest at a rate of 8% per annum and all outstanding
principal and accrued and unpaid interest was due on November 8, 2024. At any time, the Company may prepay all or any portion of the principal
amount of the November 2022 Note and any accrued and unpaid interest without penalty. As security for payment of the principal and interest
on the November 2022 Note, the Company and the lender Investor previously entered into that certain Loan and Security Agreement dated
May 10, 2021, which is incorporated into the November 2022 Note. On December 31, 2022, accrued interest payable under this Promissory
Note amounted to $2,367 and is included in accrued expenses on the accompanying consolidated balance sheets. On December 31, 2022, the
principal amount due under this Promissory Note amounted to $200,000. In May 2023, the November 2022 Note and all unpaid interest was
paid in full (See Note 16).
During the year ended December 31, 2023, in connection
with the acquisition of a vehicle and an air conditioner unit, the Company entered into three vehicle and equipment loans in the amount
of $117,721. These loans bear interest at rates ranging from 10.0% to 35.1% and are payable monthly through September 2028. On December
31, 2023, notes payable related to the vehicle and equipment loans amounted to $97,708. The net book value on December 31, 2023 relating
to the collateralized assets was $85,489.
For the years ended December 31, 2023 and 2022,
amortization of debt discounts related to all of the above notes payable amounted to $93,631 and $121,408, respectively, which has been
included in interest expense on the accompanying consolidated statements of operations. The Company recognized a loss on debt extinguishment
associated with the write off of the remaining debt discount and related note repayments in fiscal 2023 of approximately $49,300.
PPP Loan
On April 28, 2020, the Company entered into a
Paycheck Protection Program Promissory Note (the “PPP Note”) with respect to a loan of $156,200 (the “PPP Loan”)
from Comerica Bank. The PPP Loan was obtained pursuant to the Paycheck Protection Program (the “PPP”) of the Coronavirus Aid,
Relief, and Economic Security Act (the “CARES act”) administered by the U.S. Small Business Administration (“SBA”).
The PPP Loan matures on April 28, 2022 and bears interest at a rate of 1.00% per annum. The PPP Loan is payable in 18 equal monthly payments
of approximately $8,900 commencing November 1, 2020. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties.
The Company may apply to have the loan forgiven pursuant to the terms of the PPP if certain criteria are met. The Company applied for
forgiveness of its PPP Loan, and on November 4, 2021, the Company was notified that the Small Business Administration forgave $95,000
of the principal loan amount and $1,442 of interest. As of November 4, 2021, the remaining principal balance of the loan was $61,200 and
the remaining accrued interest balance was $935. During the year ended December 31, 2022, the Company repaid the PPP Loan principal of
$30,107. On December 31, 2023 and 2022, the principal amount due under the PPP Loan amounted to $18,823. As of December 31, 2023 and 2022,
accrued interest payable amounted to $358 and $170, respectively.
On December 31, 2023, future annual maturities
of notes payable are as follows:
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
On December 12, 2019, the Company filed an Amendment
to its Articles of Incorporation to designate a series of preferred stock, the Series B Convertible Preferred Stock (the “Series
B”), with the Secretary of State of the State of Colorado. The Certificate of Designations established 100,000 shares of the Series
B, par value $0.10, having such designations, preferences, and rights as determined by the Company’s Board of Directors in its sole
discretion, in accordance with the Company’s Articles of Incorporation and Amended and Restated Bylaws. The Certificate of Designations
became effective with the State of Colorado upon filing.
The Series B ranks senior with respect to dividends
and right of liquidation with the Company’s common stock and junior to all existing and future indebtedness of the Company. The
Series B has a stated value per share of $1,000, subject to adjustment as provided in the Certificate of Designations (the “Stated
Value”), and a dividend rate of 2% per annum of the Stated Value.
The Series B is subject to redemption (at Stated
Value, plus any accrued, but unpaid dividends (the “Liquidation Value”) by the Company no later than three years after a Deemed
Liquidation Event and at the Company’s option after one year from the issuance date of the Series B, subject to a ten-day notice
(to allow holder conversion). A “Deemed Liquidation Event” will mean: (a) a merger or consolidation in which the Company is
a constituent party or a subsidiary of the Company is a constituent party and the Company issues shares of its capital stock pursuant
to such merger or consolidation, except any such merger or consolidation involving the Company or a subsidiary in which the shares of
capital stock of the Company outstanding immediately prior to such merger or consolidation continue to represent, or are converted into
or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting
power, of the capital stock of the surviving or resulting corporation or, if the surviving or resulting corporation is a wholly-owned
subsidiary of another corporation immediately following such merger or consolidation, the parent corporation of such surviving or resulting
corporation; or (b) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions,
by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a
whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially all of
the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease,
transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company.
The Series B is convertible into common stock
at the option of a holder or if the closing price of the common stock exceeds 400% of the Conversion Price for a period of twenty consecutive
trading days, at the option of the Company. Conversion Price means a price per share of the common stock equal to 100% of the lowest daily
volume weighted average price of the common stock during the two years preceding or subsequent two years following the Issuance Date,
subject to adjustment as otherwise provided in the Certificate of Designations (the “Conversion Price”).
In the event of a conversion of any Series B,
the Company shall issue to the holder a number of shares of common stock equal to the sum of the Stated Value plus accrued but unpaid
dividends multiplied by the number of shares of Series B Preferred Stock being converted divided by the Conversion Price.
Upon liquidation of the Company after payment
or provision for payment of liabilities of the Company and after payment or provision for any liquidation preference payable to the holders
of any preferred stock ranking senior to the Series B but prior to any distribution to the holders of Common Stock or preferred stock
ranking junior upon liquidation to the Series B, the holders of Series B will be entitled to be paid out of the assets of the Company
available for distribution to its stockholders an amount with respect to each share of Series B equal to the Liquidation Value.
The Series B has voting rights per Series B Share
equal to the Liquidation Value per share, divided by the Conversion Price, multiplied by fifty (50). Subject to applicable Colorado law,
the holders of Series B will have functional voting control in situations requiring shareholder vote.
These Series B preferred share issuances with
redemption provisions that permit the issuer to settle in either cash or common stock, at the option of the issuer, were evaluated to
determine whether temporary or permanent equity classification on the consolidated balance sheet was appropriate. As per the terms of
the Series B preferred stock agreements, Series B preferred stock is redeemable for cash and other assets on the occurrence of a deemed
liquidation event. A deemed liquidation event includes a change of control which is not in the Company’s control. As such, since
Series B preferred stock is redeemable upon the occurrence of an event that is not within the Company’s control, the Series B preferred
stock is classified as temporary equity.
The Company concluded that the Series B Preferred
Stock represented an equity host and, therefore, the redemption feature of the Series B Preferred Stock was not considered to be clearly
and closely related to the associated equity host instrument. However, the redemption features did not meet the net settlement criteria
of a derivative and, therefore, were not considered embedded derivatives that required bifurcation. The Company also concluded that the
conversion rights under the Series B Preferred Stock were clearly and closely related to the equity host instrument. Accordingly, the
conversion rights feature on the Series B Preferred Stock were not considered an embedded derivative that required bifurcation. The conversion
feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial on the commitment date.
On January 6, 2022, the Board of Directors of
the Company agreed to satisfy $278,654 of accrued compensation owed to its executive officers (collectively, the “Management”)
as of December 31, 2021. Management agreed to accept 278 shares of the Company’s Series B convertible preferred stock in settlement
of this accrued compensation. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial
on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur
any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $957,556 related to the beneficial
conversion feature arising from the issuance of Series B Preferred Stock.
On January 17, 2023, the Board of Directors of
the Company agreed to satisfy $144,000 of accrued compensation owed to its executive officers (collectively, the “Management”)
which, as of December 31, 2022 was included in accrued compensation on the accompanying consolidated balance sheet. Management agreed
to accept 144 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation. The beneficial
conversion feature of the Series B Preferred Stock at the time of issuance was determined to be deminimis on the commitment date.
By mutual agreement between the parties, the vesting
date of 842 previously granted shares of Series B Preferred stock was extended through May 2024.
During the years ended December 31, 2023 and 2022,
the Company accrued dividends of $22,766 and $19,936, respectively, which was included in Series B convertible preferred stock on the
accompanying consolidated balance sheets.
As of December 31, 2023, the net Series B Preferred
Stock balance was $1,203,967, which includes stated value of $1,144,624 and accrued dividends payable of $59,343. As of December 31, 2022,
the net Series B Preferred Stock balance was $1,037,201, which includes stated value of $1,000,624 and accrued dividends payable of $36,577.
The net Series B Preferred Stock balance is included on the accompanying consolidated balance sheets.
Series C Preferred Stock
On August 20, 2020, the Company filed an Amendment
to its Articles of Incorporation to designate a series of preferred stock, the Series C Convertible Preferred Stock (the “Series
C”), with the Secretary of State of the State of Colorado. The Certificate of Designations established 100,000 shares of the Series
C, par value $0.10, having such designations, preferences, and rights as determined by the Company’s Board of Directors in its sole
discretion, in accordance with the Company’s Articles of Incorporation and Amended and Restated Bylaws. The Certificate of Designations
became effective with the State of Colorado upon filing.
The Series C ranks senior with respect to dividends
and right of liquidation with the Company’s common stock and junior to all existing and future indebtedness of the Company. The
Series C has a stated value per share of $100, subject to adjustment as provided in the Certificate of Designations (the “Stated
Value”), and a dividend rate of 2% per annum of the Stated Value.
The Company has no option to redeem the Series
C Preferred Stock. If the Company determines to liquidate, dissolve or wind-up its business and affairs, or effect any Deemed Liquidation
Event as defined below, each of which has been approved by the holders of a majority of the shares of Series C Preferred Stock then outstanding,
the Company will redeem all of the shares of Series C Preferred Stock outstanding immediately prior to such mandatory redemption event
at a price per share of Series C Preferred Stock equal to the aggregate Series C Liquidation Value, which is 150% of the sum of the Stated
Value plus accrued and unpaid dividends, for the shares of Series C Preferred Stock being redeemed.
The Company will deliver ten-day advance written
notice prior to the consummation of any mandatory redemption event via email or overnight courier (“Notice of Mandatory Redemption”)
to each Holder whose shares are to be redeemed. The Series C is subject to redemption at liquidation Value noted above by the Company.
Upon receipt by any Holder of a Notice of Mandatory Redemption, if Holder does not choose to convert, such Holder will promptly submit
to the Company such Holder’s Series C Preferred Stock certificates on the Redemption Payment Date. Upon receipt of such Holder’s
Series C Preferred Stock certificates, the Company will pay the applicable redemption price to such Holder in cash. A “Deemed Liquidation
Event” will mean: (a) a merger or consolidation in which the Company is a constituent party or a subsidiary of the Company is a
constituent party and the Company issues shares of its capital stock pursuant to such merger or consolidation, except any such merger
or consolidation involving the Company or a subsidiary in which the shares of capital stock of the Company outstanding immediately prior
to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that represent,
immediately following such merger or consolidation, at least a majority, by voting power, of the capital stock of the surviving or resulting
corporation or, if the surviving or resulting corporation is a wholly-owned subsidiary of another corporation immediately following such
merger or consolidation, the parent corporation of such surviving or resulting corporation; or (b) the sale, lease, transfer, exclusive
license or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company
of all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger
or otherwise) of one or more subsidiaries of the Company if substantially all of the assets of the Company and its subsidiaries taken
as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition
is to a wholly owned subsidiary of the Company. Since the Company has determined that a deemed liquidation event is not probable, the
Series C is stated at the Stated Value plus accrued and unpaid dividends rather than redemption value, which is liquidation value.
The Series C is convertible at the option of a
holder at any time following the issuance date. In the event of a conversion of any Series C Preferred Stock, the Company shall issue
to such Holder a number of Conversion Shares equal to (x) the sum of (1) the Stated Value per share of Series C Preferred Stock plus (2)
any accrued but unpaid dividends thereon multiplied by (y) the number of shares of Series C Preferred Stock held by such Holder and subject
to the Holder Conversion Notice, divided by (z) the Conversion Price with respect to such Series C Preferred Stock. Conversion Price means
a price per share of the common stock equal to the lowest daily volume weighted average price of the common stock for any trading day
during the two years preceding the date of delivery of the conversion notice, subject to adjustment as otherwise provided in the Series
C Certificate of Designation.
Upon liquidation of the Company after payment
or provision for payment of liabilities of the Company and after payment or provision for any liquidation preference payable to the holders
of any preferred stock ranking senior to the Series C but prior to any distribution to the holders of Common Stock or preferred stock
ranking junior upon liquidation to the Series C, the holders of Series C will be entitled to be paid out of the assets of the Company
available for distribution to its stockholders an amount with respect to each share of Series C equal to the Liquidation Value.
Through April 28, 2021, each share of Series C
Preferred Stock was entitled to vote on all matters requiring shareholder vote. Each share of Series C Preferred Stock was entitled to
the number of votes per share based on the calculation of the number of conversion shares of Series C Preferred Stock is then convertible.
On April 28, 2021, the Company filed an Amended and Restated Certificate of Designations of Preferences, Rights, and Limitations of Series
C Convertible Preferred Stock (the “Amended Certificate”). The Amended Certificate changed the voting rights of the Series
C Preferred Stock on any matters requiring shareholder approval or any matters on which the common shareholders are permitted to vote.
Series C Preferred Stock shall have no right to vote on any matters requiring shareholder approval or any matters on which the common
shareholders (or other preferred stock of the Company which may vote with the common shareholders) are permitted to vote. With respect
to any voting rights of the Series C Preferred Stock set forth herein, the Series C Preferred Stock shall vote as a class, each share
of Series C Preferred Stock shall have one vote on any such matter, and any such approval may be given via a written consent in lieu of
a meeting of the Holders of the Series C Preferred Stock. Any reference herein to a determination, decision or election being made by
the “Majority Holders” shall mean the determination, decision or election as made by Holders holding a majority of the issued
and outstanding shares of Series C Preferred Stock at such time. It also adjusts the conversion feature of the Series C Preferred Stock
so that any Holder of Series C Preferred Stock cannot convert any portion of the Series C in excess of that number of Series C Preferred
Stock that upon conversion would result in beneficial ownership by the Holder of more than 4.99% of the outstanding shares of common stock
of the Company.
These Series C preferred stock issuances with
redemption provisions that permit the issuer to settle in either cash or common stock, at the option of the holder, were evaluated to
determine whether temporary or permanent equity classification on the consolidated balance sheet was appropriate. As per the terms of
the Series C preferred stock agreements, Series C preferred stock is redeemable for cash and other assets on the occurrence of a deemed
liquidation event. A deemed liquidation event includes a change of control which is not in the Company’s control. As such, since
Series C preferred stock is redeemable upon the occurrence of an event that is not within the Company’s control, the Series C preferred
stock is classified as temporary equity.
The Company concluded that the Series C Preferred
Stock represented an equity host and, therefore, the redemption feature of the Series C Preferred Stock was not considered to be clearly
and closely related to the associated equity host instrument. However, the redemption features did not meet the net settlement criteria
of a derivative and, therefore, were not considered embedded derivatives that required bifurcation. The Company also concluded that the
conversion rights under the Series C Preferred Stock were clearly and closely related to the equity host instrument. Accordingly, the
conversion rights feature on the Series C Preferred Stock were not considered an embedded derivative that required bifurcation. The conversion
feature of the Series C Preferred Stock at the time of issuance was determined to be beneficial on the commitment date.
On January 12, 2022, the Company issued 1,543,151
shares of its common stock upon the conversion of 120 shares of Series C preferred with a stated redemption value of $12,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
On April 20, 2022, the Company issued 13,184,548
shares of its common stock upon the conversion of 1,020 shares of Series C preferred with a stated redemption value of $102,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
On December 1, 2022, the Company issued 6,535,274
shares of its common stock upon the conversion of 250 shares of Series C preferred with a stated redemption value of $25,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
During the three months ended March 31, 2023,
the Company issued 26,585,614 shares of its common stock upon the conversion of 1,014 shares of Series C preferred with a stated redemption
value of $101,400. The conversion price was based on contractual terms of the related Series C preferred shares.
During the three months ended June 30, 2023, the
Company issued 23,157,922 shares of its common stock upon the conversion of 826 shares of Series C preferred with a stated redemption
value of $82,600. The conversion price was based on contractual terms of the related Series C preferred shares.
During the three months ended September 30, 2023,
the Company issued 8,584,376 shares of its common stock upon the conversion of 300 shares of Series C preferred with a stated redemption
value of $30,000. The conversion price was based on contractual terms of the related Series C preferred shares.
During the years ended December 31, 2023 and 2022,
the Company accrued dividends of $31,429 and $35,719, respectively, which was included in Series C convertible preferred stock on the
accompanying consolidated balance sheets.
As of December 31, 2023, the net Series C Preferred
Stock balance was $1,621,160, which includes stated liquidation value of $1,515,000 and accrued dividends payable of $106,160. As of December
31, 2022, the net Series C Preferred Stock balance was $1,803,731, which includes stated value of $1,729,000 and accrued dividends payable
of $74,731. The net Series C Preferred Stock balance is included on the accompanying consolidated balance sheets.
Common Stock
Common Stock Issued for Cash and Accrued
Compensation
On January 17, 2023, the Company entered into
a Subscription Agreement with its Chairman and Chief Executive Officer, Scott R. Silverman (the “Subscription Agreement”),
whereby Mr. Silverman purchased 54,545,455 shares (the “Subscription Shares”) of the Company’s common stock for $300,000,
or $0.0055 per share, based on the quoted closing price of the Company’s common stock on the measurement date (the “Consideration”).
The Consideration consisted of a cash payment of $275,000 the conversion of $25,000 of accrued compensation owed to Mr. Silverman.
On January 17, 2023, Barry Edelstein, a member
of the Company’s Board of Directors, elected to convert $53,000 of accrued compensation into 9,636,364 shares of unregistered common
stock of the Company. The shares were valued at $53,000, or $0.0055, based on the quoted closing price of the Company’s common stock
on the measurement date.
Issuance of Common Stock for Services
Issuance of Common Stock for Professional Fees
2022
On June 7, 2022, the Company issued an aggregate
of 4,000,000 shares of its common stock for business development and consulting services rendered and to be rendered. These shares were
valued at $48,000, or $0.012 per common share, based on the quoted closing price of the Company’s common stock on the measurement
date, and will be amortized into stock-based consulting fees over the term of the agreement. In connection with the issuance of these
shares, during the years ended December 31, 2023 and 2022, the Company recorded stock-based professional fees of $21,000 and $27,000,
respectively.
On June 24, 2022, the Company issued an aggregate
of 3,000,000 shares of its common stock for business development and consulting services rendered and to be rendered. These shares were
valued at $54,000, or $0.018 per common share, based on the quoted closing price of the Company’s common stock on the measurement
date, and will be amortized into stock-based consulting fees over the term of the agreement. In connection with the issuance of these
shares, during the year ended December 31, 2022, the Company recorded stock-based professional fees of $54,000.
On July 1, 2022, the Company granted a restricted
stock award of 2,500,000 common shares of the Company to a consultant of the Company for business development and consulting services
rendered, which shares were valued at $31,250, or $0.0125 per common share, based on the quoted closing price of the Company’s common
stock on the measurement date, and will be amortized into stock-based consulting fees over the term of the agreement. In connection with
the issuance of these shares, during the year ended December 31, 2022, the Company recorded stock-based professional fees of $31,250.
On July 15, 2022, the Company granted a restricted
stock award of 5,454,545 common shares of the Company to a consultant of the Company for government relations services to be rendered,
which shares were valued at $60,000, or $0.011 per common share, based on the quoted closing price of the Company’s common stock
on the measurement date, and will be amortized into stock-based consulting fees over the term of the agreement. In connection with the
issuance of these shares, during the years ended December 31, 2023 and 2022, the Company recorded stock-based professional fees of $5,000
and $55,000, respectively.
On October 3, 2022, the Company issued 3,000,000
shares of its common stock for investor relations services to be rendered. These shares were valued at $24,000, or $0.008 per common share,
based on the quoted closing price of the Company’s common stock on the measurement date. In connection with the issuance of these
shares, during the years ended December 31, 2023 and 2022, the Company recorded stock-based professional fees of $12,000 and $12,000,
respectively.
During the year ended December 31, 2022, the Company
recorded stock-based professional fees of $119,321 in connection with the amortization of prepaid expenses of $119,321 related to common
shares previously issued.
2023
On February 6, 2023, the Company issued 6,666,667
shares of its common stock for public relations services to be rendered. These shares were valued at $40,000, or $0.006 per common share,
based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares, the Company
recorded stock-based professional fees of $40,000, which was amortized into professional fees over the term of the agreement.
On April 3, 2023, the Company issued 5,000,000
shares of its common stock for investor relations services to be rendered. These shares were valued at $22,500, or $0.0045 per common
share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares,
the Company recorded stock-based professional fees of $22,500, which was amortized into professional fees over the term of the agreement.
On June 3, 2023, the Company issued 1,500,000
shares of its common stock for investor relations services to be rendered. These shares were valued at $16,950, or $0.0011 per common
share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares,
the Company recorded stock-based professional fees of $16,950, which was amortized into professional fees over the remaining term of the
agreement.
On September 3, 2023, the Company issued 1,000,000
shares of its common stock for investor relations services to be rendered. These shares were valued at $4,500, or $0.0045 per common share,
based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares, the Company
recorded stock-based professional fees of $2,250 and prepaid expenses of $2,250, which will be amortized into professional fees over the
remaining term of the agreement.
Issuance of Common Stock for Stock-Based Compensation
2022
On March 24, 2022, the Company granted restricted
stock awards of 500,000 vested common shares of the Company to an employee of the Company for services rendered. The awards were valued
at $14,250, or $0.0285 per common share, based on the quoted closing price of the Company’s common stock on the measurement date.
In connection with these shares, the Company recognized stock-based compensation of $14,250 on the date of issuance.
On July 12, 2022, the Company granted a restricted
stock award of 1,000,000 common shares of the Company to an employee of the Company. The shares will vest on May 1, 2023. These shares
were valued on the date of grant at $11,000, or $0.011 per common share based on the quoted closing price of the Company’s common
stock on the measurement date. In connection with these shares, the Company shall record stock-based compensation over the vesting period.
On August 12, 2022, the Company granted a restricted
stock award of 2,000,000 common shares of the Company to a board member of the Company. The shares will vest on May 1, 2023. These shares
were valued on the date of grant at $24,000 or $0.012 per common share based on the quoted closing price of the Company’s common
stock on the measurement date. In connection with these shares, the Company shall record stock-based compensation over the vesting period.
2023
On June 7, 2023, the Company issued 2,500,000
shares of its common stock to employees for services for services rendered. These shares were valued at $26,000, or $0.0104 per common
share, based on the quoted closing price of the Company’s common stock on the measurement date.
During the years ended December 31, 2023 and 2022,
aggregate accretion of stock-based compensation expense on granted common shares amounted to $42,183 and $82,387, respectively. Total
unrecognized compensation expense related to these unvested common shares on December 31, 2023 amounted to $0. By mutual agreement between
the parties, the vesting date of previously granted shares was extended through May 2024.
The following table summarizes activity related
to non-vested shares:
Number of Non-Vested Shares
Weighted Average Grant Date Fair Value
Non-vested, December 31, 2021
14,270,120
$
0.140
Granted
3,500,000
0.014
Shares vested
(800,000
)
(0.037
)
Non-vested, December 31, 2022
16,970,120
0.119
Shares vested
(2,000,000
)
(0.021
)
Non-vested, December 31, 2023
14,970,120
$
0.132
Shares Issued for Accounts Payable
On January 6, 2022, the Company issued 90,859
common shares upon conversion of accounts payable of $2,174, or $0.024 per common share, based on the quoted closing price of the Company’s
common stock on the measurement date.
Common Stock Issued in Connection with Notes
Payable
2022
In connection with the March 2022 Note, the Company
issued 823,529 shares of its common stock to the placement agent as a fee for the capital raise. The 823,529 shares of common stock issued
were recorded as a debt discount of $12,963 based on the relative fair value method to be amortized over the life of the Note.
In connection with the June 2022 GS Capital Note,
the Company issued 1,750,000 shares of its common stock as a commitment fee. The 1,750,000 shares of common stock issued were recorded
as a debt discount of $32,736 based on the relative fair value method to be amortized over the life of the Note (See Note 8).
In connection with the July 2022 GS Capital Note,
on July 28, 2022, the Company issued 2,600,000 shares of its common stock as a commitment fee and the Company issued 998,008 shares of
its common stock to the placement agent as a fee for the capital raises. The aggregate of 3,598,008 shares of common stock issued were
recorded as a debt discount of $34,606 based on the relative fair value method to be amortized over the life of the July 2022 Note (See
Note 8).
In connection with the September 2022 GS Capital
Note, on September 6, 2022, the Company issued 3,300,000 shares of its common stock as a commitment fee and the Company issued 773,626
shares of its common stock to the placement agent as fee for the capital raises. The aggregate of 4,073,626 shares of common stock issued
were recorded as a debt discount of $30,326 based on the relative fair value method to be amortized over the life of the September 2022
Note (See Note 8).
In connection with the Letter Agreement dated
December 15, 2022, to induce GS Capital to extend the due dates of the GS Capital Notes, the Company issued 15,000,000 shares of the Company’s
common stock. These shares were valued at $112,500, or $0.0075 per common share, based on the quoted closing price of the Company’s
common stock on the measurement date. In connection with the issuance of these shares, during the year ended December 31, 2022, the Company
recorded an expense of $112,500 which was included in loss on debt extinguishment on the accompanying consolidated statement of operations.
2023
During April and May 2023, the Company issued
21,371,481 shares of its common stock upon the conversion of principal of $62,000, accrued interest of $4,139, and fees of $2,250.
In May 2023, the Company issued the Lender 22,000,000
shares of common stock of the Company in exchange for settlement of the remaining $200,000 of the loan and all accrued interest amounting
to $317,293, which were deemed paid in full (see Note 8 - BOCO Investment Note). The 22,000,000 shares issued were valued at $132,000,
or $0.006 per share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with
the issuance of these shares, the Company recorded a gain from debt extinguishment of $68,000 calculated as the different in the principal
amount settled for shares of $200,000 and the fair value of the shares on the measurement date of $132,000.
Common Stock Issued for Conversion of Series
C Preferred Stock
2022
On January 12, 2022, the Company issued 1,543,151
shares of its common stock upon the conversion of 120 shares of Series C preferred with a stated redemption value of $12,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
On April 20, 2022, the Company issued 13,184,548
shares of its common stock upon the conversion of 1,020 shares of Series C preferred with a stated redemption value of $102,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
On December 1, 2022, the Company issued 6,535,274
shares of its common stock upon the conversion of 250 shares of Series C preferred with a stated redemption value of $25,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
2023
During the three months ended March 31, 2023,
the Company issued 26,585,614 shares of its common stock upon the conversion of 1,014 shares of Series C preferred with a stated redemption
value of $101,400. The conversion price was based on contractual terms of the related Series C preferred shares.
During the three months ended June 30, 2023, the
Company issued 23,157,922 shares of its common stock upon the conversion of 826 shares of Series C preferred with a stated redemption
value of $82,600. The conversion price was based on contractual terms of the related Series C preferred shares.
During the three months ended September 30, 2023,
the Company issued 8,584,376 shares of its common stock upon the conversion of 300 shares of Series C preferred with a stated redemption
value of $30,000. The conversion price was based on contractual terms of the related Series C preferred shares.
Stock Options
For the years ended December 31, 2023 and 2022,
the Company recorded no compensation expense related to stock options. Total unrecognized compensation expense related to unvested stock
options on December 31, 2023 and 2022 amounted to $0.
Stock option activities for the years ended December
31, 2023 and 2022 are summarized as follows:
Number of Options
Weighted Average Exercise Price
Weighted Average Remaining Contractual Term (Years)
Aggregate Intrinsic Value
Balance Outstanding, December 31, 2021
8,445,698
$
0.40
4.43
-
Exercised
-
-
-
-
Balance Outstanding, December 31, 2022
8,445,698
0.40
3.43
-
Exercised
-
-
-
-
Balance Outstanding, December 31, 2023
8,445,698
$
0.40
2.43
$
-
Exercisable, December 31, 2023
8,445,698
$
0.40
2.43
$
-
Warrants
On April 20, 2022, in connection with an Exchange
Agreement (See Note 8), the Company issued warrants to purchase an aggregate amount up to 33,000,000 shares of the Company’s common
stock (the “New Warrants”). The New Warrants are exercisable at any time on or after the date of the issuance and entitled
this investor to purchase shares of the Company’s common stock for a period of five years from the initial date the warrants become
exercisable. Under the terms of the New Warrants, the holder is entitled to exercise the Warrants to purchase up to 33,000,000 shares
of the Company’s common stock at an initial exercise price of $0.025, subject to adjustment as detailed in the New Warrants. In
connection with the issuance of the New Warrants, on the initial measurement date, the relative fair value of the warrants of $325,785
was recorded as a debt discount and an increase in paid-in capital (See Note 8). On June 23, 2022, the Company issued common stock equivalents
with an initial conversion price of $0.011 per share and accordingly, the conversion price and warrant down-round provisions were triggered.
As a result, the conversion price of the New April 2022 Note was reduced to $0.011 per share and the exercise price of the New April 2022
Warrant was lowered to $0.011. As a result of the June 23, 2022 down-round provisions, the Company calculated the difference between the
warrants fair value on June 23, 2022, the date the down-round feature was triggered using the then current exercise price of $0.025 and
the new exercise price of $0.011. On June 23, 2022, the Company recorded a deemed dividend of $3,702 which represents the fair value transferred
to the warrant holders from the down round feature being triggered. Additionally, on September 6, 2022, the Company issued common stock
equivalents with an initial conversion price of $0.009 per share and accordingly, the conversion price and warrant down-round provisions
were triggered. As a result, the conversion price of the New April 2022 Note was reduced to $0.009 per share and the exercise price of
the New April 2022 Warrant was lowered to $0.009. As a result of the September 6, 2022 down-round provisions, the Company calculated the
difference between the warrants fair value on September 6, 2022, the date the down-round feature was triggered using the then current
exercise price of $0.011 and the new exercise price of $0.009. On September 6, 2022, the Company recorded a deemed dividend of $733 which
represents the fair value transferred to the warrant holders from the down round feature being triggered. No additional beneficial conversion
feature amount was recorded based on the September 6, 2022 valuation as the ratcheted beneficial conversion feature value was lower than
the original amount.
Warrant activities for the years ended December
31, 2023 and 2022 are summarized as follows:
Number of Warrants
Weighted Average Exercise Price
Weighted Average Remaining Contractual Term (Years)
Aggregate Intrinsic Value
Balance Outstanding December 31, 2021
17,500,000
$
0.05
4.67
$
-
Granted
33,000,000
0.025
-
-
Cancelled
(16,500,000
)
(0.05
)
-
-
Balance Outstanding December 31, 2022
34,000,000
0.011
3.73
-
Granted
-
-
-
-
Balance Outstanding December 31, 2023
34,000,000
$
0.011
2.73
$
-
Exercisable, December 31, 2023
34,000,000
$
0.011
2.73
$
-
2018 Long-Term Incentive Plan
On June 7, 2018, a majority of the Company’s
shareholders and its board approved the adoption of a 2018 Long-Term Incentive Plan (the “2018 Plan”). The purpose of the
2018 Plan is to advance the interests of the Company, its affiliates and its stockholders and promote the long-term growth of the Company
by providing employees, non-employee directors and third-party service providers with incentives to maximize stockholder value and to
otherwise contribute to the success of the Company and its affiliates, thereby aligning the interests of such individuals with the interests
of the Company’s stockholders and providing them additional incentives to continue in their employment or affiliation with the Company.
The Plan was adopted on June 7, 2018 and effective on August 2, 2018. Under the 2018 Plan, the Plan Administrator may grant:
●
options to acquire the Company’s common stock, both incentive stock options that are intended to satisfy the requirements of Section 422 of the Internal Revenue Code and nonqualified stock options which are not intended to satisfy such requirements. The exercise price of options granted under our 2018 Plan must at least be equal to the fair market value of the Company’s common stock on the date of grant and the term of an option may not exceed ten years, except that with respect to an incentive stock option granted to any employee who owns more than 10% of the voting power of all classes of the Company’s outstanding stock as of the grant date the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date.
●
stock appreciation rights, or SARs, which allow the recipient to receive the appreciation in the fair market value of the Company’s common stock between the date of grant and the exercise date. The amount payable under the stock appreciation right may be paid in cash or with shares of the Company’s common stock, or a combination thereof, as determined by the Administrator.
●
restricted stock awards, which are awards of the Company’s shares of common stock that vest in accordance with terms and conditions established by the Administrator.
●
restricted stock units, which are awards that are based on the value of the Company’s common stock and may be paid in cash or in shares of the Company’s common stock.
●
other types of stock-based or stock-related awards not otherwise described by the terms and provision of the 2018 Plan, including the grant or offer for sale of unrestricted shares of the Company’s common stock, and which may involve the transfer of actual shares of the Company’s common stock or payment in cash or otherwise of amounts based on the value of shares of the Company’s common stock and may be designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States.
●
other cash-based awards to eligible persons in such amounts and upon such terms as the Administrator shall determine.
An award granted under the 2018 Plan must include
a minimum vesting period of at least one year, provided, however, that an award may provide that the award will vest before the completion
of such one-year period upon the death or qualifying disability of the grantee of the award or a change of control of the Company and
awards covering, in the aggregate, 25,000,000 shares of our Common Stock may be issued without any minimum vesting period.
The aggregate number of shares of common stock
and number of shares of the Company’s common stock that may be subject to incentive stock options granted under the 2018 Plan is
50,000,000 shares, of which 11,445,698 shares have been issued or granted under incentive stock options and 29,451,070 shares of restricted
stock have been issued as of December 31, 2023. All shares underlying grants are expected to be issued from the Company’s unissued
authorized shares available.
The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).
From time to time, the Company may be involved
in litigation related to claims arising out of its operations in the normal course of business. As of December 31, 2023, other than discussed
below, the Company is not involved in any other pending or threatened legal proceedings that it believes could reasonably be expected
to have a material adverse effect on its financial condition, results of operations, or cash flows.
On January 20, 2022, we received
an Order Directing Examination and Designating Officers to Take Testimony (a “Formal Order”) from the SEC. The Formal Order
authorizes that an examination be made to determine whether a stop order should be issued under Section 8(d) of the Securities Act of
1933 with respect to the Company’s Registration Statement on Form S-1, and any supplements and amendments thereto. The Formal Order
indicates that the Form S-1 may be deficient in that it may contain untrue statements of material fact or omit to state material facts
necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading concerning, among
other things, the Company’s revenue and financial condition. On April 15, 2022, the Company filed an amendment to its Annual Report
on Form 10-K for the fiscal year ended December 31, 2020. The restatement had the cumulative effect of decreasing the Company’s
reported revenue for fiscal year 2020 by $102,569 and decreasing the Company’s bad debt expense for the same period by $102,569.
There was no effect on the Company’s reported net loss for fiscal year 2020 or on the financial condition of the Company on December
31, 2020. The Company received a subpoena from the SEC on April 25, 2022, requesting all documents and communications concerning the review
of C-Bond’s revenue recognition practices for fiscal year 2020. In response, the Company has provided the requested information
and its Chief Executive Officer provided his testimony regarding this Formal Order in October 2022. The Company also filed a request
to withdraw its Registration Statement on Form S-1 (“S-1”) (File No. 333-261472) (the “Registration Statement”),
filed by the Company with the Securities and Exchange Commission on December 3, 2021. The S-1 related to shares of common stock underlying
certain convertible promissory notes held by selling securityholders. The S-1 was not declared effective and no securities were sold in
reliance thereon. The Company and its Chief Executive Officer have submitted an offer to settle and close the pending SEC investigation.
The Company and its Chief Executive Officer are awaiting a formal response to such offer of settlement. As of December 31, 2023 and based
on a proposed settlement, the Company has accrued $175,000 of settlement expense association with this matter, which is reflected in other
income (expenses) on the accompanying statement of operations during the year ended December 31, 2023.
On March 8, 2021, a former officer of the Company
resigned. Both parties alleged certain claims against the other, including with respect to certain compensation claims. Neither party
has filed litigation. The Company intends to vigorously defend itself against any possible claims and assert any relevant claims against
the former executive and believes it will prevail. As a result of the evidence disclosed and discovered during the aforementioned SEC
investigation, the Company has concluded that the actions of the former President and Acting CFO of the Company may be viewed as potentially
dishonest and fraudulent. As a result, the Board of Directors of the Company have resolved and taken action in February 2024 to cause
the forfeiture of equity and deferred compensation owed/outstanding by said officer and forwarded a formal demand letter to said officer
and his wife, the former Controller of the Company.
In July 2021, a former consultant of the Company
filed a small claims case for approximately $16,000 in Harris County, TX, and the Company filed its response in August 2021. The
Company received a civil notice of trial setting for September 7, 2023. On September 7, 2023, the Company and the former consultant entered
into a settlement agreement, whereby the Company paid $9,000 as full settlement of this claim. Accordingly, the Company recorded a gain
on debt extinguishment of $9,250. As of December 31, 2023 and 2022, the Company had accrued compensation of $0 and $18,250 to this
former employee, which was included in accrued compensation on the accompanying consolidated balance sheets.
Employment Agreements
On October 18, 2017, the Company entered into
an employment agreement with Mr. Scott Silverman, pursuant to which he serves as the Chief Executive Officer of the Company for an initial
term of three years that extends for successive one-year renewal terms unless either party gives 30-days’ advance notice of non-renewal.
As consideration for these services, the employment agreement provides Mr. Silverman with the following compensation and benefits:
●
An annual base salary of $300,000, with a 10% increase on each anniversary date contingent upon achieving certain performance objectives as set by the Board. Until the Company raises $1,000,000 in debt or equity financing after entering into this agreement, Mr. Silverman will receive ½ of the base salary on a monthly basis with the other ½ being deferred. Upon the financing being raised, Mr. Silverman will receive the deferred portion of his compensation and his base salary will be paid in full moving forward.
●
After the first $500,000 of equity investments is raised by the Company, after entering into this employment agreement, Mr. Silverman will receive a capital raise success bonus of 5% of all equity capital raised from investors/lenders introduced by him to the Company.
●
Annual cash performance bonus opportunity as determined by the Board.
●
An option to acquire 3,000,000 common shares of the Company, with a strike price of $0.31 per unit. These options vested pro rata on a monthly basis for the term of the employment agreement. On each anniversary, Mr. Silverman will be eligible to be granted a minimum of 500,000 stock options of the Company at a strike price of $0.85 per common unit contingent upon the achievement of certain performance objectives.
●
Certain other employee benefits and perquisites, including reimbursement of necessary and reasonable travel and participation in retirement and welfare benefits.
The receipt of $1,240,000 in connection with
the April 25, 2018 financing triggered the right of the employee to receive the deferred salary and the 5% bonus provision disclosed above.
Mr. Silverman’s employment agreement provides
that, in the event that his employment is terminated by the Company without “cause” (as defined in his employment agreement),
or if Mr. Silverman resigned for “good reasons” (as defined in his new employment agreement), subject to a complete release
of claims, he will be entitled to (i) retain all stock options previously granted; and (ii) receive any benefits then owed or accrued
along with one year of base salary and any unreimbursed expenses incurred by him. All amounts shall be paid on the termination date. In
the event that Mr. Silverman’s employment is terminated by the Company for “cause” (as defined in his employment agreement),
or if Mr. Silverman resigned without “good reasons” (as defined in his employment agreement), subject to a complete release
of claims, he will be entitled to receive any unpaid base salary and benefits then owed or accrued and any unreimbursed expenses incurred
by him. Additionally, if a change of control (as defined in his employment agreement) occurs during the term of this agreement, all unvested
stock options will vest in full and if the valuation of the Company in the change of control transaction is greater than $0.85 per common
share, then Mr. Silverman shall be paid a bonus equal to two times his minimum base salary and minimum target bonus. Pursuant to the employment
agreement, Mr. Silverman will be subject to a confidentiality covenant, a two-year post-termination non-competition covenant and a two-year
post-termination non-solicitation covenant. On June 30, 2020, the Company amended the employment agreement of Mr. Silverman to provide
for successive one-year extensions until either the executive or the Board of Directors of the Company gives notice to terminate the employment
agreement per its terms. This employment agreement amendment also includes an allowance of up to $10,000 per year to cover uncovered medical/dental
expenses for Mr. Silverman and his family.
On July 21, 2021, the Company entered into the
Employment Agreement with Mr. Wanke, the President of Patriot Glass, to serve as the President of C-Bond’s Safety Solutions Group.
Under the three-year Employment Agreement, Mr. Wanke will receive a base salary of $240,000 per year, which may be increased from time
to time with the approval of the board of directors. In addition, Mr. Wanke may receive an annual bonus as determined by the board of
directors. It is understood that although Mr. Wanke’s base salary will be paid by Patriot Glass, 50% of the base salary will be
allocated to the expenses of Patriot Glass, and the other 50% of the base salary will be allocated to the expenses of the Company. The
term of this Agreement (the “Initial Term”) shall begin as of July 21, 2021 (the “Effective Date”) and shall end
on the earlier of (i) the third anniversary of the Effective Date and (ii) the time of the termination of the Executive’s employment
in accordance with the Employment Agreement. This Initial Term and any Renewal Term (as defined below) shall automatically be extended
for one or more additional terms of one (1) year each (each a “Renewal Term” and together with the Initial Term, the “Term”),
unless either the Company or Executive provide notice to the other Party of their desire to not so renew the Initial Term or Renewal Term
(as applicable) at least thirty (30) days prior to the expiration of the then-current Initial Term or Renewal Term, as applicable. All
unvested shares of stock and stock options shall expire upon such termination, if any. The Executive shall be eligible for an annual bonus
payment in an amount to be determined by the Board of Directors of the Company (the “Bonus”). The Bonus shall be determined
and payable based on the achievement of certain performance objectives of the Company as established by the Board and communicated to
and agreed to by the Executive in writing as soon as practicable after commencement of the year in respect of which the Bonus is paid.
The Bonus, if earned, is payable in cash and/or restricted stock at the discretion of the Board. It is understood between the Parties
that the target bonus for each year shall be up to 50% of the Base Salary.
On December 7, 2022, the Company’s board
of directors approved a bonus to certain officers in the aggregate amount of $160,000. This bonus was paid 10% in cash of $16,000, which
was paid in December 2022, and 90% in equity amounting to $144,000 which as of December 31, 2022 had been accrued and as of December 31,
2022, was included in accrued compensation on the accompanying consolidated balance sheet. On January 17, 2023, the Board of Directors
of the Company agreed to satisfy $144,000 of the bonus owed to its executive officers (collectively, the “Management”). Management
agreed to accept 144 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation (See
Note 9).
On December 7, 2023, the Company’s board
of directors approved a bonus to two officers in the aggregate amount of $480,000. For the bonus approved for Mr. Silverman, which amounted
to $300,000, this bonus was paid 50%, or $150,000, in cash, which was paid in December 2023, and 50% in equity amounting to $150,000 which
as of December 31, 2023 has been accrued and as of December 31, 2023, is included in accrued compensation on the accompanying consolidated
balance sheet. For the bonus approved for Ms. Tomek, which amounted to $180,000, this bonus is to be paid 10% in cash of $18,000 and 90%
in equity amounting to $162,000, which as of December 31, 2023 has been accrued and as of December 31, 2023, is included in accrued compensation
on the accompanying consolidated balance sheet. On January 2, 2024, the Board of Directors of the Company agreed to satisfy the aggregate
of $312,000 of the bonus owed to these executive officers (collectively, the “Management”). Management agreed to accept an
aggregate of 312 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation (See Note
18).
Anti-dilution rights related to C-Bond Systems,
LLC
Prior to the Merger, C-Bond Systems, LLC entered
into certain contracts, described below, which provided certain anti-dilution protection to the counterparties to those contracts.
The Company believes that these contracts do not apply to any future issuances of equity by C-Bond Systems, Inc.
In 2013, pursuant to a subscription agreement,
the Company’s subsidiary. C-Bond Systems, LLC issued 2,425,300 common shares. To the extent that during the term of the agreement
C-Bond Systems, LLC issues any “down-round” or subsequent investments based upon an enterprise value of less than $2,000,000
(“Dilutive Transaction”) (other than an issuance pursuant to an option agreement with an employee or otherwise to compensate
an employee, or incident to an acquisition of assets by C-Bond Systems, LLC in which common units were issued to the seller of such assets)
contemporaneously with the Dilutive Transaction, the contract obligated C-Bond Systems, LLC to issue the investor additional common units
in C-Bond Systems, LLC in an amount which would provide them with the ownership percentage interest which they would have held in C-Bond
Systems, LLC represented by the common units purchased by them on this date.
In 2015, pursuant to a subscription agreement,
C-Bond Systems, LLC issued 3,880,480 common shares to an entity at $0.77 per common share. This agreement entitled the subscriber to anti-dilution
protection to the extent that C-Bond Systems, LLC issued any equity in a “down-round” based upon a value of less than $0.77
per common unit of C-Bond Systems, LLC (other than an issuance pursuant to an option agreement with an employee or consultant or otherwise
to compensate an employee or consultant, or incident to an acquisition of assets by C-Bond Systems, LLC in which common units are issued
to the seller of such assets (“Dilutive Transaction”)). Contemporaneously with the Dilutive Transaction, the contract obligated
C-Bond Systems, LLC to issue the Subscriber additional common units in C-Bond Systems, LLC in an amount which would provide the investor
with the ownership percentage interest in C-Bond Systems, LLC on a fully diluted basis which Subscriber held immediately prior to the
Dilutive Transaction.
In 2016, pursuant to a subscription agreement,
C-Bond Systems, LLC issued 1,175,902 common shares to an entity at $0.85 per common share. This agreement entitled this investor to customary
broad-based weighted average anti-dilution protection to the extent that after the date of this subscription agreement C-Bond Systems,
LLC issued any equity in a “down round” based upon a value of less than $0.85 per common share, including the issuance of
options with an exercise price per share of less than $0.85 to compensate employees or consultants (“Dilutive Transaction”),
subject to exclusions for issuances of common shares or options in connection with strategic partnerships, equity kickers to lenders
or vendors, mergers or acquisitions. The agreement obligated C-Bond Systems, LLC to give to this investor written notice (an “Issuance
Notice”) of any proposed issuance by C-Bond Systems, LLC of any C-Bond Systems, LLC common units, or other form of equity interest
(excluding issuances of C-Bond Systems, LLC options or other equity to compensate employees or consultants and the issuance of shares
in connection with strategic partnerships, equity kickers to lenders or vendors, mergers or acquisitions) at least ten business days
prior to the proposed issuance date. This contract entitled the investor to purchase their pro rata portion of such shares or other equity
interest of C-Bond Systems, LLC at the price and on the other terms and conditions specified in the issuance notice.
Option to purchase 20% of Patriot Glass
In connection with the Exchange Agreement with
Patriot Glass and the Patriot Glass Shareholder (See Note 1), the Company had the option to acquire the remaining 20% of Patriot Glass’s
issued and outstanding membership interests in exchange for a number of shares of the Company’s common stock equal to 300% of Patriot
Glass’s average EBIT value, divided by the price of the Company’s common stock as defined in the Exchange Agreement. On September
20, 2023, the Company and the Patriot Glass Shareholder entered into an amendment to the Exchange Agreement (the “Amended Exchange
Agreement”). Pursuant to the Amended Exchange Agreement, the Company shall have the option (the “Option”), beginning
on July 1, 2025 (the “Option Start Date”) and ending on 5:00 P.M. EST on the date that is thirty calendar days after the Option
Start Date (the “Option Period”), to acquire the remaining 20% of Patriot Glass Units (the “Additional Units”),
representing 20% of Patriot Glass’s issued and outstanding membership interests, collectively (the “Additional Closing”).
If the Company exercises the Option, the Company
shall acquire the Additional Units in exchange for (i) a number of shares of Company Common Stock equal to (a) the Share Value (as defined
below) divided by (b) the Additional Closing Share Price (as defined below) (the “Additional Closing Exchange Shares”), and
(ii) a cash payment equal to the Net Income (as below). “Total EBIT Value” shall mean the sum of (i) Patriot Glass’s
net income, before income tax expense and interest expense have been deducted, for the period beginning on July 1, 2023 and ending on
June 30, 2025 plus (ii) $240,000. “EBIT Value” shall mean the Total EBIT Value divided by two (2). “Share Value”
shall mean (i) 300% of the EBIT Value (the “Triple EBIT Value”), minus (ii) the Net Income. “Net Income” shall
mean Patriot Glass’s net income, after income tax expense and interest expense have been deducted, for the period beginning on July
1, 2023 and ending on June 30, 2025. Any salary paid by Patriot Glass, including but not limited to any salary paid to the Patriot Glass
Shareholder, shall not be included in Net Income. If the Company Common Stock is quoted or listed for trading on a Trading Market on July
1, 2025, then “Additional Closing Share Price” shall mean the average of all of the closing prices of Company Common Stock
on such Trading Market during the calendar month of June 2024.
M&A advisory agreement
On October 18, 2023, the Company and Maxim Group
LLC (“Maxim”) entered into an engagement letter, whereby Maxim was engaged as the Company’s exclusive financial advisor
to perform merger and acquisition advisory services. Either Maxim or the Company may terminate this Agreement at any time upon thirty
(30) days’ prior written notice to the other party after the six (6) month anniversary of this Agreement. The Company paid Maxim
a one-time non-refundable cash fee of $25,000 due promptly upon execution of the Agreement (the “Retainer”). The Retainer
shall be creditable against the Success Fee. If during the term of this Agreement a Transaction is consummated or the Company enters into
an agreement regarding a Transaction (which is consummated subsequent to the completion of the Term), a fee (the “Success Fee”)
will be payable in U.S. dollars upon the closing of the Transaction to Maxim equal to six and a half percent (6.5%) of the Consideration
(as defined hereinafter), provided however, that if a Transaction is consummated or the company enters into an agreement regarding
a Transaction with Curtis Stout Inc., such Success Fee shall be reduced to four percent (4.0%) of Consideration from Curtis Stout Inc.
In the event that the Company enters into an agreement with respect to a Transaction during the term of this Agreement that is subsequently
terminated, and the Company becomes entitled to a break-up, termination, topping, expense reimbursement or similar fee or payment (including
any judgment for damages or amount in settlement of any dispute as a result of such termination, or any profit on any stock acquired from,
or stock option granted by, any party to such transaction), a fee (the “Break-up Fee”) equal to 10.0% of all such amounts,
payable promptly upon receipt of such amounts by the Company. Upon the closing of a Transaction, for a period of twelve (12) months from
such closing, the Company grants Maxim the right of first refusal to act as sole managing underwriter and sole book runner, sole placement
agent, or sole sales agent, for any and all future public or private equity, equity-linked or debt (excluding commercial bank debt) offerings
for which the Company retains the service of an underwriter, agent, advisor, finder or other person or entity in connection with such
offering period of the Company, or any successor to or any subsidiary of the Company. The Company shall not offer to retain any entity
or person in connection with any such offering on terms more favorable than terms on which it offers to retain Maxim. Such offer shall
be made in writing in order to be effective. Maxim shall notify the Company within ten (10) business days of its receipt of the written
offer contemplated above as to whether or not it agrees to accept such retention. If Maxim should decline such retention, the Company
shall have no further obligations to Maxim with respect to the offering for which it has offered to retain Maxim, except as otherwise
provided for herein. As of the date of this report, no funds have been raised.
Financial instruments that potentially subject
the Company to concentrations of credit risk consist primarily of trade accounts receivable and cash deposits. The Company places its
cash in banks at levels that, at times, may exceed federally insured limits. On December 31, 2023, the Company had cash in bank in excess
of FDIC insured levels of $322,007. To reduce its risk associated with the failure of such financial institution, the Company evaluates
at least annually the rating of the financial institution in which it holds deposits. Any material loss that the Company may experience
in the future could have an adverse effect on its ability to pay its operational expenses or make other payments and may require the Company
to move its cash to other high quality financial institutions. The Company reviews its bank relationships in order to mitigate
its risk to ensure that its exposure is limited or reduced to the FDIC protection limits. The Company has not experienced any losses in
such accounts through December 31, 2023.
Geographic Concentrations of Sales
During the years ended December 31, 2023 and 2022,
all sales were in the United States.
Customer Concentrations
For the year ended December 31, 2023, one customer
accounted for approximately 10.8% of total sales. For the year ended December 31, 2022, no customer accounted for over 10% of total sales.
On December 31, 2023, two customers accounted for 41.8% (29.5% and 12.3%, respectively) of the total accounts receivable balance. On
December 31, 2022, three customers accounted for 41.1% (10.3%, 19.3% and 11.5%, respectively) of the total accounts receivable balance.
Vendor concentrations
Generally, the Company purchases substantially
all of its inventory from four suppliers. The loss of these suppliers may have a material adverse effect on the Company’s consolidated
results of operations and financial condition. However, the Company believes that, if necessary, alternate vendors could supply similar
products in adequate quantities to avoid material disruptions to operations.
The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.
Through May 8, 2023, the date that the Company
entered into an Asset Purchase Agreement with Apex Protect GPS, LLC agreed to sell its C-Bond nanoShield™ product line (See Note
16), the Company operated in two reportable business segments - (1) the manufacture and sale of a windshield strengthening water repellent
solution as well as a disinfection product, and the sale of multi-purpose glass strengthening primer and window film mounting solutions,
including ballistic-resistant film systems and a forced entry system (the “C-Bond Segment”), and (2) the distribution and
installation of window film solutions (the “Patriot Glass Segment”). The Company’s reportable segments were strategic
business units that offered different products. They were managed separately based on the fundamental differences in their operations
and locations. Upon the sale of the C-Bond nanoShield™ business, the legacy C-Bond business is being conducted through Patriot Glass
in order to combine administrative functions and they are now being managed together.
Information with respect to these reportable business
segments for the years ended December 31, 2023 and 2022 was as follows:
For the Year Ended December 31,
2023
2022
Revenues:
C-Bond
$
124,372
$
378,736
Patriot Glass
2,364,121
1,853,910
2,488,493
2,232,646
Depreciation and amortization:
C-Bond
570
7,109
Patriot Glass
88,289
82,110
88,859
89,219
Interest expense:
C-Bond
357
23
Patriot Glass
34,566
20,212
Other (a)
440,507
1,599,854
475,430
1,620,089
Net income (loss):
C-Bond
(912,436
)
(1,097,069
)
Patriot Glass
(44,289
)
(192,566
)
Other (a)
2,843,532
(3,866,843
)
$
1,886,807
$
(5,156,478
)
December 31, 2023
December 31, 2022
Identifiable long-lived tangible assets on December 31, 2023 and 2022 by segment:
C-Bond
$
-
$
1,684
Patriot Glass
171,606
94,622
$
171,606
$
96,306
(a)
The Company does not allocate any general and administrative or financing expenses of its holding company activities to its reportable segments, because these activities are managed at the corporate level.
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
Prior to the sale of the Company’s C-Bond
segment in May 2023, the revenue that the Company recognized arose from purchase requests the Company received from its customers. The
Company’s performance obligations under purchase orders or by a verbal order correspond to each shipment of product that the Company
makes to its customer under the purchase order or verbal order. As a result, each purchase order or verbal order generally contains more
than one performance obligation based on the number of products ordered, the quantity of product to be shipped and the mode of shipment
requested by the customer. Control of the Company’s products transfers to its customers when the customer is able to direct the
use of, and obtain substantially all of the benefits from, the Company’s products, which generally occurs at the later of when the
customer obtains title to the product or when the customer assumes risk of loss of the product. The transfer of control generally occurs
at the time of shipment from the Company’s warehouse. Once this occurs, the Company has satisfied its performance obligation and
the Company recognizes revenue. In connection with the Company’s C-Bond segment, when the Company receives a purchase order
or verbal order from a customer, the Company is obligated to provide the product during a mutually agreed upon time period. Depending
on the terms of the purchase order or verbal order, either the Company or the customer arranges delivery of the product to the customer’s
intended destination. In situations where the Company has agreed to arrange delivery of the product to the customer’s intended destination
and control of the product transfers upon loading of the Company’s product onto transportation equipment, the Company has elected
to account for any freight income associated with the delivery of these products as freight revenue, since this activity fulfills the
Company’s obligation to transfer the product to the customer.
In connection with the Company’s Patriot
Glass segment, the revenue that the Company recognizes arises from purchase requests the Company receives from its customers. The Company’s
performance obligations under purchase order or a signed proposal correspond to each job for the distribution and installation of window
film solutions. As a result, each purchase order or signed proposal generally may contain more than one performance obligation based on
the specific job. Control of the Company’s products transfers to its customers when the customer is able to direct the use of, and
obtain substantially all of the benefits from, the Company’s products, which generally occurs when the job or a specific portion
of the job is completed. Once this occurs, the Company has satisfied its performance obligation and the Company recognizes revenue.
Revenues from contracts for the distribution and installation of window film solutions are recognized over time on the basis of the Company’s
estimates of the progress towards completion of contracts using various output of input methods including (1) the ratio of number of labor
hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed
method. These methods are used because management considers these methods to be the best available measure of progress on these contracts.
Transaction Price
The Company agrees with its customers on the selling
price of each transaction. This transaction price is generally based on the product, market conditions, including supply and demand balances,
labor costs, and freight. In the Company’s C-Bond contracts with customers, the Company allocates the entire transaction price to
the sale of product to the customer, which is the basis for the determination of the relative standalone selling price allocated to each
performance obligation. Returns of the Company’s product by its customers are permitted only when the product is not to specification
and were not material for the years ended December 31, 2023 and 2022. Any sales tax, value added tax, and other tax the Company collects
concurrently with its revenue-producing activities are excluded from revenue.
Revenue Disaggregation
The Company tracks its revenue by product. The
following table summarizes our revenue by product for the years ended December 31, 2023 and 2022:
For the Years Ended December 31,
2023
2022
C-Bond Secure multi-purpose and BRS ballistic resistant glass protection systems
$
9,709
$
17,311
C-Bond Nanoshield solution sales
112,413
345,470
Disinfection products
-
10,880
Window tint installation and sales recognized over time
The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.
In October 2019, the Company entered into an 18-month
lease agreement for the lease of office and warehouse space under a non-cancelable operating lease through May 31, 2021. From the lease
commencement date of December 1, 2019 until November 30, 2020, monthly rent shall be $4,444 and from December 1, 2020 to May 31, 2021,
monthly rent shall be $4,577 per month. On May 12, 2021 and effective June 1, 2021, the Company entered into an amendment to the lease
which extended the lease for one year until May 31, 2022 at a monthly base rent of $5,283. On May 4, 2022 and effective June 1, 2022,
the Company entered into an amendment to the lease which extended the lease for three years until May 31, 2025. On June 15, 2023, in connection
with the sale of the Company’s nanoShield product line, the purchaser assumed the operating lease and the Company vacated the premises.
In connection with the 2021 Exchange Agreement
between in the Company and Patriot Glass, the Company was named as guarantor (“Guarantor”) of a Commercial Lease Agreement
dated July 21, 2021, by and between landlord MDW Management, LLC, a company owned by Mr. Wanke and his wife and tenant Patriot Glass d/b/a
A-1 Glass (the “Lease”). The term of the Lease is 60 months, at a minimum monthly rent of $5,600 (not including tax), with
two five-year options for the tenant to renew. The Company’s obligation as Guarantor of the Lease will terminate upon the occurrence
of earlier of the following: (i) the date of Guarantor’s acquisition of 100% of the ownership interests of Patriot Glass; (ii) the
date that Guarantor beneficially owns less than an eighty percent (80%) ownership interest in Patriot Glass; or (iii) two (2) years from
and after the effective date of the guaranty. During the year ended December 31, 2023, the Company’s obligation as Guarantor expired.
In September 2021, the Company entered into a
48-month lease agreement for the lease of office equipment under a non-cancelable operating lease through September 2025. The monthly
base rent is $365 per month. This lease has been assumed by CB NANOSHIELD LLC as part of its purchase of the nanoShield Assets (see Note
16).
In February 2022, the Company entered into a 36-month
lease agreement for the lease of a vehicle under a non-cancelable operating lease through January 2025. The monthly base rent is $788
per month.
In adopting ASC Topic 842, Leases (Topic 842)
on January 1, 2019, the Company had elected the ‘package of practical expedients’, which permitted it not to reassess under
the new standard its prior conclusions about lease identification, lease classification and initial direct costs (see Note 2). In addition,
the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 months or less. Upon signing of new leases for property
and equipment, the Company analyzed the new leases and determined it is required to record a lease liability and a right of use asset
on its consolidated balance sheets, at fair value.
During the years ended December 31, 2023 and 2022,
in connection with its property operating leases, the Company recorded rent expense of $101,501 and $167,875 respectively, which is expensed
during the year and included in general and administrative expenses on the accompanying consolidated statements of operations.
The significant assumption used to determine the
present value of the lease liabilities in February 2022 was a discount rate of 6.79% which was based on the Company’s estimated
incremental borrowing rate.
On December 31, 2023 and 2022, right-of-use asset
(“ROU”) is summarized as follows:
December 31, 2023
December 31, 2022
Office leases and office equipment right of use assets
$
279,162
$
480,293
Less: accumulated amortization
(120,678
)
(104,881
)
Balance of ROU assets
$
158,484
$
375,412
On December 31, 2023 and 2022, operating lease
liabilities related to the ROU assets are summarized as follows:
December 31,
2023
December 31, 2022
Lease liabilities related to office leases right of use assets
$
157,752
$
376,566
Less: current portion of lease liabilities
(60,503
)
(117,671
)
Lease liabilities – long-term
$
97,249
$
258,895
On December 31, 2023, future minimum base lease
payments due under non-cancelable operating leases are as follows:
Twelve months ended December 31,
Amount
2024
$
75,866
2025
67,988
2026
39,200
Total minimum non-cancelable operating lease payments
The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.
On May 2, 2022, the Company entered into a Promissory
Note (the “May 2022 Note”) in the principal amount of $250,000 with the Company’s chief executive officer. The May 2022
Note was funded in May 2022 and the Company received net proceeds of $250,000. The May 2022 Note bears interest at a rate of 6% per annum
and all outstanding principal and accrued and unpaid interest is due on May 2, 2024. At any time, the Company may prepay all or any portion
of the principal amount of the May 2022 Note and any accrued and unpaid interest without penalty. For the year ended December 31, 2023,
interest expense – related party amounted to $5,663. In May 2023, the Company repaid $200,000 of the May 2022 Note. In August 2023,
the Company repaid the remaining $50,000 of the May 2022 Note and repaid accrued interest of $15,690. On December 31, 2023, the principal
amount due and accrued interest payable - related party amounted to $0. On December 31, 2022, the principal amount due and accrued interest
payable - related party amounted to $250,000 and $10,027, respectively.
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
On May 8, 2023, the Company entered into an Asset
Purchase Agreement (the “APA”) with Apex Protect GPS, LLC (the “Buyer”), a Texas limited liability company, whereby
the Company agreed to sell its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process,
furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShield division (the “Assets”)
to the Buyer for a purchase price of $4,000,000 in cash (the “Transaction”). The Transaction closed on May 8, 2023. Following
the Closing, the parties entered into an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among
the Company; Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned
all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the
foregoing to Assignee.
The Assets were sold and transferred to buyer
by means of (i) with respect to the physical assets, a Bill of Sale; and (ii) with respect to intangible assets or intellectual property,
a Patent and Trademark Assignment Agreement, a Patent and Know-How License Agreement, and a Patent License-Back Agreement.
The APA contains customary representations, warranties,
and covenants by each party including, among other things, that no bankruptcy or similar insolvency proceeding under state or federal
law has been filed, or is currently being contemplated, with respect to the Company; that the Company has provided the Seller a true and
accurate list of each of the following items of Intellectual Property which comprises a part of the Assets, including, among other things,
patents and trademarks (the “Sold Intellectual Property”); and that the Company has good, valid, and legal title to, and is
the sole and exclusive owner of all rights, title and interest in and to, the Sold Intellectual Property, free and clear of all liens.
Under the terms of the APA, the Parties entered
into a Patent and Trademark Assignment Agreement, whereby the Company conveyed, transferred, and assigned to Buyer, among other assets,
the C-Bond nanoShield trademark (the “Trademark”) and U.S. Patent No. 11,155,491 B2 (the “C-Bond nanoShield Patent”),
and the Company agreed to execute and deliver an assignment of the Trademark and C-Bond nanoShield Patent, for recording with governmental
authorities including, but not limited to, the U.S. Patent and Trademark Office.
The Parties also entered into a Patent and Know-How
License Agreement whereby the Company granted to the Buyer a non-transferable, non-sub-licensable, exclusive right and license to four
patents owned by the Company and licensed know-how to make, have made, use, offer to sell, sell and import glass and other products and
components used in or in relation to the manufacture and operation of civilian, agricultural or military vehicles and equipment (the “Licensed
Product”) in the United States and its legal territories.
Lastly, the Parties entered into a Patent License-Back
Agreement whereby the Buyer agreed to grant to the Company a perpetual, non-exclusive, worldwide, royalty-free, non-transferable, non-sublicensable
license to the C-Bond nanoShield Patent, for all uses and applications except for any that involve, market to, sell to, do business with,
provide related goods or services to, or are consumed by any uses and applications of the patented technology within the civilian or military
automotive, vehicle and/or transportation industry. The Patent License-Back Agreement also stipulates that all improvements made by either
Party to the technology covered by the C-Bond nanoShield Patent shall be owned by the Buyer. In the event that the Company desires to
utilize such improvements to the C-Bond nanoShield Patent made by either Party, the Parties hereby agree that they will negotiate in good
faith a separate license agreement having pricing and other terms and conditions that are mutually acceptable to both Parties.
Following the Closing, the Parties completed a
transaction wherein the Company assigned to Buyer, and Buyer took assignment from the Company, the lease for the premises located at 6035
South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to a lease assignment and assumption agreement as agreed to by
the Parties and the lessor pursuant to the Lease.
In connection with the APA, the Company received
net proceeds of $1,989,755, after the repayment and settlement of notes payable and convertible notes payable as follows:
1)
The Company repaid and settled the BOCO Investments, LLC Note (See Note 8) with a principal balance of $400,000 and accrued interest payable of $317,293 for a cash payment of $200,000 and the issuance of 22,000,000 shares of the Company’s common stock (See Note 8 and 9).
2)
The Company repaid GS Capital Partners, LLC $419,260 for notes dated June 23, 2022, July 26, 2022, and September 6, 2022 (collectively, the “GS Notes”), and GS Capital Partners, LLC deemed the GS Notes paid in full (See Note 8).
3)
The Company repaid Mercer Street Global Opportunity Fund, LLC (“Mercer”) $271,825 for notes dated March 14, 2022 and November 22, 2022 (collectively, the “Secured Mercer Notes”) (See Note 7).
4)
The Company repaid Jeff Badders $875,000 for notes dated May 5, 2021, November 8, 2022, and April 4, 2023 (See Note 8).
5)
The Company repaid 1800 Diagonal Lending, LLC $288,035 for notes dated November 4, 2022, December 27, 2022, and March 17, 2023 (collectively, the “1800 Diagonal Notes”), and 1800 Diagonal Lending, LLC deemed the 1800 Diagonal Notes paid in full (See Note 7).
6)
The Company repaid its CEO $250,000 for the note dated May 2, 2022, and the CEO deemed the note paid in full.
In accordance with ASC 205-20, the sale of the
C-Bond nanoShield product line was not reported in discontinued operations since the disposal did not represent a strategic shift that
has (or will have) a major effect on the Company’s operations and financial results. The C-Bond nanoShield product line was only
a component of the C-Bond segment which comprised of operations and cash flows that were not clearly distinguished, operationally and
for financial reporting purposes, from the rest of the C-Bond segment.
In connection with the sale of the C-Bond nanoShield
product line, the Company recorded a gain from the sale of the product line of $4,051,709.
The Company accounts for income tax using the
liability method prescribed by ASC 740, “Income Taxes”. Under this method, deferred tax assets and liabilities are determined
based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in
effect in the year in which the differences are expected to reverse. The deferred tax assets on December 31, 2023 and 2022 consist only
of net operating loss carryforwards. The net deferred tax asset has been fully offset by a valuation allowance because of the uncertainty
of the attainment of future taxable income.
The items accounting for the difference between income taxes at the
effective statutory rate and the provision for income taxes for the years ended December 31, 2023 and 2022 were as follows:
2023
2022
Income tax expense (benefit) at U.S. statutory rate
$
396,229
$
(1,081,240
)
Non-deductible expenses
(64,617
)
506,677
Change in valuation allowance
(331,612
)
574,563
Total provision for income tax
$
-
$
-
The Company’s approximate net deferred tax asset as of December
31, 2023 and 2022 was as follows:
Deferred Tax Asset:
December 31, 2023
December 31, 2022
Net operating loss carryforward
$
2,176,983
$
2,512,665
Allowance for bad debt
4,070
-
Total deferred tax asset before valuation allowance
2,181,053
2,512,665
Valuation allowance
(2,181,053
)
(2,512,665
)
Net deferred tax asset
$
-
$
-
The net operating loss carryforward was approximately
$10,386,000 on December 31, 2023. The Company provided a valuation allowance equal to the net deferred income tax asset as of December
31, 2023 and 2022 because it was not known whether future taxable income will be sufficient to utilize the loss carryforward. During the
year ended December 31, 2023, the valuation allowance decreased by $331,612. Additionally, the future utilization of the net operating
loss carryforward to offset future taxable income is subject to an annual limitation as a result of ownership changes that may occur in
the future. The potential tax benefit arising from the loss carryforward may be carried forward indefinitely subject to usage limitations.
The Company does not have any uncertain tax positions or events
leading to uncertainty in a tax position. The Company’s 2023, 2022 and 2021 Corporate Income Tax Returns are subject to
Internal Revenue Service examination.
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
Issuance of Series B preferred stock for accrued
compensation and compensation
On January 2, 2024, the Board of Directors of
the Company agreed to satisfy $312,000 of accrued compensation owed to its executive officers (collectively, the “Management”)
as of December 31, 2023, which was included in accrued compensation on the accompanying consolidated balance sheet. Management agreed
to accept 312 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation.
On January 2, 2024, the Board of Directors of
the Company agreed to issue 50 shares of the Company’s Series B convertible preferred stock to a director for services rendered.
Common Stock Issued for Conversion of Series
C Preferred Stock
On February 1, 2024, the Company issued 5,772,973
shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
On March 1, 2024, the Company issued 5,781,562
shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated redemption value of $20,000. The conversion
price was based on contractual terms of the related Series C preferred shares.
Promissory Note
On March 1, 2024, the Company executed a Promissory
Note (“Note”) in favor of 1800 Diagonal Lending LLC (the “Investor”) in the aggregate principal amount of $157,000
(the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default,
as discussed below, is the Note convertible into shares of the Company’s common stock. The Note was funded on March 4, 2024, in
the amount of $125,000, which is net of an original issue discount of $13,000 and a one-time interest charge of approximately $19,000.
A one-time interest charge of twelve percent (12%) (the “Interest Rate”) was applied on the issuance date to the Principal.
Under the terms of the Note, the Company is required to make monthly payments as outlined in the Note, beginning on August 30, 2024 and
the Note matures on December 30, 2024. Any amount of principal or interest on this Note which is not paid when due shall bear interest
at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”).
Monthly payment shall be as follows:
Payment Date
August 30, 2024
$
87,920
September 30, 2024
$
21,980
October 30, 2024
$
21,980
November 30, 2024
$
21,980
December 30, 2024
$
21,980
Total
$
175,840
Among other things, an event of default (“Event
of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether at maturity, upon acceleration
or otherwise. Upon the occurrence of any Event of Default, the Note shall become immediately due and payable and the Company shall pay
to the Investor, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of the then outstanding principal
amount of this Note plus accrued and unpaid interest on the unpaid principal amount of this Note to the date of payment plus Default Interest,
if any. At any time following an Event of Default, the Holder shall have the right to convert all or any part of the outstanding and unpaid
amount of this Note into fully paid and non-assessable shares of the Company’s Common Stock. The conversion price (the “Conversion
Price”) shall be the greater of $0.0025 per share (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing
bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion
Price”). At no time may the Note be converted into shares of our common stock if such conversion would result in the Investor and
its affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of our common stock.
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
Basis of Presentation and Principles of Consolidation
The Company’s consolidated financial statements
include the financial statements of its wholly owned subsidiary, C-Bond Systems, LLC, and its 80% owned subsidiary, Patriot Glass. All
significant intercompany accounts and transactions have been eliminated in consolidation.
These consolidated financial statements have been
prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the
normal course of business. As reflected in the accompanying consolidated financial statements, the Company had net income of $1,886,807
for the year ended December 31, 2023, which included a gain from the sale of the Company’s nanoShield product line of $4,051,709. Net
cash used in operations was $1,602,218 for the year ended December 31, 2023. Additionally, as of December 31, 2023, the Company had
an accumulated deficit, shareholders’ deficit, and working capital deficit of $60,851,714, $4,324,535 and $1,351,954, respectively.
On May 8, 2023, the Company sold its nanoShield product line and received proceeds of $4,042,631. The proceeds were used to repay
convertible notes payable, notes payable and related accrued interest. On December 31, 2023, the Company had cash of $736,461. These factors
raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance
date of this report. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash
flow positive or raise additional debt and/or equity capital. The Company is seeking to raise capital through additional debt and/or equity
financings to fund its operations in the future. Although the Company has historically raised capital from sales of common shares and
preferred shares, and from the issuance of promissory notes and convertible promissory notes, there is no assurance that it will be able
to continue to do so. If the Company is unable to raise additional capital or secure additional lending in the near future, management
expects that the Company will need to curtail its operations. These consolidated financial statements do not include any adjustments related
to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the
Company be unable to continue as a going concern.
The preparation of consolidated financial statements
in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those
estimates. Estimates during the years ended December 31, 2023 and 2022 include estimates for allowance for doubtful accounts on accounts
receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted
jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair
value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value
of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash
equity transactions.
Fair Value of Financial Instruments and Fair Value Measurements
The carrying amounts reported in the consolidated
balance sheets for cash, accounts receivable, contract assets and liabilities, notes payable, convertible note payable, accounts payable,
accrued expenses, accrued compensation, and lease liabilities approximate their fair market value based on the short-term maturity of
these instruments.
The Company analyzes all financial instruments
with features of both liabilities and equity under the Financial Accounting Standard Board’s (the “FASB”) accounting
standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest
level of input that is significant to the fair value measurement. The Company did not identify any assets or liabilities that are required
to be presented on the balance sheet at fair value in accordance with Accounting Standards Codification (“ASC”) Topic 820.
ASC 825-10 “Financial Instruments”,
allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair
value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value
option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent
reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.
For purposes of the consolidated statements of
cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money
market accounts to be cash equivalents. The Company had no cash equivalents as of December 31, 2023 and 2022.
The Company recognizes an allowance for losses
on accounts receivable and notes receivable in an amount equal to the estimated probable losses net of recoveries under the current expected
credit loss method. The allowance is based on an analysis of historical bad debt experience, current receivables aging and expected future
write-offs, as well as an assessment of specific identifiable customer accounts and notes receivable considered at risk or uncollectible.
On January 1, 2023, the Company adopted ASC 326, “Financial Instruments - Credit Losses”. In accordance with ASC 326, an allowance
is maintained for estimated forward-looking losses resulting from the possible inability of customers to make required payments (current
expected losses). The amount of the allowance is determined principally on the basis of past collection experience and known financial
factors regarding specific customers. The expense associated with the allowance for doubtful accounts on accounts receivable is recognized
in general and administrative expenses.
Inventory, consisting of raw materials and finished
goods, are stated at the lower of cost and net realizable value utilizing the first-in, first-out (FIFO) method. A reserve is established
when management determines that certain inventories may not be saleable. If inventory costs exceed expected net realizable value due to
obsolescence or quantities in excess of expected demand, the Company will record reserves for the difference between the cost and the
net realizable value. These reserves are recorded based on estimates and included in cost of sales.
Property and equipment are stated at cost and
are depreciated using the straight-line method over their estimated useful lives, which range from one to seven years. Leasehold improvements
are depreciated over the shorter of the useful life or lease term including scheduled renewal terms. Maintenance and repairs are charged
to expense as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and
any resulting gains or losses are included in income in the year of disposition. The Company examines the possibility of decreases in
the value of these assets when events or changes in circumstances reflect the fact that their recorded value may not be recoverable.
Goodwill represents the future economic benefit
arising from other assets acquired that could not be individually identified and separately recognized. Any goodwill arising from the
Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets
may have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line
basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets are being amortized over
a useful life of 5 years.
Goodwill is not subject to amortization but is
subject to impairment tests at least annually. The Company reviews the carrying amounts of goodwill by reporting unit at least annually,
or when indicators of impairment are present, to determine if goodwill may be impaired. To test goodwill impairment, the Company first
assesses qualitative factors to determine whether it is more likely than not that the fair value of goodwill is less than its carrying
value. The Company would not be required to quantitatively determine the fair value of goodwill unless it determines, based on the qualitative
assessment there are indicators of impairment. Under the quantitative test of goodwill, the Company compares the fair value of the reporting
unit to its carrying value, including goodwill. If the carrying value exceeds the fair value, then the goodwill is impaired by the excess
amount. The Company performs its annual testing for goodwill during the fourth quarter of each fiscal year or more frequently if an event
occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit.
Intangible assets determined to have finite lives
are amortized over their estimated useful lives of 5 years. The useful life of an intangible asset is the period over which the asset
is expected to contribute directly or indirectly to future cash flows. The Company periodically evaluates both finite and indefinite lived
intangible assets for impairment upon occurrence of events or changes in circumstances that indicate the carrying amount of intangible
assets may not be recoverable.
As of December 31, 2023 and 2022, the Company
performed its annual goodwill impairment test for its one reporting unit. The results of the Company’s annual impairment test indicated
that the fair value of the reporting unit exceeded its carrying value. Therefore, no impairment of goodwill or intangibles assets was
recorded as of December 31, 2023 or 2022.
In accordance with ASC Topic 360, the Company
reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may
not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future
cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s
estimated fair value and its book value.
The Company provides limited warranties on its
products for product defects for periods ranging from 12 months to the life of the product. Warranty costs may include the cost of product
replacement, refunds, labor costs and other costs. Allowances for estimated warranty costs are recorded during the period of sale. The
determination of such allowances requires the Company to make estimates of product warranty claim rates and expected costs to repair or
to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each
product line combined with liability estimates based on the prior 12 months’ sales activities. If actual return rates and/or repair
and replacement costs differ significantly from the Company’s estimates, adjustments to recognize additional cost of sales may be
required in future periods. Historically the warranty accrual and the expense amounts have been immaterial. The warranty liability is
included in accrued expenses on the accompanying consolidated balance sheets and amounted to $1,000 and $26,648 on December 31, 2023 and
2022, respectively. During the years ended December 31, 2023 and 2022, warranty costs were de minimis.
The Company follows ASC Topic 606, Revenue
from Contracts with Customers (“ASC 606”). This standard establishes a single comprehensive model for entities to use
in accounting for revenue arising from contracts with customers and supersedes most of the existing revenue recognition guidance. ASC
606 requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the entity expects to be entitled in exchange for those goods or services and requires certain additional disclosures.
The Company sells its products which include standard
warranties primarily to distributors and authorized dealers. Product sales are recognized at a point in time when the product is shipped
to the customer and title is transferred and are recorded net of any discounts or allowances. The warranty does not represent a separate
performance obligation.
Revenues from contracts for the distribution and
installation of window film solutions are recognized over time on the basis of the Company’s estimates of the progress towards completion
of contracts using various output or input methods depending on the type of contract terms including (1) the ratio of number of labor
hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed
method. These methods are used because management considers these to be the best available measure of progress on these contracts. We
use the same method for similar types of contracts. The asset, “contract assets” represents revenues recognized in excess
of amounts billed. The liability, “contract liabilities,” represents billings in excess of revenues recognized.
Cost of sales includes inventory costs, packaging
costs and warranty expenses.
Cost of revenues from fixed-price contracts for
the distribution and installation of window film solutions include all direct material, sub-contractor, labor and certain other direct
costs, as well as those indirect costs related to contract performance, such as indirect labor and fringe benefits. Provisions for estimated
losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions
and estimated profitability may result in revisions to cost and income, which are recognized in the period in which the revisions are
determined. Changes in estimated job profitability resulting from job performance, job conditions, claims, change orders, and settlements,
are accounted for as changes in estimates in the current period.
Shipping and handling costs incurred for product
shipped to customers are included in general and administrative expenses and amounted to $16,288 and $45,455 for the years ended December
31, 2023 and 2022, respectively. Shipping and handling costs charged to customers are included in sales.
Research and development costs incurred in the
development of the Company’s products are expensed as incurred and includes costs such as labor, materials, and other allocated
costs incurred. For the years ended December 31, 2023 and 2022, research and development costs incurred in the development of the Company’s
products were $0.
The Company may participate in various advertising
programs. All costs related to advertising of the Company’s products are expensed in the period incurred. For the years ended December
31, 2023 and 2022, advertising costs charged to operations were $31,743 and $69,737, respectively and are included in general and administrative
expenses on the accompanying consolidated statements of operations. These advertising expenses do not include cooperative advertising
and sales incentives which shall been deducted from sales.
The Company accounts for income tax using the
liability method prescribed by ASC 740, “Income Taxes”. Under this method, deferred tax assets and liabilities are determined
based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in
effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax
assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets
will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes
the enactment date.
The Company follows the accounting guidance for
uncertainty in income taxes using the provisions of ASC 740 “Income Taxes”. Using that guidance, tax positions initially
need to be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the
tax authorities. As of December 31, 2023 and 2022, the Company had no uncertain tax positions that qualify for either recognition or disclosure
in the financial statements. Tax years that remain subject to examination are the years ending on and after December 31, 2018. The Company
recognizes interest and penalties related to uncertain income tax positions in other expense. However, no such interest and penalties
were recorded as of December 31, 2023 and 2022.
Stock-based compensation is accounted for based
on the requirements of ASC 718 – “Compensation –Stock Compensation”, which requires recognition in the
financial statements of the cost of employee, director, and non-employee services received in exchange for an award of equity instruments
over the period the employee, director, or non-employee is required to perform the services in exchange for the award (presumptively,
the vesting period). The ASC also requires measurement of the cost of employee, director, and non-employee services received in exchange
for an award based on the grant-date fair value of the award. The Company has elected to recognize forfeitures as they occur as permitted
under the FASB’s Accounting Standards Update (“ASU”) 2016-09 Improvements to Employee Share-Based Payment.
The Company accounts for leases in accordance
with ASC 842. The lease standard requires certain leases to be reported on the consolidated balance sheets as right-of-use assets and
lease liabilities. The Company elected the practical expedients permitted under the transition guidance of this standard that retained
the lease classification and initial direct costs for any leases that existed prior to adoption of the standard. The Company does not
reassess whether any contracts entered into prior to adoption are leases or contain leases.
The Company categorizes leases with contractual
terms longer than twelve months as either operating or finance. Finance leases are generally those leases that would allow the Company
to substantially utilize or pay for the entire asset over its estimated life. Assets acquired under finance leases are recorded in property
and equipment, net. All other leases are categorized as operating leases. The Company does not have any finance leases as of December
31, 2023 and 2022. The Company’s leases generally have terms that range from three to four years for property and equipment and
five years for property. The Company elected the accounting policy to include both the lease and non-lease components of our agreements
as a single component and account for them as a lease.
Lease liabilities are recognized at the present
value of the fixed lease payments using a discount rate based on the Company’s current borrowing rate. Lease assets are recognized
based on the initial present value of the fixed lease payments, reduced by landlord incentives, plus any direct costs from executing the
leases. Leasehold improvements are capitalized at cost and amortized over the lesser of their expected useful life or the lease term.
When the Company has the option to extend the
lease term, terminate the lease before the contractual expiration date, or purchase the leased asset, and it is reasonably certain that
the Company will exercise the option, the Company considers these options in determining the classification and measurement of the lease.
Costs associated with operating lease assets are recognized on a straight-line basis within operating expenses over the term of the lease.
ASC 260 “Earnings Per Share”, requires
dual presentation of basic and diluted earnings per common share (“EPS”) with a reconciliation of the numerator and denominator
of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilutive securities and
non-vested forfeitable shares. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue
common shares were exercised or converted into common shares or resulted in the issuance of common shares that then shared in the earnings
of the entity. Basic net loss per common share is computed by dividing net loss available to members by the weighted average number of
common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average
number of common shares, common share equivalents and potentially dilutive securities outstanding during each period. Potentially dilutive
common shares consist of stock options and non-vested forfeitable shares (using the treasury stock method) and shares issuable upon conversion
of preferred shares and convertible notes payable (using the as-if converted method). These common share equivalents may be dilutive in
the future.
The following table presents a reconciliation
of basic and diluted net income (loss) per common share:
Year Ended December 31,
2023
2022
Net income (loss) per common share - basic:
Net income (loss) attributable to common shareholders
$
1,841,470
$
(5,178,055
)
Weighted average common shares outstanding – basic
490,113,378
308,121,062
Net income (loss) per common share – basic
$
0.00
$
(0.02
)
Net income (loss) per common share - diluted:
Net income (loss) attributable to common shareholders - basic
$
1,841,470
$
(5,178,055
)
Add: preferred stock dividends
54,195
-
Add: interest of convertible debt
186,536
-
Numerator for income (loss) per common share – diluted
$
2,082,201
$
(5,178,055
)
Weighted average common shares outstanding – basic
490,113,378
308,121,062
Add: dilutive shares related to:
Convertible debt
1,220,101,111
-
Series B preferred
376,239,688
-
Series C preferred
438,151,351
-
Weighted average common shares outstanding – diluted
2,524,605,528
308,121,062
Net income (loss) per common share – diluted
$
0.00
$
(0.02
)
For the year ended December 31, 2022, all potentially
dilutive common shares were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact
on the Company’s net losses. For the year ended December 31, 2023, stock options and warrants were excluded from the computation
of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net income. As of December 31,
2023 and 2022, common share equivalents and potentially dilutive securities consisted of the following:
From January 1, 2022 to May 8, 2023, the Company
operated in two reportable business segments which consisted of (1) the manufacture and sale of a windshield strengthening water repellent
solution as well as disinfection products, and the sale of multi-purpose glass strengthening primer and window film mounting solutions,
including ballistic-resistant film systems and a forced entry system, and (2) the distribution and installation of window film solutions.
The Company’s reportable segments were strategic business units that offered different products and were managed separately based
on the fundamental differences in their operations and locations. On May 8, 2023, the Company sold its C-Bond nanoShield™ product
line and the remaining segment (1) as described above was combined into segment (2) and is now being managed together (see Note 16).
The Company accounts for noncontrolling interest
in accordance with ASC Topic 810-10-45, which requires the Company to present noncontrolling interests as a separate component of total
shareholders’ deficit on the consolidated balance sheets and the consolidated net loss attributable to its noncontrolling interest
be clearly identified and presented on the face of the consolidated statements of operations.
The Company operates in an industry that is subject to intense competition
and changes in consumer and commercial demand. The Company’s operations are subject to significant risk and uncertainties including
financial and operational risks including the potential risk of business failure.
The Company has experienced, and in the future expects to continue
to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the
cyclical nature of the business, (ii) general economic conditions in the various local markets in which the Company competes, including
a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s products and services.
These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.
In August 2020, the FASB issued ASU 2020-06, Debt—Debt
with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for
convertible instruments by removing major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments
will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain
settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity
contracts to qualify for the exception. The ASU also simplifies the diluted net income per share calculation in certain areas. The new
guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and early
adoption is permitted. The Company is currently evaluating the impact of the adoption of the standard on the consolidated financial statements.
In June 2016, the FASB issued ASU No. 2016-13, Financial
Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which significantly changes
how entities will measure credit losses for most financial assets, including accounts receivable. ASU No. 2016-13 will replace today’s
“incurred loss” approach with an “expected loss” model, under which companies will recognize allowances based
on expected rather than incurred losses. On November 15, 2019, the FASB delayed the effective date of Topic 326 for certain small public
companies and other private companies until fiscal years beginning after December 15, 2022 for SEC filers that are eligible to be smaller
reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities. In March 2022, the FASB
issued ASU No. 2022-02, Financial Instruments-Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.
The guidance was issued as improvements to ASU No. 2016-13 described above. The vintage disclosure changes require an entity to disclose
current-period gross write-offs by year of origination for financing receivables. The guidance is effective for financial statements issued
for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. The adoption of ASU No. 2022-02 on
January 1, 2023 did not have a material impact on the Company’s consolidated financial statements.
Other accounting standards that have been issued
or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial
statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated
to its financial condition, results of operations, cash flows or disclosures.
Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.
Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.
Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.
Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.
Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
On April 20, 2022 (the Exchange Agreement date)
along with various re-pricings as outlined below, the fair value of the stock warrants were estimated at issuance using the Binomial Valuation
Model with the following assumptions:
Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.
Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.
Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.
Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.
Information with respect to these reportable business
segments for the years ended December 31, 2023 and 2022 was as follows:
For the Year Ended December 31,
2023
2022
Revenues:
C-Bond
$
124,372
$
378,736
Patriot Glass
2,364,121
1,853,910
2,488,493
2,232,646
Depreciation and amortization:
C-Bond
570
7,109
Patriot Glass
88,289
82,110
88,859
89,219
Interest expense:
C-Bond
357
23
Patriot Glass
34,566
20,212
Other (a)
440,507
1,599,854
475,430
1,620,089
Net income (loss):
C-Bond
(912,436
)
(1,097,069
)
Patriot Glass
(44,289
)
(192,566
)
Other (a)
2,843,532
(3,866,843
)
$
1,886,807
$
(5,156,478
)
(a)
The Company does not allocate any general and administrative or financing expenses of its holding company activities to its reportable segments, because these activities are managed at the corporate level.
Identifiable long-lived tangible assets on December 31, 2023 and 2022 by segment:
C-Bond
$
-
$
1,684
Patriot Glass
171,606
94,622
$
171,606
$
96,306
(a)
The Company does not allocate any general and administrative or financing expenses of its holding company activities to its reportable segments, because these activities are managed at the corporate level.
Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.
Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.
Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.
Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.
The items accounting for the difference between income taxes at the
effective statutory rate and the provision for income taxes for the years ended December 31, 2023 and 2022 were as follows:
2023
2022
Income tax expense (benefit) at U.S. statutory rate
Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.
Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.
Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.
Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
The Company had the right to prepay the November
2022, December 2022 and March 2023 Diagonal Notes (principal and accrued interest) at any time during the first six months the note is
outstanding at the rate of 115% during the first 30 days after issuance, 120% during the 31st to 60th day after
issuance, and 125% during the 61st to the 180th day after issuance. The November 2022, December 2022 and March 2023
Diagonal Notes may not be prepaid after the 180th day following the issuance date, unless Diagonal agrees to such repayment and such terms,
which was agreed to in connection with the May 8, 2023 repayment. Diagonal had in its option, at any time beginning 180 days after the
date of the Diagonal Note, to convert the outstanding principal and interest on the November 2022, December 2022 and March 2023 Diagonal
Notes into shares of our common stock at a conversion price per share equal to 65% of the average of the three lowest closing bid prices
of our common stock during the 10 trading days prior to the date of conversion.
Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.
The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
Amount of outstanding long-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured.
Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.
The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.
The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.
Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.
Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.
Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.
Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.
Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Including the current and noncurrent portions, carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the normal operating cycle if longer.
Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Current portion of the total carrying amount as of the balance sheet date due within one year or the operating cycle, if longer, on all notes payable to banks paid on an installment with long term maturities. This can include the amount of any loans from the applicant firm. This does not, however, include any mortgage balances.
The total amount due within more than 12 month, or the operating cycle if longer, on all notes payable to banks paid on an installment. This can include the amount of any loans from the applicant firm. This does not, however, include any mortgage balances.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.
Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.
The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.
Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
In connection with the September 2022 GS Capital
Note, on September 6, 2022, the Company issued 3,300,000 shares of its common stock as a commitment fee and the Company issued 773,626
shares of its common stock to the placement agent as fee for the capital raises. The aggregate of 4,073,626 shares of common stock issued
were recorded as a debt discount of $30,326 based on the relative fair value method to be amortized over the life of the September 2022
Note (See Note 8).
the Company issued the Lender 22,000,000
shares of common stock of the Company in exchange for settlement of the remaining $200,000 of the loan and all accrued interest amounting
to $317,293, which were deemed paid in full (see Note 8 - BOCO Investment Note). The 22,000,000 shares issued were valued at $132,000,
or $0.006 per share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with
the issuance of these shares, the Company recorded a gain from debt extinguishment of $68,000 calculated as the different in the principal
amount settled for shares of $200,000 and the fair value of the shares on the measurement date of $132,000.
In connection with the July 2022 GS Capital Note,
on July 28, 2022, the Company issued 2,600,000 shares of its common stock as a commitment fee and the Company issued 998,008 shares of
its common stock to the placement agent as a fee for the capital raises. The aggregate of 3,598,008 shares of common stock issued were
recorded as a debt discount of $34,606 based on the relative fair value method to be amortized over the life of the July 2022 Note (See
Note 8).
Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Discount on common shares, or any unamortized balance thereof, shown separately as a deduction from the applicable account(s) as circumstances require.
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.
The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.
The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
Cash Flows between a transferee and a transferor attributable to servicing fees related to a securitization, asset-backed financing arrangement, or similar transfer in which the transferor has continuing involvement with the transferred financial assets underlying the transaction (including, but not limited to, servicing, recourse, and restrictions on transferor's interests in the transferred financial assets).
Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold.
The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.
Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.
The Company does not allocate any general and administrative or financing expenses of its holding company activities to its reportable segments, because these activities are managed at the corporate level.
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Operating Lease Right-of-Use (“ROU”) Assets and Operating Lease Liabilities (Details) - Schedule of Operating Lease Liabilities Related to the ROU Assets - USD ($)
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.
Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.
The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.
The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.
Sum of the carrying values as of the balance sheet date of (a) interest payable on all forms of debt, including trade payables, that has been incurred, and (b) dividends declared but unpaid on equity securities issued by the entity and outstanding (also includes dividends collected on behalf of another owner of securities that are being held by the entity).
The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.
Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.
The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
Unearned discounts (other than cash or quantity discounts and the like), finance charges, and interest included in the face amount of receivables, that are shown as a deduction from the related receivables. For example, 1) finance charges booked as a receivable when a loan is made and recognized as income at a later date; and 2) interest charges deducted from the face loan amount, resulting in a discounted amount actually advanced to the borrower (wherein the receivable includes the amount actually advanced to the borrower and the as yet unearned interest income).
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
Indicates, if estimable, (as a percentage) the approximate extent to which the proceeds from liquidation of any assets held either as collateral or by third parties would be expected to cover the maximum potential amount of future payments under the guarantee or each group of similar guarantees.
Tabular disclosure of significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, losses resulting from fire or flood, losses on receivables, significant realized and unrealized gains and losses that result from changes in quoted market prices of securities, declines in market prices of inventory, changes in authorized or issued debt (SEC), significant foreign exchange rate changes, substantial loans to insiders or affiliates, significant long-term investments, and substantial dividends not in the ordinary course of business.